study on enhancing the endocrine disrupter priority list ... · dhi water & environment...

252
Revised report to DG Environment May 2007 Study on enhancing the Endocrine Disrupter priority list with a focus on low production volume chemicals ENV.D.4/ETU/2005/0028r

Upload: others

Post on 20-Jul-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

Revised report to DG Environment

May 2007

Study on enhancing the Endocrine Disrupter priority list with a focus on low production volume chemicals

ENV.D.4/ETU/2005/0028r

Page 2: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

Study on enhancing the Endocrine Disrupter priority list with a focus on low production volume chemicals ENV.D.4/ETU/2005/0028r

Agern Allé 5

DK-2970 Hørsholm, Denmark

Tel: +45 4516 9200

Fax: +45 4516 9292

e-mail: [email protected]

Web: www.dhigroup.com

Client

DG Environment

Client’s representative

Project

Study on enhancing the Endocrine Disrupter priority list with a focus on low production volume chemicals

Project No.

53559

Date 2007.06.04

Authors

Gitte Petersen Dorte Rasmussen Kim Gustavson

Approved by

Torben Madsen

03

02 Revised report GIP DOR TMA 2007.06.04

01 Final report GIP DOR TMA 2006.12.14

Revision Description By Checked Approved Date

Key words

Endocrine disrupter, priority list, low production volume chemicals

Classification

Open

Internal

Proprietary

Distribution No. of copies

DG Environment DHI: GIP/DOR/KIG/ERA

4

Page 3: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 i

CONTENTS

1 PREFACE .....................................................................................................................1

2 EXECUTIVE SUMMARY...............................................................................................2

3 INTRODUCTION.........................................................................................................15 3.1 Background.................................................................................................................15 3.2 Objectives and scope of the current project.................................................................16 3.3 Study approach ...........................................................................................................18

4 METHODOLOGY........................................................................................................19 4.1 Identification of relevant stakeholders (Task 1)............................................................19 4.2 Identification of new candidate LPVC for further evaluation of their endocrine disrupting

properties (Task 2) ......................................................................................................19 4.3 Collection and evaluation of data/information on LPVC to establish priorities for further

evaluation of their role in endocrine disruption (Task 3)...............................................20 4.3.1 Data search strategy and data collection (Task 3.1) ....................................................20 4.3.2 Evaluation of endocrine potential (Task 3.2)................................................................22 4.3.3 Evaluation of exposure of humans and wildlife (Task 3.3) ...........................................22 4.4 Update of database and list (Task 4)...........................................................................29

5 RESULTS ...................................................................................................................30 5.1 Identification of relevant stakeholders (Task 1)............................................................30 5.2 Identification of new candidate LPVC for further evaluation of their endocrine disrupting

properties (Task 2) ......................................................................................................30 5.3 Collection and evaluation of data/information on LPVC to establish priorities for further

evaluation of their role in endocrine disruption (Task 3)...............................................32 5.3.1 Evaluation of endocrine potential (Task 3.2)................................................................32 5.3.2 Evaluation of exposure of humans and wildlife (Task 3.3) ...........................................76 5.4 Update of database and list (Task 4)...........................................................................93 Appendices A Minutes from the meeting: Kick-off meeting. 17 November 2005 B Minutes from the meeting: Discussion of list of substances. 15 March 2006 C Minutes from the meeting: Discussion of interim report. 29 June 2006 D Minutes from the meeting: Discussion of draft final deliverables, i.e. report, database

and list. 8 December 2006 E List of stakeholders contacted F The questionnaire for identification of new candidate LPVC with potential endocrine

disrupting effects G The request to CEFIC H Request for comments to the draft final deliverables I The revised list of priority substances for evaluation in the present study J References to studies and reports on endocrine disruption incorporated in the database K Manual for the VIEW version of the EDC Database L Updated ranked priority list

Page 4: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 1

1 PREFACE

By letter of 10 November 2005, the European Commission, DG Environment (DG ENV) commissioned DHI Water & Environment (DHI) to conduct a study entitled “Study on enhancing the Endocrine Disrupter priority list with a focus on low produc-tion volume chemicals” (reference: ENV.D.4/ETU/2005/0028r). This study is a follow-up study for the establishment by the Commission of a priority list of substances for fur-ther evaluation of their role in endocrine disruption. Two studies in this area were pre-viously carried out by BKH in 2000 and by RPS BKH in 2002. The present study is thus the last of three evaluations going through the list of candidate substances from the EU candidate list including 553 substances. Project coordinator for the present project for the EC was Katharina Spens (DG ENV) from beginning of the project and until May 2006 and hereafter Reinhild Puergy (DG ENV) took over. The project coordinator for DHI is Gitte I. Petersen. A kick-off meeting with the Commission (DG ENV) on the set-up of the project was held on 15 November 2005. Furthermore, meetings with the Commission were held on 15 March 2006 (evaluation of the list of substances to be evaluated), on 29 June 2006 (interim report meeting) and on 8 December 2006 (discussion of final deliverables). It should be noted that the results of this study (as the results of the two previous stud-ies) will be used as a basis for the consultation process by the Commission. This consul-tation process constitutes the third step in the establishment of a priority list of sub-stances for further in depth evaluation of their role in endocrine disruption, as outlined in the Commission Communication to Council and European Parliament on a Commu-nity Strategy for Endocrine Disrupters COM(2001)262 of June 2001.

Page 5: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 2

2 EXECUTIVE SUMMARY

The present study “Study on enhancing the Endocrine Disrupter priority list with a fo-cus on low production volume chemicals” is a follow-up study for the establishment of a priority list of substances to be used for further in-depth evaluation of their role in en-docrine disruption. Two previous studies in this area were carried out by BKH in 2000 and by RPS BKH in 2002. The present study is thus the latest of three evaluations work-ing up the EU candidate list that included 553 substances in total. For reasons of consis-tency, as the present study is the last of three evaluations of the candidate substances, the methodology for substance evaluation used in the previous RPS-BKH 2002 project was applied. In the present study, the remaining substances (mainly Low Production Volume Chemi-cals (LPVC)) from the candidate list were evaluated. A priority list of substances was prepared. The ranked priority list is based on this evaluation together with the evalua-tions performed in the two previous studies. The compilation of the priority list was based on a screening of available literature and should therefore be regarded as a starting point for further in-depth evaluation of the substances placed on the priority list with highest priority given to substances placed in the Category 1 group (clear evidence for endocrine disrupting effects in an intact organ-ism). The evaluations shall be seen in line with the previous studies and are NOT con-sidered comprehensive risk assessments. In the future in-depth evaluations, a methodol-ogy needs to be developed to make the list iterative, i.e. that a substance can enter or be deleted from the list on the basis of an agreed approach. The subject of this project falls under the short-term priority actions in the current prior-ity of the implementation of the Community Strategy on EDS. The following study approach was applied: • Identification of relevant stakeholders • Identification of new candidate substances • Collection and evaluation of data/information on candidate substances • Evaluation of exposure to humans and wildlife • Update of database and priority list of substances

In the very beginning of the project, 160 stakeholders were identified and invited to go through the candidate list of substances to be evaluated in the project. Stakeholders were invited to forward potential information on the candidate substances as well as asked to identify new substances, if any, to the list. During this task, 22 new candidate sub-stances were identified. During a thorough evaluation of the compiled candidate list (173 substances from the ordinary list + 22 new candidate substances), it was found that, most probably, several substances were no longer in use. It was also found that few of the substances were High Production Volume Chemicals (HPVC) and that the majority of the substances

Page 6: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 3

were neither HPVC nor LPVC. They are existing substances but they are produced or imported in amounts ≤10 tons per year. Based on this information, it was decided that the present study should only include HPVC and LPVC plus existing substances registered in the ECB-ESIS database al-though they were produced or imported in amounts ≤10 tons per year. Based on a close examination of the candidate substances list including the 22 new substances added by the invited stakeholders (195 substances), it turned out that 73 substances could not be found on the ESIS database and no CAS No. were identified for 15 substances. In total, 107 substances remained for the present evaluation. As already outlined, the outcome of the present study shall be consistent with the out-come of the previous studies and end up in a ranked priority list of substances. The categorisation of the substances was performed according to the following evalua-tion criteria:

CAT 1 At least one in-vivo study providing clear evidence for endocrine disruption in an intact organism.

CAT 2 Potential for endocrine disruption. In-vitro data indicating potential for endocrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated.

CAT 3a No scientific basis for inclusion in list (ED studies available but no indications of ED effects)

CAT 3b Substances with no or insufficient data gathered

Several studies were included and evaluated in accordance with screening criteria but only one study was selected as the key study and the categorisation of the substance was thus mainly based on the key study. All evaluated studies are reflected in the database. However, it should be emphasized that the amount of evidence provided by other stud-ies not selected key studies (all of which are included in the database) has influenced the conclusions as to categorisation as well. The choice of catetories was made solely by the consultant, and apart from the clear evaluation criteria for the categories given above, it may thus be regarded as subjective. For all Category 1 substances, monitoring data were searched. However, only a few monitoring data were found and it was thus decided to base the exposure evaluations on EUSES calculations. EUSES is designed to be a decision support system for the evalua-tion of the exposure of chemicals to man and the environment. The overall results and output from the EUSES modelling include among other things: • Release to the environment on local, regional and continental scale • Concentration in water, soil and sediment on local scale (highest concentration) • Concentration in water and sediment local, regional and continental • Concentration in fish for secondary poisoning (fresh water) • Concentration in fish-eating marine top predators • Concentration in earthworms from agricultural soil

Page 7: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 4

Based on an evaluation of the results of the EUSES calculations together with an evaluation of the Use Category (e.g. cosmetics, pesticide etc.), a subjective evaluation of exposure concern (high, medium, low) was performed. E.g., if a substance turned out to be readily biodegradable but used in cosmetics, a relatively high human exposure can be foreseen and the substance was rated as ‘high concern’. It shall be clearly empha-sized that the exposure evaluation is not a risk assessment and that the choice of catego-ries (high, medium, low concern) was made solely by the consultant. A brief overview, the historical evaluation process of the candidate substances and the number of priority substances (CAT 1 substances) is presented in Table 2.1. Table 2.1 Overview of candidate list substances

Selection criteria Number of substances

Number of substances

CAT 1 substances

Original candidate list of substances with ED effects

565 565

Excluded at the ED expert meeting of 1999 12 Candidate list of substances with ED effects, 2000

553 553

HPV already restricted or banned (109) + WRc evaluation (9)

118 66

Remaining substances 435 435 HPV and/or persistent and/or high exposure (evaluation by RPS BKH 2002)

204 94

Group names (not to be evaluated) 13 Mixtures or polymers (not to be evaluated) 41 Substances twice in list (not to be evaluated) 4 Remaining substances on the candidate list to be evaluated in the DHI 2006 project

173 173

New substances identified by stakeholders 22 Total number of substances to be evaluated in the DHI 2006 project

195 195

Not in ESIS database (excluded from the evalua-tion)

73

No CAS No (excluded from the evaluation) 15 Final number of substances evaluated in the DHI 2006 project

107 107 34

Total number of priority substances (Category 1)

194

A brief overview (CAS No, substance name, Use Category; exposure evaluation and le-gal status) of CAT 1 substances identified in the present study is given in Table 2.2.

Page 8: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

5

Tab

le 2

.2

Brie

f ove

rvie

w o

f eva

luat

ed s

ubst

ance

s w

hich

hav

e sh

owed

evi

denc

e of

end

ocrin

e di

srup

ting

effe

cts

in a

n in

tact

org

anis

m (

CA

T 1

su

bsta

nces

)

CA

SN

R

NA

ME

C

oncl

usio

n 10

043-

35-3

B

oric

aci

d B

ori

c ac

id is

use

d in

con

sum

er p

rodu

cts

as e

.g. c

osm

etic

s an

d is

acc

ordi

ng to

the

ES

IS d

atab

ase

a H

PV

sub

stan

ce.

For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0000

tone

s pe

r ye

ar h

as b

een

used

. Bor

ic a

cid

is n

ot b

ioac

cu-

mul

ativ

e an

d is

rea

dily

bio

degr

adab

le in

the

envi

ronm

ent.

EU

SE

S c

alcu

latio

ns fo

r se

cond

ary

pois

onin

g sh

ows

that

th

e su

bsta

nce

is n

ot a

ccum

ulat

ed in

sig

nific

ant a

mou

nts

in fi

sh a

nd to

p pr

edat

ors.

A r

elat

ivel

y hi

gh h

uman

exp

osur

e is

how

ever

exp

ecte

d du

e to

the

defin

ed u

se o

f the

sub

stan

ce. B

ased

on

thes

e ev

alua

tions

Bor

ic a

cid

is c

onsi

dere

d as

bei

ng o

f Med

ium

Co

nce

rn. P

rese

ntly

no

EU

cla

ssifi

catio

n is

app

lied

to B

oric

aci

d. A

ris

k as

sess

men

t on

Bor

ic

acid

is a

t the

mom

ent b

eing

per

form

ed b

y A

ustr

ia. P

ropo

sed

clas

sific

atio

n: R

62; R

63

104-

40-5

4-

Non

ylph

enol

(4-

NP

) N

on

ylp

hen

ol (

NP

) is

wid

ely

used

as

a co

mpo

nent

of d

eter

gent

s, p

aint

s, p

estic

ides

, and

man

y ot

her

form

ulat

ed

prod

ucts

. 4-N

onyl

phen

ol is

pro

duce

d is

low

am

ount

and

is a

ccor

ding

to th

e E

SIS

dat

abas

e ne

ither

a H

PV

or

LPV

su

bsta

nce.

4-N

onyl

phen

ol is

not

rea

dily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oacc

umul

ate

(log

Kow

=5.

76).

4-

Non

ylph

enol

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sedi

men

ts a

nd a

gric

ultu

ral s

oils

. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g 4-

Non

ylph

enol

is e

xpec

ted

to b

e fo

und

both

in fi

sh a

nd to

p pr

edat

ors

in c

once

ntra

tions

up

to 1

000

mg/

kg w

et w

eigh

t. Lo

cal d

aily

hum

an in

take

is e

stim

ated

to b

e up

to 2

50

mg/

kg b

ody

wei

ght p

er d

ay. D

ue to

an

expe

cted

clo

se h

uman

con

tact

to 4

-Non

ylph

enol

via

det

erge

nts

and

pain

ts, 4

-N

onyl

phen

ol is

con

side

red

as b

eing

of H

igh

Co

nce

rn. I

n th

e E

U th

ere

is a

res

tric

tion

on th

e us

e of

non

ylph

enol

and

its

eth

oxyl

ates

(A

nnex

I of

Dire

ctiv

e 76

/769

/EE

C)

limiti

ng th

e in

clus

ion

of th

ese

subs

tanc

es in

a v

arie

ty o

f pro

duct

s to

no

mor

e th

an 0

.1%

. Pro

pose

d cl

assi

ficat

ion:

Rep

.3;R

62 R

ep.3

;R63

Xn;

R22

C;R

34 N

;R50

/53

1113

-02-

6 O

met

hoat

e O

met

ho

ate

is u

sed

as a

pes

ticid

e. O

met

hoat

e is

acc

ordi

ng to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S

calc

ulat

ions

a p

rodu

ctio

n vo

lum

e of

500

tone

s pe

r ye

ar h

as b

een

used

. Om

etho

ate

is n

ot r

eadi

ly b

iode

grad

able

, but

ha

s a

low

pot

entia

l to

bioa

ccum

ulat

e (lo

g K

ow=

-0.7

5).

Bas

ed o

n E

US

ES

est

imat

ions

Om

etho

ate

expe

cted

to b

e fo

und

in lo

cal s

urfa

ce w

ater

in c

once

ntra

tions

up

to 4

mg/

L. A

s O

met

hoat

e is

not

pot

entia

l bio

accu

mul

ativ

e th

e su

b-st

ance

is n

ot e

xpec

ted

to g

ive

any

prob

lem

s in

rel

atio

n to

sec

onda

ry p

oiso

ning

. Om

etho

ate

is c

onsi

dere

d as

bei

ng o

f L

ow

Co

nce

rn. C

over

ed b

y C

ounc

il D

irect

ive

91/4

14/E

EC

. No

RA

R h

as b

een

prov

ided

and

the

subs

tanc

e is

not

in-

clud

ed in

the

list f

or p

estic

ides

to b

e re

view

ed. C

lass

ifica

tion:

XN

;R21

T;R

25 N

;R50

11

31-6

0-8

4-C

yclo

hexy

lphe

nol

4-C

yclo

hex

ylp

hen

ol i

s us

ed in

the

form

atio

n of

res

in. R

esin

is w

idel

y us

ed p

rodu

ct. 4

-Cyc

lohe

xylp

heno

l is

acco

rdin

g to

the

ES

IS d

atab

ase

prod

uced

in lo

w a

mou

nt a

nd is

nei

ther

a H

PV

or

LPV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a

prod

uctio

n vo

lum

e of

10

tone

s pe

r ye

ar h

as b

een

used

. 4-C

yclo

hexy

lphe

nol i

s no

t rea

dily

bio

degr

adab

le a

nd h

as a

hi

gh p

oten

tial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

4.22

). 4

-Cyc

lohe

xylp

heno

l is

in th

e en

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

er a

s w

ell a

s se

dim

ents

and

agr

icul

tura

l soi

ls. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g 4-

Cyc

lohe

xylp

heno

l is

expe

cted

to b

e fo

und

in fi

sh a

nd to

p pr

edat

ors

in m

inor

am

ount

. A m

ediu

m h

uman

ex

posu

re is

exp

ecte

d. 4

-Cyc

lohe

xylp

heno

l is

cons

ider

ed a

s be

ing

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d, h

owev

er th

e su

bsta

nce

is r

elat

ed to

non

ylph

enol

.

Page 9: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

6

CA

SN

R

NA

ME

C

oncl

usio

n 12

0-47

-8

eth

yl 4

-hy

drox

yben

zoat

e E

thyl

4-h

ydro

xyb

enzo

ate

is u

sed

as p

rese

rvat

ives

in fo

od, p

harm

aceu

tical

and

cos

met

ic fo

rmul

atio

ns. E

thyl

4-

hydr

oxyb

enzo

ate

is p

rodu

ced

in a

mou

nts

up to

50

tone

s pe

r ye

ar a

nd th

us a

LP

V s

ubst

ance

. Eth

yl 4

-hy

drox

yben

zoat

e is

rea

dily

bio

degr

adab

le a

nd h

as a

med

ium

pot

entia

l for

bio

accu

mul

atio

n. B

ased

EU

SE

S c

alcu

la-

tions

Eth

yl 4

-hyd

roxy

benz

oate

is e

xpec

ted

to b

e re

leas

ed to

the

envi

ronm

ent i

n in

sign

ifica

nt a

mou

nts

and

is n

ot e

x-pe

cted

to g

ive

any

prob

lem

s in

rel

atio

n to

sec

onda

ry p

oiso

ning

. How

ever

, as

ethy

l 4-h

ydro

xybe

nzoa

te a

s a

pres

erva

-tiv

e in

food

and

cos

met

ics

a hi

gh h

uman

exp

osur

e is

exp

ecte

d. E

thyl

4-h

ydro

xybe

nzoa

te is

thus

con

side

red

as b

eing

of

Med

ium

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

13

1-18

-0

Di-n

-pen

tylp

htha

late

(D

PP

) =

D

ipen

tylp

htha

late

Con

sum

er a

nd in

dust

rial a

pplic

atio

ns fo

r ph

thal

ates

are

num

erou

s an

d ra

nge

from

mak

ing

nail

polis

h fle

xibl

e an

d sc

rew

driv

er h

andl

es le

ss b

rittle

to h

elpi

ng m

ake

the

time-

rele

ase

coat

ings

on

num

erou

s ph

arm

aceu

tical

pro

duct

s.

Dip

enty

lph

thal

ate

is a

ccor

ding

to th

e E

SIS

dat

abas

e a

LPV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

50

tone

s pe

r ye

ar h

as b

een

used

. Dip

enty

lpht

hala

te is

inhe

rent

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bioa

ccum

ulat

e (lo

g K

ow=

5.62

). B

ased

on

EU

SE

S c

alcu

latio

ns d

ipen

tylp

htha

late

is n

ot e

xpec

ted

to b

e fo

und

in s

ig-

nific

ant a

mou

nts

in th

e en

viro

nmen

t (su

rfac

e w

ater

s an

d se

dim

ents

). H

owev

er a

s D

ipen

tylp

htha

late

is o

f med

ium

co

ncer

n in

rel

atio

n to

sec

onda

ry p

oiso

ning

. Dip

enty

lpht

hala

te is

thus

con

side

red

as b

eing

of M

ediu

m C

on

cern

. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

13

1-55

-5

Ben

zoph

enon

e-2

(Bp-

2), 2

,2',4

,4'-

tetr

ahyd

roxy

benz

o-ph

enon

e

Ben

zop

hen

on

e-2

(Bp

-2),

2,2

',4,4

'-tet

rah

ydro

xyb

enzo

ph

eno

ne

is u

sed

as a

UV

sun

scre

en in

cos

met

ics.

Ben

zo-

phen

one-

2 (B

p-2)

, 2,2

',4,4

'-tet

rahy

drox

yben

zoph

enon

e is

acc

ordi

ng to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0 to

nes

per

year

has

bee

n us

ed. B

enzo

phen

one-

2 (B

p-2)

, 2,2

',4,4

'-te

trah

ydro

xybe

nzop

heno

ne is

not

rea

dily

bio

degr

adab

le a

nd h

as a

med

ium

pot

entia

l to

bioa

ccum

ulat

e. B

enzo

phe-

none

-2 (

Bp-

2), 2

,2',4

,4'-t

etra

hydr

oxyb

enzo

phen

one

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sed

imen

ts a

nd a

gric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

Ben

zoph

enon

e-2

(Bp-

2),

2,2'

,4,4

'-tet

rahy

drox

yben

zoph

enon

e is

not

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s. A

hig

h hu

man

exp

osur

e is

ex

pect

ed m

ainl

y du

e to

the

fact

that

the

subs

tanc

e is

use

d as

a U

V s

cree

n in

cos

met

ics.

Ben

zoph

enon

e-2

(Bp-

2),

2,2'

,4,4

'-tet

rahy

drox

yben

zoph

enon

e is

ther

efor

e co

nsid

ered

as

bein

g of

Hig

h C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d.

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

-no

n =

Res

benz

ophe

-no

ne

2,4-

Dih

ydro

xyb

enzo

ph

eno

n is

use

d as

a U

V s

unsc

reen

in c

osm

etic

s. 2

,4-D

ihyd

roxy

benz

ophe

non

is a

ccor

ding

to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0 to

nes

per

year

has

be

en u

sed.

2,4

-Dih

ydro

xybe

nzop

heno

n is

not

rea

dily

bio

degr

adab

le a

nd h

as a

pot

entia

l to

bioa

ccum

ulat

e in

the

envi

-ro

nmen

t (lo

g ko

w=

2.96

). 2

,4-D

ihyd

roxy

benz

ophe

non

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sed

imen

ts a

nd a

gric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

2,4-

Dih

ydro

xybe

nzop

heno

n is

not

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s. A

hig

h hu

man

exp

osur

e is

exp

ecte

d m

ainl

y du

e to

the

fact

that

the

subs

tanc

e is

use

d as

a U

V s

cree

n in

cos

met

ics.

2,4

-Dih

ydro

xybe

nzop

heno

n is

ther

e-fo

re c

onsi

dere

d as

bei

ng o

f Hig

h C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d.

Page 10: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

7

CA

SN

R

NA

ME

C

oncl

usio

n 13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Con

sum

er a

nd in

dust

rial a

pplic

atio

ns fo

r ph

thal

ates

are

num

erou

s an

d ra

nge

from

mak

ing

nail

polis

h fle

xibl

e an

d sc

rew

driv

er h

andl

es le

ss b

rittle

to h

elpi

ng m

ake

the

time-

rele

ase

coat

ings

on

num

erou

s ph

arm

aceu

tical

pro

duct

s.

Mo

no

-n-b

uty

lph

thal

ate

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd th

us n

ot a

LP

V

subs

tanc

e. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

10

tone

s pe

r ye

ar h

as b

een

used

. Mon

o-n-

buty

lpht

hala

te is

rea

dily

bio

degr

adab

le a

nd h

as a

med

ium

pot

entia

l to

bioa

ccum

ulat

e (lo

g K

ow=

2.84

). B

ased

on

EU

SE

S c

alcu

latio

ns M

ono-

n-bu

tylp

htha

late

is n

ot e

xpec

ted

to b

e fo

und

in s

igni

fican

t am

ount

s in

the

envi

ronm

ent

(sur

face

wat

ers

and

sedi

men

ts)

and

is n

ot e

xpec

ted

to g

ive

any

prob

lem

s in

rel

atio

n to

sec

onda

ry p

oiso

ning

and

hu-

man

inta

ke. M

ono-

n-bu

tylp

htha

late

is c

onsi

dere

d as

bei

ng o

f Lo

w C

on

cern

. Non

e sp

ecifi

cally

reu

lato

ry o

r le

gal

stat

us fo

r th

is s

ubst

ance

was

foun

d. T

he r

elat

ed s

ubst

ance

Dib

utyl

phth

alat

is o

n th

e lis

t of d

ange

rous

sub

stan

ces

(Ann

ex I

to D

irect

ive

67/5

48/E

EC

) 13

593-

03-8

Q

uina

lpho

s =

Chi

-na

lpho

s Q

uin

alp

ho

s is

use

d as

a in

sect

icid

e. Q

uina

lpho

s is

acc

ordi

ng t

o th

e E

SIS

dat

abas

e a

LPV

sub

stan

ce. Q

uina

lpho

s is

no

t rea

dily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oacc

umul

ate

(log

Kow

=4.

44).

Bas

ed o

n E

US

ES

est

imat

ions

Q

uina

lpho

s ex

pect

ed to

be

foun

d in

loca

l sur

face

wat

er in

con

cent

ratio

ns u

p to

2 m

g/L.

Due

to th

e pe

rsis

tenc

y of

the

subs

tanc

e an

d th

e hi

gh p

oten

tial b

ioac

cum

ulat

ion

Qui

nalp

hos

is o

f med

ium

con

cern

in r

elat

ion

to s

econ

dary

poi

son-

ing

and

daily

hum

an in

take

. Qui

nalp

hos

is c

onsi

dere

d as

bei

ng o

f Med

ium

Co

nce

rn. Q

uina

lpho

s is

cov

ered

by

Cou

ncil

Dire

ctiv

e 91

/414

/EE

C. N

o R

AR

has

bee

n pr

ovid

ed a

nd th

e su

bsta

nce

is n

ot in

clud

ed in

the

list f

or p

estic

ides

to

be

revi

ewed

. Cla

ssifi

catio

n: X

N;R

21 T

;R25

N;R

50/5

3 15

087-

24-8

3-

Ben

zylid

ene

cam

-ph

or (

3-B

C)

3-B

enzy

liden

e ca

mp

ho

r is

use

d as

a U

V s

unsc

reen

in c

osm

etic

s. 3

-Ben

zylid

ene

cam

phor

is a

ccor

ding

to th

e E

SIS

da

taba

se a

LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0 to

nes

per

year

has

bee

n us

ed. 3

-B

enzy

liden

e ca

mph

or is

not

rea

dily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

4.67

). 3

-Ben

zylid

ene

cam

phor

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sedi

men

ts

and

agric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

3-B

enzy

liden

e ca

mph

or is

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s in

min

or a

mou

nt. A

hig

h hu

man

exp

osur

e is

exp

ecte

d m

ainl

y du

e to

the

fact

that

th

e su

bsta

nce

is u

sed

as a

UV

scr

een

in c

osm

etic

s. 2

,4-3

-Ben

zylid

ene

cam

phor

is th

eref

ore

cons

ider

ed a

s be

ing

of

Hig

h C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d.

Page 11: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

8

CA

SN

R

NA

ME

C

oncl

usio

n 15

82-0

9-8

Trif

lura

lin

Tri

flu

ralin

is u

sed

as a

pes

ticid

e an

d is

acc

ordi

ng to

the

ES

IS d

atab

ase

a H

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

-tio

ns a

pro

duct

ion

volu

me

of 1

0000

tone

s pe

r ye

ar h

as b

een

used

. Trif

lura

lin is

not

rea

dily

bio

degr

adab

le a

nd h

as a

hi

gh p

oten

tial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

5.34

). T

riflu

ralin

is in

the

env

ironm

ent m

ainl

y di

strib

uted

to

sur

face

wat

er a

s w

ell a

s se

dim

ents

and

agr

icul

tura

l soi

ls. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g 2,

4- T

riflu

ralin

is e

xpec

ted

to b

e fo

und

in fi

sh a

nd to

p pr

edat

ors

in e

xtre

mel

y hi

gh a

mou

nts.

A h

igh

hum

an e

xpos

ure

up to

70

mg/

kg/d

ay is

exp

ecte

d. T

riflu

ralin

is in

the

pres

ent e

valu

atio

n co

nsid

ered

as

bein

g of

Hig

h C

on

cern

. Trif

lu-

ralin

is c

over

ed b

y C

ounc

il D

irect

ive

91/4

14/E

EC

. No

RA

R h

as b

een

prov

ided

and

the

subs

tanc

e is

not

incl

uded

in

the

list f

or p

estic

ides

to b

e re

view

ed. C

lass

ifica

tion:

XI;R

36 R

43 N

;R50

/53.

Fin

alis

ed a

sses

smen

ts r

evie

w b

y E

FS

A.

Agr

eem

ent t

hat t

here

is o

nly

limite

d ev

iden

ce fo

r en

docr

ine

effe

cts

and

that

this

was

rec

orde

d at

hig

h do

se le

vels

an

d w

as h

ard

to d

istin

guis

h fr

om s

yste

mic

toxi

city

. 16

34-0

4-4

met

hyl t

ertia

ry b

utyl

et

her

(MT

BE

) M

eth

yl t

erti

ary

bu

tyl e

ther

is u

sed

as a

pet

rol a

dditi

ve a

nd is

acc

ordi

ng to

the

ES

IS d

atab

ase

a H

PV

sub

stan

ce. F

or

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0000

tone

s pe

r ye

ar h

as b

een

used

. Met

hyl t

ertia

ry b

utyl

eth

er is

no

t rea

dily

bio

degr

adab

le a

nd h

as a

low

pot

entia

l to

bioa

ccum

ulat

e in

the

envi

ronm

ent (

log

kow

=1.

06).

Met

hyl t

erti-

ary

buty

l eth

er is

in th

e en

viro

nmen

t mai

nly

dist

ribut

ed t

o su

rfac

e w

ater

s. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

con-

dary

poi

soni

ng 2

,4-

Met

hyl t

ertia

ry b

utyl

eth

er is

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s in

min

or a

mou

nt. A

re

lativ

ely

low

dai

ly h

uman

inta

ke is

exp

ecte

d. D

ue to

the

fact

that

Met

hyl t

ertia

ry b

utyl

eth

er is

a h

igh

volu

me

sub-

stan

ce a

nd n

ot r

eadi

ly b

iode

grad

able

rel

ativ

ely

high

con

cent

ratio

ns in

sur

face

wat

ers

can

be e

xpec

ted

and

Met

hyl

tert

iary

but

yl e

ther

is th

us c

onsi

dere

d as

bei

ng o

f Med

ium

Co

nce

rn. R

AR

from

200

2 is

ava

ilabl

e on

ES

IS. C

lass

ifica

-tio

n: F

;R11

XI;R

38

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le

(BH

A)

Ter

t.-B

uty

lhyd

roxy

anis

ole

(B

HA

) is

use

d as

an

antio

xida

nt to

pre

serv

e an

d st

abili

ze th

e fr

eshn

ess

of fo

od a

nd fe

ed

and

is a

ccor

ding

to th

e E

SIS

dat

abas

e a

LPV

sub

stan

ce. B

HA

is n

ot r

eadi

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bio

accu

mul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

3.29

). B

HA

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g B

HA

is n

ot e

xpec

ted

to b

e of

sig

nific

ant c

once

rn. A

rel

ativ

ely

low

dai

ly h

uman

inta

ke is

exp

ecte

d. H

owev

er, a

s B

HA

is a

dded

dire

ctly

to fo

od it

ems

to p

rese

rve

and

stab

ilize

the

fres

hnes

s of

food

and

feed

a d

irect

hum

an e

xpos

ure

is o

bvio

us. B

HA

is th

us c

onsi

dere

d as

bei

ng o

f Hig

h C

on

cern

. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

Page 12: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

9

CA

SN

R

NA

ME

C

oncl

usio

n 27

193-

28-8

P

heno

l, (1

,1,3

,3-

tetr

amet

hylb

utyl

)- =

O

ctyl

phen

ol

Oct

ylp

hen

ol i

s us

ed a

s a

prec

urso

r to

pro

duce

sur

fact

ants

(et

hoxy

late

s) a

nd in

pla

stic

pro

duct

s. O

ctyl

phen

ol is

ac-

cord

ing

to th

e E

SIS

dat

abas

e no

t a L

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

10

tone

s pe

r ye

ar h

as b

een

used

. Oct

ylph

enol

is n

ot r

eadi

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bioa

ccum

ulat

e in

the

envi

-ro

nmen

t (lo

g ko

w=

5.5)

. Oct

ylph

enol

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sedi

men

ts

and

agric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

Oct

ylph

enol

is e

xpec

ted

to b

e of

me-

dium

con

cern

. A h

igh

loca

l dai

ly h

uman

inta

ke is

exp

ecte

d (u

p to

app

rox.

170

mg/

kg/d

ay).

Oct

ylph

enol

is c

onsi

dere

d as

bei

ng o

f Hig

h C

on

cern

. The

PB

T p

rope

rtie

s ha

ve b

een

asse

ssed

by

the

EU

and

it w

as c

oncl

uded

that

Oct

ylph

e-no

l doe

s no

t ful

fil th

e P

BT

crit

eria

. T

he d

atab

ase

for

p-te

rt.-

octy

lphe

nol i

s ve

ry c

ompr

ehen

sive

, inc

ludi

ng a

hig

h qu

al-

ity m

ulti-

gene

ratio

n st

udy.

The

EU

CM

R g

roup

rec

ently

dec

ided

that

Oct

ylph

enol

sho

uld

not b

e cl

assi

fied

for

repr

o-to

xic

effe

cts.

33

204-

76-1

2,

6-ci

s-D

iphe

nylh

exam

ethy

l-cy

clot

etra

silo

xane

-

2,6-

cis-

[(P

hMe-

SiO

)2(M

e2S

iO)2

][

Dip

hen

ylh

exam

eth

ylcy

clo

tetr

asilo

xan

e is

use

d fo

r va

rious

pur

pose

s as

e.g

. bre

ast i

mpl

ants

and

bea

ring

grea

se.

Dip

heny

lhex

amet

hylc

yclo

tetr

asilo

xane

is a

ccor

ding

to th

e E

SIS

dat

abas

e no

t a L

PV

sub

stan

ce. F

or th

e E

US

ES

cal

-cu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. D

iphe

nylh

exam

ethy

lcyc

lote

tras

iloxa

ne is

not

re

adily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

7.52

). D

iphe

nylh

exa-

met

hylc

yclo

tetr

asilo

xane

is in

the

envi

ronm

ent d

istr

ibut

ed to

sur

face

wat

er a

s w

ell a

s se

dim

ents

and

agr

icul

tura

l so

ils. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g D

iphe

nylh

exam

eth

ylcy

clot

etra

silo

xane

is e

xpec

ted

to b

e of

med

ium

con

cern

. A h

igh

loca

l dai

ly h

uman

inta

ke is

exp

ecte

d (u

p to

app

rox.

275

mg/

kg/d

ay).

Dip

heny

lhex

ame-

thyl

cycl

otet

rasi

loxa

ne is

con

side

red

as b

eing

of H

igh

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

su

bsta

nce

was

foun

d.

3686

1-47

-9

3-(4

-M

ethy

lben

-zy

liden

e)ca

mph

or

3-(4

-Met

hyl

ben

zylid

ene)

cam

ph

or

is u

sed

as a

UV

sun

scre

en in

cos

met

ics.

3-(

4-M

ethy

lben

zylid

ene)

cam

phor

is a

c-co

rdin

g to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0 to

nes

per

year

has

bee

n us

ed. 3

-(4-

Met

hylb

enzy

liden

e)ca

mph

or is

not

rea

dily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oac-

cum

ulat

e in

the

envi

ronm

ent (

log

kow

=5.

22).

3-(

4-M

ethy

lben

zylid

ene)

cam

phor

is in

the

envi

ronm

ent m

ainl

y di

strib

-ut

ed to

sur

face

wat

er a

s w

ell a

s se

dim

ents

and

agr

icul

tura

l soi

ls. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

poi-

soni

ng 3

-(4-

Met

hylb

enzy

liden

e)ca

mph

or is

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s in

am

ount

s up

to a

ppro

x.

2000

mg/

kg w

w. A

hig

h hu

man

exp

osur

e is

exp

ecte

d m

ainl

y du

e to

the

fact

that

the

sub

stan

ce is

use

d as

a U

V

scre

en in

cos

met

ics.

3-(

4-M

ethy

lben

zylid

ene)

cam

phor

is th

eref

ore

cons

ider

ed a

s be

ing

of H

igh

Co

nce

rn. N

one

spe-

cific

ally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d.

Page 13: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

10

CA

SN

R

NA

ME

C

oncl

usio

n 43

76-2

0-9

Mon

o 2

eth

yl h

exyl

-ph

thal

ate

(ME

HP

) M

on

o 2

eth

yl h

exyl

ph

thal

ate

(ME

HP

) is

the

maj

or D

EH

P m

etab

olite

. ME

HP

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

o-du

ced

in a

mou

nts

< 1

0 to

nes/

year

and

thus

not

a L

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

10

tone

s pe

r ye

ar h

as b

een

used

. ME

HP

is n

ot r

eadi

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bioa

ccum

ulat

e (lo

g K

ow=

4.73

). M

EH

P is

in th

e en

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

er a

s w

ell a

s se

dim

ents

and

agr

icul

-tu

ral s

oils

. Bas

ed o

n E

US

ES

cal

cula

tions

ME

HP

is e

xpec

ted

to g

ive

min

or p

robl

ems

in r

elat

ion

to s

econ

dary

poi

son-

ing

and

hum

an in

take

. Due

to th

e pe

rsis

tenc

y an

d hi

gh b

ioac

cum

ulat

ion

pote

ntia

l Mon

o-n-

buty

lpht

hala

te is

con

sid-

ered

as

bein

g of

Med

ium

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

50

-18-

0 C

yclo

phos

pham

ide

Cyc

lop

ho

sph

amid

e is

use

d as

a in

sect

icid

e as

wel

l as

in c

hem

othe

rap

y. C

yclo

phos

pham

ide

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd th

us n

ot a

LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pr

oduc

tion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. C

yclo

phos

pham

ide

is n

ot r

eadi

ly b

iode

grad

able

and

has

a

low

pot

entia

l to

bioa

ccum

ulat

e (lo

g K

ow=

0.63

). B

ased

on

EU

SE

S e

stim

atio

ns C

yclo

phos

pham

ide

is e

xpec

ted

to b

e fo

und

in lo

cal s

urfa

ce w

ater

in c

once

ntra

tions

up

to a

ppro

x. 1

mg/

L. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

poi-

soni

ng a

nd h

uman

inta

ke C

yclo

phos

pham

ide

is e

xpec

ted

to b

e fo

und

in fi

sh, p

reda

tors

and

hum

an fo

od in

min

or

amou

nts.

Chl

ordi

mef

orm

is c

onsi

dere

d as

bei

ng o

f Lo

w C

on

cern

. The

sub

stan

ce is

cov

ered

by

Cou

ncil

Dire

ctiv

e 91

/414

/EE

C. N

o R

AR

has

bee

n pr

ovid

ed a

nd th

e su

bsta

nce

is n

ot in

clud

ed in

the

list f

or p

estic

ides

to b

e re

view

ed.

5466

-77-

3 2-

ethy

l-hex

yl-4

-m

etho

xyci

nnam

ate

2-et

hyl

-hex

yl-4

-met

ho

xyci

nn

amat

e is

use

d as

a U

V s

unsc

reen

in c

osm

etic

s. 2

-eth

yl-h

exyl

-4-m

etho

xyci

nnam

ate

is

acco

rdin

g to

the

ES

IS d

atab

ase

a H

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

500

0 to

nes

per

year

has

bee

n us

ed. 2

-eth

yl-h

exyl

-4-m

etho

xyci

nnam

ate

is r

eadi

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bio-

accu

mul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

5.8)

. 2-e

thyl

-hex

yl-4

-met

hoxy

cinn

amat

e is

in th

e en

viro

nmen

t mai

nly

dis-

trib

uted

to s

urfa

ce w

ater

as

wel

l as

sedi

men

ts a

nd a

gric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

2-et

hyl

-hex

yl-4

-met

hoxy

cinn

amat

e is

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s in

am

ount

s up

to

appr

ox. 7

0000

mg/

kg w

w. F

urth

erm

ore

a hi

gh r

egio

nal h

uman

exp

osur

e is

exp

ecte

d. B

esid

es a

hig

h hu

man

exp

o-su

re is

exp

ecte

d m

ainl

y du

e to

the

fact

that

the

subs

tanc

e is

use

d as

a U

V s

cree

n in

cos

met

ics.

2-e

thyl

-hex

yl-4

-m

etho

xyci

nnam

ate

is th

eref

ore

cons

ider

ed a

s be

ing

of H

igh

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

55

6-67

-2

Cyc

lote

tras

iloxa

ne

Cyc

lote

tras

iloxa

ne

has

num

erou

s in

dust

rial a

nd c

onsu

mer

app

licat

ions

and

is a

ccor

ding

to th

e E

SIS

dat

abas

e a

HP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 5

0000

tone

s pe

r ye

ar h

as b

een

used

. Cyc

lote

t-ra

silo

xane

is n

ot r

eadi

ly b

iode

grad

able

and

has

a h

igh

pote

ntia

l to

bioa

ccum

ulat

e in

the

envi

ronm

ent (

log

kow

=5.

45).

C

yclo

tetr

asilo

xane

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

. Bas

ed o

n E

US

ES

est

imat

ions

for

sec-

onda

ry p

oiso

ning

Cyc

lote

tras

iloxa

ne is

exp

ecte

d to

be

foun

d in

fish

and

top

pred

ator

s in

min

or a

mou

nts.

Cyc

lote

tras

i-lo

xane

has

a p

oten

tial f

or h

uman

exp

osur

e as

it is

use

d in

num

erou

s in

dust

rial a

nd c

onsu

mer

. App

licat

ions

. C

yclo

tet-

rasi

loxa

ne is

con

side

red

as b

eing

of H

igh

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce

was

foun

d. C

lass

ifica

tion:

R

EP

3;R

62 R

53

Page 14: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

11

CA

SN

R

NA

ME

C

oncl

usio

n 61

1-99

-4

4,4'

-D

ihyd

roxy

benz

ophe

-no

n

4,4'

-Dih

ydro

xyb

enzo

ph

eno

n is

use

d as

a U

V s

unsc

reen

in c

osm

etic

s. 4

,4'-D

ihyd

roxy

benz

ophe

non

is a

ccor

ding

to

the

ES

IS d

atab

ase

prod

uced

in a

mou

nts

< 1

0 to

nes/

year

and

thus

not

a L

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a

prod

uctio

n vo

lum

e of

10

tone

s pe

r ye

ar h

as b

een

used

. 4,4

'-Dih

ydro

xybe

nzop

heno

n is

not

rea

dily

bio

degr

adab

le

and

has

a m

ediu

m p

oten

tial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

2.19

). 4

,4'-D

ihyd

roxy

benz

ophe

non

is in

th

e en

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

er. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g 4,

4-D

ihyd

roxy

benz

ophe

non

is e

xpec

ted

to b

e fo

und

in fi

sh a

nd to

p pr

edat

ors

in m

inor

am

ount

s. A

hig

h hu

man

exp

osur

e is

exp

ecte

d m

ainl

y du

e to

the

fact

that

the

subs

tanc

e is

use

d as

a U

V s

cree

n in

cos

met

ics.

4,4

-D

ihyd

roxy

benz

ophe

non

is th

eref

ore

cons

ider

ed a

s be

ing

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal

stat

us fo

r th

is s

ubst

ance

was

foun

d.

6164

-98-

3 C

hlor

dim

efor

m

Ch

lord

imef

orm

is u

sed

as a

inse

ctic

ide.

Chl

ordi

mef

orm

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd th

us n

ot a

LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

ha

s be

en u

sed.

Chl

ordi

mef

orm

is n

ot r

eadi

ly b

iode

grad

able

and

has

a m

ediu

m p

oten

tial t

o bi

oacc

umul

ate

(log

Kow

=2.

89).

Bas

ed o

n E

US

ES

est

imat

ions

Chl

ordi

mef

orm

is e

xpec

ted

to b

e fo

und

in lo

cal s

urfa

ce w

ater

s in

con

cen-

trat

ions

up

to a

ppro

x. 1

mg/

L. B

ased

on

EU

SE

S e

stim

atio

ns fo

r se

cond

ary

pois

onin

g an

d hu

man

inta

ke C

hlor

dim

e-fo

rm is

exp

ecte

d to

be

foun

d in

fish

, pre

dato

rs a

nd h

uman

food

in m

inor

am

ount

s. C

hlor

dim

efor

m is

con

side

red

as

bein

g of

Lo

w C

on

cern

. Cov

ered

by

Cou

ncil

Dire

ctiv

e 91

/414

/EE

C. N

o R

AR

has

bee

n pr

ovid

ed a

nd th

e su

bsta

nce

is

not i

nclu

ded

in th

e lis

t for

pes

ticid

es to

be

revi

ewed

. 74

00-0

8-0

p-C

oum

aric

aci

d (P

CA

) p

-Co

um

aric

aci

d (

PC

A)

is a

nat

ural

phe

nolic

aci

d. P

CA

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd th

us n

ot a

LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

ha

s be

en u

sed.

PC

A is

rea

dily

bio

degr

adab

le a

nd h

as a

low

pot

entia

l to

bioa

ccum

ulat

e (lo

g K

ow=

1.79

). B

ased

on

EU

SE

S e

stim

atio

ns P

CA

is e

xpec

ted

to b

e fo

und

in lo

cal s

urfa

ce w

ater

in c

once

ntra

tions

up

to a

ppro

x. 1

mg/

L.

Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

and

hum

an in

take

PC

A is

exp

ecte

d to

be

foun

d in

fish

, pre

da-

tors

and

hum

an fo

od in

insi

gnifi

cant

am

ount

s. P

CA

is c

onsi

dere

d as

bei

ng o

f Lo

w C

on

cern

. Non

e sp

ecifi

cally

reg

u-la

tory

or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

77

-09-

8 3,

3'-B

is(4

-hy

drox

y-ph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e

Ph

eno

lph

thal

ein

is u

sed

as a

labo

rato

ry r

eage

nt a

nd a

cid-

base

indi

cato

r an

d in

ove

r-th

e-co

unte

r la

xativ

e pr

epar

a-tio

ns. P

heno

lpht

hale

in is

acc

ordi

ng to

the

ES

IS d

atab

ase

prod

uced

in a

mou

nts

< 1

0 to

nes/

year

and

thus

not

a L

PV

su

bsta

nce.

For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. P

heno

lpht

hale

in is

no

t rea

dily

bio

degr

adab

le a

nd h

as p

oten

tial t

o bi

oacc

umul

ate

(log

Kow

=3.

06).

Bas

ed o

n E

US

ES

est

imat

ions

Phe

nol-

phth

alei

n is

exp

ecte

d to

be

foun

d in

loca

l sur

face

wat

er in

rel

ativ

ely

high

con

cent

ratio

ns (

appr

ox. 1

0 m

g/L)

as

wel

l as

sedi

men

ts a

nd a

gric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

and

hum

an in

take

Chl

ordi

-m

efor

m is

exp

ecte

d to

be

foun

d in

fish

, pre

dato

rs a

nd h

uman

food

in in

sign

ifica

nt a

mou

nts.

Bas

ed o

n th

e ex

pect

ed

high

con

cent

ratio

ns in

sur

face

wat

ers

PC

A is

con

side

red

as b

eing

of

Med

ium

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

Page 15: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

12

CA

SN

R

NA

ME

C

oncl

usio

n 77

-40-

7 2,

2-B

is(4

-hy

drox

yphe

nyl)-

n-bu

tan

= B

isph

enol

B

Bis

ph

eno

l B is

com

pone

nt o

f Phe

nolic

Res

in w

hich

is th

erm

oset

ting

resi

n us

ed a

s A

dhes

ive

and

Rei

nfor

cem

ent.

Bis

phen

ol B

is u

sed

in m

any

indu

stria

l app

licat

ions

. Bis

phen

ol B

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

low

am

ount

and

is n

eith

er a

HP

V o

r LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. B

isph

enol

B is

not

rea

dily

bio

degr

adab

le a

nd h

as a

hig

h po

tent

ial t

o bi

oacc

umul

ate

in th

e en

vi-

ronm

ent (

log

kow

=4.

69).

Bis

phen

ol B

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

as

wel

l as

sedi

men

ts

and

agric

ultu

ral s

oils

. Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

Bis

phen

ol B

is e

xpec

ted

to b

e fo

und

in

fish

and

top

pred

ator

s in

min

or a

mou

nt. A

med

ium

hum

an e

xpos

ure

is e

xpec

ted.

Bis

phen

ol B

is c

onsi

dere

d as

bei

ng

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d.

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-

Phe

nylp

heno

l 4-

Ph

enyl

ph

eno

l in

an in

dust

rial i

nter

med

iate

. 4-P

heny

lphe

nol i

s ac

cord

ing

to th

e E

SIS

dat

abas

e a

LPV

sub

stan

ce.

For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

000

tone

s pe

r ye

ar h

as b

een

used

. 4-P

heny

lphe

nol i

s no

t rea

d-ily

bio

degr

adab

le a

nd h

as p

oten

tial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=3

.2).

4-P

heny

lphe

nol i

s in

the

en-

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

er in

con

cent

ratio

ns u

p to

app

rox.

4 m

g/L.

Bas

ed o

n E

US

ES

est

imat

ions

fo

r se

cond

ary

pois

onin

g an

d hu

man

inta

ke 4

-Phe

nylp

heno

l is

expe

cted

to b

e fo

und

in fi

sh, p

reda

tors

and

hum

an

food

in m

inor

am

ount

s. 4

-Phe

nylp

heno

l is

cons

ider

ed a

s be

ing

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

92

-88-

6 4,

4'-

Dih

ydro

xybi

phen

yl =

4,

4'-B

iphe

nol

4,4'

-Bip

hen

ol u

sed

as s

unsc

reen

s, p

rese

rvat

ives

, dis

infe

ctan

ts, a

ntio

xida

nts,

flav

orin

gs, o

r fo

r pe

rfum

ery.

4,4

'-B

iphe

nol i

s ac

cord

ing

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd is

thus

not

a L

PV

sub

stan

ce.

For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. 4

,4'-B

iphe

nol i

s no

t rea

dily

bi

odeg

rada

ble

and

has

a m

ediu

m p

oten

tial t

o bi

oacc

umul

ate

in th

e en

viro

nmen

t (lo

g ko

w=

2.8)

. 4,4

'-Bip

heno

l is

in th

e en

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

er in

con

cent

ratio

ns u

p to

app

rox.

1 m

g/L.

Bas

ed o

n E

US

ES

est

ima-

tions

for

seco

ndar

y po

ison

ing

and

hum

an in

take

4,4

'-Bip

heno

l is

expe

cted

to b

e fo

und

in fi

sh, p

reda

tors

and

hum

an

food

in in

sign

ifica

nt a

mou

nts,

how

ever

, a h

igh

hum

an e

xpos

ure

is e

xpec

ted

due

to th

e de

fined

use

of t

he s

ubst

ance

. 4,

4'-B

iphe

nol i

s co

nsid

ered

as

bein

g of

Hig

h C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

w

as fo

und.

94

-13-

3 n-

prop

yl p

-hy

drox

yben

zoat

e N

-pro

pyl

p-h

ydro

xyb

enzo

ate

is u

sed

as a

pre

serv

ativ

e in

food

, pha

rmac

eutic

al a

nd c

osm

etic

form

ulat

ions

. N-p

ropy

l p-

hydr

oxyb

enzo

ate

is p

rodu

ced

in a

mou

nts

up to

10

tone

s pe

r ye

ar a

nd th

us a

LP

V s

ubst

ance

. N-p

rop

yl p

-hy

drox

yben

zoat

e is

rea

dily

bio

degr

adab

le a

nd h

as p

oten

tial f

or b

ioac

cum

ulat

ion

(log

Kow

=3.

04).

Bas

ed E

US

ES

cal

-cu

latio

ns N

-pro

pyl p

-hyd

roxy

benz

oate

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

s in

con

cent

ratio

ns u

p to

app

rox.

10

mg/

L. N

-pro

pyl p

-hyd

roxy

benz

oate

is e

xpec

ted

to b

e fo

und

in fi

sh, p

reda

tors

and

hum

an fo

od in

insi

g-ni

fican

t am

ount

s. H

owev

er, a

s n-

prop

yl p

-hyd

roxy

benz

oate

is u

sed

as a

pre

serv

ativ

e in

food

and

cos

met

ics

a hi

gh

hum

an e

xpos

ure

is e

xpec

ted.

N-p

ropy

l p-h

ydro

xybe

nzoa

te is

thus

con

side

red

as b

eing

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d. It

is th

e op

iniu

m o

f the

Sci

entif

ic C

omm

itee

on

Con

sum

er P

rodu

cts

(SC

CP

) th

at, v

iew

ing

the

curr

ent k

now

ledg

e, th

ere

is n

o ev

iden

ce o

f dem

onst

rabl

e ris

k fo

r th

e de

velo

pmen

t of b

reas

t can

cer

caus

ed b

y th

e us

e of

und

erar

m c

osm

etic

s in

clud

ing

para

bens

Page 16: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

13

CA

SN

R

NA

ME

C

oncl

usio

n 94

-26-

8 n-

But

yl p

-H

ydro

xybe

nzoa

te

n-B

uty

l p-H

ydro

xyb

enzo

ate

is u

sed

as a

pre

serv

ativ

e in

food

, pha

rmac

eutic

al a

nd c

osm

etic

form

ulat

ions

. N-B

utyl

p-

hydr

oxyb

enzo

ate

is a

ccor

ding

to th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd is

thus

not

a L

PV

su

bsta

nce.

For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. N

-But

yl p

-hy

drox

yben

zoat

e is

rea

dily

bio

degr

adab

le a

nd h

as a

rel

ativ

ely

high

pot

entia

l for

bio

accu

mul

atio

n (lo

g K

ow=

3.57

).

Bas

ed E

US

ES

cal

cula

tions

N-B

utyl

p-h

ydro

xybe

nzoa

te is

in th

e en

viro

nmen

t mai

nly

dist

ribut

ed to

sur

face

wat

ers

in

conc

entr

atio

ns u

p to

app

rox.

1 m

g/L.

N-B

utyl

p-h

ydro

xybe

nzoa

te is

exp

ecte

d to

be

foun

d in

fish

, pr

edat

ors

and

hu-

man

food

in in

sign

ifica

nt a

mou

nts.

How

ever

, as

n-B

utyl

p-h

ydro

xybe

nzoa

te is

use

d as

a p

rese

rvat

ive

in fo

od a

nd

cosm

etic

s a

high

dire

ct h

uman

exp

osur

e is

exp

ecte

d. N

-But

yl p

-hyd

roxy

benz

oate

is th

us c

onsi

dere

d as

bei

ng o

f M

e-d

ium

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as fo

und.

It is

the

opin

ium

of t

he S

ci-

entif

ic C

omm

itee

on C

onsu

mer

Pro

duct

s (S

CC

P)

that

, vie

win

g th

e cu

rren

t kno

wle

dge,

ther

e is

no

evid

ence

of d

e-m

onst

rabl

e ris

k fo

r th

e de

velo

pmen

t of b

reas

t can

cer

caus

ed b

y th

e us

e of

und

erar

m c

osm

etic

s in

clud

ing

para

bens

96

-12-

8 D

ibro

moc

hlor

opro

-pa

ne (

DB

CP

) D

ibro

mo

chlo

rop

rop

ane

(DB

CP

) is

use

d as

a p

estic

ide

as w

ell a

s an

indu

stria

l int

erm

edia

te. D

BC

P is

acc

ordi

ng to

th

e E

SIS

dat

abas

e pr

oduc

ed in

am

ount

s <

10

tone

s/ye

ar a

nd is

thus

not

a L

PV

sub

stan

ce. F

or th

e E

US

ES

cal

cula

-tio

ns a

pro

duct

ion

volu

me

of 1

0 to

nes

per

year

has

bee

n us

ed. D

BC

P is

not

rea

dily

bio

degr

adab

le a

nd h

as m

ediu

m

pote

ntia

l to

bioa

ccum

ulat

e in

the

envi

ronm

ent (

log

kow

=2.

96).

DB

CP

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

ur-

face

wat

er in

con

cent

ratio

ns u

p to

app

rox.

1 m

g/L.

Bas

ed o

n E

US

ES

est

imat

ions

for

seco

ndar

y po

ison

ing

and

hu-

man

inta

ke D

BC

P is

exp

ecte

d to

be

foun

d in

fish

, pre

dato

rs a

nd h

uman

food

in m

inor

am

ount

s. D

BC

P is

con

side

red

as b

eing

of M

ediu

m C

on

cern

. Cov

ered

by

Cou

ncil

Dire

ctiv

e 91

/414

/EE

C. N

o R

AR

has

bee

n pr

ovid

ed a

nd th

e su

b-st

ance

is n

ot in

clud

ed in

the

list f

or p

estic

ides

to b

e re

view

ed. C

lass

ifica

tion:

CA

RC

2;R

45 M

UT

2;R

46 R

EP

1;R

60

T;R

25 X

N;R

48/2

0/22

R52

/53

99-7

6-3

Met

hyl p

-H

ydro

xybe

nzoa

te

Met

hyl

p-H

ydro

xyb

enzo

ate

is u

sed

as a

pre

serv

ativ

e in

food

, pha

rmac

eutic

al a

nd c

osm

etic

form

ulat

ions

. Met

hyl p

-H

ydro

xybe

nzoa

te is

acc

ordi

ng to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

vol-

ume

of 5

00 to

nes

per

year

has

bee

n us

ed. M

ethy

l p-h

ydro

xybe

nzoa

te is

rea

dily

bio

degr

adab

le a

nd h

as a

low

pot

en-

tial f

or b

ioac

cum

ulat

ion

(log

Kow

=1.

96).

Bas

ed E

US

ES

cal

cula

tions

Met

hyl p

-hyd

roxy

benz

oate

is in

the

envi

ronm

ent

mai

nly

dist

ribut

ed to

sur

face

wat

er in

con

cent

ratio

ns u

p to

app

rox.

1 m

g/L.

Met

hyl p

-hyd

roxy

benz

oate

is e

xpec

ted

to

be fo

und

in fi

sh, p

reda

tors

and

hum

an fo

od in

insi

gnifi

cant

am

ount

s. H

owev

er, a

s M

ethy

l p-h

ydro

xybe

nzoa

te is

use

d as

a p

rese

rvat

ive

in fo

od a

nd c

osm

etic

s a

high

dire

ct h

uman

exp

osur

e is

exp

ecte

d. M

ethy

l p-h

ydro

xybe

nzoa

te is

th

us c

onsi

dere

d as

bei

ng o

f Med

ium

Co

nce

rn. N

one

spec

ifica

lly r

egul

ator

y or

lega

l sta

tus

for

this

sub

stan

ce w

as

foun

d. It

is th

e op

iniu

m o

f the

Sci

entif

ic C

omm

itee

on C

onsu

mer

Pro

duct

s (S

CC

P)

that

, vie

win

g th

e cu

rren

t kno

wl-

edge

, the

re is

no

evid

ence

of d

emon

stra

ble

risk

for

the

deve

lopm

ent o

f bre

ast c

ance

r ca

used

by

the

use

of u

nder

arm

co

smet

ics

incl

udin

g pa

rabe

ns

Page 17: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

ERA/53559/Revised report/2007.06.04

DHI Water & Environment

14

CA

SN

R

NA

ME

C

oncl

usio

n 99

-96-

7 p-

Hyd

roxy

benz

oic

acid

p

-Hyd

roxy

ben

zoic

aci

d is

the

com

mon

met

abol

ite o

f all

para

bens

and

thus

use

d as

a p

rese

rvat

ive

in fo

od, p

harm

a-ce

utic

al a

nd c

osm

etic

form

ulat

ions

. p-H

ydro

xybe

nzoa

te is

acc

ordi

ng to

the

ES

IS d

atab

ase

a LP

V s

ubst

ance

. For

the

EU

SE

S c

alcu

latio

ns a

pro

duct

ion

volu

me

of 1

000

tonn

es p

er y

ear

has

been

use

d. P

-hyd

roxy

benz

oic

acid

is r

eadi

ly

biod

egra

dabl

e an

d ha

s a

low

pot

entia

l for

bio

accu

mul

atio

n (lo

g K

ow=

1.58

). B

ased

EU

SE

S c

alcu

latio

ns p

-H

ydro

xybe

nzoi

c ac

id is

dis

trib

uted

to th

e en

viro

nmen

t at l

ow c

once

ntra

tions

. P-h

ydro

xybe

nzoi

c ac

id is

exp

ecte

d to

be

foun

d in

fish

, pre

dato

rs a

nd h

uman

food

in in

sign

ifica

nt a

mou

nts.

How

ever

, as

P-h

ydro

xybe

nzoi

c ac

id is

use

d as

a

pres

erva

tive

in fo

od a

nd c

osm

etic

s a

high

dire

ct h

uman

exp

osur

e is

exp

ecte

d. P

-hyd

roxy

benz

oic

acid

is th

us c

on-

side

red

as b

eing

of M

ediu

m C

on

cern

. Non

e sp

ecifi

cally

reg

ulat

ory

or le

gal s

tatu

s fo

r th

is s

ubst

ance

was

foun

d. It

is

the

opin

ium

of t

he S

cien

tific

Com

mite

e on

Con

sum

er P

rodu

cts

(SC

CP

) th

at, v

iew

ing

the

curr

ent k

now

ledg

e, th

ere

is

no e

vide

nce

of d

emon

stra

ble

risk

for

the

deve

lopm

ent o

f bre

ast c

ance

r ca

used

by

the

use

of u

nder

arm

cos

met

ics

incl

udin

g pa

rabe

ns

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Eth

ylen

eth

iou

rea

(ET

U)

is o

ne o

f the

deg

rada

tion

prod

ucts

of e

thyl

eneb

is-d

ithio

carb

amat

e fu

ngic

ides

, suc

h as

m

aneb

and

zin

eb, w

hich

hav

e be

en w

idel

y us

ed o

n fo

od c

rops

. ET

U is

acc

ordi

ng to

the

ES

IS d

atab

ase

a LP

V s

ub-

stan

ce. F

or th

e E

US

ES

cal

cula

tions

a p

rodu

ctio

n vo

lum

e of

100

0 to

nes

per

year

has

bee

n us

ed. E

TU

is n

ot r

eadi

ly

biod

egra

dabl

e an

d ha

s a

low

pot

entia

l for

bio

accu

mul

atio

n (lo

g K

ow=

-0.6

6). B

ased

EU

SE

S c

alcu

latio

ns E

TU

is in

the

envi

ronm

ent m

ainl

y di

strib

uted

to s

urfa

ce w

ater

in c

once

ntra

tions

up

to a

ppro

x. 0

.5 m

g/L.

ET

U is

exp

ecte

d to

be

foun

d in

fish

, pre

dato

rs a

nd h

uman

food

in in

sign

ifica

nt a

mou

nts.

ET

U is

thus

con

side

red

as b

eing

of L

ow

Co

nce

rn.

The

sub

stan

ce is

cov

ered

by

Cou

ncil

Dire

ctiv

e 91

/414

/EE

C. N

o R

AR

has

bee

n pr

ovid

ed a

nd th

e su

bsta

nce

is n

ot

incl

uded

in th

e lis

t for

pes

ticid

es to

be

revi

ewed

. Cla

ssifi

catio

n: R

EP

2;R

61 X

N;R

22

Page 18: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 15

3 INTRODUCTION

3.1 Background

In both human beings and animals, endocrine disruption is a mechanism whose effects relate to the functioning of the endocrine system, which influences development, growth, reproduction and behaviour. According to accepted Weybridge definition (EU 1997) as supported by the Commission (COM(1999) 706), an endocrine disrupter is an exogenous substance or mixture that alters function(s) of the endocrine system and con-sequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations. In recent years, there has been growing concern over a range of sub-stances, which are suspected to interfere with the endocrine system, the so-called endo-crine disrupters. Endocrine disrupters may act by the following mechanisms: • Direct damage to an endocrine organ • Direct altering of the function of an endocrine organ • Interaction with receptors • Altering the hormone metabolism, either in endocrine organs or peripherally The observed adverse effects of endocrine disrupters in humans and animals include cancer, behavioural changes and reproductive abnormalities. However, the knowledge of endocrine disrupters and their effects is still characterised by many uncertainties and data gaps. In 1996, the European Commission implemented a policy as to the use and regulation of suspected endocrine disturbing substances, and, in December 1999, it adopted a Com-munity Strategy for Endocrine Disrupters. This strategy addresses the key elements of further research, international co-operation, public communication and appropriate pol-icy actions. The strategy contains actions on short-, medium- and long-term time scales. Short-term actions include gathering of scientific data, identification of substances for further evaluation with a view to prioritising testing, guidance of research and monitoring of ef-forts and to identifying exposure target groups. Medium-term actions focus on testing issues. Long-term actions include review and possible adaptation of policy and legisla-tion. A key short-term action is the establishment of a priority list of substances for further evaluation of their role in endocrine disruption. The first study carried out in 2000 on the behalf of the Commission (BKH 2000) identified a candidate list of 553 substances. Among these substances, 59 substances were identified as mixtures and/or polymers, and/or double inputs and/or group names and will not be evaluated further, while 118 were identified as High Production Volume substances and/or persistent man-made chemicals showing scientific evidence of endocrine disruption or potential for endocrine disruption. Most of these substances (109) were already subject to bans or restrictions or were being addressed under existing Community legislation although for reasons not

Page 19: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 16

necessarily related to endocrine disruption. In the short term, priority was thus given to nine substances, which are neither restricted nor currently being addressed under exist-ing Community legislation, and for which more in depth studies were necessary. In ad-dition, three natural and/or synthetic hormones, oestrone, ethinylestradiol and oestradiol were evaluated in order to gather up-to-date evidence of environmental exposure and ef-fects related to these substances. These substances were studied by WRc and reported in: “Study on the scientific evaluation of 12 substances in the context of Endocrine Dis-rupter priority list of actions”. WRc-NSF published November 2002. A second study was performed in 2002 (RPS-BKH, 2002), in which the remaining 435 substances in the 2000 report, for which there had been insufficient data to assess endo-crine disruption or potential for endocrine disruption, were evaluated. The aim of this study was to gather data/information on persistence, production volumes and legal status of these substances. The study primarily focused on industrial chemicals used in industry, agriculture and consumer goods. The substances were categorised according to different levels of available information for the following four selection criteria: • Production volume • Persistence in the environment • Evidence for endocrine disruption from literature data • Exposure considerations Among the 553 substances of the original candidate list, 173 substances had not been evaluated for endocrine or potential endocrine effects on humans and wildlife. In the IUCLID database, 7829 chemicals are registered as Low Production Volume Chemicals (LPVC) but no information regarding their potential endocrine disrupting ef-fects is registered. It was agreed that the present evaluation should include possible identification of additional substances among these, which may have endocrine disrupt-ing properties. For this purpose, stakeholders were consulted. The endocrine properties of 173 substances plus 22 substances identified by stakeholders were thus evaluated in the present study. Throughout the present report, the definitions of ‘Low Production Volume Chemicals’ and ‘High Production Volume Chemicals’ are based on the definitions given in ESIS (European chemical substances information system): HPVC (High Production Volume Chemical). A HPVC is a chemical which is defined as being produced or imported in quantity of at least 1000 tonnes per year in EU by at least one Industry. LPVC (Low Production Volume Chemical). A LPVC, is a chemical which has been produced or imported in EU with a tonnage >10 t/y but never more than 1000 t/y. By definition, a LPV Chemical is a chemical which is not a HPV Chemical.

3.2 Objectives and scope of the current project

The main objective with the present project was to improve the database developed in the RPS-BKH 2002 project and to include collected data on endocrine disrupting prop-erties of the remaining substances placed on the candidate list.

Page 20: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 17

The subject of this project belongs to the short-term priority actions of the European Commission. It entails a study to gather data and information on LPVC as well as on substances with a production volume < 10 tonnes/year and to enhance the Endocrine Disrupter priority list with a view to providing information on the priority list at the DG Environment Endocrine Disrupters Website and inform relevant EU policy areas. According to the Community Strategy for Endocrine Disrupters (1999), the present study is a short-term key action and a follow-up on the EC DG-ENV study (2002) “To-wards the establishment of a priority list of substances for further evaluation of their role in endocrine disruption – preparation of a candidate list of substances as a basis for priority setting”. The present study “Study on enhancing the Endocrine Disrupter priority list with a fo-cus on low production volume chemicals” is a follow-up study for the establishment of a priority list of substances for further in-depth evaluation of their role in endocrine dis-ruption. Two previous studies in this area were carried out by BKH in 2000 and by RPS BKH in 2002. The present study is thus the last of three evaluations going through the remaining candidate substances (173 substances) from the EU candidate list including 553 substances in total. For comparability reasons and as the present study is the last of three evaluations of the candidate substances, the same methodology as used in the pre-vious RPS-BKH 2002 project was applied. The compilation of the priority list is based on a screening of available literature and should therefore be regarded as a starting point for further hazard and risk assessments of the substances placed on the priority list. The evaluations shall be seen in line with the previous studies (BKH 2000 and RPS-BKH 2002) and shall NOT be seen as risk as-sessments. Future in-depth evaluations of the substances placed on the list need to be performed and a methodology must be developed to make the list iterative meaning that a substance can enter or be deleted from the list based on a weight of evidence ap-proach. The present evaluation included: 1. A written consultation with stakeholders, which, as far as possible, ensured that pos-

sible new candidates for the Endocrine Disrupter candidate list were identified among substances listed in the ESIS database

2. The identified substances were evaluated for endocrine disrupting effects and the following screening criteria have as far as possible been taken into account:

• Relevance of effect parameter • Test reliability • Dose-response relationship • Endocrine disruption potency • Comparison with systemic toxicity • Evaluation of exposure concern to humans and wildlife • Consumption/use patterns • Environmental concentration ranges

Page 21: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 18

In order to reach the objectives, the following four tasks were formulated:

• Identification of relevant stakeholders • Identification of new candidate LPVC for further evaluation of their endocrine

disrupting properties • Collection and evaluation of data/information on LPVC to establish priorities for

further evaluation of their role in endocrine disruption • Update of database, list and meetings

Below, the methodology used to fulfil the tasks is described.

3.3 Study approach

Below, the four tasks identified to fulfil the study objectives are described. Task 1 Identification of relevant stakeholders

• Relevant stakeholders were identified in consultation with the Commission • The same stakeholders were used as a written consultation group based on

a web-based response

Task 2 Identification of new candidate LPVC for further evaluation of their endocrine disrupting properties • The substances were identified by a written consultation with the stake-

holders identified in Task 1. Task 3 Collection and evaluation of data/information on LPVC to establish priorities

for further evaluation of their role in endocrine disruption The execution of this task was based on the following activities:

• Data search strategy, data collection and data evaluation • Evaluation of exposure of humans and wildlife

Task 4 Update of database, list and meetings

• The major objective of this task was to report the study in a way that en-ables the Commission to make the results available at the Commission’s Endocrine Disrupters Website.

• The progress of the study was placed at the web site: (http://projects.dhi.dk/Endocrine_Disrupter/testsite/) together with the ex-isting version of the database. A link to the DHI homepage was placed at the ECB homepage on endocrine disrupters (http://ec.europa.eu/environment/endocrine/strategy/substances_en.htmon) allowing third party to follow the progress in the project as well as provid-ing comments on the draft final report and the final outcome of the data-base.

• In order to ensure close co-operation with the Commission, four meetings took place during the project period

Page 22: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 19

4 METHODOLOGY

4.1 Identification of relevant stakeholders (Task 1)

The main objective of this task was to identify relevant contacts among stakeholders. Relevant stakeholders were contacted in the written consultation described under Task 2. Task 1.1 Identification of stakeholders for written consultation Relevant stakeholders were identified in consultation with the Commission taking a starting point in the following groups: • National focal points in EU Member States • ECETOC • Experts involved in international work regarding endocrine disrupters, e.g. OECD

Validation Management Groups for Ecotoxicity Tests (VMG-eco) and Mammalian toxicity test (VMG-mammal) of the Task Force on Endocrine Disrupters Testing and Assessment (EDTA)

• Members of the EU projects on endocrine disrupters e.g., CREDO, EDEN, FIRE • Environmental NGOs • Industrial branch organisations, e.g. CEFIC, EUROCHLOR and individual indus-

tries, Task 1.2 Identification of stakeholders for consultation group At the interim report meeting (29 June 2006) between DHI and DG ENV, it was de-cided that all contacted stakeholders were invited to go through the draft final report and the collected data on substances categorised as Category 1 substances (evidence for en-docrine disrupting effects) in the database. Due to cost limitations, it was decided not to have a physical meeting but instead have web-based stakeholder responses.

4.2 Identification of new candidate LPVC for further evaluation of their endocrine disrupting properties (Task 2)

The major objective of this task was to identify substances (preferably LPVC) with a potential for endocrine disruption, which have not been included in previous lists. The substances were identified by a written consultation with the stakeholders identified in Task 1.1. The request included a brief presentation of the background for the query with reference to the existing lists of potentially endocrine disrupting substances. Fur-thermore, a short questionnaire included questions regarding the knowledge of endo-crine disrupting properties of other chemicals, references regarding this knowledge and possible information relevant to exposure assessment, e.g. regarding production vol-umes and use of the chemicals.

Page 23: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 20

4.3 Collection and evaluation of data/information on LPVC to estab-lish priorities for further evaluation of their role in endocrine disruption (Task 3)

The major objective of this task was to gather data/information on LPVC specifically on their potential role in endocrine disruption. The study was based on the the remaining of the 553 substances placed on the candidate substance list, which were identified in the BKH Report of 2000, and on new candidate substances, which were identified in Task 2 as described above. Starting points were the methodology developed in the RPS-BKH report (2002) and the database containing the candidate substances identified in the BKH report of 2000, with data from background documents. The methodological approaches and evaluation of the selected substances with respect to endocrine disrupter potency towards humans and wildlife were elaborated by the project team and included the subtasks described below.

4.3.1 Data search strategy and data collection (Task 3.1) Literature was searched in different databases both free databases available on the inter-net and licensed databases purchased by DHI. For all substances, a general screening of the literature was performed. The following databases were searched (for the specific CAS number or name): • HSDB (Hazardous Substances Data Bank) • RTECS via Thomes (Thomson, Micromedex)

The following databases were searched for original peer-review scientific papers: • TOXCENTER (Toxicology Center) is a bibliographic database that covers the phar-

macological, biochemical, physiological and toxicological effects of drugs and other chemicals.

TOXCENTER is composed of the following file segments:

• ANEUPL - Aneuploidy File • BIOSIS - 1969 to the present • CAplus - 1907 to the present • CIS - CIS Abstracts • CRISP - Toxicology Research Projects • DART - Development and Reproductive Toxicology File • EMIC - Environmental Mutagen Information Center File • EPIDEM - Epidemiology Information System, • ETIC - Environmental Teratology Information Center File • FEDRIP - Federal Research in Progress • HAPAB - Health Aspects of Pesticides Abstract Bulletin • HMTC - Hazardous Materials Technical Center File • IPA - 1970 to the present • MEDLINE - 1950 to the present

Page 24: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 21

• PESTAB - Pesticides Abstracts • PPBIB - Poisonous Plants Bibliography • RISKLINE - Swedish National Chemicals Inspecorate • TSCATS - Toxic Substances Control Act Test Submissions

The records in the file contain bibliographic data, abstracts, indexing terms, chemical names and CAS Registry Numbers.

• EMBASE (Excerpta Medica) is a comprehensive bibliographic database that covers

the worldwide literature on biomedical and pharmaceutical fields. It is produced by Elsevier B.V., the world's largest publisher of scientific information.

• Science Citation Index (SciSearch®) contains all records published in Science Cita-

tion Index ExpandedTM. Records from January 1991 up to the present. It includes abstracts, author keywords, and KeyWords Plus®. Authors, bibliographic informa-tion cited references and KeyWords Plus are searchable.

The search strategy for the substances was: • Search on CAS No., chemical name and synonyms • The hits identified searching on CAS No. and names were combined with the fol-

lowing search terms: For substances with many hits, the following search terms were used: testes, undescended OR testis, undescended OR testic? feminization OR androgen in-sensitivity OR oestrus OR estrus OR cryptorchidism OR hypospadias OR uterotrophic OR Hershberger OR gonadal disorder# OR gonadal dysgenesis OR gonadal agenesis OR gonad? Inhibiting hormone# OR estrogen? receptor# OR oestrogen? receptor# OR estrogen? Effect# OR oestrogen? effect# OR anti-androgen? effect# OR androgen? re-ceptor# OR vitellogen? OR 11-ketotestosterone OR progesterone# receptor# OR testos-terone# receptor# OR endocrine disrupt? OR thyroid? hormone# For substances with few hits, the following search terms were used: testes OR testis OR testic? OR androgen? OR oestrus OR estrus OR cryptorchidism OR hypospadias OR uterotrophic OR Hershberger OR preputial OR vagina? OR sperm? OR gonad? OR estrogen? OR oestrogen? OR anti-androgen? OR vitellogen? OR 11-ketotestosterone OR pituitary OR progesterone# OR testosterone# OR endocrine dis-rupt? OR thyroid? If more than approx. 100-150 hits were identified by either of these search strategies, a further limitation was performed. In few cases, the exclusion of in-vitro studies was used as a limitation criterion but this only resulted in a small limitation of hits. Limita-tion on year of publication was mostly used by starting with excluding literature pub-lished before 1980 and then excluding literature with 5-10 years intervals until approx. 100 hits were reached.

Page 25: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 22

The identified hits were screened for relevant/valuable titles. For selected titles, ab-stracts were downloaded. Due to cost limitations (the database search and downloading of abstracts turned out to be very costly), evaluations were mainly based on the downloaded abstracts.

4.3.2 Evaluation of endocrine potential (Task 3.2) The evaluation of endocrine disrupting-related effects on humans and wildlife has re-sulted in categorisation of the substances based on the following screening criteria: • Relevance of test parameter (with aspects such as endocrine specific effects in con-

trast to general toxicity (teratogenic effects)) • Test reliability (validated protocols; experimental design; suitability, health and life

stage of test species; statistics). Ranked indication of Data Quality (DQ 1-4). DQ: Good Data Quality, fulfilling all (important) criteria; DQ2: Sufficient Data Quality, study fulfilling most of the (important) criteria; DQ3: Insufficient Data Quality, study cannot be used for identification; and DQ4: Not evaluated .

• Dose-response relationship or indications of effect thresholds • Endocrine disruption potency (including a categorisation of the chemicals into three

groups: 1. Evidence for endocrine disrupting (ED) effect; 2. Potential ED effect; 3. No evidence for ED effect)

• Endocrine disruption structure-activity relationship • Comparison with systemic toxicity (Standard toxicity data –NOECs/LOECs,

E(E)C50s, NOALs/LOAELs from RTECS, ECOTOX (AQUIRE), DOSE and Ver-shuren databases)

Based on the above screening, the substances have been divided into the following four Categories:

CAT 1 At least one in-vivo study providing clear evidence for endocrine disruption in an intact organism. Not a formal weight of evidence approach.

CAT 2 Potential for endocrine disruption. In-vitro data indicating potential for endocrine disruption in intact organisms. May also include in-vivo effects, however, then with insufficient convincing character.

CAT 3a No scientific basis for inclusion in list (ED studies available but no indications of ED effects)

CAT 3b. Substances with no or insufficient data gathered.

4.3.3 Evaluation of exposure of humans and wildlife (Task 3.3) For substances categorised as CAT 1 and CAT 2, evaluation of exposure of humans and wildlife have been based on the following methodology: 1. Data on production and import quantity (ECB, IUCLID database). Also consump-

tion/use patterns have been obtained from the ECB, IUCLID database on existing substances manufactured or imported in quantities of more than 10 tonnes per year. For substances manufactured or imported in quantities less than 10 tonnes per year a

Page 26: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 23

default value of 10 tonnes per year was used. The information includes quantity and use pattern (Main Category, Industrial Category) data.

2. Environmental concentration ranges (COMMPS, European Environment Agency (EEA)).

3. Evaluation of exposure of humans and environment by use of the PC program EUSES.

1) Data on production, import and use quantities (IUCLID) Data concerning quantity of chemicals manufactured in or imported to the EU, and the use within the EU is based on information provided by the European Chemical Bureau (September 2004) as extracts of the IUCLID database. These data reflects the use re-ported to the ECB during the years 1999-2004. The IUCLID database contains informa-tion, which has been submitted by manufacturers and importers of existing chemicals in quantities exceeding 10 tonnes per year. The following data were obtained for each entry: • CAS numbers (several entries per CAS) • DSN number coding for the registrant (one or more registrants per CAS) • Quantities manufactured or imported per year (per entry) • Industry Category (IC) • Use Category (UC) • Main Categories (MC) The IUCLID extract contains separate entries defined by the substance CAS number, the registrant DSN and the year for which the quantity pertains. For example, if one substance is registered by 3 registrants and each of them registers the quantity for 3 years, there will be 9 separate entries for the CAS number. Each registration dossier from a manufacturer or importer of a chemical contains the to-tal quantity of the chemical produced or imported per year. It also contains information on the Main Categories (MC) used to characterise the general release scenarios of the chemical as well as information on the more specific Industrial Categories (IC) and Use Categories (UC) describing the production and use of the chemical in more detail. Chemicals may have different use within different industries according to different products and processes. In agreement to this, one chemical may have several codes for Industrial Categories and Use Categories (UC). In our case, EUSES calculation is based on maximum quantities manufactured or imported per year by one or several manufac-turer and the most likely use pattern. 2) Environmental concentration ranges (COMMPS) Environmental concentration ranges for CAT 1 and CAT 2 substances were searched in COMMPS database/EEA. COMMPS includes water and sediment monitoring data from all EEC Member States. 3) EUSES The PC program EUSES is designed to be a decision-support system for the evaluation of the exposure of chemicals to man and the environment. The system is fully described in the EUSES documentation (http://ecb.jrc.it/euses/) and is based on the EU Technical

Page 27: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 24

Guidance Documents (TGDs; EC-TGD, 2003) for risk assessment of new and existing substances and biocides. Input to the EUSES calculations are data on volume produced, imported or used, the use pattern and physico-chemical properties of the chemical con-cerned. The EUSES summary reports include among other things information concerning: • Volume produced, imported or used in EU (IUCLID, ECB data (1999-2004) • Codes for use pattern (IUCLID, ECB data) • Physico-chemical properties of the substance (complied and evaluated data) • Release to environment on local, regional and continental scale • Concentration in water, soil, sediment on local scale (highest concentration) • Concentration in water and sediment local, regional and continental • Concentration in fish for secondary poisoning (fresh water) • Concentration in top predators • Concentration in earthworms from agricultural soil • Human daily intake doses due the environment on local and regional scale

4.3.3.1 Using EUSES For many chemicals, information on actual exposure doses or concentrations is limited or even absent and concentrations generally vary significantly in time and space. There-fore, doses and environmental concentrations of a chemical are predicted in a two-step procedure: • First, releases to environmental compartments or the indoor environment are pre-

dicted on the basis of the volume produced, imported or used, the use pattern and physico-chemical properties of the chemical concerned.

• Next, environmental concentrations and human daily intake doses are calculated us-ing models, which take into account the transport and fate of the substance.

The main structure of EUSES is presented in Figure 4.1. In the present project, only the release estimation, the environmental distribution and the exposure assessment are in-cluded. If effect data are entered EUSES also gives the possibility to calculate the envi-ronmental risk, risk for human health as well as calculations of exposure via working places. These calculations are not included in the present evaluations.

Page 28: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 25

Figure 4.1 The main modules of EUSES

INPUT The following physico-chemical input data are needed: • Melting point (Mp) • Boiling point (Bp) • Vapour pressure (Psat) • Henry’s Law constant (KH) • Water solubility (Ws) • Octanol-water partition coeffients (Kow) • Organic carbon-water partition coefficient (Koc) • Bioconcentration factor (BCF) • Abiotic degradation (OH radical oxidation) in air (t½(air)) • Abiotic degradation in surface waters by hydrolysis (t½(hydro)) • Biodegradation – ready/inherent biodegradability The input data were compiled from the following free data sources: • IUCLID • RAR (ORATS)

RELEASE ESTIMATION Use data

Local and regional emissions

ENVIRONMENTAL DISTRIBUTION Sewage treatment plant model

Local dedicated models Regional model

EXPOSURE ASSESSMENT Bioconcentration factors

Secondary poisoning Human exposure through the environment

Consumer exposure Non-professional user esposure (biocides)

INPUT Substance identification

Physico-chemical properties Partition coefficients Degradation rates

Page 29: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 26

• CHRIP NITE Biodegradation and bio-concentration • SYRACUSE-CHEMFATE • MST-database • EPI-Suite IUCLID The International Uniform ChemicaL Information Database (IUCLID database) con-tains various measured and estimated physico-chemical parameters and fate properties on 2,465 high production volume chemicals reported by European Industry in the frame of the European existing chemicals risk assessment programme. RAR (ORATS) Provides on-line access to the 141 complete and draft European risk assessment reports (RARs). The reports contain evaluated risk assessment data. Chemical Risk Information Platform (CHRIP) - CHRIP NITE Biodegradation and Bioconcentration Formerly Biodegradation and Bio Accumulation of Existing Chemicals (Chemical Evaluation and Research Institute, Japan) The database on Biodegradation and Bioconcentration of the Existing Chemical Sub-stances under the Chemical Substances Control Law (Japan) contains information on biodegradation and bioconcentration of existing chemical substances and on their test-ing conditions (i.e. measured data), which have been published in the Official Bulletin of Economy, Trade and Industry. The Biodegradation and Bioconcentration of the Ex-isting Chemical Substances under the Chemical Substances Control Law system con-tains data on 1,294 chemical compounds. Syracuse-Chemfate The Syracuse Chemfate contains 25 categories of measured environmental fate and physico-chemical property information on 1,728 chemical compounds. All in all, Chem-fate contains 17,260 records. MST-database (not public available) This database has been developed by the QSAR team of the Danish Environmental Pro-tection Agency (DEPA). It contains QSAR estimates on various physico-chemical, fate and ecotoxicological endpoints on 45,453 EINECs chemicals. The physico-chemical data and fate parameters have been estimated by application of EPI-Suite (see below). The database is not an online facility but a stand-alone database. EPI-Suite -The EPI SuiteTM (previously EPIWIN) This database has been developed by the USEPA Office of Pollution Prevention Toxics and the Syracuse Research Corporation (SRC). EPI SuiteTM uses a single input such as structure (i.e. SMILES notation), CAS No. or name to run the following physico-chemical and fate property estimation models: KOWWINTM, HENRYWINTM, MPBPWINTM, WSKOWWINTM and STPWINTM. The EPI Suite also contains the Syracuse PhysProp database, which includes measured physico-chemical properties on 25,000 chemical compounds.

Page 30: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 27

Prioritization and selection of data In the present project all compiled data were evaluated in relation to their quality ac-cording to the approach shown in Figure 4.2 and assigned a quality index(QI) between 1 (low quality) and 4 (high quality).

Figure 4.2 General data prioritization approach

The data are assigned a quality index primarily based on origin (estimation/measure-ment) and secondly on a general uncertainty assessment. For the measured data, the un-certainty is estimated from the method of measurement (standard/non-standard meas-urement) and for the estimated data, the uncertainty is estimated from the estimation al-gorithm input (property/structure). (QI= Quality Index, QSAR = Quantitative Structure-Activity Relationship, QPPR= Quantitative Property-Property Relationship, info.=information). It is, however, clear that in some cases only data having the same quality index (for in-stance only QSAR data) are available for a given property of a specific chemical com-pound. In such cases, it is necessary to perform an expert assessment of the data origin and evaluate the credibility and uncertainty of the data origin. Complementary to the quality index data, the credibility of the database/sources was used in the selection procedures of data. Databases and data sources were ranked ac-cording to credibility.

Table 4.1 Credibility of database/data sources. Values from 1-6 indicate credibility from high to low.

1 IUCLID 2 RAR (ORATS) 3 CHRIP NITE Biodegradation and bio-concentration 4 SYRACUSE-CHEMFATE 5 MST-database 6 EPI-Suite

Data for the EUSES evaluation of the exposure of chemicals to man and the environ-ment were selected by use of the following procedure:

QI=3QI=2

Have the data been measured or estimated?

QI=1

Have the data been estimated using QSAR or

QPPR?

QI=4

Have the data been measured according to a

standard method?

Estimated/no info. Measured

QPPR QSAR/no info.According to standard

No/no info.

Page 31: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 28

• Data with the highest QI is selected. • If the QI values are equal, firstly, data obtained at 25ºC and neutral pH 7 and, sec-

ondly, data from database/sources with the highest credibility are selected. • Possible comments attached to the data may affect the selection of data The following general criteria were applied in selection of data: • Tests conducted at > 25-30ºC are not included • Only boiling points obtained at ≈ 1013 hPa are included • Biodegradation: Only tests performed under aerobic conditions are included and

where many data are available, primarily OECD 301 tests are considered • IUCLID database: Where method is described as “other”, the origin is assumed to

be EXP (experimental). A note about the origin is made in “Comments” • EPISUITE database: Biodegradation from this reference is evaluated on the basis of

data from EPISUITE algorithms RELEASE ESTIMATION Based on the known properties, uses and functions of a substance, emission factors for various life-cycle stages are chosen from a database with default values. Daily emission rates are subsequently calculated using either again default values or specific emission models. EUSES operates with 16 different Industry Categories (IC) and 56 different Use Cate-gories (UC) with reference to use pattern. The different categories determine the magni-tude and pattern of release, distribution and exposure to humans and the environment. For every use pattern, the emission input data must be specified, consisting of Industrial Category, Use Category and (if appropriate) extra details on Use Category, and the frac-tion of tonnage for each application. Furthermore, it needs to be indicated here which stages of the life cycle are relevant for the current use pattern in the assessment. If rele-vant for the following stages of the life cycle, i.e. production, formulation and process-ing, the Main Category may be specified (otherwise a default value is used). Releases to the environment can take place at any stage of the life cycle of a chemical substance. The life cycle is split up in six stages: 1. Production is the stage in which the substance is manufactured, i.e. formed by

chemical reaction(s), isolated, purified, drummed or bagged, etc. 2. Formulation is the stage in which chemicals are combined in a process of blending

and mixing to obtain a product or a preparation. 3. Industrial use. The processing stage consists of all kinds of processes whereby the

substance as such, as a formulation or as an article containing the substance assessed is applied or used. The substance may be used as a processing aid or be incorporated in a product.

4. Private use. This stage considers the use and application of substances (as such or in

formulations) on the scale of households.

Page 32: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 29

5. Service life. A substance might be released during the life span of an article in

which it is present. Release may be caused by diffusion, leaching or abrasion 6. Waste treatment (disposal). At the stage of disposal, the substance (or the products

containing the substance) is disposed of with waste or waste water. Waste water may be treated in a sewage treatment plant. Waste materials may be incinerated or dumped. At the stage of disposal, recovery to the environment may take place. For some Industrial Categories, recovery was considered.

ENVIRONMENTAL DISTRIBUTION This module contains all the models necessary to estimate the distribution of a sub-stance in the environment at the appropriate spatial scale. End-points are concentrations in the relevant environmental compartments (air, surface water, marine water, sediment, soil and groundwater). EXPOSURE ASSESSMENT Based on estimated environmental concentrations, this module calculates the exposure levels for predating birds and mammals (through fish and earthworms) and humans. For humans, exposure through the environment can be estimated as well as exposure through consumer products, including biocides, and exposure at the workplace.

4.4 Update of database and list (Task 4)

The major objective of this task was to report the study in a way that enables the Com-mission to make the results available at the Commission’s Endocrine Disrupters Web-site. The reporting included written reports and revision of the database and list of the sub-stances categorized in the BKH 2000 and RPS-BKH 2002 reports, to include those categorized in the present study and make the information and list available in Access, Excel and PDF formats. Furthermore, a DHI homepage was prepared (http://projects.dhi.dk/Endocrine_Disrupter/testsite/). in which the work progress was presented together with the possibility get access to the existing version of the database. A link to the DHI homepage was placed on the ECB homepage (http://ec.europa.eu/environment/endocrine/strategy/substances_en.htmon) allowing third party to follow the progress in the project. Meetings In order to ensure close co-operation with the Commission, four meetings were planned with the following issues: 1. Kick-off meeting. 17 November 2005. Minutes from the meeting are presented in

Appendix A 2. Discussion of list of substances to be evaluated. 15 March 2006. Minutes from the

meeting are presented in Appendix B 3. Discussion of interim report. 29 June 2006. Minutes from the meeting are presented

in Appendix C

Page 33: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 30

4. Discussion of draft final deliverables, i.e. report, database and list. 8 December 2006. Minutes from the meeting are presented in Appendix D

5 RESULTS

5.1 Identification of relevant stakeholders (Task 1)

The questionnaire was sent to 160 potential stakeholders both by mail and by e-mail in December 2005. Two letters and 5 e-mails were returned with a message on delivery failure. Thus, in total, the request was sent to approx. 155 people and organisations. Although the deadline for response was 1 February 2006, quite many did not respond before late February/early March. A total of 34 stakeholders responded to the question-naire. This means that the answer percentage was approx. 22%, which is considered ac-ceptable. Most of the responses received were kind replies that the questionnaire was received but that no further data could be provided (65%). However, among the replies, in which new information and data were provided, a total of 22 new substances has been suggested for addition to the list and thus to be evaluated in the present project. Due to financial issues in connection with accommodations and travel expenses, it was decided at the interim report meeting (29 June 2006) not to have a physical meeting in connection with the draft final deliverables but instead have web-based responses from stakeholders to the draft final report and database. The stakeholders and experts con-tacted for written consultation were thus invited to go through the draft final report and the collected data on the selected CAT 1 substances evaluated in the present study. The list of stakeholders and experts contacted are presented in Appendix E. The group of stakeholders for consultation at meeting are indicated as shaded names in Appendix A.

5.2 Identification of new candidate LPVC for further evaluation of their endocrine disrupting properties (Task 2)

The questionnaire for identification of new candidate LPVC with potential endocrine disrupting effects is presented in Appendix F. As the amount of information, which followed the suggested new substances, was quite diverse (from just a CAS No. to detailed information about the substances including at-tached references about EDC effects), it was decided to include all suggested chemicals in the present study and perform the evaluation on these as on the rest of the priority substances. The suggested substances to be added to the list are shown in Table 5.1.

Page 34: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 31

Table 5.1 New candidate substances identified by stakeholders

556-67-2 Cyclotetrasiloxane HPV 81-14-1 1-tert-Butyl-3,5-dimethyl-2,6-dinitro-4-

acetylbenzene LPV

1222-05-5 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta(g)-2-benzopyrane

HPV

13171-00-1 4-Acetyl-1,1-dimethyl-6-tert.-butylindane LPV 5466-77-3 2-Ethyl-hexyl-4-methoxycinnamate HPV 118-56-9 3,3,5-Trimethyl-cyclohexyl salicilate LPV 21245-02-3 2-Ethyl-hexyl-4-dimethyl-aminobenzoate LPV 36861-47-9 3-(4-Methylbenzylidene)camphor LPV 131-57-7 2-Hydroxy-4-methoxy-benzophenone LPV 99-96-7 p-Hydroxybenzoic acid LPV 99-76-3 Methyl p-Hydroxybenzoate LPV 120-47-8 Ethyl 4-hydroxybenzoate LPV 94-13-3 n-Propyl p-hydroxybenzoate LPV 15087-24-8 3-Benzylidene camphor (3-BC) LPV 131-55-5 Benzophenone-2 (Bp-2), 2,2',4,4'-

tetrahydroxybenzophenone LPV

10043-35-3 Boric acid HPV 1582-09-8 Trifluralin HPV 100-02-7 4-Nitrophenol HPV 106-44-5 4-Nitro-3-phenylphenol HPV 33704-61-9 6,7-Dihydro-1,1,2,3,3-pentamethyl-4(5H)indanone Neither LPV nor HPV 94-26-8 n-Butyl p-Hydroxybenzoate Neither LPV nor HPV 2581-34-2 3-Methyl-4-nitrophenol Neither LPV nor HPV

During a thorough evaluation of the candidate list to be evaluated in the present study (173 substances from the ordinary list + 22 new candidate substances) it was found that several substances were not included in the ECB-ESIS database and thus not considered as relevant for evaluation of their endocrine disrupting effects as they probaply are not in use any longer. It was also found that a few of the substances were HPVC and that the majority of the substances were neither HPVC nor LPVC. They are existing sub-stances but produced or imported in amounts ≤10 tons per year. Based on this information, it was decided that the present work should only include HPVC and LPVC plus existing substances registered in the ECB-ESIS database al-though they were produced or imported in amounts ≤10 tons per year. Based on a close evaluation of the candidate substances list including the 22 new substances added by the written stakeholders (195 substances), the substances were divided into the following subgroups: 1. Current LPVC (26 substances) and HPVC (10 substances) according to ECB-ESIS 2. Substances found on ECB-ESIS list but neither LPVC nor HPVC (production vol-

ume < 10 ton/year) (73 substances) 3. Substances not found on ECB-ESIS list and therefore excluded from the evaluation

(73 substances) 4. Substances with no CAS number and therefore excluded from the evaluation (15

substances) For substances in Categories 3 and 4, it was decided to contact CEFIC to ask if they had any knowledge whether the substances are still produced and if yes in which amounts.

Page 35: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 32

The request to CEFIC is presented in Appendix G. No answer from CEFIC was ob-tained on either this specific request or the request for identification of new candidate substances. No cooperation with the industry, e.g. identification of new ED substances, availability of ED data on substances placed on the candidate list or information about substances without CAS numbers, was thus obtained. The revised list of priority substances is presented in Appendix I.

5.3 Collection and evaluation of data/information on LPVC to estab-lish priorities for further evaluation of their role in endocrine disruption (Task 3)

5.3.1 Evaluation of endocrine potential (Task 3.2) The tender from the Commission and the proposal submitted by DHI clearly stated the data evaluation to be performed was given. I.e., “Starting points are the methodology used in the RPS-BKH report (2002) and the database including the candidate substances which were identified in the BKH report of 2000, with data from background docu-ments. The methodological approaches and evaluation of the selected substances with respect to endocrine disrupter potency towards humans and wildlife will be elaborated by the project team.” The evaluation of endocrine disrupting potential was based on the following screening criteria: 1. Relevance of test parameter (with aspects such as endocrine specific effects in con-

trast to general toxicity (teratogenic effects)) 2. Test reliability (validated protocols; experimental design; suitability, health and life

stage of test species; statistics. Ranked indication of Data Quality (DQ 1-4). DQ: Good Data Quality, fulfilling all (important) criteria; DQ2: Sufficient Data Quality, study fulfilling most of the (important) criteria; DQ3: Insufficient Data Quality, study cannot be used for identification; and DQ4: Not evaluated

3. Dose-response relationship or indications of effect thresholds 4. Endocrine disruption potency (including a categorization of the chemicals into three

groups: 1. Evidence for endocrine disrupting (ED) effect; 2. Potential ED effect; 3. No evidence for ED effect)

5. Comparison with systemic toxicity (Standard toxicity data – NOECs/LOECs, E(L)C50s, NOALs/LOAELs from RTECS and HSDB.

As indicated in Section 4.3.1, literature was searched in different databases to obtain in-formation on endocrine disruption effects and systemic toxicity. Additionally, informa-tion was provided by stakeholders on 22 substances. All information from these sources was evaluated and incorporated in the EDS database. A thorough literature search was thus performed but mainly the abstracts were evaluated. In cases, in which the informa-tion obtained from the abstracts was not sufficient for categorisation of the individual substance, a primary reference check was performed (the original article was pur-chased). In the database, the abstracts are found in the remark field. The abstracts were evaluated according to the screening criteria described and an evaluated extract of the effects obtained are reflected in the ‘effect field’.

Page 36: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 33

As the outcome from the present study shall be comparable to the outcome from the 2002 work and end up with a priority list of CAT 1 candidates the same methodology as the one one developed in the previous work performed by RPS-BKH 2002 was used. The categorisation of the substances was performed according to the following evalua-tion criteria:

CAT 1 At least one in-vivo study providing clear evidence for endocrine disruption in an intact organism.

CAT 2 Potential for endocrine disruption. In-vitro data indicating potential for endocrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated.

CAT 3a No scientific basis for inclusion in list (ED studies available but no indications of ED effects)

CAT 3b Substances with no or insufficient data gathered

In the database, several studies are included and evaluated according to the screening criteria but only one study was selected as the key study and the categorisation of the substance was thus mainly based on the key study. It shall however, be emphasized that the amount of evidence provided by other studies not selected as key studies has influ-enced the conclusions for categorisation as well. The choice of categories was made solely by the consultant, and apart from the clear evaluation criteria for the categories given above, it may thus be regarded as subjective. As the present study is based on a screening of available data on the substances on the priority list (a total of 107 substances) and as the quality of the available data is not standardised but quite diverse, a description of a more standardised procedure than the one given above is not possible. When it comes to a future, in-depth evaluation of the selected CAT 1 candidates, the methodology for characterising the substances as having endocrine disrupting properties shall be well defined and fully transparent. Furthermore, it shall be clearly stated how the priority list can be developed as an iterative list. It shall thus be possible to enter chemicals as well as take out chemicals from the priority list based on sufficient weight of evidence evaluated case by case. As a starting point, a total of 195 substances were evaluated. An overview of the evalua-tion and the final categorisation is presented in Table 5.2.

Page 37: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 34

Table 5.2 Overview of the evaluation and the final categorisation

Category Substance identification Number of substances Remaining substances on the Candidate list 173 Stakeholder-identified substances 22 Total 195

LPVC 26 HPVC 10 Neither LPVC nor HPVC 73 Substances not in ESIS database 73 Substances with no CAS No. 15 Substances included in the present evaluation 107

CAT 1 At least one study providing evidence for endo-

crine disruption in an intact organism 34

CAT 2 Potential for endocrine disruption. In-vitro data indicating potential for endocrine disruption in intact organisms.

21

CAT 3a No scientific basis for inclusion in list (ED studies available but no indications of ED effects)

4

CAT 3b Substances with no or insufficient data gathered 48 The human health effects resulting in CAT 1 substances were selected on a wide range of endocrine disrupting effects as presented in Table 5.3. The main effects were effects on uterus-, testes- or other sex organ weight, effect on sperm development, effects on progeny and effects on sex hormone and levels. Information on wildlife ED effects is relatively scarce and when wildlife effects were used as decisive for a CAT 1 conclu-sions, these effects were mainly ED-effects on fish, e.g. an in-vivo Vitellogenin re-sponse. The effects resulting in CAT 2 substances are as CAT 1 substances based on a wide range of endocrine disrupting effects but solely based on in-vitro data as presented in Table 5.4.

Page 38: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

35ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Tab

le 5

.3

ED

effe

cts

obse

rved

in C

ateg

ory

1 su

bsta

nces

. Hum

an [H

H] a

nd w

ildlif

e [W

L] r

elat

ed d

ata

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

1004

3-35

-3

Bor

ic a

cid

Rat

in v

ivo

stud

y: A

fter

a 4-

wk

adm

inis

trat

ion

by g

avag

e, te

stis

an

d ep

idid

ymis

wts

. wer

e de

crea

sed

in th

e 30

0 an

d 50

0 m

g/kg

gr

oups

Am

phib

ian

in v

ivo

stud

y: B

oric

aci

d ex

erte

d re

prod

uctiv

e to

xici

ty in

Xen

opus

laev

is +

tra

nsge

nera

tiona

l tox

icity

to th

e de

velo

ping

pro

geny

. 10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

in v

ivo

stud

y: U

terin

e w

eigh

t, ut

erin

e/bo

dy w

eigh

t sig

nifi-

cant

ly in

crea

sed

in 9

0 m

g/kg

and

120

mg/

kg g

roup

s an

d a

dose

-res

pons

e re

latio

nshi

p w

as o

bser

ved.

Fis

h in

viv

o st

udy:

Indu

ctio

n of

VT

G. L

OE

C=

24.

8 ug

/l

1113

-02-

6 O

met

hoat

e M

ice

in v

ivo

stud

y: In

crea

se in

bod

y w

t. an

d de

crea

sed

test

icle

w

t. T

he a

ctiv

ities

of A

KP

, AC

P, L

DH

in m

ouse

test

icle

s si

gnifi

-ca

ntly

incr

ease

d co

mpa

red

with

the

cont

rol.

No

or in

suff

icie

nt d

ata

gath

ered

1131

-60-

8 4- C

yclo

hexy

lphe

nol

Rat

in v

ivo

stud

y: U

tero

trop

hic

assa

y. In

crea

sed

uter

ine

wei

ght.

LOA

EL=

200

mg/

kg

No

or in

suff

icie

nt d

ata

gath

ered

120-

47-8

et

hyl

4-

hydr

oxyb

enzo

ate

Rat

and

mic

e in

viv

o st

udy:

Incr

ease

d ut

erin

e w

eigh

t in

imm

a-tu

re a

nd o

varie

ctom

ized

ani

mal

s. E

D50

18-

74 µ

mol

/ kg

body

w

eigh

t

Fis

h in

viv

o st

udy.

VT

G in

duct

ion

in r

ainb

ow tr

outs

. LO

AE

L=10

0 m

g/kg

131-

18-0

D

i-n-

pent

ylph

thal

ate

(DP

P)

=

Dip

enty

lpht

hala

te

Mic

e in

viv

o st

udy:

A c

ontin

uous

bre

edin

g pr

otoc

ol w

as u

tiliz

ed

to e

xam

ine

the

repr

oduc

tive

toxi

city

of d

i-n-p

enty

l pht

hala

te

(DP

P).

DP

P w

as to

xic

to th

e re

prod

uctiv

e sy

stem

as

evid

ence

d by

a c

ompl

ete

inhi

bitio

n of

fert

ility

at 1

.25

and

2.5%

DP

P a

nd

redu

ced

fert

ility

(lit

ter

size

)

No

or in

suff

icie

nt d

ata

gath

ered

131-

55-5

B

enzo

phen

one-

2 (B

p-2)

, 2,2

',4,4

'-te

trah

ydro

xybe

n-zo

phen

one

Rat

in v

ivo

stud

y: In

crea

sed

rat u

terin

e w

eigh

ts. E

D10

=54

4.6

mg/

kg b

ody

wei

ght/d

ay

Fis

h in

viv

o st

udy:

Dos

e re

spon

se r

elat

ed V

TG

indu

ctio

n.

LOE

C =

878

3 m

g/L

131-

56-6

2,

4-D

ihyd

roxy

benz

o-ph

enon

= R

es-

benz

ophe

none

Rat

in v

ivo

stud

y: B

enzo

phen

one

(Bp)

-1 in

crea

sed

uter

ine

wt.

in im

mat

ure

rats

. Fur

ther

mor

e, b

enzo

phen

one-

1 (B

p-1)

was

in

a pr

evio

us in

vitr

o ex

perim

ent (

MC

F-7

cel

ls)

show

n to

hav

e cl

ear

estr

ogen

ic a

ctiv

ity (

EC

-50:

2.0

8 uM

)

Fis

h in

viv

o st

udy:

Aqu

atiic

exp

osur

e of

fath

ead

min

now

w

ith B

P1

indu

ced

vite

lloge

nin

sign

ifica

ntly

at 4

919

mg/

l

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at in

viv

o st

udy:

Dec

reas

ed m

ale

anog

enita

l dis

tanc

e an

d in

crea

sed

inci

denc

e of

fetu

ses

with

und

esce

nded

test

es.

LOA

EL=

250

mg/

kg b

ody

wei

ght/d

ay

No

or in

suff

icie

nt d

ata

gath

ered

1359

3-03

-8

Qui

nalp

hos

=

Chi

nalp

hos

In v

ivo

rat s

tudy

: Sub

leth

al c

hron

ic a

dmin

istr

atio

n of

qui

nalp

hos

resu

lted

in: d

ecre

ased

test

icul

ar m

ass

and

AC

hE a

ctiv

ity in

ce

ntra

l as

wel

l as

perip

hera

l org

ans;

incr

ease

d se

rum

LH

, F

SH

, pro

lact

in, a

nd te

stos

tero

ne c

oncn

s.; d

ecre

ased

pitu

itary

or

incr

ease

d te

stic

ular

AC

E. E

d 7-

14 m

g/kg

/da

y.

Fis

h in

viv

o st

udy:

Impa

irmen

t of

test

is fu

nctio

n du

e to

the

inhi

bitio

n of

ste

roid

ogen

ic e

nzym

es a

ctiv

ities

. EC

=0.

025

mg/

L

Page 39: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

36ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

1508

7-24

-8

3-B

enzy

liden

e ca

mph

or (

3-B

C)

Rat

in v

ivo

stud

y: In

crea

se in

ute

rus

wei

ght.

LOE

D =

2 m

g/kg

bo

dy w

eigh

t.day

F

ish

in v

ivo

stud

y: V

itello

geni

n in

duct

ion.

ED

10, E

D50

and

E

D90

of 3

-ben

zylid

ene

cam

phor

afte

r 6

days

(2

inje

ctio

ns)

wer

e 6.

4, 1

6 an

d 26

mg/

kg/in

ject

ion,

res

p 15

82-0

9-8

Trif

lura

lin

In v

ivo

ewe

stud

y. C

once

ntra

tions

of e

stra

diol

wer

e si

gnifi

-ca

ntly

incr

ease

d in

ew

es g

iven

trifl

ural

in. N

o ef

fect

on

thyr

oxin

e co

ncen

trat

ion.

Mea

n se

rum

con

cent

ratio

ns o

f LH

wer

e m

ark-

edly

dec

reas

ed b

y tr

iflur

alin

, and

bas

al L

H c

once

ntra

tions

wer

e si

gnifi

cant

ly d

ecre

ased

. Onl

y on

e do

sis

(17.

5 m

g/kg

2 ti

mes

pe

r w

eek)

was

inve

stig

ated

Fis

h in

viv

o st

udy:

Pitu

itary

effe

cts

- po

ssib

ly in

dire

ct e

ffect

of

exp

osur

e.

1634

-04-

4 m

ethy

l ter

tiary

bu

tyl e

ther

(M

TB

E)

Rat

in v

io s

tudy

: Inc

reas

e of

test

is w

eigh

t. In

ters

titia

l flu

id a

nd

seru

m te

stos

tero

ne le

vels

as

wel

l as

seru

m p

rola

ctin

leve

ls

wer

e de

crea

sed

only

in a

nim

als

trea

ted

with

150

0 m

g M

TB

E/k

g/da

y fo

r 15

day

s.

Am

phib

ian

in v

ivo

stud

y: A

ccel

arat

ed d

evel

opm

ent a

nd e

ar-

lier

met

amor

phos

is. L

OE

C<

2500

mg/

L

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

ni-

sole

(B

HA

)

In v

ivo

rat s

tudy

. In

one-

gene

ratio

n ra

ts, s

ex r

atio

of m

ale

was

de

crea

sed

and

the

anog

enita

l dis

tanc

es w

ere

shor

tene

d an

d va

gina

l pat

ency

and

pre

putia

l sep

arat

ion

wer

e ob

serv

ed la

ter

than

con

trol

gro

up. A

lso,

BH

A d

ecre

ased

spe

rm m

otili

ty a

nd

num

ber

and

the

wid

th a

nd le

ngth

. LO

EL=

10 m

g/kg

bod

y w

eigh

t/day

Fis

h in

viv

o st

udy:

Incr

ease

d vi

tello

geni

n sy

nthe

sis.

E

C50

=14

.14

ug/L

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-te

tram

ethy

lbut

yl)-

=

Oct

ylph

enol

Rat

in v

ivo

stud

y. R

educ

ed s

perm

cou

nts

resu

lting

from

low

-er

ed p

lasm

a te

stos

tero

ne in

mal

e ra

ts ju

st a

fter

pube

rty.

ED

=3

mg/

kg b

ody

wei

ght.d

ay

Fis

h in

viv

o st

udy.

VT

G in

duct

ion

+ in

ters

ex g

onad

s.

LOE

C=

11.4

ug/

L

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

ame-

thyl

cycl

otet

rasi

-lo

xane

- 2

,6-c

is-

[(P

hMe-

SiO

)2(M

e2S

iO)2

][

In v

ivo

rat s

tudy

. Inh

ibite

d fe

rtili

ty a

nd a

ltera

tions

in m

easu

red

char

acte

ristic

s of

the

ejac

ulat

e. L

OA

EL=

0.5

mg/

kg/d

ay

No

or in

suff

icie

nt d

ata

gath

ered

3686

1-47

-9

3-(4

-M

ethy

lben

-zy

liden

e)ca

mph

or

Rat

in v

ivo

stud

y. D

elay

ed m

ale

pube

rty,

and

dos

e-de

pend

ently

affe

cted

rep

rodu

ctiv

e or

gan

wts

. of a

dult

mal

e an

d fe

mal

e F

1 of

fspr

ing,

with

par

tly d

iffer

ent e

ffect

pat

tern

s. T

hy-

roid

wt.

was

incr

ease

d by

hig

her

4-M

BC

dos

es. L

OA

EL=

7 m

g/kg

/day

Am

phib

ian

in v

ivo

stud

y.T

he r

ate

of m

etam

orph

osis

was

not

af

fect

ed, a

nd n

o ob

viou

s di

ffere

nces

in b

ody

and

tail

leng

th

com

pare

d to

con

trol

s w

ere

obse

rved

.

4376

-20-

9 M

ono

2 et

hyl

hex

-yl

phth

alat

e (M

EH

P)

Rat

in v

ivo

stud

y. S

igni

fican

tly d

ecre

ased

bod

y w

eigh

ts a

nd

mot

ile s

perm

s. L

OA

EL=

250

mg/

kg b

ody

wei

ght/d

ay

No

or in

suff

icie

nt d

ata

gath

ered

Page 40: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

37ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

50-1

8-0

Cyc

loph

os-

pham

ide

Rat

in v

ivo

assa

y: D

ecre

ased

ova

rian

and

uter

in w

eigh

t and

re

duct

ion

seru

m e

stra

diol

and

pro

gest

eron

e. L

OA

EL=

50 m

g/kg

bo

dy w

eigh

t

No

or in

suff

icie

nt d

ata

gath

ered

5466

-77-

3 2-

ethy

l-hex

yl-4

-m

etho

xyci

nna-

mat

e

Rat

in v

ivo

assa

y. U

terin

e w

t. w

as d

ose-

depe

nden

tly in

crea

sed

by O

MC

(E

D50

935

mg/

kg/d

ay)

Fis

h in

viv

o as

say.

Incr

ease

in p

lasm

a V

TG

+ a

nd in

-cr

ease

d m

RN

A e

xpre

ssio

n le

vels

of e

stro

gen

rece

ptor

(E

R)

alph

a, a

mon

g se

x ho

rmon

e re

cept

ors

in th

e liv

er.

556-

67-2

C

yclo

tetr

asilo

x-an

e R

at in

viv

o as

say.

Ute

rotr

ophi

c as

say

with

two

spec

ies:

Rel

a-tiv

e ut

erin

e w

ts. a

nd u

terin

e ep

ithel

ial c

ell h

eigh

t wer

e st

atis

ti-ca

lly s

igni

fican

tly in

crea

sed

in b

oth

stra

ins

of r

ats

at d

oses

ab

ove

100

mg/

kg/d

ay. L

OA

EL=

250

mg/

kg/d

ay

No

or in

suff

icie

nt d

ata

gath

ered

611-

99-4

4,

4'-

Dih

ydro

xybe

nzo-

phen

on

rat i

n vi

vo a

ssay

: Ind

uced

ute

rotr

ophy

and

exe

rted

bot

h es

tro-

gen

agon

istic

effe

ct a

nd r

educ

ed th

e es

trog

enic

effe

ct o

f eth

y-ny

lest

radi

ol

Fis

h in

viv

o as

say:

VT

G r

espo

nse.

In v

itro:

Ful

l dos

e-re

spon

se c

urve

s in

in v

itro

assa

y (r

ecom

bina

nt y

east

car

ry-

ing

the

estr

ogen

rec

epto

r of

rai

nbow

trou

t (rt

ER

a)).

In v

ivo:

V

TG

res

pons

e 61

64-9

8-3

Chl

ordi

mef

orm

In

viv

o ra

t stu

dy. D

elay

in b

reed

ing

and

a si

gnifi

cant

red

n. in

lit

ter

size

. ED

=50

mg/

kg.

No

or in

suff

icie

nt d

ata

gath

ered

7400

-08-

0 p-

Cou

mar

ic a

cid

(PC

A)

Rat

in v

ivo

assa

y: 1

89 a

nd 2

01%

thyr

oid

wts

incr

ease

com

-pa

red

to c

ontr

ol v

alue

. hyr

oid

lesi

ons

in p

-cou

mar

ic a

cid

grou

p w

ere

asso

cd. w

ith s

igni

fican

t inc

reas

es in

cel

lula

r pr

olife

ratio

n as

indi

cate

d b

y [3

H]th

ymid

ine

inco

rpor

atio

n. In

add

n., t

he g

oi-

trog

enic

effe

ct o

f p-c

oum

aric

aci

d w

as fu

rthe

r co

nfirm

ed b

y si

gnifi

cant

dec

reas

es (

50%

) in

ser

um tr

iiodo

thyr

onin

e (T

3) a

nd

thyr

oxin

e (T

4), a

nd a

par

alle

l inc

reas

e (9

0%)

in s

erum

TS

H

com

pare

d to

con

trol

gro

up. E

D=

0.25

mm

ol/k

g/da

y

No

or in

suff

icie

nt d

ata

gath

ered

77-0

9-8

3,3'

-Bis

(4-

hydr

oxy-

phen

yl)p

htha

lid =

P

heno

lpht

hale

ine

Rat

and

mic

e in

viv

o st

udy.

Exp

osur

e of

mic

e to

phe

nolp

htha

l-ei

n in

feed

for

2 ye

ars

resu

lted

in in

crea

sed

inci

denc

es o

f at

ypic

al h

yper

plas

ia o

f the

thym

us in

mal

es a

nd fe

mal

es, d

e-ge

nera

tion

of th

e ge

rmin

al e

pith

eliu

m o

f the

test

is in

mal

es,

and

ovar

ian

hype

rpla

sia

in fe

mal

es. L

OA

EL=

300

mg/

kg

No

or in

suff

icie

nt d

ata

gath

ered

77-4

0-7

2,2-

Bis

(4-

hydr

oxyp

heny

l)-n-

buta

n =

Bis

phen

ol

B

In v

ivo

imm

atur

e ra

t ute

rotr

ophi

c as

say:

Pos

itive

res

pons

e in

th

e ut

erot

roph

ic a

ssay

. Dos

e re

pons

e re

latio

nshi

p (0

, 2, 2

0 an

d 20

0 m

g/kg

)

No

or in

suff

icie

nt d

ata

gath

ered

92-6

9-3

4- Hyd

roxy

biph

enyl

=

4-P

heny

lphe

nol

Rat

in v

ivo

assa

y: U

tero

trop

hic

assa

y an

d C

albi

ndin

-D9k

(C

aBP

-9K

) m

RN

A e

xpre

ssio

n w

ere

exam

d. in

ova

riect

omiz

ed

Spr

ague

-Daw

ley

fem

ale

rats

. 4-

phen

ylph

enol

pro

duce

d do

se-

depe

nden

t (10

, 50,

200

, and

400

mg/

kg/d

ay(

incr

ease

s in

the

uter

ine

wts

. of o

varie

ctom

ized

rat

s). L

OA

EL=

200

mg/

kg/d

ay

No

or in

suff

icie

nt d

ata

gath

ered

Page 41: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

38ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

92-8

8-6

4,4'

-D

ihyd

roxy

bi-

phen

yl =

4,4

'-B

iphe

nol

Rat

in v

ivo

stud

y. R

at u

tero

trop

hic

assa

y. U

terin

e w

eigh

t in-

crea

se. L

OA

EL=

60 m

g/kg

bod

y w

eigh

t/day

. In

vitr

o st

udy.

Rec

ombi

nant

yea

st a

ssay

for

trou

t ER

and

tr

out h

epat

ocyt

e cu

lture

s. C

ompe

titiv

e bi

ndin

g to

ER

94-1

3-3

n-pr

opyl

p-

hydr

oxyb

enzo

ate

In v

ivo

rat a

ssay

: The

epi

didy

mal

spe

rm r

eser

ves

and

conc

en-

trat

ions

dec

reas

ed d

ose

depe

nden

tly a

nd th

e di

ffere

nce

was

si

gnifi

cant

at d

oses

of 0

.1%

and

abo

ve. L

OA

EL=

0.1%

Fis

h in

viv

o as

say:

Cle

ar d

ose

resp

onse

incr

ease

in V

TG

re

spon

se. E

D50

= 2

2 m

g kg

-1 2

-d. N

OE

C =

225

mg/

L

94-2

6-8

n-B

utyl

p-

Hyd

roxy

benz

oate

In

viv

o m

ice

stud

y. A

dos

e-de

pend

ent d

ecre

ase

of b

oth

roun

d an

d el

onga

ted

sper

mat

id o

unts

in s

tage

s V

II-V

III s

emin

ifero

us

tubu

les

was

obs

erve

d, a

nd th

e el

onga

ted

sper

mat

id c

ount

s w

ere

sign

ifica

ntly

low

er in

all

of th

e tr

eate

d gr

oups

. The

ser

um

test

oste

rone

con

cent

ratio

n de

crea

sed

in a

dos

e-de

pend

ent

fash

ion

and

was

sig

nific

ant a

t 1.0

0%. L

OA

EL=

1504

mg/

kg

body

wei

ght.

Day

Rai

nbow

trou

t in

vivo

stu

dy. V

itello

geni

n re

spon

se. L

OE

D:

oral

exp

osur

e to

9 m

g bu

tylp

arab

en k

g-1

2d-1

96-1

2-8

Dib

rom

ochl

oro-

prop

ane

(DB

CP

) E

xpos

ed h

uman

wor

kers

. Azo

ospe

rmia

olig

ospe

rmia

and

do

se-d

epen

dent

cha

nge

in F

SH

, LH

and

test

icle

siz

e N

o or

insu

ffic

ient

dat

a ga

ther

ed

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

In v

ivo

rat a

ssay

: Alte

ratio

n in

thyr

oid

func

tion

and

a si

gnifi

cant

ch

ange

in th

yroi

d m

orph

ol (

125

and

625

ppm

) .

NO

EC

= 2

5 pp

m

Am

phib

ian

in v

ivo

assa

y: In

a s

tand

ardi

sed

ringt

este

d te

st

prop

osal

(X

enop

us m

etam

orph

osis

ass

ay)

and

five

diffe

rent

E

TU

con

cns.

(5,

10,

25,

50,

and

100

mg/

L) a

con

cn.-

depe

nden

t inh

ibiti

on o

f met

amor

phos

is w

as o

bsd.

99

-76-

3 M

ethy

l p-

Hyd

roxy

benz

oate

In

viv

o m

ice

assa

y: T

he h

ighe

st M

ePbe

n do

se (

165

mg/

kg)

was

abl

e to

pro

duce

ute

rotr

ophi

c ef

fect

s (3

8 to

76%

) co

mpa

red

to E

-2 e

fect

s (1

00%

). L

OA

EL=

165

mg/

kg

No

or in

suff

icie

nt d

ata

gath

ered

99-9

6-7

p-H

ydro

xybe

nzoi

c ac

id

Rat

in v

ivo

assa

y: D

ose-

depe

nden

t res

pons

e (0

.5, 5

, 50,

and

50

0 g/

kg)

on v

agin

al c

orni

ficat

ion

and

uter

otro

phic

act

ivity

in

both

imm

atur

e an

d ad

ult o

varie

ctom

ized

mic

e.

No

or in

suff

icie

nt d

ata

gath

ered

Page 42: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

39ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Tab

le 5

.4

ED

effe

cts

obse

rved

in C

ateg

ory

2 su

bsta

nces

. Hum

an [H

H] a

nd w

ildlif

e [W

L] r

elat

ed d

ata

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

100-

02-7

4-

nitr

ophe

nol

In v

itro

assa

y: A

nti-a

ndro

geni

city

in a

ll fo

ur n

itrop

heno

ls in

clud

-in

g 4-

nitr

ophe

nol.

No

or in

suff

icie

nt d

ata

gath

ered

106-

44-5

p-

cres

ol

in v

itro

assa

y: A

nti-a

ndro

geni

city

in a

ll fo

ur n

itrop

heno

ls in

clud

-in

g 4-

nitr

ophe

nol i

nclu

ding

4-n

itro-

3-ph

enyl

phen

ol (

P-c

reso

l).

No

or in

suff

icie

nt d

ata

gath

ered

121-

29-9

P

yret

hrin

In

viv

o m

ice

assa

y: S

igni

fican

t per

cent

age

of s

perm

abn

orm

ali-

ties.

LO

AE

L=45

mg/

kg b

ody

wei

ght.

Wea

k en

docr

ine

effe

ct.

No

or in

suff

icie

nt d

ata

gath

ered

131-

16-8

D

i-n-

prop

ylph

thal

ate

(Dpr

P)

=

Dip

ropy

lpht

hala

te

In v

itro

mic

e st

udy.

Rep

rodu

ctio

n/te

rato

geni

c ef

fect

s. 4

4% r

e-du

ctio

n in

the

num

ber

of li

ve p

ups

per

litte

r. H

ighe

st d

ose

grou

p (8

.63

g/kg

) st

erile

No

or in

suff

icie

nt d

ata

gath

ered

131-

54-4

2,

2'-D

ihyd

roxy

-4,

4'-

dim

etho

xybe

nzo-

phen

on

In v

itro

assa

y: C

ompa

red

with

the

vehi

cle

cont

rol 2

,2’-

Dih

ydro

xy-

4,4’

-dim

etho

xybe

nzop

heno

ne s

how

ed p

ositi

ve e

f-fe

ct in

theM

CF

-7 c

ell p

rolif

erat

ion

assa

y.

No

or in

suff

icie

nt d

ata

gath

ered

131-

57-7

2-

hydr

oxy-

4-m

etho

xy-

benz

ophe

none

In v

itro

test

.: H

MB

at a

low

-tox

ic le

vel (

0.25

mM

) in

the

hepa

to-

cyte

sus

pens

ions

was

con

vert

ed e

nzym

atic

ally

to 2

,4-

dihy

drox

yben

zoph

enon

e (D

HB

). D

HB

at c

once

ntra

tions

from

10

-8 to

10-

6 M

cau

sed

a co

ncen

trat

ion-

depe

nden

t pro

lifer

atio

n of

MC

F-7

cel

ls. H

ydro

xyla

ted

inte

rmed

iate

s su

ch a

s D

HB

ra

ther

than

the

pare

nt c

ompo

und

act a

s a

xeno

estr

ogen

via

bi

otra

nsfo

rmat

ion.

Rec

ombi

nant

yea

st c

arry

ing

the

estr

ogen

rec

epto

r of

rai

n-bo

w tr

out (

rtE

Ra)

was

use

d. R

elat

ivel

y lo

w a

ctiv

ity o

f ben

-zo

phen

one-

3 w

as d

etec

ted

1400

7-30

-8

2,2-

Bis

(4-

hydr

oxyp

heny

l)-n-

hexa

ne

Rat

in v

ivo

assa

y: C

orni

ficat

ion

of v

agin

al e

pith

eliu

m. L

O-

AE

L=25

mg/

anim

al. V

ery

old

refe

renc

e N

o or

insu

ffic

ient

dat

a ga

ther

ed

1806

-29-

7 2,

2'-

Dih

ydro

xybi

-ph

enyl

= 2

,2'-

Bip

heno

l

in v

ivo

rat a

ssay

: Inc

reas

e ut

erus

gly

coge

n. L

OA

EL=

40 m

g/kg

2,

2'-B

iphe

nol s

how

ed a

ver

y w

eak

estr

ogen

ic a

ctiv

ity, r

e-qu

ring

> 1

0.00

0 fo

ld e

xces

s co

ncen

trat

ion

to in

hibi

t 50%

bi

ndin

g of

E2.

2042

7-84

-3

4- Non

ylph

enol

di-

etho

xyla

te

(NP

2EO

)

In v

itro

assa

y: 4

-non

ylph

enol

diet

hoxy

late

sho

wed

onl

y ve

ry

wea

k or

no

com

petit

ion

(rel

ativ

e bi

ndin

g af

finiti

es <

< 0

.1%

c.f.

es

trad

iol)

Fis

h in

viv

o as

say.

Slig

ht in

crea

se in

vite

lloge

nin

synt

hesi

s (E

C=

38uL

)

2051

-60-

7 P

CB

1 (

2-C

hlor

obip

heny

l) In

vitr

o su

dy. I

nduc

tion

of M

CF

-7 F

oci.

LOE

L=5x

10-6

M

No

or in

suff

icie

nt d

ata

gath

ered

2051

-61-

8 P

CB

2 (

3-C

hlor

obip

heny

l) R

at in

viv

o st

udy.

Incr

ease

d ut

erus

wei

ght.

LOA

EL=

160

mg/

kg.

Old

ref

eren

ce -

nee

ds to

be

conf

irmed

. N

o or

insu

ffic

ient

dat

a ga

ther

ed

Page 43: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

40ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

Q

ualif

ying

rem

arks

_HH

Q

ualif

ying

rem

arks

_WL

2051

-62-

9 P

CB

3 (

4-C

hlor

obip

heny

l) In

vitr

o as

say.

Indu

ctio

n of

MC

F-7

foci

N

o or

insu

ffici

ent d

ata

gath

ered

2581

-34-

2 3-

met

hyl-4

-ni

trop

heno

l In

vitr

o as

say:

Pos

itive

est

roge

nic

and

anti-

andr

ogen

ic a

ctiv

ity

No

or in

suff

icie

nt d

ata

gath

ered

3115

-49-

9 4-

nony

lphe

noxy

ac

etic

aci

d In

vitr

o as

say:

For

[3H

]est

radi

ol b

indi

ng to

AF

P, 4

-no

nylp

heno

xyac

etic

aci

d sh

owed

sig

nific

ant c

ompe

titio

n at

co

ncns

. abo

ut 1

00-f

old

grea

ter

than

est

radi

ol

Fis

h in

viv

o as

say:

Incr

ease

d pl

asm

a vi

tello

geni

n le

vel

491-

80-5

B

ioch

anin

A

In v

itro

stud

y. A

ctiv

atio

n of

ER

and

est

roge

nic

effe

ct o

n se

nsi-

tive

bioc

hem

ical

par

amet

ers

in m

ouse

ute

rus

No

or in

suff

icie

nt d

ata

gath

ered

6807

-17-

6 2,

2-B

is(4

-hy

drox

yphe

nyl)-

4-m

ethy

l-n-p

enta

ne

In v

ivo

+ in

vitr

o as

say.

Pos

itive

effe

ct in

ute

rotr

ophi

c as

say

+

posi

tive

in th

e re

port

er g

ene

assa

y fo

r E

R-a

lpha

ago

nist

s N

o or

insu

ffic

ient

dat

a ga

ther

ed

81-9

2-5

2-[B

is(4

-hy

drox

y-ph

enyl

)met

hyl]b

enz

ylal

koho

l =

Phe

nolp

htha

lol

In v

ivo

assa

y: In

crea

sed

uter

us w

eigh

t. LO

AE

L=4

mg/

kg. O

ld

refe

renc

e N

o or

insu

ffic

ient

dat

a ga

ther

ed

83-0

5-6

p,p'

-DD

A

In v

itro

assa

y: in

hibi

tion

of p

roge

ster

one-

indu

ced

repo

rter

gen

e ac

tivity

in a

dos

e-de

pend

ent m

anne

r Ja

pane

se q

uail

- T

hyro

id g

land

: dec

reas

e in

folli

cula

r re

-so

rptio

n va

cuol

es, a

nd a

n in

crea

se in

folli

cula

r si

ze. O

ld

refe

renc

e 84

-69-

5 D

iisob

utyl

phth

a-la

te

The

stu

dy d

emon

stra

tes

a de

velo

pmet

al to

xici

ty o

f DIB

P a

d-m

inis

tere

d to

rat

s by

gav

age,

thro

ugho

ut th

e em

bryo

nic

and

feta

l per

iod.

Fur

ther

exp

erim

ents

are

nee

ded

to c

hara

cter

ize

the

full

scal

e of

DIB

P d

evel

opm

enta

l tox

icity

.

No

or in

suff

icie

nt d

ata

gath

ered

84-7

5-3

Di-n

-hex

yl p

htha

-la

te (

DnH

P)

=

Dih

exyl

phth

alat

e (D

HP

)

Rev

iew

: The

dat

a ar

e su

ffici

ent t

o in

dica

te th

at D

nHP

is a

re-

prod

uctiv

e to

xica

nt in

bot

h se

xes

of tw

o ro

dent

spe

cies

follo

w-

ing

oral

exp

osur

e +

indi

catio

n of

thyr

oid

effe

cts.

No

or in

suff

icie

nt d

ata

gath

ered

99-7

1-8

4-se

c-B

utyl

phen

ol

= 4

-(1-

Met

hylp

ro-

pyl)p

heno

l

In v

itro

assa

y. S

timul

atio

n of

cel

l pro

lifer

atio

n. L

OE

L=10

uM

In v

itro

assa

y. o

-t-b

utyl

phen

ol e

xhib

ited

TR

-bin

ding

act

ivi-

ties

with

RE

C10

val

ues

of 4

.8 ×

10-

5 M

2597

-03-

7'

Els

an =

Di-

mep

hent

hoat

e N

o or

insu

ffici

ent d

ata

gath

ered

in

viv

o fis

h as

say:

Sig

nific

ant r

edn.

in th

e ov

aria

n w

eigh

t. LO

EC

=21

1ppb

Page 44: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

41ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Tab

le 5

.5

Ove

rvie

w o

f the

hum

an h

ealth

rel

evan

t sys

tem

ic to

xici

ty d

ata

of C

ateg

ory

1 su

bsta

nces

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 10

043-

35-3

B

oric

aci

d ra

bbits

D

ecre

ased

food

inta

ke a

nd v

agin

al

blee

ding

ass

ocd.

with

pre

gnan

cy lo

ss

wer

e th

e on

ly c

lear

man

ifest

atio

ns o

f to

xici

ty

LOE

D

250

mg/

kg b

ody

wei

ght.

day

1004

3-35

-3

Bor

ic a

cid

Spr

ague

-D

awle

y m

ale

rats

Effe

ct le

vel n

ot g

iven

1004

3-35

-3

Bor

ic a

cid

rats

S

igni

fican

t dec

reas

e in

HD

L3-

chol

este

rol.

No

chan

ge in

bod

y or

tes-

ticul

ar w

eigh

t bet

wee

n th

e co

ntro

l and

tr

eatm

ent g

roup

s

ED

2

mg/

day

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

End

ocrin

e -

Est

roge

nic

Mat

erna

l Ef-

fect

s -

Ute

rus,

cer

vix,

vag

ina

Oth

ers

- C

hang

es in

ute

rine

wei

ght

TD

Lo

270

mg/

kg/3

D in

-te

rmitt

ent

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Mat

erna

l Effe

cts

- O

varie

s, fa

llopi

an

tube

s M

ater

nal E

ffect

s -

Ute

rus,

cer

vix,

va

gina

TD

Lo

300

mg/

kg /3

D in

-te

rmitt

ent

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

600

mg/

kg /3

D in

-te

rmitt

ent

10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

End

ocrin

e -

Cha

nges

in p

itui-

tary

wei

ght N

utrit

iona

l and

Gro

ss

Met

abol

ic -

Wei

ght l

oss

or d

ecre

ased

w

eigh

t gai

n

TD

Lo

2000

m

g/kg

/20D

in

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Kid

ney,

Ure

ter,

and

Bla

dder

- C

hang

es

in k

idne

y w

eigh

t Mat

erna

l Effe

cts

- O

varie

s, fa

llopi

an tu

bes

Mat

erna

l Ef-

fect

s -

Ute

rus,

cer

vix,

vag

ina

TD

Lo

2000

m

g/kg

/20D

in

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Oth

ers

- C

hang

es in

ute

rine

wei

ght

T

DLo

15

0 m

g/kg

/3D

in-

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Oth

ers

- C

hang

es in

ute

rine

wei

ght

T

DLo

60

0 m

g/kg

/3D

in-

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Mat

erna

l Effe

cts

- O

ther

effe

cts

Effe

cts

on N

ewbo

rn -

Gro

wth

sta

tistic

s (e

.g.,

redu

ced

wei

ght g

ain)

Effe

cts

on N

ew-

born

- B

ehav

iora

l

TD

Lo

1.25

m

g/kg

Page 45: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

42ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

M

ater

nal E

ffect

s -

Men

stru

al c

ycle

ch

ange

s or

dis

orde

rs

TD

Lo

2500

m

g/kg

/25D

in-

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Mat

erna

l Effe

cts

- M

enst

rual

cyc

le

chan

ges

or d

isor

ders

T

DLo

20

00

mg/

kg /2

0D

inte

rmitt

ent

10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

M

ater

nal E

ffect

s -

Oth

er e

ffect

s

TD

Lo

4625

ug

/kg

10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

LD50

16

20

mg/

kg

10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

E

ndoc

rine

- E

stro

geni

c O

ther

s -

Cha

nges

in u

terin

e w

eigh

t

TD

Lo

600

mg/

kg/3

D in

-te

rmitt

ent

10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Rat

M

ater

nal E

ffect

s -

Ute

rus,

cer

vix,

va-

gina

T

DLo

70

0 m

g/kg

/14D

in-

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

200

mg/

kg

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na

TD

Lo

1000

m

g/kg

/20D

in

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Mat

erna

l Effe

cts

- M

enst

rual

cyc

le

chan

ges

or d

isor

ders

T

DLo

30

0 m

g/kg

/3D

in-

term

itten

t

104-

40-5

4-

Non

ylph

enol

(4-

NP

) R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Hep

atob

iliar

y sy

stem

Spe

cific

Dev

el-

opm

enta

l Abn

orm

aliti

es -

Uro

geni

tal

syst

em

TD

Lo

120

mg/

kg

1113

-02-

6 O

met

hoat

e C

hick

en

LD

50

125

mg/

kg

11

13-0

2-6

Om

etho

ate

Cat

LD50

50

m

g/kg

1113

-02-

6 O

met

hoat

e G

uine

a P

ig

LD

50

100

mg/

kg

11

13-0

2-6

Om

etho

ate

Rab

bit

LD

50

50

mg/

kg

11

13-0

2-6

Om

etho

ate

Mou

se

Bio

chem

ical

- T

rue

chol

ines

tera

se

LD50

19

m

g/kg

1113

-02-

6 O

met

hoat

e M

ouse

LD50

13

m

g/kg

1113

-02-

6 O

met

hoat

e M

ouse

B

ioch

emic

al -

Tru

e ch

olin

este

rase

LD

50

140

mg/

m3/

4H

11

13-0

2-6

Om

etho

ate

Rat

LD50

30

m

g/kg

1113

-02-

6 O

met

hoat

e R

at

LC

50

>15

00

mg/

m3/

1H

11

13-0

2-6

Om

etho

ate

Rat

LD50

70

0 m

g/kg

1113

-02-

6 O

met

hoat

e R

at

LD

50

55

mg/

kg

11

13-0

2-6

Om

etho

ate

Rat

B

lood

- O

ther

cha

nges

Bio

chem

ical

-

Tru

e ch

olin

este

rase

T

DLo

45

500

ug/k

g/13

W in

-te

rmitt

ent

11

13-0

2-6

Om

etho

ate

Hum

an

90

mg/

L

1113

-02-

6 O

met

hoat

e B

acte

ria -

E

Col

i

63

85

ug/p

late

(-S

9)

Page 46: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

43ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 11

13-0

2-6

Om

etho

ate

Qua

il (L

abo-

rato

ry)

LD

50

50

mg/

kg

1113

-02-

6 O

met

hoat

e C

hick

en

Pat

erna

l Effe

cts

- O

ther

effe

cts

on m

ale

LD

50

75

mg/

kg

11

13-0

2-6

Om

etho

ate

Rat

B

ioch

emic

al -

Tru

e ch

olin

este

rase

LD

50

1440

0 ug

/kg

11

13-0

2-6

Om

etho

ate

Mou

se

Blo

od -

Cha

nges

in b

one

mar

row

not

in

clud

ed a

bove

T

DLo

45

00

ug/k

g/5D

in-

term

itten

t

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t

TD

Lo

440

mg/

kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

K

idne

y, U

rete

r, a

nd B

ladd

er -

Oth

er

chan

ges

in u

rine

com

posi

tion

T

DLo

22

0 m

g/kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Mou

se

Effe

cts

on N

ewbo

rn -

Liv

e bi

rth

inde

x (s

imila

r to

T26

, exc

ept m

easu

red

afte

r bi

rth)

TD

Lo

504

gm/k

g

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Mou

se

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

50

4 gm

/kg/

15W

co

ntin

uous

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Mou

se

Live

r -

Cha

nges

in li

ver

wei

ght K

idne

y,

Ure

ter,

and

Bla

dder

- C

hang

es in

kid

-ne

y w

eigh

t Nut

ritio

nal a

nd G

ross

Met

a-bo

lic -

Wei

ght l

oss

or d

ecre

ased

wei

ght

gain

TD

Lo

504

gm/k

g/15

W

cont

inuo

us

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

E

ndoc

rine

- E

stro

geni

c B

lood

-

Cha

nges

in s

erum

com

posi

tion

(e.g

., T

P, b

iliru

bin,

cho

lest

erol

)

TD

Lo

9000

m

g/kg

/9D

in-

term

itten

t

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Spe

rmat

ogen

esis

(in

clud

ing

gene

tic m

ater

ial,

sper

m

mor

phol

ogy,

mot

ility

, and

cou

nt)

TD

Lo

1100

m

g/kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Mou

se

Effe

cts

on N

ewbo

rn -

Liv

e bi

rth

inde

x (s

imila

r to

T26

, exc

ept m

easu

red

afte

r bi

rth)

TD

Lo

504

gm/k

g

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

O

ther

s -

Cha

nges

in te

stic

ular

wei

ght

T

DLo

22

00

mg/

kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Mou

se

Effe

cts

on F

ertil

ity -

Fem

ale

fert

ility

in-

dex

(e.g

., #

fem

ales

pre

gnan

t pe

r #

sper

m p

ositi

ve f

emal

es #

fem

ales

pr

egna

nt p

er #

fem

ales

mat

ed)

Effe

cts

on N

ewbo

rn -

Liv

e bi

rth

inde

x (s

imila

r to

T26

, exc

ept m

easu

red

afte

r bi

rth)

TD

Lo

26.6

gm

/kg

Page 47: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

44ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

1-18

-0

Di-n

-pen

tylp

htha

late

(D

PP

) =

D

ipen

tylp

htha

late

M

ouse

E

ffect

s on

Fer

tility

- F

emal

e fe

rtili

ty in

-de

x (e

.g.,

# fe

mal

es p

regn

ant

per

# sp

erm

pos

itive

fem

ales

# fe

mal

es

preg

nant

per

# fe

mal

es m

ated

) E

ffect

s on

Fer

tility

- M

ale

fert

ility

inde

x (e

.g.,

# m

ales

impr

egna

ting

fem

ales

per

#

mal

es e

xpos

ed to

fert

ile n

TD

Lo

316

gm/k

g

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t

TD

Lo

6600

m

g/kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Oth

er e

ffect

s on

mal

e

TD

Lo

2206

m

g/kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Spe

rmat

ogen

esis

(in

clud

ing

gene

tic m

ater

ial,

sper

m

mor

phol

ogy,

mot

ility

, and

cou

nt)

Pat

er-

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, spe

rm

duct

Effe

cts

on F

ertil

ity -

Mal

e fe

rtili

ty

inde

x (e

.g.,

# m

ales

impr

egna

ting

fe-

mal

es p

er #

mal

es e

xpos

ed

TD

Lo

2 gm

/kg

131-

18-0

D

i-n-p

enty

lpht

hala

te (

DP

P)

=

Dip

enty

lpht

hala

te

Rat

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t Pat

erna

l Effe

cts

- P

rost

ate,

se

min

al v

essi

cle,

Cow

per's

gla

nd, a

c-ce

ssor

y g

land

s

TD

Lo

2800

0 m

g/kg

/10D

in-

term

itten

t

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

R

at

Gas

troi

ntes

tinal

- O

ther

cha

nges

Kid

-ne

y, U

rete

r, a

nd B

ladd

er -

Cha

nges

in

tubu

les

(incl

udin

g ac

ute

rena

l fa

ilure

, ac

ute

tubu

lar

necr

osis

)

LD50

86

00

mg/

kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

M

amm

al -

U

nspe

cifie

d S

peci

es

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

1020

0 m

g/kg

/85D

in-

term

itten

t

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

M

ouse

N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

T

DLo

99

00

mg/

kg/3

5D in

-te

rmitt

ent

13

1-56

-6

2,4-

Dih

ydro

xybe

nzop

heno

n =

R

esbe

nzop

heno

ne

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t Blo

od -

P

igm

ente

d or

nuc

leat

ed r

ed b

lood

cel

ls

Blo

od -

Cha

nges

in e

ryth

rocy

te (

RB

C)

coun

t

TD

Lo

5460

0 m

g/kg

/91D

in-

term

itten

t

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

R

abbi

t M

ild

DR

AIZ

E

reac

tion

100

mg/

24H

Page 48: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

45ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

1-56

-6

2,4-

Dih

ydro

xybe

nzop

heno

n =

R

esbe

nzop

heno

ne

Mou

se

Gas

troi

ntes

tinal

- O

ther

cha

nges

Kid

-ne

y, U

rete

r, a

nd B

ladd

er -

Cha

nges

in

tubu

les

(incl

udin

g ac

ute

rena

l fa

ilure

, ac

ute

tubu

lar

necr

osis

)

LD50

25

00

mg/

kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

M

ouse

LD50

10

0 m

g/kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

R

at

End

ocrin

e -

Est

roge

nic

T

DLo

47

.5

mg/

kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

R

at

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

1000

m

g/kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

R

at

Beh

avio

ral -

Som

nole

nce

(gen

eral

de-

pres

sed

activ

ity)

Beh

avio

ral -

Foo

d in

-ta

ke (

anim

al)

Gas

troi

ntes

tinal

- H

yper

-m

otili

ty, d

iarr

hea

LD50

86

00

mg/

kg

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

=

Res

benz

ophe

none

M

ouse

LD50

85

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Beh

avio

ral -

Foo

d in

take

(an

imal

) N

utri-

tiona

l and

Gro

ss M

etab

olic

- W

eigh

t lo

ss o

r de

crea

sed

wei

ght g

ain

TD

Lo

1500

m

g/kg

/3D

in-

term

itten

t

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Live

r -

Cha

nges

in li

ver

wei

ght B

lood

-

Cha

nges

in s

erum

com

posi

tion

(e.g

., T

P, b

iliru

bin,

cho

lest

erol

) B

ioch

emic

al -

Li

pids

incl

udin

g tr

ansp

ort

TD

Lo

8400

m

g/kg

/1W

con

-tin

uous

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cra

niof

acia

l (in

clud

ing

nose

and

to

ngue

) S

peci

fic D

evel

opm

enta

l Ab-

norm

aliti

es -

Oth

er d

evel

opm

enta

l ab-

norm

aliti

es

TD

Lo

4500

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Beh

avio

ral -

Foo

d in

take

(an

imal

) N

utri-

tiona

l and

Gro

ss M

etab

olic

- W

eigh

t lo

ss o

r de

crea

sed

wei

ght g

ain

TD

Lo

4500

m

g/kg

/9D

con

-tin

uous

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on E

mbr

yo o

r F

etus

- O

ther

ef-

fect

s to

em

bryo

T

DLo

40

0 m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Uro

geni

tal s

yste

m

TD

Lo

1500

m

g/kg

Page 49: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

46ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Rat

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

U

roge

nita

l sys

tem

TD

Lo

2250

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Uro

geni

tal s

yste

m

TD

Lo

750

mg/

kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Beh

avio

ral -

Foo

d in

take

(an

imal

) N

utri-

tiona

l and

Gro

ss M

etab

olic

- W

eigh

t lo

ss o

r de

crea

sed

wei

ght g

ain

Oth

ers

- C

hang

es in

ute

rine

wei

ght

TD

Lo

9000

m

g/kg

/9D

con

-tin

uous

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

TD

Lo

1200

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Beh

avio

ral -

Str

aub

Tai

l

TD

Lo

4500

m

g/kg

13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Rat

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m S

peci

fic D

e-ve

lopm

enta

l Abn

orm

aliti

es -

Oth

er d

e-ve

lopm

enta

l abn

orm

aliti

es

TD

Lo

1875

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on F

ertil

ity -

Pre

-impl

anta

tion

mor

talit

y (e

.g.,

redu

ctio

n in

num

ber

of

impl

ants

per

fem

ale

tota

l num

ber

of

impl

ants

per

cor

pora

lute

a) E

ffect

s on

F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

pe

r to

tal n

umbe

r of

i

TD

Lo

2250

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

32

00

mg/

kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

M

ouse

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) E

ffect

s on

Em

bryo

or

Fet

us -

Fet

al

deat

h

TD

Lo

400

mg/

kg

Page 50: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

47ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Mou

se

Effe

cts

on E

mbr

yo o

r F

etus

- F

etot

oxic

-ity

(ex

cept

dea

th, e

.g.,

stun

ted

fetu

s)

TD

Lo

1200

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

M

ouse

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t

TD

Lo

1680

0 m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on F

ertil

ity -

Pre

-impl

anta

tion

mor

talit

y (e

.g.,

redu

ctio

n in

num

ber

of

impl

ants

per

fem

ale

tota

l num

ber

of

impl

ants

per

cor

pora

lute

a) E

ffect

s on

F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

pe

r to

tal n

umbe

r of

i

TD

Lo

6750

m

g/kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

M

ouse

1.

6 gm

/kg

13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Mou

se

LD

50

1 gm

/kg

13

1-70

-4

Mon

o-n-

buty

lpht

hala

te

Mou

se

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

400

mg/

kg

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Uro

geni

tal s

yste

m

TD

Lo

40

gm/k

g

131-

70-4

M

ono-

n-bu

tylp

htha

late

R

at

Effe

cts

on F

ertil

ity -

Pre

-impl

anta

tion

mor

talit

y (e

.g.,

redu

ctio

n in

num

ber

of

impl

ants

per

fem

ale

tota

l num

ber

of

impl

ants

per

cor

pora

lute

a) E

ffect

s on

F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

pe

r to

tal n

umbe

r of

i

TD

Lo

9000

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

abbi

t S

ense

Org

ans

and

Spe

cial

Sen

ses

(Nos

e, E

ye, E

ar, a

nd T

aste

) -

Chr

o-m

odac

ryor

rhea

Beh

avio

ral -

Mus

cle

cont

ract

ion

or s

past

icity

Bio

chem

ical

-

Tru

e ch

olin

este

rase

LD50

50

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Pat

erna

l Effe

cts

- O

ther

eff

ects

on

mal

e E

ndoc

rine

- C

hang

e in

GH

End

ocrin

e -

And

roge

nic

TD

Lo

6500

ug

/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

abbi

t S

ever

e D

RA

IZE

re

actio

n 10

0 uL

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

igeo

n B

ehav

iora

l - A

ltere

d sl

eep

time

(incl

ud-

ing

chan

ge in

rig

htin

g re

flex)

Lun

g,

Tho

rax,

or

Res

pira

tion

- D

yspn

ea G

as-

troi

ntes

tinal

- H

yper

mot

ility

, dia

rrhe

a

LD50

10

500

ug/k

g

Page 51: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

48ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Chi

cken

B

ehav

iora

l - A

ltere

d sl

eep

time

(incl

ud-

ing

chan

ge in

rig

htin

g re

flex)

Lun

g,

Tho

rax,

or

Res

pira

tion

- D

yspn

ea G

as-

troi

ntes

tinal

- H

yper

mot

ility

, dia

rrhe

a

LD50

10

250

ug/k

g

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s C

hick

en

LD

50

20

mg/

kg

13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Chi

cken

LD50

25

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s D

og

LD

50

100

mg/

kg ['

Pre

hled

P

rum

yslo

ve

Tox

ikol

ogie

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s G

erbi

l B

ehav

iora

l - C

onvu

lsio

ns o

r ef

fect

on

seiz

ure

thre

shol

d Lu

ng, T

hora

x, o

r R

espi

ratio

n -

Bro

nchi

olar

con

stric

tion

Gas

troi

ntes

tinal

- H

yper

mot

ility

, dia

r-rh

ea

LD50

11

910

ug/k

g

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct P

ater

nal E

ffect

s -

Pro

stat

e,

sem

inal

ves

sicl

e, C

owpe

r's g

land

, ac-

cess

ory

gla

nds

Pat

erna

l Effe

cts

- O

ther

effe

cts

on m

ale

TD

Lo

6500

ug

/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s G

uine

a P

ig

Sen

se O

rgan

s an

d S

peci

al S

ense

s (N

ose,

Eye

, Ear

, and

Tas

te)

- C

hro-

mod

acry

orrh

ea B

ehav

iora

l - M

uscl

e co

ntra

ctio

n or

spa

stic

ity B

ioch

emic

al -

T

rue

chol

ines

tera

se

LD50

25

0 m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s C

at

Sen

se O

rgan

s an

d S

peci

al S

ense

s (N

ose,

Eye

, Ear

, and

Tas

te)

- C

hro-

mod

acry

orrh

ea B

ehav

iora

l - M

uscl

e co

ntra

ctio

n or

spa

stic

ity B

ioch

emic

al -

T

rue

chol

ines

tera

se

LD50

75

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

LD50

56

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

S

ense

Org

ans

and

Spe

cial

Sen

ses

(Nos

e, E

ye, E

ar, a

nd T

aste

) -

Chr

o-m

odac

ryor

rhea

Beh

avio

ral -

Mus

cle

cont

ract

ion

or s

past

icity

Bio

chem

ical

-

Tru

e ch

olin

este

rase

LD50

74

500

ug/k

g

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

LD50

34

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

LC50

33

0 m

g/m

3/4H

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

LD

50

300

mg/

kg

Page 52: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

49ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Rat

LD50

55

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

LD

50

26

mg/

kg

13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Rat

LD50

39

m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

LC

50

175

mg/

m3

13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Dom

estic

A

nim

als

- G

oat,

She

ep

Per

iphe

ral N

erve

and

Sen

satio

n -

Spa

stic

par

alys

is w

ith o

r w

ithou

t sen

-so

ry c

hang

e B

ehav

iora

l - S

omno

lenc

e (g

ener

al d

epre

ssed

act

ivity

) G

astr

oin-

test

inal

- C

hang

es in

str

uctu

re o

r fu

nc-

tion

of s

aliv

ary

glan

ds

LDLo

85

00

ug/k

g

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s H

amst

er

LC

50

600

mg/

m3/

4H

13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Mou

se

Tum

orig

enic

- N

eopl

astic

by

RT

EC

S

crite

ria L

ung,

Tho

rax,

or

Res

pira

tion

- O

ther

cha

nges

TD

Lo

30

mg/

kg/3

W

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

End

ocrin

e -

Est

roge

nic

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is, s

perm

duc

t Bio

-ch

emic

al -

Mul

tiple

enz

yme

effe

cts

TD

Lo

3.75

m

g/kg

/15D

in-

term

itten

t

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Oth

ers

- D

eath

T

DLo

55

7 m

g/kg

/60D

in-

term

itten

t

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Bio

chem

ical

- T

rue

chol

ines

tera

se

TD

Lo

1080

0 m

g/kg

/90D

co

ntin

uous

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

) B

io-

chem

ical

- T

rue

chol

ines

tera

se

TD

Lo

105

mg/

kg/1

5D in

-te

rmitt

ent

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

) B

io-

chem

ical

- T

rue

chol

ines

tera

se O

ther

s -

Cha

nges

in te

stic

ular

wei

ght

TD

Lo

150

mg/

kg/1

5D in

-te

rmitt

ent

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct O

ther

s -

Cha

nges

in te

s-tic

ular

wei

ght

TD

Lo

750

ug/k

g/3D

in-

term

itten

t

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Beh

avio

ral -

Tre

mor

Pat

erna

l Effe

cts

- S

perm

atog

enes

is (

incl

udin

g ge

netic

m

ater

ial,

sper

m m

orph

olog

y, m

otili

ty,

and

coun

t) O

ther

s -

Cha

nges

in te

stic

u-la

r w

eigh

t

TD

Lo

210

mg/

kg/1

5D in

-te

rmitt

ent

Page 53: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

50ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Gui

nea

Pig

B

rain

and

Cov

erin

gs -

Cha

nges

in b

rain

w

eigh

t Kid

ney,

Ure

ter,

and

Bla

dder

-

Cha

nges

in b

ladd

er w

eigh

t Oth

ers

- C

hang

es in

ova

rian

wei

ght

TD

Lo

60

mg/

kg/3

0D

cont

inuo

us

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s D

omes

tic

Ani

mal

s -

Goa

t, S

heep

Blo

od -

Oth

er c

hang

es B

ioch

emic

al -

T

rue

chol

ines

tera

se B

ioch

emic

al -

O

ther

est

eras

es

TD

Lo

1050

0 ug

/kg/

21D

con

-tin

uous

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

5

mg/

kg

13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Mou

se

5 m

g/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Effe

cts

on E

mbr

yo o

r F

etus

- F

etot

oxic

-ity

(ex

cept

dea

th, e

.g.,

stun

ted

fetu

s)

TD

Lo

2250

0 ug

/kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s R

at

Mat

erna

l Effe

cts

- O

ther

effe

cts

T

DLo

75

00

ug/k

g

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s G

erbi

l P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t

TD

Lo

15

mg/

kg

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s M

ouse

5

mg/

kg

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

Kid

ney,

Ure

ter,

and

Bla

dder

- C

hang

es

in b

ladd

er w

eigh

t Blo

od -

Cha

nges

in

seru

m c

ompo

sitio

n (e

.g.,

TP

, bili

rubi

n,

chol

este

rol)

Nut

ritio

nal a

nd G

ross

M

etab

olic

- C

a

TD

Lo

27

gm/k

g/90

D in

-te

rmitt

ent

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

LC

50

2800

0 m

g/m

3/2H

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

6

gm/k

g

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cra

niof

acia

l (in

clud

ing

nose

and

to

ngue

) S

peci

fic D

evel

opm

enta

l Ab-

norm

aliti

es -

Mus

culo

skel

etal

TC

Lo

8000

pp

m/6

H

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Effe

cts

on E

mbr

yo o

r F

etus

- F

etot

oxic

-ity

(ex

cept

dea

th, e

.g.,

stun

ted

fetu

s)

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Mus

culo

skel

etal

sys

tem

TC

Lo

4000

pp

m/6

H

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

E

ffect

s on

New

born

- V

iabi

lity

inde

x (e

.g.,

# al

ive

at d

ay 4

per

# b

orn

aliv

e)

Effe

cts

on N

ewbo

rn -

Gro

wth

sta

tistic

s (e

.g.,

redu

ced

wei

ght g

ain)

TC

Lo

8000

pp

m/6

H

Page 54: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

51ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

>14

8 m

g/kg

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

incr

ease

d se

rum

cor

ticos

tero

ne le

vels

LO

EL

8000

pp

m

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Bac

teria

- S

T

yphi

mur

ium

15

00

ug/p

late

(+

S9)

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

T

DLo

4.

2 gm

/kg/

2W c

on-

tinuo

us

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) M

ouse

LD50

59

60

uL/k

g

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Beh

avio

ral -

Gen

eral

ane

sthe

tic

LC50

14

1 gm

/m3/

15M

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

LD50

4

gm/k

g

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

LC50

41

000

mg/

m3/

4H

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

LC

50

2357

6 pp

m/4

H

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

LD

Lo

148

mg/

kg

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

End

ocrin

e -

And

roge

nic

T

DLo

10

00

mg/

kg

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) M

ouse

LD50

17

00

uL/k

g

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

De-

hydr

atio

n O

ther

s -

Cha

nges

in te

stic

u-la

r w

eigh

t

TD

Lo

4200

0 m

g/kg

/28D

in-

term

itten

t

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

K

idne

y, U

rete

r, a

nd B

ladd

er -

Cha

nges

in

tubu

les

(incl

udin

g ac

ute

rena

l fa

il-ur

e, a

cute

tubu

lar

necr

osis

)

TC

Lo

1516

pp

m/6

H/1

0D

inte

rmitt

ent

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

End

ocrin

e -

Cha

nges

in p

ituita

ry w

eigh

t M

ater

nal E

ffect

s -

Ute

rus,

cer

vix,

va-

gina

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TC

Lo

8000

pp

m/1

6W c

on-

tinuo

us

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na M

ater

nal E

ffect

s -

Men

stru

al c

ycle

ch

ange

s or

dis

orde

rs O

ther

s -

Cha

nges

in

ute

rine

wei

ght

TC

Lo

8000

pp

m/3

2W c

on-

tinuo

us

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mam

mal

-

Uns

peci

fied

Spe

cies

Kid

ney,

Ure

ter,

and

Bla

dder

- O

ther

ch

ange

s B

ioch

emic

al -

Cyt

ochr

ome

oxid

ases

(in

clud

ing

oxid

ativ

e ph

os-

phor

ylat

ion)

Bio

chem

ical

- T

rans

ami-

nase

s

TC

Lo

180

mg/

m3/

6H/1

5W

inte

rmitt

ent

Page 55: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

52ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) M

ouse

E

ndoc

rine

- C

hang

es in

pitu

itary

wei

ght

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na O

ther

s -

Cha

nges

in u

terin

e w

eigh

t

TC

Lo

8000

pp

m/2

1D c

on-

tinuo

us

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

B

rain

and

Cov

erin

gs -

Rec

ordi

ngs

from

sp

ecifi

c ar

c-as

of C

NS

Bio

chem

ical

-

Cat

alas

es B

ioch

emic

al -

Oth

er e

n-zy

mes

TD

Lo

210

mg/

kg/1

4D

cont

inuo

us

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Mou

se

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na

TC

Lo

8000

pp

m/3

D c

on-

tinuo

us

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

End

ocrin

e -

Cha

nges

in a

dren

al w

eigh

t N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

De-

hydr

atio

n

TD

Lo

2250

0 m

g/kg

/15D

in-

term

itten

t

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

per-

func

tion

T

DLo

15

000

mg/

kg/1

5D in

-te

rmitt

ent

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

End

ocrin

e -

And

roge

nic

Oth

ers

- D

eath

T

DLo

75

00

mg/

kg/1

1D in

-te

rmitt

ent

16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

at

Live

r -

Cha

nges

in li

ver

wei

ght E

ndo-

crin

e -

And

roge

nic

Nut

ritio

nal a

nd

Gro

ss M

etab

olic

- W

eigh

t los

s or

de-

crea

sed

wei

ght g

ain

TD

Lo

1120

0 m

g/kg

/28D

in-

term

itten

t

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t Kid

ney,

U

rete

r, a

nd B

ladd

er -

Cha

nges

in b

lad-

der

wei

ght B

lood

- C

hang

es in

ser

um

com

posi

tion

(e.g

., T

P, b

iliru

bin,

cho

les-

tero

l)

TD

Lo

49

gm/k

g/28

D in

-te

rmitt

ent

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Rat

K

idne

y, U

rete

r, a

nd B

ladd

er -

Cha

nges

in

bla

dder

wei

ght B

lood

- C

hang

es in

er

ythr

ocyt

e (R

BC

) co

unt N

utrit

iona

l and

G

ross

Met

abol

ic -

Wei

ght l

oss

or d

e-cr

ease

d w

eigh

t gai

n

TD

Lo

20

gm/k

g/14

D in

-te

rmitt

ent

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

T

umor

igen

ic -

Neo

plas

tic b

y R

TE

CS

cr

iteria

Lun

g, T

hora

x, o

r R

espi

ratio

n -

Tum

ors

42

00

mg/

kg/1

0W

cont

inuo

us

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

728

gm/k

g/2Y

con

-tin

uous

Page 56: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

53ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

Gas

troi

ntes

tinal

- T

umor

s

87

4 gm

/kg/

1Y c

on-

tinuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Lung

, Tho

rax,

or

Res

pira

tion

- C

hang

es in

Lun

g W

eigh

t Blo

od -

Oth

er

hem

olys

is w

ith o

r w

ithou

t ane

mia

Nut

ri-tio

nal a

nd G

ross

Met

abol

ic -

Wei

ght

loss

or

decr

ease

d w

eigh

t gai

n

TD

Lo

2688

m

g/kg

/7D

in-

term

itten

t

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

En-

docr

ine

- T

umor

s

87

4 gm

/kg/

2Y c

on-

tinuo

us

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria K

idne

y, U

rete

r, a

nd B

ladd

er -

T

umor

s T

umor

igen

ic -

Cel

ls (

cultu

red)

tr

ansf

orm

ed

26

9 gm

/kg/

32W

co

ntin

uous

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Ham

ster

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

T

DLo

43

7 gm

/kg/

1Y c

on-

tinuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) H

amst

er

100

umol

/L

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) O

ther

Mic

ro-

orga

nism

s

12

500

ug/L

(-S

9)

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

T

DLo

72

8 gm

/kg/

2Y c

on-

tinuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Tum

orig

enic

- E

quiv

ocal

tum

orig

enic

ag

ent b

y R

TE

CS

crit

eria

Gas

troi

ntes

ti-na

l - T

umor

s

18

2 gm

/kg/

2Y c

on-

tinuo

us

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t

TD

Lo

182

mg/

kg/2

Y c

on-

tinuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Live

r -

Oth

er c

hang

es N

utrit

iona

l and

G

ross

Met

abol

ic -

Oth

er c

hang

es B

io-

chem

ical

- H

epat

ic m

icro

som

al m

ixed

ox

idas

e (d

ealk

ylat

ion,

hyd

roxy

latio

n,

etc.

)

TD

Lo

3300

m

g/kg

/12D

in-

term

itten

t

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mon

key

Live

r -

Oth

er c

hang

es L

iver

- C

hang

es

in li

ver

wei

ght B

ioch

emic

al -

Pho

s-ph

atas

es

TD

Lo

14

gm/k

g/4W

in-

term

itten

t

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mon

key

Gas

troi

ntes

tinal

- O

ther

cha

nges

Liv

er -

C

hang

es in

live

r w

eigh

t Bio

chem

ical

-

Oth

er e

nzym

es

TD

Lo

15

gm/k

g/84

D in

-te

rmitt

ent

Page 57: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

54ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Tum

orig

enic

- N

eopl

astic

by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

202

gm/k

g/24

W

cont

inuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) H

amst

er

Tum

orig

enic

- N

eopl

astic

by

RT

EC

S

crite

ria G

astr

oint

estin

al -

Tum

ors

202

gm/k

g/24

W

cont

inuo

us

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) M

ouse

T

umor

igen

ic -

Equ

ivoc

al tu

mor

igen

ic

agen

t by

RT

EC

S c

riter

ia G

astr

oint

esti-

nal -

Tum

ors

TD

Lo

874

gm/k

g/1Y

con

-tin

uous

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t Bio

-ch

emic

al -

Pho

spha

tase

s

TD

Lo

700

mg/

kg/7

D in

-te

rmitt

ent

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Live

r -

Oth

er c

hang

es L

iver

- C

hang

es

in li

ver

wei

ght B

ioch

emic

al -

Hep

atic

m

icro

som

al m

ixed

oxi

dase

(de

alky

la-

tion,

hyd

roxy

latio

n, e

tc.)

TD

Lo

4676

m

g/kg

/28D

co

ntin

uous

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mou

se

Lung

, Tho

rax,

or

Res

pira

tion

- T

umor

s T

umor

igen

ic -

Pro

tect

s ag

ains

t ind

uc-

tion

of e

xper

imen

tal t

umor

s T

umor

i-ge

nic

- A

ctiv

e as

ant

i-can

cer

agen

t

TD

Lo

1154

gm

/kg/

8W in

-te

rmitt

ent

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mou

se

Live

r -

Oth

er c

hang

es L

iver

- C

hang

es

in li

ver

wei

ght B

ioch

emic

al -

Hep

atic

m

icro

som

al m

ixed

oxi

dase

(de

alky

la-

tion,

hyd

roxy

latio

n, e

tc.)

TD

Lo

1090

0 ng

/kg/

12D

in-

term

itten

t

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

Li

ver

- T

umor

s T

umor

igen

ic -

Pro

tect

s ag

ains

t ind

uctio

n of

exp

erim

enta

l tu-

mor

s T

umor

igen

ic -

Act

ive

as a

nti-

canc

er a

gent

TD

Lo

6300

m

g/kg

/6W

con

-tin

uous

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Hum

an

400

umol

/L

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Bio

chem

ical

- O

ther

tran

sfer

ases

T

DLo

96

0 m

g/kg

/2D

in-

term

itten

t

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

25

0 um

ol/L

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mou

se

Beh

avio

ral -

Alte

red

slee

p tim

e (in

clud

-in

g ch

ange

in r

ight

ing

refle

x) B

ehav

-io

ral -

Ata

xia

Lung

, Tho

rax,

or

Res

pira

-tio

n -

Res

pira

tory

stim

ulat

ion

LD50

11

00

mg/

kg

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Mou

se

Effe

cts

on N

ewbo

rn -

Beh

avio

ral

T

DLo

12

600

mg/

kg

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rab

bit

LD

50

2100

m

g/kg

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

E

ffect

s on

New

born

- G

row

th s

tatis

tics

(e.g

., re

duce

d w

eigh

t gai

n)

TD

Lo

30

gm/k

g

Page 58: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

55ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Blo

od -

Hem

orrh

age

LD

50

881

mg/

kg

25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) R

at

Bio

chem

ical

- H

epat

ic m

icro

som

al

mix

ed o

xida

se (

deal

kyla

tion,

hyd

roxy

-la

tion,

etc

.)

TD

Lo

480

mg/

kg

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

E

ffect

s on

New

born

- W

eani

ng o

r la

cta-

tion

inde

x (e

.g.,

# al

ive

at w

eani

ng p

er

# al

ive

at d

ay

4)

TD

Lo

36

gm/k

g

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

17

6 gm

/kg/

21W

co

ntin

uous

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Rat

B

ehav

iora

l - A

ltere

d sl

eep

time

(incl

ud-

ing

chan

ge in

rig

htin

g re

flex)

Beh

av-

iora

l - A

taxi

a Lu

ng, T

hora

x, o

r R

espi

ra-

tion

- R

espi

rato

ry s

timul

atio

n

LD50

2

gm/k

g

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-tet

ram

ethy

lbut

yl)-

=

Oct

ylph

enol

R

at

Oth

ers

- C

hang

es in

ute

rine

wei

ght

T

DLo

90

0 m

g/kg

/3D

in-

term

itten

t

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-tet

ram

ethy

lbut

yl)-

=

Oct

ylph

enol

M

ouse

LD50

25

m

g/kg

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-tet

ram

ethy

lbut

yl)-

=

Oct

ylph

enol

D

omes

tic

Ani

mal

s -

Goa

t, S

heep

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

End

ocrin

e sy

stem

T

DLo

6

mg/

kg

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-tet

ram

ethy

lbut

yl)-

=

Oct

ylph

enol

R

at

Oth

ers

- C

hang

es in

ute

rine

wei

ght

T

DLo

24

00

mg/

kg/3

D in

-te

rmitt

ent

33

204-

76-1

2,

6-ci

s-D

iphe

nylh

exam

ethy

lcyc

lote

tras

i-lo

xane

- 2

,6-c

is-

[(P

hMeS

iO)2

(Me2

SiO

)2][

Rab

bit

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

)

TD

Lo

1800

ug

/kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Mon

key

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

28

0 m

g/kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Mon

key

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

)

TD

Lo

28

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Dog

P

ater

nal E

ffect

s -

Pro

stat

e, s

emin

al

vess

icle

, Cow

per's

gla

nd, a

cces

sory

gl

ands

TD

Lo

400

mg/

kg

Page 59: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

56ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 33

204-

76-1

2,

6-ci

s-D

iphe

nylh

exam

ethy

lcyc

lote

tras

i-lo

xane

- 2

,6-c

is-

[(P

hMeS

iO)2

(Me2

SiO

)2][

Dog

P

ater

nal E

ffect

s -

Spe

rmat

ogen

esis

(in

clud

ing

gene

tic m

ater

ial,

sper

m

mor

phol

ogy,

mot

ility

, and

cou

nt)

Pat

er-

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, spe

rm

duct

TD

Lo

400

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rab

bit

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

4

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Mou

se

Pat

erna

l Effe

cts

- P

rost

ate,

sem

inal

ve

ssic

le, C

owpe

r's g

land

, acc

esso

ry

glan

ds

TD

Lo

210

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

M

ater

nal E

ffect

s -

Ute

rus,

cer

vix,

va-

gina

T

DLo

3

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

E

ffect

s on

Fer

tility

- F

emal

e fe

rtili

ty in

-de

x (e

.g.,

# fe

mal

es p

regn

ant

per

# sp

erm

pos

itive

fem

ales

# fe

mal

es

preg

nant

per

# fe

mal

es m

ated

)

TD

Lo

1 m

g/kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Dog

P

ater

nal E

ffect

s -

Pro

stat

e, s

emin

al

vess

icle

, Cow

per's

gla

nd, a

cces

sory

gl

ands

Pat

erna

l Effe

cts

- O

ther

effe

cts

on m

ale

TD

Lo

10

gm/k

g

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Mou

se

LD

50

>5

gm/k

g

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

M

ater

nal E

ffect

s -

Ute

rus,

cer

vix,

va-

gina

T

DLo

30

0 ug

/kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

E

ffect

s on

Fer

tility

- O

ther

mea

sure

s of

fe

rtili

ty

TD

Lo

3 m

g/kg

Page 60: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

57ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 33

204-

76-1

2,

6-ci

s-D

iphe

nylh

exam

ethy

lcyc

lote

tras

i-lo

xane

- 2

,6-c

is-

[(P

hMeS

iO)2

(Me2

SiO

)2][

Rat

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

)

TD

Lo

10

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

P

ater

nal E

ffect

s -

Pro

stat

e, s

emin

al

vess

icle

, Cow

per's

gla

nd, a

cces

sory

gl

ands

TD

Lo

7 m

g/kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t Pat

erna

l Effe

cts

- P

rost

ate,

se

min

al v

essi

cle,

Cow

per's

gla

nd, a

c-ce

ssor

y g

land

s

TD

Lo

231

mg/

kg

3320

4-76

-1

2,6-

cis-

Dip

heny

lhex

amet

hylc

yclo

tetr

asi-

loxa

ne -

2,6

-cis

-[(

PhM

eSiO

)2(M

e2S

iO)2

][

Rat

LD50

>

5 gm

/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Bio

chem

ical

- D

ehyd

roge

nase

s

TD

Lo

675

mg/

kg/9

0D

cont

inuo

us

43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Ham

ster

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t

TD

Lo

9 gm

/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Fer

tility

- P

re-im

plan

tatio

n m

orta

lity

(e.g

., re

duct

ion

in n

umbe

r of

im

plan

ts p

er fe

mal

e to

tal n

umbe

r of

im

plan

ts p

er c

orpo

ra lu

tea)

TD

Lo

350

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) B

acte

ria -

B

Sub

tilis

40

0 ug

/dis

c

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

200

umol

/L/2

4H

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) H

amst

er

750

mg/

L (+

S9)

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

T

DLo

51

11

mg/

kg/1

9D

cont

inuo

us

43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t Bio

-ch

emic

al -

Deh

ydro

gena

ses

Bio

chem

i-ca

l - O

ther

tran

sfer

ases

TD

Lo

7 gm

/kg/

14D

in-

term

itten

t

Page 61: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

58ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t Blo

od -

C

hang

es in

ser

um c

ompo

sitio

n (e

.g.,

TP

, bili

rubi

n, c

hole

ster

ol)

Bio

chem

ical

-

Lipi

ds in

clud

ing

tran

spor

t

TD

Lo

8400

m

g/kg

/1W

con

-tin

uous

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Live

r -

Cha

nges

in li

ver

wei

ght

T

DLo

68

25

mg/

kg/2

6W

cont

inuo

us

43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Ham

ster

Li

ver

- C

hang

es in

live

r w

eigh

t Bio

-ch

emic

al -

Hep

atic

mic

roso

mal

mix

ed

oxid

ase

(dea

lkyl

atio

n, h

ydro

xyla

tion,

et

c.)

Bio

chem

ical

- O

ther

tran

sfer

ases

TD

Lo

7 gm

/kg/

14D

in-

term

itten

t

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

LD

50

415

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) H

amst

er

750

mg/

L

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Blo

od -

Pig

men

ted

or n

ucle

ated

red

bl

ood

cells

Blo

od -

Cha

nges

in le

uko-

cyte

(W

BC

) co

unt

TD

Lo

168

mg/

kg/2

8D

cont

inuo

us

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) H

amst

er

375

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

25

m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

LD

50

150

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

LD

50

1340

m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) H

amst

er

25

mg/

L

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

2 m

mol

/L

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

LD50

24

0 m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

LD50

20

8 m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

40

0 m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Not

rep

orte

d D

RA

IZE

re

actio

n 10

0 m

g

Page 62: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

59ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Mou

se

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

Effe

cts

on E

mbr

yo o

r F

etus

- O

ther

ef-

fect

s to

em

bryo

TD

Lo

1241

m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) E

ffect

s on

Em

bryo

or

Fet

us -

Fet

al

deat

h

TD

Lo

665

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) H

uman

5

mm

ol/L

/1H

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m

TD

Lo

100

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) E

ffect

s on

Fer

tility

- L

itter

siz

e (e

.g.,

# fe

tuse

s pe

r lit

ter,

mea

sure

d b

efor

e bi

rth)

TD

Lo

596.

7 m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Effe

cts

on N

ewbo

rn -

Oth

er n

eona

tal

mea

sure

s or

effe

cts

T

DLo

45

00

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

T

DLo

10

0 m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

)

TD

Lo

3750

m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

T

DLo

25

46

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Pat

erna

l Effe

cts

- S

perm

atog

enes

is

(incl

udin

g ge

netic

mat

eria

l, sp

erm

m

orph

olog

y, m

otili

ty, a

nd c

ount

)

TD

Lo

2 gm

/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Pat

erna

l Effe

cts

- T

este

s, e

pidi

dym

is,

sper

m d

uct

T

DLo

63

20

ug/k

g

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) R

at

Pat

erna

l Effe

cts

- O

ther

effe

cts

on m

ale

T

DLo

50

0 m

g/kg

Page 63: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

60ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 43

76-2

0-9

Mon

o 2

eth

yl h

exyl

phth

alat

e (M

EH

P)

Rat

P

ater

nal E

ffect

s -

Pro

stat

e, s

emin

al

vess

icle

, Cow

per's

gla

nd, a

cces

sory

gl

ands

TD

Lo

1 gm

/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Fer

tility

- L

itter

siz

e (e

.g.,

# fe

tuse

s pe

r lit

ter,

mea

sure

d b

efor

e bi

rth)

TD

Lo

4360

m

g/kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

E

ffect

s on

Fer

tility

- P

ost-

impl

anta

tion

mor

talit

y (e

.g.,

dead

and

or

res

orbe

d im

plan

ts p

er to

tal n

umbe

r of

impl

ants

) E

ffect

s on

Fer

tility

- L

itter

siz

e (e

.g.,

# fe

tuse

s pe

r lit

ter,

mea

sure

d b

efor

e bi

rth)

Effe

cts

on E

mbr

yo o

r F

etus

- F

e-to

toxi

city

(ex

cep

TD

Lo

1193

.4

mg/

kg

4376

-20-

9 M

ono

2 et

hyl

hex

ylph

thal

ate

(ME

HP

) M

ouse

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

ardi

ovas

cula

r (c

ircul

ator

y) s

yste

m

TD

Lo

1387

m

g/kg

611-

99-4

4,

4'-D

ihyd

roxy

benz

ophe

non

Rat

E

ndoc

rine

- E

stro

geni

c

TD

Lo

47.5

m

g/kg

611-

99-4

4,

4'-D

ihyd

roxy

benz

ophe

non

Mou

se

>50

0 m

g/kg

611-

99-4

4,

4'-D

ihyd

roxy

benz

ophe

non

Ham

ster

20

0 um

ol/L

611-

99-4

4,

4'-D

ihyd

roxy

benz

ophe

non

Rat

O

ther

s -

Cha

nges

in u

terin

e w

eigh

t

TD

Lo

600

mg/

kg/3

D in

-te

rmitt

ent

61

64-9

8-3

Chl

ordi

mef

orm

R

at

End

ocrin

e -

Oth

er c

hang

es

TD

Lo

40

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

M

ouse

LD50

71

m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Mou

se

Blo

od -

Tum

ors

T

DLo

21

84

mg/

kg/1

04W

co

ntin

uous

6164

-98-

3 C

hlor

dim

efor

m

Rat

E

ndoc

rine

- C

hang

e in

gon

adot

ropi

ns

End

ocrin

e -

Evi

denc

e of

thyr

oid

hypo

-fu

nctio

n E

ndoc

rine

- A

ndro

geni

c

TD

Lo

100

mg/

kg

6164

-98-

3 C

hlor

dim

efor

m

Ham

ster

E

ndoc

rine

- E

ffect

on

men

stru

al c

ycle

LD

50

200

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

R

at

LD

50

160

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

m

ice

decr

ease

in Ig

M a

ntib

ody-

form

ing

cells

LO

EL

20

mg/

kg b

ody-

wei

ght.d

ay

6164

-98-

3 C

hlor

dim

efor

m

Mam

mal

-

Uns

peci

fied

Spe

cies

LC

50

>58

00

mg/

m3/

1H

6164

-98-

3 C

hlor

dim

efor

m

Rab

bit

LD

50

625

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

R

abbi

t S

ever

e D

RA

IZE

re

actio

n 10

0 m

g

Page 64: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

61ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 61

64-9

8-3

Chl

ordi

mef

orm

R

abbi

t

LD50

64

0 m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

E

ffect

s on

New

born

- B

ehav

iora

l

TD

Lo

1800

ug

/kg

61

64-9

8-3

Chl

ordi

mef

orm

R

at

Beh

avio

ral -

Alte

ratio

n if

oper

ant c

ondi

-tio

ning

T

DLo

60

m

g/kg

/3D

in-

term

itten

t

6164

-98-

3 C

hlor

dim

efor

m

Mou

se

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

Vas

cula

r -

Tum

ors

Lung

, Tho

-ra

x, o

r R

espi

ratio

n -

Tum

ors

TD

Lo

6552

m

g/kg

/78W

co

ntin

uous

6164

-98-

3 C

hlor

dim

efor

m

Hum

an

1 m

mol

/L

61

64-9

8-3

Chl

ordi

mef

orm

In

sect

s -

D

Mel

anog

aste

r

10

pp

b

6164

-98-

3 C

hlor

dim

efor

m

Bac

teria

- S

T

yphi

mur

ium

2

umol

/pla

te (

-S

9)

61

64-9

8-3

Chl

ordi

mef

orm

R

at

60

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

H

amst

er

End

ocrin

e -

Oth

er c

hang

es

TD

Lo

75

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

R

at

Bio

chem

ical

- E

ffect

on

infla

mm

atio

n or

m

edia

tion

of in

flam

mat

ion

T

DLo

40

m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

C

ardi

ac -

Cha

nge

in r

ate

Vas

cula

r -

BP

lo

wer

ing

not c

hara

cter

ized

in a

uto-

nom

ic s

ectio

n

TD

Lo

5 m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

E

ndoc

rine

- A

ndro

geni

c P

ater

nal E

f-fe

cts

- S

perm

atog

enes

is (

incl

udin

g ge

-ne

tic m

ater

ial,

sper

m m

orph

olog

y, m

o-til

ity, a

nd c

ount

) N

utrit

iona

l and

Gro

ss

Met

abol

ic -

Wei

ght l

oss

or d

ecre

ased

w

eigh

t gai

n

TD

Lo

200

mg/

kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

E

ndoc

rine

- C

hang

e in

gon

adot

ropi

ns

Blo

od -

Oth

er c

hang

es

TD

Lo

50

mg/

kg

6164

-98-

3 C

hlor

dim

efor

m

rat

incr

ease

in A

CT

H, C

OR

T a

nd P

L LO

EL

20

mg/

kg b

ody

wei

ght

6164

-98-

3 C

hlor

dim

efor

m

Rat

E

ndoc

rine

- A

dren

al c

orte

x hy

perp

lasi

a

TD

Lo

20

mg/

kg

61

64-9

8-3

Chl

ordi

mef

orm

R

at

Blo

od -

U28

T

DLo

20

m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Ham

ster

E

ndoc

rine

- C

hang

e in

gon

adot

ropi

ns

Mat

erna

l Effe

cts

- O

ogen

esis

Mat

erna

l E

ffect

s -

Ova

ries,

fallo

pian

tube

s

TD

Lo

150

mg/

kg

6164

-98-

3 C

hlor

dim

efor

m

Mou

se

Bra

in a

nd C

over

ings

- O

ther

deg

ener

a-tiv

e ch

ange

s

TD

Lo

35

mg/

kg

Page 65: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

62ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 61

64-9

8-3

Chl

ordi

mef

orm

H

amst

er

End

ocrin

e -

Cha

nge

in G

H E

ndoc

rine

- E

stro

geni

c

TD

Lo

37.5

m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

LD50

90

m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Rat

LD50

26

3 m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Hum

an

1 m

mol

/L

61

64-9

8-3

Chl

ordi

mef

orm

M

ouse

LD50

16

0 m

g/kg

6164

-98-

3 C

hlor

dim

efor

m

Mou

se

LD

50

225

mg/

kg

74

00-0

8-0

p-C

oum

aric

aci

d (P

CA

) M

ouse

E

ffect

s on

Fer

tility

- A

bort

ion

T

DLo

50

m

g/kg

74

00-0

8-0

p-C

oum

aric

aci

d (P

CA

) M

ouse

LD50

65

7 m

g/kg

7400

-08-

0 p-

Cou

mar

ic a

cid

(PC

A)

Mou

se

Effe

cts

on F

ertil

ity -

Oth

er m

easu

res

of

fert

ility

T

DLo

35

m

g/kg

7400

-08-

0 p-

Cou

mar

ic a

cid

(PC

A)

Rat

P

ater

nal E

ffect

s -

Tes

tes,

epi

didy

mis

, sp

erm

duc

t Pat

erna

l Effe

cts

- P

rost

ate,

se

min

al v

essi

cle,

Cow

per's

gla

nd, a

c-ce

ssor

y g

land

s E

ffect

s on

Fer

tility

-

Mat

ing

perf

orm

ance

(e.

g., #

spe

rm

posi

tive

fem

ales

per

# fe

mal

es m

ated

#

copu

latio

ns p

er #

est

rus

cy

TD

Lo

2800

m

g/kg

7400

-08-

0 p-

Cou

mar

ic a

cid

(PC

A)

Mam

mal

-

Uns

peci

fied

Spe

cies

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na

TD

Lo

9600

m

g/kg

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

End

ocrin

e -

Est

roge

nic

T

DLo

95

m

g/kg

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

16

80

mg/

kg/1

4D

cont

inuo

us

77

-09-

8 3,

3'-B

is(4

-hyd

roxy

phen

yl)p

htha

lid

= P

heno

lpht

hale

ine

Mou

se

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

Blo

od -

Lym

phom

as in

clud

ing

Hod

gkin

's d

isea

se

TD

Lo

4326

00

mg/

kg/1

03W

co

ntin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

Tum

orig

enic

- N

eopl

astic

by

RT

EC

S

crite

ria E

ndoc

rine

- A

dren

al c

orte

x tu

-m

ors

TD

Lo

3605

00

mg/

kg/1

03W

co

ntin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

LD

Lo

500

mg/

kg

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

U

roge

nita

l sys

tem

T

DLo

84

0 m

g/kg

Page 66: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

63ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 77

-09-

8 3,

3'-B

is(4

-hyd

roxy

phen

yl)p

htha

lid

= P

heno

lpht

hale

ine

Mou

se

Effe

cts

on N

ewbo

rn -

Liv

e bi

rth

inde

x (s

imila

r to

T26

, exc

ept m

easu

red

afte

r bi

rth)

TD

Lo

840

mg/

kg

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

Live

r -

Cha

nges

in li

ver

wei

ght B

lood

-

Cha

nges

in s

erum

com

posi

tion

(e.g

., T

P, b

iliru

bin,

cho

lest

erol

) N

utrit

iona

l an

d G

ross

Met

abol

ic -

Wei

ght l

oss

or

decr

ease

d w

eigh

t gai

n

TD

Lo

324

gm/k

g/13

W

cont

inuo

us

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

Li

ver

- C

hang

es in

live

r w

eigh

t Blo

od -

C

hang

es in

ery

thro

cyte

(R

BC

) co

unt

Oth

ers

- C

hang

es in

test

icul

ar w

eigh

t

TD

Lo

106

gm/k

g/13

W

cont

inuo

us

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

Li

ver

- T

umor

s T

umor

igen

ic -

Act

ive

as

anti-

canc

er a

gent

T

DLo

28

8400

m

g/kg

/103

W

cont

inuo

us

77

-09-

8 3,

3'-B

is(4

-hyd

roxy

phen

yl)p

htha

lid

= P

heno

lpht

hale

ine

Rat

T

umor

igen

ic -

Equ

ivoc

al tu

mor

igen

ic

agen

t by

RT

EC

S c

riter

ia K

idne

y, U

re-

ter,

and

Bla

dder

- K

idne

y tu

mor

s

TD

Lo

1442

000

mg/

kg/1

03W

co

ntin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e H

uman

23

.2

mg/

L/22

H

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

umor

s S

kin

and

App

enda

ges

- T

umor

s

TD

Lo

281

gm/k

g/2Y

con

-tin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria B

lood

- L

ymph

omas

incl

udin

g H

odgk

in's

dis

ease

TD

Lo

2884

00

mg/

kg/1

03W

co

ntin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

Kid

ney,

Ure

ter,

and

Bla

dder

-

Tum

ors

End

ocrin

e -

Adr

enal

cor

tex

tu-

mor

s

TD

Lo

364

gm/k

g/2Y

con

-tin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

Tum

orig

enic

- E

quiv

ocal

tum

orig

enic

ag

ent b

y R

TE

CS

crit

eria

End

ocrin

e -

Adr

enal

cor

tex

tum

ors

TD

Lo

3605

00

mg/

kg/1

03W

co

ntin

uous

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

>1

gm/k

g

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

K

idne

y, U

rete

r, a

nd B

ladd

er -

Cha

nges

in

kid

ney

wei

ght P

ater

nal E

ffect

s -

Tes

-te

s, e

pidi

dym

is, s

perm

duc

t

TD

Lo

123.

48

gm/k

g/21

W

cont

inuo

us

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

ouse

M

ater

nal E

ffect

s -

Par

turit

ion

Effe

cts

on

Fer

tility

- O

ther

mea

sure

s of

fert

ility

T

DLo

29

.4

gm/k

g

Page 67: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

64ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 77

-09-

8 3,

3'-B

is(4

-hyd

roxy

phen

yl)p

htha

lid

= P

heno

lpht

hale

ine

Mou

se

Effe

cts

on N

ewbo

rn -

Liv

e bi

rth

inde

x (s

imila

r to

T26

, exc

ept m

easu

red

afte

r bi

rth)

TD

Lo

123.

48

gm/k

g

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e R

at

End

ocrin

e -

Est

roge

nic

End

ocrin

e -

Cha

nges

in e

ndoc

rine

wei

ght (

unsp

eci-

fied)

Bio

chem

ical

- O

ther

car

bohy

-dr

ates

TD

Lo

160

mg/

kg/1

8H

77-0

9-8

3,3'

-Bis

(4-h

ydro

xyph

enyl

)pht

halid

=

Phe

nolp

htha

lein

e M

an

Gas

troi

ntes

tinal

- G

astr

itis

Gas

troi

ntes

-tin

al -

Nau

sea

or v

omiti

ng K

idne

y,

Ure

ter,

and

Bla

dder

- O

ther

cha

nges

in

urin

e co

mpo

sitio

n

TD

Lo

29

mg/

kg

77-4

0-7

2,2-

Bis

(4-h

ydro

xyph

enyl

)-n-

buta

n =

Bis

phen

ol B

R

at

Mat

erna

l Effe

cts

- U

teru

s, c

ervi

x, v

a-gi

na M

ater

nal E

ffect

s -

Oth

er e

ffect

s

TD

Lo

600

mg/

kg/3

D in

-te

rmitt

ent

92

-69-

3 4-

Hyd

roxy

biph

enyl

= 4

-P

heny

lphe

nol

Mou

se

LD

50

150

mg/

kg

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-

Phe

nylp

heno

l M

ouse

Li

ver

- O

ther

cha

nges

LD

50

150

mg/

kg

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-

Phe

nylp

heno

l M

ouse

T

umor

igen

ic -

Equ

ivoc

al tu

mor

igen

ic

agen

t by

RT

EC

S c

riter

ia L

ung,

Tho

rax,

or

Res

pira

tion

- T

umor

s B

lood

- L

eu-

kem

ia

TD

Lo

153

gm/k

g/78

W

inte

rmitt

ent

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-

Phe

nylp

heno

l M

ouse

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria B

lood

- T

umor

s

TD

Lo

1000

m

g/kg

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Mou

se

Blo

od -

Cha

nges

in b

one

mar

row

not

in

clud

ed a

bove

T

DLo

40

m

g/kg

/12H

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Hum

an

100

nmol

/L

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Mou

se

40

mg/

kg

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Hum

an

5 um

ol/L

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Rab

bit

LD

50

1780

m

g/kg

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Rat

Lu

ng, T

hora

x, o

r R

espi

ratio

n -

Oth

er

chan

ges

Live

r -

Oth

er c

hang

es K

idne

y,

Ure

ter,

and

Bla

dder

- O

ther

cha

nges

LD50

49

20

mg/

kg

Page 68: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

65ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 92

-88-

6 4,

4'-D

ihyd

roxy

biph

enyl

= 4

,4'-

Bip

heno

l R

at

End

ocrin

e -

Est

roge

nic

T

DLo

19

0 m

g/kg

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-B

iphe

nol

Mou

se

LD

50

100

mg/

kg

94-1

3-3

Phe

nol,

2-oc

tyl-

Rat

LD50

28

00

mg/

kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

End

ocrin

e -

Thy

roid

tum

ors

T

DLo

10

815

mg/

kg/1

03W

co

ntin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

T

DLo

75

m

g/kg

/8W

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

hyro

id tu

mor

s

TD

Lo

5475

m

g/kg

/1Y

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t End

o-cr

ine

- C

hang

es in

thyr

oid

wei

ght

T

DLo

37

5 m

g/kg

/8W

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria L

ung,

Tho

rax,

or

Res

pira

tion

- T

umor

s E

ndoc

rine

- T

hyro

id tu

mor

s

TD

Lo

5306

m

g/kg

/77W

co

ntin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

C

ardi

ac -

Cha

nges

in h

eart

wei

ght

T

DLo

22

81

mg/

kg/2

6W

cont

inuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

End

ocrin

e -

Thy

roid

tum

ors

T

DLo

90

12.5

m

g/kg

/103

W

cont

inuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Kid

ney,

Ure

ter,

and

Bla

dder

- C

hang

es

in k

idne

y w

eigh

t End

ocrin

e -

Cha

nges

in

Spl

een

wei

ght

TD

Lo

1500

m

g/kg

/8W

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

T

DLo

11

40.6

m

g/kg

/26W

co

ntin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

per-

func

tion

T

DLo

22

81

mg/

kg/1

Y c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

End

ocrin

e -

Oth

er c

hang

es E

ndoc

rine

- C

hang

es in

thyr

oid

wei

ght B

lood

-

Cha

nges

in s

erum

com

posi

tion

(e.g

., T

P, b

iliru

bin,

cho

lest

erol

)

TD

Lo

764

mg/

kg/9

0D

cont

inuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

hyro

id tu

mor

s

TD

Lo

9125

m

g/kg

/1Y

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

Liv

er -

Tum

ors

End

ocrin

e -

Thy

-ro

id tu

mor

s

TD

Lo

8652

0 m

g/kg

/103

W

cont

inuo

us

Page 69: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

66ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) M

ouse

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria L

iver

- T

umor

s E

ndoc

rine

- T

hy-

roid

tum

ors

TD

Lo

8736

0 m

g/kg

/2Y

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Man

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

T

CLo

10

ug

/m3/

10Y

in-

term

itten

t

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- O

ther

cha

nges

Blo

od -

C

hang

es in

ser

um c

ompo

sitio

n (e

.g.,

TP

, bili

rubi

n, c

hole

ster

ol)

TD

Lo

297

mg/

kg/2

8D

cont

inuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- O

ther

cha

nges

End

ocrin

e -

Cha

nges

in th

yroi

d w

eigh

t Nut

ritio

nal

and

Gro

ss M

etab

olic

- W

eigh

t los

s or

de

crea

sed

wei

ght g

ain

TD

Lo

3600

m

g/kg

/17W

co

ntin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

End

ocrin

e -

Cha

nges

in th

yroi

d w

eigh

t

TD

Lo

34.8

6 m

g/kg

/7D

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

T

DLo

29

.05

mg/

kg/7

D c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

End

ocrin

e -

Cha

nges

in S

plee

n w

eigh

t T

DLo

54

75

mg/

kg/2

6W

cont

inuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) M

ouse

Li

ver

- C

hang

es in

live

r w

eigh

t End

o-cr

ine

- E

vide

nce

of th

yroi

d hy

pofu

nctio

n B

ioch

emic

al -

Cyt

ochr

ome

oxid

ases

(in

clud

ing

oxid

ativ

e ph

osph

oryl

atio

n)

TD

Lo

840

mg/

kg/7

D c

on-

tinuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- E

vide

nce

of th

yroi

d hy

po-

func

tion

T

DLo

10

950

mg/

kg/1

Y c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) M

ouse

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria L

iver

- T

umor

s B

lood

- L

ym-

phom

as in

clud

ing

Hod

gkin

's d

isea

se

TD

Lo

77

gm/k

g/82

W

cont

inuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Live

r -

Cha

nges

in li

ver

wei

ght E

ndo-

crin

e -

Evi

denc

e of

thyr

oid

hypo

func

tion

T

DLo

27

7.2

mg/

kg/7

D c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Beh

avio

ral -

Foo

d in

take

(an

imal

) E

n-do

crin

e -

Cha

nges

in th

yroi

d w

eigh

t N

utrit

iona

l and

Gro

ss M

etab

olic

-

Wei

ght l

oss

or d

ecre

ased

wei

ght g

ain

TD

Lo

220

mg/

kg/7

W c

on-

tinuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ndoc

rine

- C

hang

es in

thyr

oid

wei

ght

Nut

ritio

nal a

nd G

ross

Met

abol

ic -

W

eigh

t los

s or

dec

reas

ed w

eigh

t gai

n

TD

Lo

900

mg/

kg/8

W c

on-

tinuo

us

Page 70: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

67ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Kid

ney,

Ure

ter,

and

Bla

dder

- C

hang

es

in k

idne

y w

eigh

t

TD

Lo

1800

m

g/kg

/8W

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

hyro

id tu

mor

s

TD

Lo

1092

0 m

g/kg

/2Y

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

Li

ver

- C

hang

es in

live

r w

eigh

t

TD

Lo

450

mg/

kg/8

W c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cen

tral

ner

vous

sys

tem

Effe

cts

on

New

born

- W

eani

ng o

r la

ctat

ion

inde

x (e

.g.,

# al

ive

at w

eani

ng p

er #

aliv

e at

da

y 4)

TD

Lo

30

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

Effe

cts

on E

mbr

yo o

r F

etus

- F

etal

de

ath

Spe

cific

Dev

elop

men

tal A

bnor

-m

aliti

es -

Mus

culo

skel

etal

sys

tem

TD

Lo

2 gm

/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cra

niof

acia

l (in

clud

ing

nose

and

to

ngue

)

TD

Lo

2 gm

/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Mus

culo

skel

etal

sys

tem

T

DLo

2

gm/k

g

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Neo

plas

tic b

y R

TE

CS

cr

iteria

End

ocrin

e -

Thy

roid

tum

ors

T

DLo

27

37.5

m

g/kg

/1Y

con

-tin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

entr

al n

ervo

us s

yste

m S

peci

fic D

e-ve

lopm

enta

l Abn

orm

aliti

es -

Cra

niof

a-ci

al (

incl

udin

g no

se a

nd t

ongu

e) S

pe-

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Mus

culo

skel

etal

sys

tem

TD

Lo

300

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

2 gm

/kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cen

tral

ner

vous

sys

tem

Spe

cific

De-

velo

pmen

tal A

bnor

mal

ities

- C

rani

ofa-

cial

(in

clud

ing

nose

and

ton

gue)

Spe

-ci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m

TD

Lo

100

mg/

kg

Page 71: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

68ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Mus

culo

skel

etal

sys

tem

Spe

cific

De-

velo

pmen

tal A

bnor

mal

ities

- H

omeo

-st

asis

TD

Lo

80

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

entr

al n

ervo

us s

yste

m S

peci

fic D

e-ve

lopm

enta

l Abn

orm

aliti

es -

Cra

niof

a-ci

al (

incl

udin

g no

se a

nd t

ongu

e)

TD

Lo

80

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

New

born

- V

iabi

lity

inde

x (e

.g.,

# al

ive

at d

ay 4

per

# b

orn

aliv

e)

Effe

cts

on N

ewbo

rn -

Wea

ning

or

lact

a-tio

n in

dex

(e.g

., #

aliv

e at

wea

ning

per

#

aliv

e at

da

y 4)

TD

Lo

10

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

G

astr

oint

estin

al s

yste

m

TD

Lo

100

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m

TD

Lo

50

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Effe

cts

on E

mbr

yo o

r F

etus

- F

etot

oxic

-ity

(ex

cept

dea

th, e

.g.,

stun

ted

fetu

s)

TD

Lo

2400

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

rani

ofac

ial (

incl

udin

g no

se a

nd

tong

ue)

TD

Lo

60

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

Effe

cts

on N

ewbo

rn -

Sex

rat

io

TD

Lo

1600

m

g/kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Uro

geni

tal s

yste

m

TD

Lo

60

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

New

born

- V

iabi

lity

inde

x (e

.g.,

# al

ive

at d

ay 4

per

# b

orn

aliv

e)

TD

Lo

30

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

entr

al n

ervo

us s

yste

m E

ffect

s on

N

ewbo

rn -

Wea

ning

or

lact

atio

n in

dex

(e.g

., #

aliv

e at

wea

ning

per

# a

live

at

day

4)

TD

Lo

30

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

New

born

- G

row

th s

tatis

tics

(e.g

., re

duce

d w

eigh

t gai

n)

TD

Lo

30

mg/

kg

Page 72: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

69ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Effe

cts

on F

ertil

ity -

Litt

er s

ize

(e.g

., #

fetu

ses

per

litte

r, m

easu

red

bef

ore

birt

h) S

peci

fic D

evel

opm

enta

l Abn

or-

mal

ities

- C

entr

al n

ervo

us s

yste

m E

f-fe

cts

on N

ewbo

rn -

Via

bilit

y in

dex

(e.g

., #

aliv

e at

da

y 4

per

# bo

rn a

live)

TD

Lo

30

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m

TC

Lo

2720

0 ug

/m3/

3H

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

al

deat

h

TC

Lo

120

mg/

m3/

3H

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rab

bit

Mild

D

RA

IZE

re

actio

n 50

0 m

g/24

H

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

LD

50

7800

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

LD

50

3 gm

/kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) M

ouse

LD50

20

0 m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

LD50

18

32

mg/

kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

End

ocrin

e -

Oth

er c

hang

es

TD

Lo

1000

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

T

DLo

84

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Yea

st -

S

Cer

evis

iae

50

mg/

L

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

hyro

id tu

mor

s

11

466

mg/

kg/7

8W

cont

inuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Tum

orig

enic

- E

quiv

ocal

tum

orig

enic

ag

ent b

y R

TE

CS

crit

eria

Liv

er -

Tum

ors

5470

m

g/kg

/26W

co

ntin

uous

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

umor

s E

ndoc

rine

- T

hyro

id tu

mor

s

91

25

mg/

kg/2

Y c

on-

tinuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

T

umor

igen

ic -

Car

cino

geni

c by

RT

EC

S

crite

ria E

ndoc

rine

- T

hyro

id tu

mor

s

14

6 gm

/kg/

2Y c

on-

tinuo

us

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

Tum

orig

enic

- C

arci

noge

nic

by R

TE

CS

cr

iteria

End

ocrin

e -

Thy

roid

tum

ors

Tum

orig

enic

Effe

cts

- T

estic

ular

tum

ors

44

gm

/kg/

2Y c

on-

tinuo

us

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Bac

teria

- E

C

oli

10

gm/L

Page 73: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

70ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) H

amst

er

80

ug/L

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rat

M

ater

nal E

ffect

s -

Par

turit

ion

Effe

cts

on

New

born

- S

tillb

irth

Effe

cts

on N

ewbo

rn

- G

row

th s

tatis

tics

(e.g

., re

duce

d w

eigh

t gai

n)

TD

Lo

2800

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mol

d -

A

Nid

ulan

s

39

200

umol

/L

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rab

bit

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

TD

Lo

1120

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Inse

cts

- D

M

elan

ogas

ter

500

umol

/L

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

6 gm

/kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) R

at

200

mg/

kg

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) H

amst

er

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cen

tral

ner

vous

sys

tem

Spe

cific

De-

velo

pmen

tal A

bnor

mal

ities

- C

rani

ofa-

cial

(in

clud

ing

nose

and

ton

gue)

TD

Lo

1200

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mou

se

1800

m

g/L

(+S

9)

96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) B

acte

ria -

E

Col

i

50

0 m

g/L

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Rab

bit

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Cen

tral

ner

vous

sys

tem

T

DLo

14

0 m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Ham

ster

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

M

uscu

losk

elet

al s

yste

m

TD

Lo

600

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Cat

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

E

ye, e

ar S

peci

fic D

evel

opm

enta

l Ab-

norm

aliti

es -

Bod

y w

all S

peci

fic D

evel

-op

men

tal A

bnor

mal

ities

- C

rani

ofac

ial

(incl

udin

g no

se a

nd t

ongu

e)

TD

Lo

600

mg/

kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Ham

ster

S

peci

fic D

evel

opm

enta

l Abn

orm

aliti

es -

C

rani

ofac

ial (

incl

udin

g no

se a

nd

tong

ue)

Spe

cific

Dev

elop

men

tal A

b-no

rmal

ities

- M

uscu

losk

elet

al s

yste

m

Spe

cific

Dev

elop

men

tal A

bnor

mal

ities

-

Gas

troi

ntes

tinal

sys

tem

TD

Lo

6480

m

g/kg

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Ham

ster

E

ffect

s on

Em

bryo

or

Fet

us -

Fet

otox

ic-

ity (

exce

pt d

eath

, e.g

., st

unte

d fe

tus)

T

DLo

21

60

mg/

kg

Page 74: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

71ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

PE

CIE

S

EF

FE

CT

C

RIT

ER

IUM

DO

SE

_CO

NC

.U

NIT

_DO

SE

_ 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) H

amst

er

Effe

cts

on F

ertil

ity -

Pos

t-im

plan

tatio

n m

orta

lity

(e.g

., de

ad a

nd o

r r

esor

bed

impl

ants

per

tota

l num

ber

of im

plan

ts)

Effe

cts

on E

mbr

yo o

r F

etus

- F

etal

de

ath

TD

Lo

2400

m

g/kg

Page 75: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

72ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Tab

le 5

.6

Ove

rvie

w o

f wild

life

rele

vant

sys

tem

ic to

xici

ty d

ata

of c

ateg

ory

1 su

bsta

nces

CA

SN

R

NA

ME

S

peci

es N

ame

EF

FE

CT

C

RIT

ER

IUM

CO

NC

EN

TR

AT

UN

IT_O

F_C

O92

-69-

3 4-

Hyd

roxy

biph

enyl

= 4

-Phe

nylp

heno

l D

aphn

ia m

agna

M

orta

lity

LC50

3.

66

mg/

l 92

-69-

3 4-

Hyd

roxy

biph

enyl

= 4

-Phe

nylp

heno

l T

etra

hym

ena

pyrif

orm

is

Pop

ulat

ion

Cha

nges

, Gen

eral

; D

ecre

ase

EC

50

7.05

m

g/l

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-P

heny

lphe

nol

Dap

hnia

mag

na

Mor

talit

y LC

50

3.66

m

g/l

92-6

9-3

4-H

ydro

xybi

phen

yl =

4-P

heny

lphe

nol

Dap

hnia

mag

na

Imm

obile

E

C50

3.

66

mg/

l 16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) R

ana

tem

pora

ria

Mor

talit

y; In

crea

se

LC50

25

00

mg/

l 16

34-0

4-4

met

hyl t

ertia

ry b

utyl

eth

er (

MT

BE

) A

lbur

nus

albu

r-nu

s M

orta

lity

LC50

10

00

mg/

l

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Pim

epha

les

prom

elas

M

orta

lity

LC50

67

2 m

g/l

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Nito

cra

spin

ipes

M

orta

lity

LC50

10

00

mg/

l 11

13-0

2-6

Om

etho

ate

Dap

hnia

mag

na

Imm

obile

E

C50

0.

021

mg/

l 11

13-0

2-6

Om

etho

ate

Aph

aniu

s fa

scia

-tu

s M

orta

lity

LC50

* 2.

69

mg/

l

1113

-02-

6 O

met

hoat

e A

rtem

ia s

p.

Mor

talit

y; In

crea

se

EC

50

25

mg/

l 11

13-0

2-6

Om

etho

ate

Dap

hnia

mag

na

Mor

talit

y LC

25

0.00

38

mg/

l 11

13-0

2-6

Om

etho

ate

Dap

hnia

mag

na

Mor

talit

y LC

50

0.00

42

mg/

l 11

13-0

2-6

Om

etho

ate

Aph

aniu

s fa

scia

-tu

s M

orta

lity

LC50

* 1.

61

mg/

l

1113

-02-

6 O

met

hoat

e A

phan

ius

fasc

ia-

tus

Mor

talit

y LC

50*

1.51

m

g/l

314-

40-9

B

rom

acil

Sce

nede

smus

su

bspi

catu

s P

opul

atio

n C

hang

es, G

ener

al;

Dec

reas

e N

OE

C

0.04

5 m

g/l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

0327

m

g/l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

064

mg/

l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

0768

m

g/l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

0514

m

g/l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s B

ella

mya

ben

-ga

lens

is

Mor

talit

y LC

50

0.00

19

mg/

l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

0313

m

g/l

Page 76: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

73ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

peci

es N

ame

EF

FE

CT

C

RIT

ER

IUM

CO

NC

EN

TR

AT

UN

IT_O

F_C

O13

593-

03-8

Q

uina

lpho

s =

Chi

nalp

hos

Tila

pia

mos

-sa

mbi

ca

Mor

talit

y; In

crea

se

LC50

0.

003

mg/

l

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s P

enae

us m

ono-

don

Mor

talit

y LC

50

0.00

0124

m

g/l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Poe

cilia

ret

icu-

lata

M

orta

lity;

Incr

ease

LC

50

7500

m

g/l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Chl

orel

la p

yre-

noid

osa

Gro

wth

, Gen

eral

E

C50

66

00

mg/

l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Onc

orhy

nchu

s m

ykis

s M

ultip

le E

ffect

s R

epor

ted

as

One

Res

ult

LOE

C

100

mg/

l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Dap

hnia

mag

na

Mor

talit

y LC

50

18

mg/

l 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) D

aphn

ia m

agna

M

orta

lity

LC50

26

.4

mg/

l 96

-45-

7 E

thyl

ene

Thi

oure

a (E

TU

) O

ncor

hync

hus

myk

iss

Gro

wth

, Gen

eral

LO

EC

10

0 m

g/l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Mic

rohy

la o

rnat

a M

orta

lity

NO

LC

5 m

g/l

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Onc

orhy

nchu

s m

ykis

s M

ultip

le E

ffect

s R

epor

ted

as

One

Res

ult

EC

50

1000

m

g/l

1582

-09-

8 T

riflu

ralin

M

ugil

ceph

alus

A

bnor

mal

; Inc

reas

e N

OE

C

0.00

3 m

g/l

1582

-09-

8 T

riflu

ralin

C

yprin

odon

va

riega

tus

Mor

talit

y LC

50-F

T

190

ug/l

1582

-09-

8 T

riflu

ralin

m

alla

rd d

uck

embr

yoni

c de

ath,

red

uced

gr

owth

, inc

reas

ed r

ate

of b

ile

form

atio

n an

d of

stu

nted

ness

of

the

embr

yos

1582

-09-

8 T

riflu

ralin

M

ugil

ceph

alus

A

bnor

mal

; Inc

reas

e LO

EC

0.

005

mg/

l 15

82-0

9-8

Trif

lura

lin

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

0.01

35

mg/

l

1582

-09-

8 T

riflu

ralin

R

asbo

ra h

et-

erom

orph

a M

orta

lity

LC50

0.

0034

7 m

g/l

1582

-09-

8 T

riflu

ralin

Le

pom

is m

acro

-ch

irus

Mor

talit

y; In

crea

se

LC50

0.

01

mg/

l

1582

-09-

8 T

riflu

ralin

O

ncor

hync

hus

myk

iss

Mor

talit

y LC

50

0.00

025

mg/

l

1582

-09-

8 T

riflu

ralin

D

aphn

ia m

agna

M

orta

lity

NO

LC

0.00

72

mg/

l 15

82-0

9-8

Trif

lura

lin

Pim

epha

les

prom

elas

M

orta

lity

NO

LC

0.01

65

mg/

l

Page 77: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

74ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

peci

es N

ame

EF

FE

CT

C

RIT

ER

IUM

CO

NC

EN

TR

AT

UN

IT_O

F_C

O92

-88-

6 4,

4'-D

ihyd

roxy

biph

enyl

= 4

,4'-B

iphe

nol

Tet

rahy

men

a th

erm

ophi

la

Pop

ulat

ion

Cha

nges

, Gen

eral

E

C50

11

.5

mg/

l

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-Bip

heno

l T

etra

hym

ena

ther

mop

hila

C

hem

ical

Avo

idan

ce; I

n-cr

ease

E

C10

9

mg/

l

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-Bip

heno

l T

etra

hym

ena

ther

mop

hila

P

opul

atio

n C

hang

es, G

ener

al

NO

EC

1

mg/

l

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-Bip

heno

l T

etra

hym

ena

ther

mop

hila

C

hem

ical

Avo

idan

ce; N

EF

E

C0

7.5

mg/

l

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,4

'-Bip

heno

l T

etra

hym

ena

ther

mop

hila

B

iom

ass;

Incl

udes

Har

vest

Y

ield

, Fru

it or

See

d Y

ield

, M

ass

of O

rgan

ism

, Mas

s of

P

opul

atio

n.

EC

20

6.9

mg/

l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) S

alm

o sa

lar

Mor

talit

y LC

50

0.19

m

g/l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) P

imep

hale

s pr

omel

as

Mor

talit

y LC

50

0.14

m

g/l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) S

alm

o sa

lar

Mor

talit

y LC

50

0.13

m

g/l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) C

hiro

nom

us te

n-ta

ns

Mor

talit

y; In

crea

se

NO

EC

0.

042

mg/

l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) D

aphn

ia m

agna

M

orta

lity

NO

LC

0.00

62

mg/

l 10

4-40

-5

4-N

onyl

phen

ol (

4-N

P)

Pim

epha

les

prom

elas

Le

sion

s; In

crea

se

LOE

C

0.00

19

mg/

l

104-

40-5

4-

Non

ylph

enol

(4-

NP

) S

alm

o sa

lar

Mor

talit

y LC

50

0.16

m

g/l

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Dre

isse

na p

oly-

mor

pha

Abi

lity

to D

etac

h fr

om S

ub-

stra

te; I

ncre

ase

EC

50

3.4

mg/

l

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Ory

zias

latip

es

Mor

talit

y LC

50

2.5

mg/

l 25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) Ic

talu

rus

punc

-ta

tus

Mor

talit

y; In

crea

se

LC50

1.

5 m

g/l

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

1 m

g/l

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Ory

zias

latip

es

Mor

talit

y LC

50

5.6

mg/

l 25

013-

16-5

te

rt.-

But

ylhy

drox

yani

sole

(B

HA

) O

ryzi

as la

tipes

M

orta

lity

LC50

2.

5 m

g/l

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le (

BH

A)

Ory

zias

latip

es

Mor

talit

y LC

50

5.5

mg/

l 43

76-2

0-9

Mon

o 2

ethy

l hex

ylph

thal

ate

(ME

HP

) C

hiro

nom

us

plum

osus

Im

mob

ile

EC

50

72

mg/

l

4376

-20-

9 M

ono

2 et

hyl h

exyl

phth

alat

e (M

EH

P)

Chi

rono

mus

pl

umos

us

Mor

talit

y; In

crea

se

LC50

72

m

g/l

Page 78: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

75ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

SN

R

NA

ME

S

peci

es N

ame

EF

FE

CT

C

RIT

ER

IUM

CO

NC

EN

TR

AT

UN

IT_O

F_C

O43

76-2

0-9

Mon

o 2

ethy

l hex

ylph

thal

ate

(ME

HP

) C

hiro

nom

us

plum

osus

Im

mob

ile; I

ncre

ase

EC

50

72

mg/

l

7400

-08-

0 p-

Cou

mar

ic a

cid

(PC

A)

Sel

enas

trum

ca

pric

ornu

tum

P

opul

atio

n C

hang

es, G

ener

al;

Dec

reas

e LO

EC

16

4.16

m

g/l

6164

-98-

3 C

hlor

dim

efor

m

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

29

mg/

l

6164

-98-

3 C

hlor

dim

efor

m

Icta

luru

s pu

nc-

tatu

s M

orta

lity;

Incr

ease

LC

50

20.2

m

g/l

6164

-98-

3 C

hlor

dim

efor

m

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

29

mg/

l

6164

-98-

3 C

hlor

dim

efor

m

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

13.2

m

g/l

6164

-98-

3 C

hlor

dim

efor

m

Icta

luru

s pu

nc-

tatu

s M

orta

lity;

Incr

ease

LC

50

20.7

m

g/l

6164

-98-

3 C

hlor

dim

efor

m

Onc

orhy

nchu

s m

ykis

s M

orta

lity;

Incr

ease

LC

50

13.2

m

g/l

6164

-98-

3 C

hlor

dim

efor

m

Onc

orhy

nchu

s m

ykis

s M

orta

lity

LC50

13

.2

mg/

l

96-1

2-8

Dib

rom

ochl

orop

ropa

ne (

DB

CP

) In

dopl

anor

bis

exus

tus

Mor

talit

y LC

50

57

mg/

l

96-1

2-8

Dib

rom

ochl

orop

ropa

ne (

DB

CP

) C

ipan

gopa

ludi

na

mal

leat

a M

orta

lity

LC50

53

m

g/l

96-1

2-8

Dib

rom

ochl

orop

ropa

ne (

DB

CP

) S

emis

ulco

spira

lib

ertin

a M

orta

lity

LC50

50

m

g/l

96-1

2-8

Dib

rom

ochl

orop

ropa

ne (

DB

CP

) P

hyse

lla a

cuta

M

orta

lity

LC50

24

m

g/l

Page 79: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 76

5.3.2 Evaluation of exposure of humans and wildlife (Task 3.3) Monitoring data for CAT 1 and CAT 2 substance has been searched in the COMMPS database/EEA. However, since COMMPS included monitoring data for only a few CAT 1 and CAT 2 substances (5 substances) it has been decided not to include these in the present project. Evaluation of the exposure of the environment has thus in the present project been based on the PC program EUSES. EUSES summary report for CAT 1 and CAT 2 substance are now included in the EDC database. Selected EUSES data (release to the environment, distribution and concentra-tion in water, sediment and soil, second poising in fish and top predators, and human in-take) are included in datasheet of the CAT 1 substances and based on an evaluation of the results of the EUSES calculations together with an evaluation of the use category (e.g. cosmetic, pesticide etc.) a subjective evaluation of exposure concern (high, me-dium, low) was performed. E.g. if a substance turned out to be ready biodegradable, but used in cosmetics a relative high human exposure can be foreseen and the substance is rated as ‘high concern’. It shall be clearly emphasised that the exposure evaluation is not a risk assessment and that the choices for the categorisation (high, medium, low concern) has solely been made by the consultant. An overview of selected EUSES data for CAT 1 substances is presented in Table 5.5 and Figures 5.1-5.6 below.

Page 80: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

77ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Tab

le 5

.5

Ove

rvie

w o

f sel

ecte

d E

US

ES

dat

a fo

r C

AT

1 s

ubst

ance

s

CA

S N

o.

Che

mic

al n

ame

Ton

nage

of

subs

tanc

e us

ed in

E

US

ES

cal

-cu

latio

ns

Tot

al r

e-le

ase

to

envi

ron-

men

t (%

of u

se)

Rel

ease

to

air

Rel

ease

to

was

te w

a-te

r

Loca

l PE

C

in s

urfa

ce

wat

er d

urin

g em

issi

on

epis

ode

(dis

solv

ed)

Loca

l PE

C in

fr

esh

wat

er

sedi

men

t du

ring

em

is-

sion

epi

sode

Con

cent

ra-

tion

in fi

sh fo

r se

cond

ary

pois

onin

g (f

resh

wat

er)

Con

cent

ra-

tion

in fi

sh-

eatin

g m

arin

e to

p-pr

edat

ors

Loca

l tot

al

daily

inta

ke

for

hum

ans

Reg

iona

l tot

al

daily

inta

ke

for

hum

ans

[tonn

es.y

r-1]

(%

) [k

g.ye

ar-1

][k

g.ye

ar-1

][m

g.l-

1]

[mg.

kgw

wt-

1]

[mg.

kgw

wt-

1][m

g.kg

ww

t-1]

[mg.

kg-1

.d-1

][m

g.kg

-1.d

-1]

1004

3-35

-3

Bor

ic a

cid

5000

0 0.

2 37

5.0

1125

00

2.4

2.1

1.4

0.2

6.7E

-02

1.6E

-05

104-

40-5

P

heno

l, 4-

nony

l- 10

2.

0 0.

1 20

0 4.

3 97

9.0

933.

0 42

4.0

2.5E

+02

1.

6E-0

4

1113

-02-

6 O

met

hoat

e 50

0 1.

5 3.

8 75

00

2.5

2.2

0.7

0.0

3.6E

-02

1.0E

-05

1131

-60-

8 P

heno

l, 4-

cycl

ohex

yl-

10

2.0

0.1

200

8.3

302.

0 8.

8 0.

2 1.

7E+

01

9.6E

-06

120-

47-8

B

enzo

ic a

cid,

4-

hydr

oxy-

, et

hyl e

ster

50

2.0

0.5

999

0.0

0.1

0.2

0.0

1.8E

-03

2.3E

-07

131-

18-0

1,

2-B

enze

nedi

-ca

rbox

ylic

aci

d,

dipe

ntyl

50

1.6

0.4

799

0.4

66.9

15

50.0

12

90.0

1.

5E+

01

7.7E

-05

131-

55-5

M

etha

none

, bi

s(2,

4-di

-hy

drox

y-ph

enyl

)-

50

2.0

0.5

1000

9.

6 68

.8

3.0

0.1

4.1E

+00

4.

1E-0

6

131-

56-6

M

etha

none

, (2

,4-

dihy

drox

y-ph

enyl

)phe

nyl-

50

5.9

1.1

2970

5.

2 45

.4

12.7

0.

3 2.

3E+

00

1.1E

-05

131-

70-4

1,

2-B

enze

nedi

-ca

rbox

ylic

aci

d,

mon

obut

yl

10

2.0

0.1

200

1.2

9.4

0.1

0.0

6.3E

-02

7.5E

-08

1359

3-03

-8

Die

thqu

inal

-ph

ion

500

1.5

3.8

7500

2.

0 93

.1

482.

0 12

.2

8.0E

+00

8.

2E-0

4

1508

7-24

-8

Bic

yclo

[2.2

.1]

hept

an-2

-one

, 1,

7,7-

trim

e

50

2.0

0.5

1000

7.

2 44

5.0

183.

0 10

.2

3.8E

+01

7.

0E-0

5

1582

-09-

8 B

enzo

ic a

cid,

4-

hydr

oxy-

, et

hyl e

ster

1000

0 0.

2 80

.1

2400

0 2.

0 27

0.0

5600

0.0

2250

0.0

6.4E

+01

8.

0E-0

3

Page 81: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

78ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

S N

o.

Che

mic

al n

ame

Ton

nage

of

subs

tanc

e us

ed in

E

US

ES

cal

-cu

latio

ns

Tot

al r

e-le

ase

to

envi

ron-

men

t (%

of u

se)

Rel

ease

to

air

Rel

ease

to

was

te w

a-te

r

Loca

l PE

C

in s

urfa

ce

wat

er d

urin

g em

issi

on

epis

ode

(dis

solv

ed)

Loca

l PE

C in

fr

esh

wat

er

sedi

men

t du

ring

em

is-

sion

epi

sode

Con

cent

ra-

tion

in fi

sh fo

r se

cond

ary

pois

onin

g (f

resh

wat

er)

Con

cent

ra-

tion

in fi

sh-

eatin

g m

arin

e to

p-pr

edat

ors

Loca

l tot

al

daily

inta

ke

for

hum

ans

Reg

iona

l tot

al

daily

inta

ke

for

hum

ans

[tonn

es.y

r-1]

(%

) [k

g.ye

ar-1

][k

g.ye

ar-1

][m

g.l-

1]

[mg.

kgw

wt-

1]

[mg.

kgw

wt-

1][m

g.kg

ww

t-1]

[mg.

kg-1

.d-1

][m

g.kg

-1.d

-1]

1634

-04-

4 P

ropa

ne, 2

-m

etho

xy-2

-m

ethy

l-

5000

0 2.

7 12

5100

0.0

7500

0 4.

7 7.

5 3.

1 0.

2 4.

0E-0

1 4.

1E-0

5

2501

3-16

-5

Phe

nol,

(1,1

-di

met

hyle

thyl

)-4-

met

hoxy

-

500

1.5

3.8

7500

2.

3 29

.1

59.8

1.

3 8.

3E-0

1 6.

3E-0

5

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-te

tram

eth

ylbu

-ty

l)-

10

2.0

0.1

200

5.2

860.

0 67

2.0

256.

0 1.

7E+

02

1.1E

-04

3320

4-76

-1

Cyc

lote

tras

i-lo

xane

, 2,

2,4,

6,6,

8-he

xam

et

10

2.0

0.1

200

0.4

727.

0 20

2.0

913.

0 2.

7E+

02

1.1E

-03

3686

1-47

-9

Rig

tig

50

1.6

0.4

799

0.9

102.

0 17

30.0

59

4.0

1.6E

+01

2.

4E-0

4 43

76-2

0-9

Mon

o(2-

ethy

l-he

xyl)p

htha

late

10

2.

0 0.

1 20

0 7.

3 48

3.0

41.8

2.

3 4.

4E+

01

2.9E

-05

50-1

8-0

Cyc

loph

os-

pham

ide

10

1.8

0.1

180

1.0

1.3

0.0

0.0

4.4E

-02

2.1E

-07

5466

-77-

3 2-

Pro

peno

ic

acid

, 3-(

4-m

etho

xy-

phen

yl)-

,

5000

0.

0 5.

0 15

000

1.1

251.

0 73

900.

0 34

400.

0 8.

9E+

01

1.3E

-02

556-

67-2

O

ctam

ethy

ltet-

rasi

loxa

ne

5000

0 0.

8 30

0000

.090

000

0.7

31.4

32

8.0

149.

0 1.

2E+

00

3.8E

-04

611-

99-4

U

nkno

wn

10

1.8

0.1

180

1.0

3.9

0.2

0.0

3.4E

-01

4.4E

-07

6164

-98-

3 C

hlor

dim

efor

m

10

1.8

0.1

180

1.0

7.7

0.7

0.0

1.3E

-01

7.5E

-07

7400

-08-

0 2-

Pro

peno

ic

acid

, 3-(

4-hy

drox

y-ph

enyl

)-

10

2.0

0.1

200

1.3

3.4

0.0

0.0

1.3E

-01

2.9E

-08

Page 82: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

79ERA/53559/Revised report/2007.06.04

DHI Water & Environment

CA

S N

o.

Che

mic

al n

ame

Ton

nage

of

subs

tanc

e us

ed in

E

US

ES

cal

-cu

latio

ns

Tot

al r

e-le

ase

to

envi

ron-

men

t (%

of u

se)

Rel

ease

to

air

Rel

ease

to

was

te w

a-te

r

Loca

l PE

C

in s

urfa

ce

wat

er d

urin

g em

issi

on

epis

ode

(dis

solv

ed)

Loca

l PE

C in

fr

esh

wat

er

sedi

men

t du

ring

em

is-

sion

epi

sode

Con

cent

ra-

tion

in fi

sh fo

r se

cond

ary

pois

onin

g (f

resh

wat

er)

Con

cent

ra-

tion

in fi

sh-

eatin

g m

arin

e to

p-pr

edat

ors

Loca

l tot

al

daily

inta

ke

for

hum

ans

Reg

iona

l tot

al

daily

inta

ke

for

hum

ans

[tonn

es.y

r-1]

(%

) [k

g.ye

ar-1

][k

g.ye

ar-1

][m

g.l-

1]

[mg.

kgw

wt-

1]

[mg.

kgw

wt-

1][m

g.kg

ww

t-1]

[mg.

kg-1

.d-1

][m

g.kg

-1.d

-1]

77-0

9-8

1(3H

)-Is

oben

zo-

fura

none

, 3,3

-bi

s(4-

hydr

o

10

2.0

0.1

200

9.5

91.9

1.

0 0.

0 4.

3E+

00

1.2E

-06

77-4

0-7

2,2-

bis(

4-hy

drox

y-ph

enyl

)but

ane

10

1.8

0.09

18

0 0.

738

46.7

35

.2

1.9

4.2E

+00

2.

9E-0

5

92-6

9-3

1,1'

-Bip

hen

yl -

4-ol

10

00

2.4

30.0

24

000

3.8

42.5

16

2.0

3.4

2.2E

+00

7.

5E-0

5

92-8

8-6

1,1'

-Bip

hen

yl -

4,4'

-dio

l 10

1.

8 0.

1 18

0 1.

0 7.

0 0.

6 0.

0 4.

1E-0

1 8.

5E-0

7

94-1

3-3

Ben

zoic

aci

d,

4-hy

drox

y-,

prop

yl e

ster

10

2.0

0.1

200

9.5

90.0

1.

0 0.

0 2.

1E+

00

1.1E

-06

94-2

6-8

Ben

zoic

aci

d,

4-hy

drox

y-,

buty

l est

er

10

2.0

0.1

200

1.2

20.4

0.

4 0.

1 1.

1E-0

1 2.

5E-0

7

96-1

2-8

Pro

pane

, 1,2

-di

brom

o-3-

chlo

ro-

10

1.9

9.0

180

0.8

6.6

0.6

0.0

4.1E

-02

1.8E

-07

96-4

5-7

2-Im

ida-

zolid

inet

hion

e 10

00

0.3

10.0

30

00

0.5

0.4

0.3

0.0

1.4E

-02

3.1E

-06

99-7

6-3

50

0 2.

0 5.

0 10

000

1.3

4.0

0.8

0.1

2.8E

-02

1.5E

-06

99-9

6-7

Ben

zoic

aci

d,

4-hy

drox

y-

1000

0.

3 10

.0

3000

0.

1 0.

1 0.

1 0.

0 8.

6E-0

3 4.

2E-0

7

Page 83: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 80

Release to air and wastewater - CAT 1 substances

0

20000

40000

60000

80000

100000

120000

140000

1004

3-35

-3

104-

40-5

1113

-02-

6

1131

-60-

8

120-

47-8

131-

18-0

131-

55-5

131-

56-6

131-

70-4

1359

3-03

-8

1508

7-24

-8

1582

-09-

8

1634

-04-

4

2501

3-16

-5

2719

3-28

-8

3320

4-76

-1

3686

1-47

-9

4376

-20-

9

50-1

8-0

5466

-77-

3

556-

67-2

611-

99-4

6164

-98-

3

7400

-08-

0

77-0

9-8

77-4

0-7

92-6

9-3

92-8

8-6

94-1

3-3

94-2

6-8

96-1

2-8

96-4

5-7

99-7

6-3

99-9

6-7

kg.y

ear-

1

Release to air [kg.year-1] Release to wastewater [kg.year-1]

Figure 5.1 Release to the environment by air and wastewater. The magnitude of release is dependent on the production tonnage, the use pattern, and the physico-chemical properties of the substances.

Local concentrations in soils and sediment - CAT 1 substances

0

500

1000

1500

2000

2500

3000

3500

4000

1004

3-35

-3

104-

40-5

1113

-02-

6

1131

-60-

8

120-

47-8

131-

18-0

131-

55-5

131-

56-6

131-

70-4

1359

3-03

-8

1508

7-24

-8

1582

-09-

8

1634

-04-

4

2501

3-16

-5

2719

3-28

-8

3320

4-76

-1

3686

1-47

-9

4376

-20-

9

50-1

8-0

5466

-77-

3

556-

67-2

611-

99-4

6164

-98-

3

7400

-08-

0

77-0

9-8

77-4

0-7

92-6

9-3

92-8

8-6

94-1

3-3

94-2

6-8

96-1

2-8

96-4

5-7

99-7

6-3

99-9

6-7

mg

kg w

wt

-1

Local PEC in fresh-water sediment during emission episode [mg.kgwwt-1] Local PEC in agric. soil (total) averaged over 180 days [mg.kgwwt-1]

Local PEC in grassland (total) averaged over 180 days [mg.kgwwt-1]

Figure 5.2 Local concentration in soils (agricultural soil and grassland) and sediments

Page 84: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 81

Local PEC in surface water during release episode (dissolved) - CAT 1 substances

0

2

4

6

8

10

12

1004

3-35

-3

104-

40-5

1113

-02-

6

1131

-60-

8

120-

47-8

131-

18-0

131-

55-5

131-

56-6

131-

70-4

1359

3-03

-8

1508

7-24

-8

1582

-09-

8

1634

-04-

4

2501

3-16

-5

2719

3-28

-8

3320

4-76

-1

3686

1-47

-9

4376

-20-

9

50-1

8-0

5466

-77-

3

556-

67-2

611-

99-4

6164

-98-

3

7400

-08-

0

77-0

9-8

77-4

0-7

92-6

9-3

92-8

8-6

94-1

3-3

94-2

6-8

96-1

2-8

96-4

5-7

99-7

6-3

99-9

6-7

mg

l-1

Figure 5.3 Local concentration in surface water

Secondary poisoning and concentrations in top predators - CAT 1 substances

0

1000

2000

3000

4000

5000

6000

7000

8000

9000

10000

1004

3-35

-310

4-40

-511

13-0

2-6

1131

-60-

812

0-47

-813

1-18

-013

1-55

-513

1-56

-613

1-70

-413

593-

03-8

1508

7-24

-815

82-0

9-8

1634

-04-

425

013-

16-5

2719

3-28

-833

204-

76-1

3686

1-47

-943

76-2

0-9

50-1

8-0

5466

-77-

355

6-67

-261

1-99

-461

64-9

8-3

7400

-08-

077

-09-

877

-40-

792

-69-

392

-88-

694

-13-

394

-26-

896

-12-

896

-45-

799

-76-

399

-96-

7

mg

kg w

wt -

1

Concentration in fish for secondary poisoning (fresh water) [mg.kgwwt-1] Concentration in top-predators [mg.kgwwt-1]

Figure 5.4 Secondary poisoning and concentration in top predators. Furthermore, consider-able concentrations are found for 5-6 more substances.

Page 85: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 82

Local total daily intake for humans - CAT 1 substancs

0

50

100

150

200

250

300

1004

3-35

-3

104-

40-5

1113

-02-

6

1131

-60-

8

120-

47-8

131-

18-0

131-

55-5

131-

56-6

131-

70-4

1359

3-03

-8

1508

7-24

-8

1582

-09-

8

1634

-04-

4

2501

3-16

-5

2719

3-28

-8

3320

4-76

-1

3686

1-47

-9

4376

-20-

9

50-1

8-0

5466

-77-

3

556-

67-2

611-

99-4

6164

-98-

3

7400

-08-

0

77-0

9-8

77-4

0-7

92-6

9-3

92-8

8-6

94-1

3-3

94-2

6-8

96-1

2-8

96-4

5-7

99-7

6-3

99-9

6-7

mg

kg

-1 d

ay-1

Figure 5.5 Estimated values for local total daily intake for humans

Regional total daily intake for humans - CAT 1 substances

0

0,002

0,004

0,006

0,008

0,01

0,012

0,014

1004

3-35

-3

104-

40-5

1113

-02-

6

1131

-60-

8

120-

47-8

131-

18-0

131-

55-5

131-

56-6

131-

70-4

1359

3-03

-8

1508

7-24

-8

1582

-09-

8

1634

-04-

4

2501

3-16

-5

2719

3-28

-8

3320

4-76

-1

3686

1-47

-9

4376

-20-

9

50-1

8-0

5466

-77-

3

556-

67-2

611-

99-4

6164

-98-

3

7400

-08-

0

77-0

9-8

77-4

0-7

92-6

9-3

92-8

8-6

94-1

3-3

94-2

6-8

96-1

2-8

96-4

5-7

99-7

6-3

99-9

6-7

mg

kg

-1 d

ay-1

Figure 5.6 Estimated values for regional total daily intake for humans

Page 86: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 83

The magnitude of release is dependent on the tonnage, the use pattern, and the physico-chemical properties of the substances. As indicated in the figures, large differences are seen in release of CAT 1 substances, from less than 1 kg/year and up to more than 1,300,000 kg/year. In average, 1.8% of the tonnage used is estimated to be released to the environment with a variability between 0-6% of the tonnage used. The EUSES estimations indicated an accumulation of substances in sediments and soils for about half of the CAT 1 substances. The concentration of CAT 1 substances in sur-face waters may be up to 10 mg/l although, for about half of the substances, a concen-tration of ≤ 1 mg/L was found. For secondary poisoning and concentration in top predators, EUSES estimations indi-cated very high concentration, up to 7,400 mg/kg wwt for two substances (CAS Nos. 1582-09-8 and 5466-77-3). Furthermore, considerable concentrations were found for 5-6 other substances. Estimations for human intake of substances via the environment depict considerable in-take of about one third of the CAT 1 substance (local human intake). In Table 5.8, an overview of the human health relevant effect data for Category 1 sub-stances in comparison with EUSES estimated local and regional intake via the environ-ment is presented. In Table 5.9, an overview of wildlife relevant effect data for Cate-gory 1 substances in comparison with EUSES estimated local surface water concentra-tions is presented.

Page 87: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

84

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

Tab

le 5

.8

Out

put f

rom

dat

abas

e: O

verv

iew

of t

he h

uman

hea

lth r

elev

ant E

D e

ffect

dat

a of

Cat

egor

y 1

subs

tanc

es. P

lus

EU

SE

S e

stim

ated

dat

a on

hu

man

inta

ke (

for

abre

vias

ions

see

Ann

ex 1

)

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 10

043-

35-3

B

oric

aci

d W

ista

r ra

ts

Rat

in v

ivo

stud

y: A

fter

a 4-

wk

adm

ini-

stra

tion

by g

avag

e, te

stis

and

epi

di-

dym

is w

ts. w

ere

decr

ease

d in

the

300

and

500

mg/

kg g

roup

s.

LOA

EL

300

mg/

kg b

ody

wei

ght.

day

GP

h131

yr06

0.06

7000

002

1.63

E-0

5

104-

40-5

4-

Non

ylph

enol

(4

-NP

) ra

ts.

uter

otro

-ph

ic a

s-sa

y

Rat

in v

ivo

stud

y: U

terin

e w

eigh

t, ut

er-

ine/

bod

y w

eigh

t sig

nific

antly

incr

ease

d in

90

mg/

kg a

nd 1

20 m

g/kg

gro

ups

and

a do

se-r

espo

nse

rela

tions

hip

was

ob-

serv

ed.

LOA

EL

90

mg/

kg

GP

h144

yr06

245

0.00

0157

1113

-02-

6 O

met

hoat

e K

unm

ing

mal

e m

ice

Mic

e in

viv

o st

udy:

Incr

ease

in b

ody

wt.

and

decr

ease

d te

stic

le w

t. T

he a

ctiv

i-tie

s of

AK

P, A

CP

, LD

H in

mou

se te

sti-

cles

sig

nific

antly

incr

ease

d co

mpa

red

with

the

cont

rol.

ED

1,

2

and

4 m

g/kg

G

Ph0

43yr

060.

0359

9999

8 1.

02E

-05

1131

-60-

8 4- C

yclo

hexy

l-ph

enol

Rat

R

at in

viv

o st

udy:

Ute

rotr

ophi

c as

say.

In

crea

sed

uter

ine

wei

ght.

LOA

EL=

200

mg/

kg.

LOE

L 20

0 m

g/kg

T

Th0

31yr

0616

.700

0007

6 9.

63E

-06

120-

47-8

et

hyl 4

-hy

drox

yben

-zo

ate

CD

1 m

ice

and

Wis

-ta

r ra

ts

Rat

and

mic

e in

viv

o st

udy:

Incr

ease

d ut

erin

e w

eigh

t in

imm

atur

e an

d ov

arie

c-to

miz

ed a

nim

als.

ED

50 1

8-74

µm

ol/ k

g bo

dy

wei

ght.

ED

50

18 to

74

µ

mol

/ kg

body

wei

ght

GP

h110

yr06

0.00

177

2.33

E-0

7

131-

18-0

D

i-n-

pent

ylph

thal

ate

(DP

P)

=

Dip

enty

lpht

hal

ate

Mic

e M

ice

in v

ivo

stud

y: A

con

tinuo

us b

reed

-in

g pr

otoc

ol w

as u

tiliz

ed to

exa

min

e th

e re

prod

uctiv

e to

xici

ty o

f di-n

-pen

tyl

phth

alat

e (D

PP

). D

PP

was

toxi

c to

the

repr

oduc

tive

syst

em a

s ev

iden

ced

by a

co

mpl

ete

inhi

bitio

n of

fert

ility

at 1

.25

and

2.5%

DP

P a

nd r

educ

ed fe

rtili

ty.

LOA

EL

1.25

%

G

Ph0

12yr

0614

.699

9998

1 7.

74E

-05

Page 88: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

85

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 13

1-55

-5

Ben

zoph

e-no

ne-2

(B

p-2)

, 2,

2',4

,4'-

tetr

ahyd

roxy

-be

nzop

he-

none

rat

Rat

in v

ivo

stud

y: In

crea

sed

rat u

terin

e w

eigh

ts. E

D10

=54

4.6

mg/

kg b

ody

wei

ght/d

ay.

ED

10

544.

6 m

g/kg

bod

y w

eigh

t. da

y G

Ph1

23yr

064.

0700

0017

2 4.

13E

-06

131-

56-6

2,

4-D

ihyd

roxy

-be

nzop

heno

n =

Res

benz

o-ph

enon

e

Long

Ev-

ans

rats

R

at in

viv

o st

udy:

Ben

zoph

enon

e (B

p)-

1 in

crea

sed

uter

ine

wt.

in im

mat

ure

rats

. Fur

ther

mor

e, b

enzo

phen

one-

1 (B

p-1)

was

in a

pre

viou

s in

vitr

o ex

-pe

rimen

t (M

CF

-7 c

ells

) sh

own

to h

ave

clea

r es

trog

enic

act

ivity

(E

C-5

0: 2

.08

uM)

ED

50

2-12

00

mg/

kg b

ody

wei

ght

GP

h026

yr06

2.31

9999

933

1.05

E-0

5

131-

70-4

M

ono-

n-bu

tylp

htha

late

W

ista

r ra

ts

Rat

in v

ivo

stud

y: D

ecre

ased

mal

e an

ogen

ital d

ista

nce

and

incr

ease

d in

ci-

denc

e of

fetu

ses

with

und

esce

nded

te

stes

. LO

AE

L=25

0 m

g/kg

bod

y w

eigh

t/day

LOA

EL

250

mg/

kg b

ody

wei

ght.

day

GP

h206

yr06

0.06

3100

003

7.52

E-0

8

1359

3-03

-8

Qui

nalp

hos

=

Chi

nalp

hos

Adu

lt m

ale

rats

In

viv

o ra

t stu

dy: S

uble

thal

chr

onic

ad-

min

istr

atio

n of

qui

nalp

hos

resu

lted

in:

decr

ease

d te

stic

ular

mas

s an

d A

ChE

ac

tivity

in c

entr

al a

s w

ell a

s pe

riphe

ral

orga

ns; i

ncre

ased

ser

um L

H, F

SH

, pr

olac

tin, a

nd te

stos

tero

ne c

oncn

s.;

decr

ease

d pi

tuita

ry o

r in

crea

sed

tes-

ticul

ar A

CE

. Ed

7-14

mg/

kg/d

ay.

ED

7-

14

mg/

kg/d

ay

GP

h050

yr06

7.96

9999

79

0.00

0822

1508

7-24

-8

3-B

enzy

liden

e ca

mph

or (

3-B

C)

Rat

ute

ro-

trop

hic

assa

y

Rat

in v

ivo

stud

y: In

crea

se in

ute

rus

wei

ght.

LOE

D =

2 m

g/kg

bod

y w

eigh

t.day

LOE

D

2 m

g/kg

bod

y w

eigh

t.day

G

Ph1

20yr

0638

6.

95E

-05

Page 89: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

86

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 15

82-0

9-8

Trif

lura

lin

Ew

es

In v

ivo

ewe

stud

y. C

once

ntra

tions

of

estr

adio

l wer

e si

gnifi

cant

ly in

crea

sed

in

ewes

giv

en tr

iflur

alin

. No

effe

ct o

n th

y-ro

xine

con

cent

ratio

n. M

ean

seru

m c

on-

cent

ratio

ns o

f LH

wer

e m

arke

dly

de-

crea

sed

by tr

iflur

alin

, and

bas

al L

H

conc

entr

atio

ns w

ere

sign

ifica

ntly

de-

crea

sed.

Onl

y on

e do

sis

(17.

5 m

g/kg

2

times

per

wee

k) w

as in

vest

igat

ed

LOE

C

17.5

m

g/kg

bod

y w

eigh

t G

Ph1

36yr

0663

.900

0015

3 0.

0079

8

1634

-04-

4 m

ethy

l ter

tiary

bu

tyl e

ther

(M

TB

E)

Spr

ague

-D

awle

y ra

ts

Rat

in v

io s

tudy

: Inc

reas

e of

test

is

wei

ght.

Inte

rstit

ial f

luid

and

ser

um te

s-to

ster

one

leve

ls a

s w

ell a

s se

rum

pro

-la

ctin

leve

ls w

ere

decr

ease

d on

ly in

an

imal

s tr

eate

d w

ith 1

500

mg

MT

BE

/kg/

day

for

15 d

ays.

LOE

C

1500

m

g/kg

/day

G

Ph0

32yr

060.

3950

0001

1 4.

1E-0

5

2501

3-16

-5

tert

.-B

utyl

hy-

drox

yani

sole

(B

HA

)

rats

(on

e-ge

nera

-tio

n re

-pr

oduc

tion

stud

y)

In v

ivo

rat s

tudy

. In

one-

gene

ratio

n ra

ts,

sex

ratio

of m

ale

was

dec

reas

ed a

nd

the

anog

enita

l dis

tanc

es w

ere

shor

t-en

ed a

nd v

agin

al p

aten

cy a

nd p

repu

tial

sepa

ratio

n w

ere

obse

rved

late

r th

an c

ontr

ol g

roup

. Als

o, B

HA

de-

crea

sed

sper

m m

otili

ty a

nd n

umbe

r an

d th

e w

idth

and

leng

th. L

OE

L=10

mg/

kg

bod

y w

eigh

t/day

LOA

EL

10

mg/

kg b

ody

wei

ght.

day

GP

h190

yr06

0.83

3999

991

6.33

E-0

5

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-te

tram

ethy

lbu-

tyl)-

= O

ctyl

-ph

enol

mal

e W

is-

tar

rats

R

at in

viv

o st

udy.

Red

uced

spe

rm

coun

ts r

esul

ting

from

low

ered

pla

sma

test

oste

rone

in m

ale

rats

just

afte

r pu

-be

rty.

ED

=3

mg/

kg b

ody

wei

ght.d

ay

ED

3

mg/

kg b

ody

wei

ght.d

ay

GP

h171

yr06

167

0.00

0107

Page 90: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

87

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 33

204-

76-1

2,

6-ci

s-D

iphe

nyl-

hexa

met

hyl-

cycl

otet

rasi

-lo

xane

- 2

,6-

cis-

[(P

hMe-

SiO

)2(M

e2S

iO

)2][

Rat

In

viv

o ra

t stu

dy. I

nhib

ited

fert

ility

and

al

tera

tions

in m

easu

red

char

acte

ristic

s of

the

ejac

ulat

e. L

OA

EL=

0.5

mg/

kg/d

ay

LOA

EL

0.5

mg/

kg/d

ay

GP

h210

yr06

273

0.00

112

3686

1-47

-9

3-(4

-M

ethy

lben

-zy

liden

e)ca

mp

hor

Lon

g E

v-an

s (L

E)

rats

.

Rat

in v

ivo

stud

y. D

elay

ed m

ale

pu-

bert

y, a

nd d

ose-

depe

nden

tly a

ffect

ed

repr

oduc

tive

orga

n w

ts. o

f adu

lt m

ale

and

fem

ale

F1

offs

prin

g, w

ith p

artly

dif-

fere

nt e

ffect

pat

tern

s. T

hyro

id w

t. w

as

incr

ease

d by

hig

her

4-M

BC

dos

es.

LOA

EL=

7 m

g/kg

/day

LOA

EL

7 m

g/kg

.day

G

Ph0

91yr

0615

.699

9998

1 0.

0002

37

4376

-20-

9 M

ono

2 et

hyl

hexy

lpht

hala

te

(ME

HP

)

5-w

eek

old

mal

e ra

ts

Spr

ague

-D

awle

y ra

ts

Rat

in v

ivo

stud

y. S

igni

fican

tly d

e-cr

ease

d bo

dy w

eigh

ts a

nd m

otile

sp

erm

s. L

OA

EL=

250

mg/

kg b

ody

wei

ght/d

ay

LOA

EL

250

mg/

kg b

ody

wei

ght.

day

GP

h202

yr06

44.2

9999

924

2.94

E-0

5

50-1

8-0

Cyc

loph

os-

pham

ide

Rat

R

at in

viv

o as

say:

Dec

reas

ed o

varia

n an

d ut

erin

wei

ght a

nd r

educ

tion

seru

m

estr

adio

l and

pro

gest

eron

e. L

OA

EL=

50

mg/

kg b

ody

wei

ght

LOE

L 50

m

g/kg

bod

y w

eigh

t C

Gh5

14

0.04

3499

999

2.12

E-0

7

5466

-77-

3 2-

eth

yl-h

exyl

-4- m

etho

xyci

n-na

mat

e

imm

atur

e Lo

ng-

Eva

ns

rats

Rat

in v

ivo

assa

y. U

terin

e w

t. w

as

dose

-dep

ende

ntly

incr

ease

d by

OM

C

(ED

50 9

35 m

g/kg

/day

)

ED

50

935

mg/

kg b

ody-

wei

ght.d

ay

GP

h084

yr06

89.1

9999

695

0.01

31

Page 91: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

88

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 55

6-67

-2

Cyc

lote

tras

i-lo

xane

S

prag

ue-

Daw

ley

(SD

) an

d F

isch

er

344

(F-

344)

rat

s

Rat

in v

ivo

assa

y. U

tero

trop

hic

assa

y w

ith tw

o sp

ecie

s: R

elat

ive

uter

ine

wts

. an

d ut

erin

e ep

ithel

ial c

ell h

eigh

t wer

e st

atis

tical

ly s

igni

fican

tly in

crea

sed

in

both

str

ains

of r

ats

at d

oses

abo

ve 1

00

mg/

kg/d

ay. L

OA

EL=

250

mg/

kg/d

ay

LOA

EL

250

mg/

kg/d

ay

GP

h063

yr06

1.14

9999

976

0.00

0384

611-

99-4

4,

4'-

Dih

ydro

xy-

benz

ophe

non

imm

atur

e ra

t ute

ro-

trop

hic

assa

y +

H

ersh

ber-

ger

assa

y

rat i

n vi

vo a

ssay

: Ind

uced

ute

rotr

ophy

an

d ex

erte

d bo

th e

stro

gen

agon

istic

ef

fect

and

red

uced

the

estr

ogen

ic e

ffect

of

eth

ynyl

estr

adio

l

S

ee

re-

mar

ks

G

Ph2

27yr

060.

3440

0001

2 4.

36E

-07

6164

-98-

3 C

hlor

dim

e-fo

rm

fem

ale

rat

In v

ivo

rat s

tudy

. Del

ay in

bre

edin

g an

d a

sign

ifica

nt r

edn.

in li

tter

size

. ED

=50

m

g/kg

.

ED

50

m

g/kg

G

Ph2

53yr

060.

1340

0000

3 7.

53E

-07

7400

-08-

0 p-

Cou

mar

ic

acid

(P

CA

) W

ista

r al

bino

rat

s R

at in

viv

o as

say:

189

and

201

% th

y-ro

id w

ts in

crea

se c

ompa

red

to c

ontr

ol

valu

e. h

yroi

d le

sion

s in

p-c

oum

aric

aci

d gr

oup

wer

e as

socd

. with

sig

nific

ant i

n-cr

ease

s in

cel

lula

r pr

olife

ratio

n as

indi

-ca

ted

by

[3H

]thym

idin

e in

corp

orat

ion.

In

addn

., th

e go

itrog

enic

effe

ct o

f p-

coum

aric

aci

d w

as fu

rthe

r co

nfirm

ed b

y si

gnifi

cant

dec

reas

es (

50%

) in

ser

um

triio

doth

yron

ine

(T3)

and

thyr

oxin

e (T

4),

and

a pa

ralle

l inc

reas

e (9

0%)

in s

erum

T

SH

com

pare

d to

con

trol

gro

up.

ED

=0.

25 m

mol

/kg/

day

ED

0.

25

mm

ol/k

g/da

yG

Ph2

38yr

060.

1309

9999

7 2.

91E

-08

77-0

9-8

3,3'

-Bis

(4-

hydr

oxy-

phen

yl)p

htha

lid

= P

heno

l-ph

thal

eine

F34

4/N

ra

ts a

nd

B6C

3F

mic

e

Rat

and

mic

e in

viv

o st

udy.

Exp

osur

e of

m

ice

to p

heno

lpht

hale

in in

fee

d fo

r 2

year

s re

sulte

d in

incr

ease

d in

cide

nces

of

aty

pica

l hyp

erpl

asia

of t

he th

ymus

in

mal

es a

nd fe

mal

es, d

egen

erat

ion

of th

e ge

rmin

al e

pith

eliu

m o

f the

test

is in

m

ales

, and

ova

rian

hype

rpla

sia

in fe

-m

ales

. LO

AE

L=30

0 m

g/kg

LOA

EL

300

mg/

kg

GP

h229

yr06

4.26

9999

981

1.22

E-0

6

Page 92: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

89

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 77

-40-

7 2,

2-B

is(4

-hy

drox

y-ph

enyl

)-n-

buta

n =

B

isph

enol

B

imm

atur

e ra

t ute

ro-

trop

hic

assa

y

In v

ivo

imm

atur

e ra

t ute

rotr

ophi

c as

say:

P

ositi

ve r

espo

nse

in th

e ut

erot

roph

ic

assa

y. D

ose

repo

nse

rela

tions

hip

(0, 2

, 20

and

200

mg/

kg)

See

rem

arks

0, 2

, 20

and

200

mg/

kg

GP

h223

yr06

4.17

9999

828

2.94

E-0

5

92-6

9-3

4- Hyd

roxy

bi-

phen

yl =

4-

Phe

nylp

heno

l

Spr

ague

-D

awle

y fe

mal

e ra

ts

Rat

in v

ivo

assa

y: U

tero

trop

hic

assa

y an

d C

albi

ndin

-D9k

(C

aBP

-9K

) m

RN

A

expr

essi

on w

ere

exam

d. in

ova

riec-

tom

ized

Spr

ague

-Daw

ley

fem

ale

rats

. 4-

phen

ylph

enol

pro

duce

d do

se-

depe

nden

t (10

, 50,

200

, and

400

m

g/kg

/day

( in

crea

ses

in th

e ut

erin

e w

ts.

of o

varie

ctom

ized

rat

s). L

OA

EL=

200

mg/

kg/d

ay

LOA

EL

200

mg/

kg/d

ay

GP

002h

yr06

2.16

0000

086

7.51

E-0

5

92-8

8-6

4,4'

-D

ihyd

roxy

bi-

phen

yl =

4,4

'-B

iphe

nol

Rat

R

at in

viv

o st

udy.

Rat

ute

rotr

ophi

c as

-sa

y. U

terin

e w

eigh

t inc

reas

e. L

O-

AE

L=60

mg/

kg b

ody

wei

ght/d

ay.

LOE

L 60

m

g/kg

bod

y w

eigh

t. da

y T

Th0

28yr

060.

4090

0000

9 8.

48E

-07

94-1

3-3

n-pr

opyl

p-

hydr

oxyb

en-

zoat

e

3.w

eek-

old

rats

In

viv

o ra

t ass

ay: T

he e

pidi

dym

al s

perm

re

serv

es a

nd c

once

ntra

tions

dec

reas

ed

dose

dep

ende

ntly

and

the

diffe

renc

e w

as s

igni

fican

t at d

oses

of 0

.1%

and

ab

ove.

LO

AE

L=0.

1%

LOE

C

0.1

%

GP

h114

yr06

2.07

9999

924

1.06

E-0

6

94-2

6-8

n-B

utyl

p-

Hyd

roxy

ben-

zoat

e

Mic

e In

viv

o m

ice

stud

y. A

dos

e-de

pend

ent

decr

ease

of b

oth

roun

d an

d el

onga

ted

sper

mat

id o

unts

in s

tage

s V

II-V

III

sem

inife

rous

tubu

les

was

obs

erve

d,

and

the

elon

gate

d sp

erm

atid

cou

nts

wer

e si

gnifi

cant

ly lo

wer

in a

ll of

the

trea

ted

grou

ps. T

he s

erum

test

oste

rone

co

ncen

trat

ion

decr

ease

d in

a d

ose-

depe

nden

t fas

hion

and

was

sig

nific

ant

at 1

.00%

. LO

AE

L=15

04 m

g/kg

bod

y w

eigh

t. D

ay

LOA

EL

1504

m

g/kg

bod

y w

eigh

t. da

y G

Ph2

72yr

060.

1049

9999

7 2.

46E

-07

Page 93: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

90

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

PE

CIE

S

Qua

lifyi

ng r

emar

ks_H

H

CR

ITE

RIO

N

DO

SE

C

ON

C.

UN

IT_D

OS

R

EC

NO

Loca

l tot

al d

aily

in

take

for

hu-

man

s (m

g/kg

/day

)

Reg

iona

l tot

al

daily

inta

ke fo

r hu

man

s (m

g/kg

/day

) 96

-12-

8 D

ibro

mo-

chlo

ropr

opan

e (D

BC

P)

Hum

an

Exp

osed

hum

an w

orke

rs. A

zoos

perm

ia

olig

ospe

rmia

and

dos

e-de

pend

ent

chan

ge in

FS

H, L

H a

nd te

stic

le s

ize

G

Fh0

09

0.04

1299

999

1.77

E-0

7

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

rat

In v

ivo

rat a

ssay

: Alte

ratio

n in

thyr

oid

func

tion

and

a si

gnifi

cant

cha

nge

in

thyr

oid

mor

phol

(12

5 an

d 62

5 pp

m)

. N

OE

C =

25

ppm

NO

EC

0,

1,

58,

125,

or

625

ppm

G

Ph0

55yr

060.

0143

3.

12E

-06

99-7

6-3

Met

hyl p

-H

ydro

xybe

n-zo

ate

adul

t ova

-rie

c-to

miz

ed

(Ovx

) C

D1

mic

e

In v

ivo

mic

e as

say:

The

hig

hest

MeP

-be

n do

se (

165

mg/

kg)

was

abl

e to

pro

-du

ce u

tero

trop

hic

effe

cts

(38

to 7

6%)

com

pare

d to

E-2

efe

cts

(100

%).

LO

-A

EL=

165

mg/

kg

LOA

EL

165

mg/

kg

GP

h103

yr06

0.02

76

1.45

E-0

6

99-9

6-7

p- Hyd

roxy

ben-

zoic

aci

d

Imm

atur

e an

d ad

ult

ovar

iec-

tom

ized

fe

mal

e m

ice

(CD

1)

Rat

in v

ivo

assa

y: D

ose-

depe

nden

t re-

spon

se (

0.5,

5, 5

0, a

nd 5

00 g

/kg)

on

vagi

nal c

orni

ficat

ion

and

uter

otro

phic

ac

tivity

in b

oth

imm

atur

e an

d ad

ult o

va-

riect

omiz

ed m

ice.

ED

0.

5, 5

, 50

, and

50

0

g/kg

G

Ph1

02yr

060.

0086

3 4.

17E

-07

Page 94: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

91

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

Tab

le 5

.9

Out

put f

rom

dat

abas

e: O

verv

iew

of t

he w

ildlif

e re

leva

nt E

D e

ffect

dat

a of

Cat

egor

y 1

subs

tanc

es. P

lus

EU

SE

S e

stim

ated

dat

a on

loca

l su

rfac

e w

ater

con

cent

ratio

ns

CA

S N

O

NA

ME

S

peci

eNam

e C

ON

C.

UN

IT

Qua

lifyi

ng r

emar

ks_W

L

Loca

l PE

C in

su

rfac

e w

ater

du

ring

em

is-

sion

epi

sode

(d

isso

lved

) (m

g/L)

15

82-0

9-8

Trif

lura

lin

Cyp

rinod

on

varie

gatu

s (s

heep

shea

d m

1-5

ug/l

Fis

h in

viv

o st

udy:

Pitu

itary

effe

cts

- po

ssib

ly in

di-

rect

effe

ct o

f exp

osur

e.

1.97

2501

3-16

-5

tert

.-B

utyl

hydr

oxya

niso

le

(BH

A)

Sal

mo

gaird

neri

14.1

4 ug

/l F

ish

in v

ivo

stud

y: In

crea

sed

vite

lloge

nin

synt

he-

sis.

EC

50=

14.1

4 ug

/L

2.33

1634

-04-

4 m

ethy

l ter

tiary

but

yl e

ther

(M

TB

E)

Ran

a te

mpo

raria

<

2500

m

g/l

Am

phib

ian

in v

ivo

stud

y: A

ccel

arat

ed d

evel

op-

men

t and

ear

lier

met

amor

phos

is. L

OE

C<

2500

m

g/L

4.73

131-

56-6

2,

4-D

ihyd

roxy

benz

ophe

non

= R

esbe

nzop

heno

ne

Pim

epha

les

pro-

mel

as

4919

µg

/l F

ish

in v

ivo

stud

y: A

quat

iic e

xpos

ure

of fa

thea

d m

inno

w w

ith B

P1

indu

ced

vite

lloge

nin

sign

ifica

ntly

at

491

9 m

g/l

5.24

1359

3-03

-8

Qui

nalp

hos

= C

hina

lpho

s C

laria

s ba

trac

hus

0.02

5 m

g/l

Fis

h in

viv

o st

udy:

Impa

irmen

t of

test

is fu

nctio

n du

e to

the

inhi

bitio

n of

ste

roid

ogen

ic e

nzym

es

activ

ities

. EC

=0.

025

mg/

L

1.98

96-4

5-7

Eth

ylen

e T

hiou

rea

(ET

U)

Not

spe

cifie

d 5,

10,

25,

50

, and

10

0

mg/

l A

mph

ibia

n in

viv

o as

say:

In a

sta

ndar

dise

d rin

g-te

sted

test

pro

posa

l (X

enop

us m

etam

orph

osis

as

say)

and

five

diff

eren

t ET

U c

oncn

s. (

5, 1

0, 2

5,

50, a

nd 1

00 m

g/L)

a c

oncn

.-de

pend

ent i

nhib

ition

of

met

amor

phos

is w

as o

bsd.

0.5

5466

-77-

3 2-

eth

yl-h

exyl

-4-

met

hoxy

cinn

amat

e O

ryzi

as la

tipes

.

. F

ish

in v

ivo

assa

y. In

crea

se in

pla

sma

VT

G +

and

in

crea

sed

mR

NA

exp

ress

ion

leve

ls o

f est

roge

n re

cept

or (

ER

) al

pha,

am

ong

sex

horm

one

rece

p-to

rs in

the

liver

.

1.06

3686

1-47

-9

3-(4

-M

ethy

lben

zylid

ene)

cam

phor

X

enop

us la

evis

1,

5 a

nd

50

µg/l

Am

phib

ian

in v

ivo

stud

y.T

he r

ate

of m

etam

orph

o-si

s w

as n

ot a

ffect

ed, a

nd n

o ob

viou

s di

ffere

nces

in

bod

y an

d ta

il le

ngth

com

pare

d to

con

trol

s w

ere

obse

rved

.

0.85

9

120-

47-8

et

hyl 4

-hyd

roxy

benz

oate

R

ainb

ow tr

out

100

mg/

kg

Fis

h in

viv

o st

udy.

VT

G in

duct

ion

in r

ainb

ow

trou

ts. L

OA

EL=

100

mgk

g 0.

0207

94-1

3-3

n-pr

opyl

p-h

ydro

xybe

nzoa

te

Onc

orch

ynch

us

myk

iss

22

mg/

kg b

ody

wei

ght.d

ay

Fis

h in

viv

o as

say:

Cle

ar d

ose

resp

onse

incr

ease

in

VT

G r

espo

nse.

ED

50 =

22

mg

kg-1

2-d

. NO

EC

9.

52

Page 95: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

92

DHI Water & Environment

ERA/53559/Revised report/2007.06.04

CA

S N

O

NA

ME

S

peci

eNam

e C

ON

C.

UN

IT

Qua

lifyi

ng r

emar

ks_W

L

Loca

l PE

C in

su

rfac

e w

ater

du

ring

em

is-

sion

epi

sode

(d

isso

lved

) (m

g/L)

=

225

mg/

L 15

087-

24-8

3-

Ben

zylid

ene

cam

phor

(3-

BC

) O

ncor

chyn

chus

m

ykis

s 6.

4 m

g/kg

/inje

ctio

nF

ish

in v

ivo

stud

y: V

itello

geni

n in

duct

ion.

ED

10,

ED

50 a

nd E

D90

of 3

-ben

zylid

ene

cam

phor

afte

r 6

days

(2

inje

ctio

ns)

wer

e 6.

4, 1

6 an

d 26

m

g/kg

/inje

ctio

n, r

esp

7.2

131-

55-5

B

enzo

phen

one-

2 (B

p-2)

, 2,

2',4

,4'-

tetr

ahyd

roxy

benz

ophe

none

Pim

epha

les

pro-

mel

as

8783

m

g/l

Fis

h in

viv

o st

udy:

Dos

e re

spon

se r

elat

ed V

TG

in

duct

ion.

LO

EC

= 8

783

mg/

L 9.

64

1004

3-35

-3

Bor

ic a

cid

Xen

opus

laev

is

.

Am

phib

ian

in v

ivo

stud

y: B

oric

aci

d ex

erte

d re

pro-

duct

ive

toxi

city

in X

enop

us la

evis

+ t

rans

gene

ra-

tiona

l tox

icity

to th

e de

velo

ping

pro

geny

.

2.37

92-8

8-6

4,4'

-Dih

ydro

xybi

phen

yl =

4,

4'-B

iphe

nol

Onc

orch

ynch

us

myk

iss

10-8

- 1

0-4

mg

In v

itro

stud

y. R

ecom

bina

nt y

east

ass

ay fo

r tr

out

ER

and

trou

t hep

atoc

yte

cultu

res.

Com

petit

ive

bind

ing

to E

R

0.96

4

104-

40-5

4-

Non

ylph

enol

(4-

NP

) O

ryzi

as la

tipes

24

.8

µg/l

Fis

h in

viv

o st

udy:

Indu

ctio

n of

VT

G. L

OE

C=

24.

8 ug

/l 4.

34

2719

3-28

-8

Phe

nol,

(1,1

,3,3

-te

tram

ethy

lbut

yl)-

= O

ctyl

-ph

enol

Ory

zias

latip

es

11.4

µg

/l F

ish

in v

ivo

stud

y. V

TG

indu

ctio

n +

inte

rsex

go-

nads

. LO

EC

=11

.4 u

g/L

5.19

611-

99-4

4,

4'-D

ihyd

roxy

benz

ophe

non

Pim

epha

les

pro-

mel

as

. .

Fis

h in

viv

o as

say:

VT

G r

espo

nse.

In v

itro:

Ful

l do

se-r

espo

nse

curv

es in

in v

itro

assa

y (r

ecom

bi-

nant

yea

st c

arry

ing

the

estr

ogen

rec

epto

r of

rai

n-bo

w tr

out (

rtE

Ra)

). In

viv

o: V

TG

res

pons

e

0.98

2

94-2

6-8

n-B

utyl

p-H

ydro

xybe

nzoa

te

Onc

orch

ynch

us

myk

iss

35

mg/

l R

ainb

ow tr

out i

n vi

vo s

tudy

. Vite

lloge

nin

re-

spon

se. L

OE

D: o

ral e

xpos

ure

to 9

mg

buty

lpar

a-be

n kg

-1 2

d-1

1.19

Page 96: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 93

5.4 Update of database and list (Task 4)

The database, which was already available for the substances categorized in the BKH 2000 and the RPS-BKH 2002 studies, was revised to include the information gathered and conclusions drawn in the present study. Likewise, the existing Endocrine Disrupter priority list was revised. The database and the Priority List were delivered in formats applicable for publication on the Commission’s Endocrine Disrupters Website (Access, Excel and PDF). The revision included the addition of the new substances (identified under Task 2 and evaluated under Task 3). The ranked priority list contains the following information on all substances: • CAS No. and substance name • Endocrine Disrupter category (1, 2, 3a or 3b). • Indication of High Production Volume or Low Production Volume substance • If the substance is assigned a R53 phrase The updated priority list is given in Appendix L as well as in the database. A short manual to supplement the manual for the former version of the database (RPS-BKH 2002) is prepared and both the former manual and the supplementary manual is available from the internet: http://projects.dhi.dk/Endocrine_Disrupter/testsite/)) as well as given in Appendix K. In total, the database now includes 428 substances. The distribution (CAT 1, 2 and 3) between the evaluated substances is given in Table 5.10. Table 5.10 Distribution of CAT 1, 2 and 3 substances now included in the database

Total number of substances evaluated 575 CAT 1 At least one study providing evidence for endocrine

disruption in an intact organism 194

CAT 2 Potential for endocrine disruption. In-vitro data indicat-ing potential for endocrine disruption in intact organ-isms.

125

CAT 3 No scientific basis for inclusion in list or no data 109 Not evaluated Not in ESIS; Mixtures; no CAS; group name etc. 147

Below, the summary profiles of the 34 category 1 substances identified in the present study are presented. The summary profiles give an overview of human and wildlife re-lated endocrine effects, physical and chemical properties, selected EUSES estimations on bioaccumulation, biodegradability in the environment, an overview of the use, pro-duction volumes, emissions, estimated environmental concentration ranges and human daily intake, the present regulatory and legal status and finally a conclusion of the level of concern (High, Medium or Low concern).

Page 97: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 94

Tert.-Butylhydroxyanisole (BHA) (CAS No.: 25013-16-5) 2(3)-tert-Butyl-4-hydroxyanisole; antioxyne b; BHA; BOA; Butylated hydroxyanisole; Butyl Hydroxyani-sole; tert-butyl-4-hydroxyanisole; tert-butyl-4-methoxyphenol; tert-butylhydroxyanisole; Vertac; Human related effects In vivo rat study. In one-generation rats, sex ratio of male was decreased and the anogenital distances were shortened and vaginal patency and preputial separation were observed later than control group. Also, BHA decreased sperm motility and number and the width and length. LOEL=10 mg/kg body weight/day Wildlife related effect Fish in vivo study: Increased vitellogenin synthesis. EC50=14.14 ug/L Chemical characteristics: Molecular formula: C11 H16 O2

Table 1: Physical/chemical properties of tert.-Butylhydroxyanisole (BHA) Parameter Value Unit Reference Molecular weight 180.25 g/mol Melting point 51 ºC EPISUITE Boiling point 268 ºC EPISUITE Vapour pressure at 25 [oC] 0.312 Pa EPISUITE Water solubility at 25 [oC] 212.8 mg/L EPISUITE Octanol-water partition coefficient 3.29 - MST Koc 1390 L/kg EPISUITE BCF 11.5 - EPISUITE Henry's law constant 0.00868 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 3.56 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 500 Tonnes/year Release to air 3.75 kg/year Release to wastewater 7500 kg/year Local PEC in surface water during emission episode (dissolved) 2.3299999 mg/l Local PEC in fresh-water sediment during emission episode 29.1 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 43.599998 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 13.5 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 59.799999 mg/(kg wet weight) Concentration in fish-eating marine top-predators 1.29 mg/(kg wet weight) Local total daily intake for humans 0.83399999 mg/(kg⋅d) Regional total daily intake for humans 6.3300002E-5 mg/(kg wet weight) Conclusion Tert.-Butylhydroxyanisole (BHA) is used as an antioxidant to preserve and stabilize the freshness of food and feed and is according to the ESIS database a LPV substance. BHA is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=3.29). BHA is in the environment

Page 98: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 95

mainly distributed to surface water. Based on EUSES estimations for secondary poisoning BHA is not expected to be of significant concern. A relatively low daily human intake is expected. However, as BHA is added directly to food items to preserve and stabilize the freshness of food and feed a direct human exposure is obvious. BHA is thus considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 99: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 96

Di-n-pentylphthalate (DPP) = Dipentylphthalate (CAS No.: 131-18-0) Amoil; Di-N-pentyl phthalate; Dipentyl 1,2-benzenedicarboxylate; dipentyl ester phthalic acid; dipentyl phthalate; DPP; amyl phthalate; Phthalic acid di-n-amyl ester; phthalic acid dipentyl ester; Human related effects Mice in vivo study: A continuous breeding protocol was utilized to examine the reproductive toxicity of di-n-pentyl phthalate (DPP). DPP was toxic to the reproductive system as evidenced by a complete inhibi-tion of fertility at 1.25 and 2.5% DPP and reduced fertility (litte Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C18 H26 O4

Table 1: Physical/chemical properties of Di-n-pentylphthalate (DPP) = Dipentylphthalate Parameter Value Unit Reference Molecular weight 306.41 g/mol Melting point ºC Boiling point 342 ºC EPISUITE Vapour pressure at 25 [oC] 0.026131112 Pa EPISUITE Water solubility at 25 [oC] 100 mg/L EPISUITE Octanol-water partition coefficient 5.62 - EPISUITE Koc 4966 L/kg EPISUITE BCF 29.17 - EPISUITE Henry's law constant 0.219 Pa·m3/mole EPISUITE Biodegradation Inherent biode-

gradable - MST

t½(hydrolysis) 3.427 Year EPISUITE t½(air) 10.605 hr EPISUITE

Page 100: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 97

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 0.3996 kg/year Release to wastewater 799.20001 kg/year Local PEC in surface water during emission episode (dissolved) 0.34999999 mg/l Local PEC in fresh-water sediment during emission episode 66.900002 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 128 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 41.099998 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 1550 mg/(kg wet weight) Concentration in fish-eating marine top-predators 1290 mg/(kg wet weight) Local total daily intake for humans 14.7 mg/(kg⋅d) Regional total daily intake for humans 0.0000774 mg/(kg wet weight) Conclusion Consumer and industrial applications for phthalates are numerous and range from making nail polish flexible and screwdriver handles less brittle to helping make the time-release coatings on numerous pharmaceutical products. Dipentylphthalate is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 50 tones per year has been used. Dipentylphthalate is inher-ently biodegradable and has a high potential to bioaccumulate (log Kow=5.62). Based on EUSES calcula-tions dipentylphthalate is not expected to be found in significant amounts in the environment (surface wa-ters and sediments). However as Dipentylphthalate is of medium concern in relation to secondary poison-ing. Dipentylphthalate is thus considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found.

Page 101: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 98

2,6-cis-Diphenylhexamethylcyclotetrasiloxane - 2,6-cis-[(PhMeSiO)2(Me2SiO)2][ (CAS No.: 33204-76-1) Quadrosilan; Human related effects In vivo rat study. Inhibited fertility and alterations in measured characteristics of the ejaculate. LOAEL=0.5 mg/kg/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C18 H28 O4 Si4

Table 1: Physical/chemical properties of 2,6-cis-Diphenylhexamethylcyclotetrasiloxane - 2,6-cis-[(PhMeSiO)2(Me2SiO)2][ Parameter Value Unit Reference Molecular weight 420.76001 g/mol Melting point 120.13 ºC EPISUITE Boiling point 360.69 ºC EPISUITE Vapour pressure at 25 [oC] 0.001116 Pa EPISUITE Water solubility at 25 [oC] 8.301e-005 mg/L EPISUITE Octanol-water partition coefficient 7.52 - EPISUITE Koc 10580000 L/kg EPISUITE BCF 7224 - EPISUITE Henry's law constant 33.5 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 26.755 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 0.39199999 mg/l Local PEC in fresh-water sediment during emission episode 727 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 376 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 87.099998 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 202 mg/(kg wet weight) Concentration in fish-eating marine top-predators 913 mg/(kg wet weight) Local total daily intake for humans 273 mg/(kg⋅d) Regional total daily intake for humans 0.00112 mg/(kg wet weight)

Page 102: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 99

Conclusion Diphenylhexamethylcyclotetrasiloxane is used for various purposes as e.g. breast implants and bear-ing grease. Diphenylhexamethylcyclotetrasiloxane is according to the ESIS database not a LPV sub-stance. For the EUSES calculations a production volume of 10 tones per year has been used. Diphenyl-hexamethylcyclotetrasiloxane is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=7.52). Diphenylhexamethylcyclotetrasiloxane is in the environment distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning Diphenylhexamethylcyclotetrasiloxane is expected to be of medium concern. A high local daily human intake is expected (up to approx. 275 mg/kg/day). Diphenylhexamethylcyclotetrasiloxane is con-sidered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 103: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 100

Ethylene Thiourea (ETU) (CAS No.: 96-45-7) 1,3-ethylene-2-thiourea; 1,3-Ethylenethiourea; Sanceller 22; sodium-22 neoprene accelerator; tetrahydro-2H-imidazole-2-thione; Vulkacit NPV/C; vulkacit npv/C2; warecure c; 2-Imidazolidimethione; 2-Imidazolidinethione; 2-mercapto-4,5-dihydroimidazole; 2-Mercaptoimidazoline; 2-thiol-dihydroglyoxaline; 4,5-dihydro-2-mercaptoimidazole; 4,5-dihydroimidazole-2(3H)-thione; Akrochem ETU-22; Ethylenethio-urea; Ethylene Thiourea; Ethylene thiourea ; ETHYLENE THIOUREA (2-IMIDAZOLIDINETHIONE); ETU; imidizolidenethione; Imidazolidinethione; Imidazoline-2-thiol; Mercaptoimidazoline; Mercozen; NA-22; NA-22-D; N,N'-ethylenethiourea; pennac cra; rhodanin s 62; Robac 22; Human related effects In vivo rat assay: Alteration in thyroid function and a significant change in thyroid morphol (125 and 625 ppm) . NOEC = 25 ppm Wildlife related effect Amphibian in vivo assay: In a standardised ringtested test proposal (Xenopus metamorphosis assay) and five different ETU concns. (5, 10, 25, 50, and 100 mg/L) a concn.-dependent inhibition of metamorphosis was obsd. Chemical characteristics: Molecular formula: C3 H6 N2 S1

Table 1: Physical/chemical properties of Ethylene Thiourea (ETU) Parameter Value Unit Reference Molecular weight 102.15 g/mol Melting point 203 ºC Boiling point 347.18 ºC Vapour pressure at 25 [oC] 0.01866508 Pa Water solubility at 25 [oC] 20000 mg/L Octanol-water partition coefficient -0.66 - Koc 6.511 L/kg BCF 25 - Henry's law constant Pa·m3/mole Biodegradation Not readily bio-

degradable -

t½(hydrolysis) Year t½(air) hr

Page 104: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 101

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 1000 Tonnes/year Release to air 9.9899998 kg/year Release to wastewater 3000 kg/year Local PEC in surface water during emission episode (dissolved) 0.5 mg/l Local PEC in fresh-water sediment during emission episode 0.44299999 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.00679 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.00162 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.28999999 mg/(kg wet weight) Concentration in fish-eating marine top-predators 5.8200001E-3 mg/(kg wet weight) Local total daily intake for humans 0.0143 mg/(kg⋅d) Regional total daily intake for humans 0.00000312 mg/(kg wet weight) Conclusion Ethylenethiourea (ETU) is one of the degradation products of ethylenebis-dithiocarbamate fungicides, such as maneb and zineb, which have been widely used on food crops. ETU is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 1000 tones per year has been used. ETU is not readily biodegradable and has a low potential for bioaccumulation (log Kow=-0.66). Based EUSES calculations ETU is in the environment mainly distributed to surface water in con-centrations up to approx. 0.5 mg/L. ETU is expected to be found in fish, predators and human food in in-significant amounts. ETU is thus considered as being of Low Concern. The substance is covered by Council Directive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed. Classification: REP2;R61 XN;R22

Page 105: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 102

Trifluralin (CAS No.: 1582-09-8) 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)-benzamine; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)benzenamine; 2,6-dinitro-N,N-dipropyl-4-trifluoromethyl-aniline; 2,6-dinitro-N,N-dipropyl-alpha,alpha,alpha-trifluoro-p-toluidine; 4-(di-n-propylamino)-3,5-dinitro-1-trifluoromethylbenzene; al-pha,alpha,alpha-Trifluoro-2,6-Dinitro-N,N-Dipropyl-p-Toluidine; Agreflan; agriflan 24; Benezeneamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-; digermin; Commence; crisalin; Elancolan; elanocolan; L-36352; lilly 36,352; nitran; N,N-di-n-propyl-2,6-dinitro-4-trifluoromethylaniline; N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline; N,N-dipropyl-4-trifluoromethyl-2,6-dinitroaniline; olitref; Scotts Stop Weeds Before They Start; su seguro carpidor; TR-10; trefanocide; treficon; Treflam; Treflan; Treflan 10G; Treflan 4EC; Treflan 5G; Treflan EC; Treflan MTF; treflanocide elancolan; Treflan TR-10; Trifluralin; Trifluralin ; trifurex; trikepin; Trilin 4EC; Trim; Human related effects In vivo ewe study. Concentrations of estradiol were significantly increased in ewes given trifluralin. No effect on thyroxine concentration. Mean serum concentrations of LH were markedly decreased by triflu-ralin, and basal LH concentrations were significantly decreased. Only one dosis (17.5 mg/kg 2 times per week) was investigated Wildlife related effect Fish in vivo study: Pituitary effects - possibly indirect effect of exposure. Chemical characteristics: Molecular formula: C13 H16 F3 N3 O4

Table 1: Physical/chemical properties of Trifluralin Parameter Value Unit Reference Molecular weight 335.29001 g/mol Melting point 49 ºC EPISUITE Boiling point 139.5 ºC EPISUITE Vapour pressure at 25 [oC] 0.0061061476 Pa EPISUITE Water solubility at 25 [oC] 0.184 mg/L EPISUITE Octanol-water partition coefficient 5.34 - EPISUITE Koc 9682 L/kg EPISUITE BCF 1.5 - EPISUITE Henry's law constant 10.43648 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 5.347 hr EPISUITE

Page 106: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 103

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10000 Tonnes/year Release to air 80.099998 kg/year Release to wastewater 24000 kg/year Local PEC in surface water during emission episode (dissolved) 1.97 mg/l Local PEC in fresh-water sediment during emission episode 270 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 540 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 192 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 56000 mg/(kg wet weight) Concentration in fish-eating marine top-predators 22500 mg/(kg wet weight) Local total daily intake for humans 63.900002 mg/(kg⋅d) Regional total daily intake for humans 7.9800002E-3 mg/(kg wet weight) Conclusion Trifluralin is used as a pesticide and is according to the ESIS database a HPV substance. For the EUSES calculations a production volume of 10000 tones per year has been used. Trifluralin is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=5.34). Trifluralin is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning 2,4- Trifluralin is expected to be found in fish and top predators in extremely high amounts. A high human exposure up to 70 mg/kg/day is expected. Trifluralin is in the present evaluation considered as being of High Concern. Trifluralin is covered by Council Direc-tive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed. Classification: XI;R36 R43 N;R50/53. Finalised assessments review by EFSA. Agreement that there is only limited evidence for endocrine effects and that this was recorded at high dose levels and was hard to distinguish from systemic toxicity. Trifluralin is considered as a POP candidate

Page 107: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 104

Quinalphos = Chinalphos (CAS No.: 13593-03-8) O,O-diethyl O-2-quinoxalinyl phosphorothioate; Bayrusil; Diethquinalphion; Diethyl O-2-quinoxalinyl phosphorothioate; Diethyl O-(2-quinoxalyl) phosphorothioate; Diethyl O-quinoxalin-2-yl thionophosphate; Diethyl O-(quinoxalin-2-yl) thiophosphate; Ekalux; Quinalphos; Quinalphos ; QUINALPHOS [O,O-DIETHYL-O-2-QUINOXALYLTHIOPHOSPHATE]; SRA 7312; Wie oben; Human related effects In vivo rat study: Sublethal chronic administration of quinalphos resulted in: decreased testicular mass and AChE activity in central as well as peripheral organs; increased serum LH, FSH, prolactin, and tes-tosterone concns.; decreased pituitary or increased testicular ACE. Ed 7-14 mg/kg/day. Wildlife related effect Fish in vivo study: Impairment of testis function due to the inhibition of steroidogenic enzymes activities. EC=0.025 mg/L Chemical characteristics: Molecular formula: C12 H15 N2 O3 P1 S1

Table 1: Physical/chemical properties of Quinalphos = Chinalphos Parameter Value Unit Reference Molecular weight 298.29999 g/mol Melting point 31.5 ºC EPISUITE Boiling point 142 ºC EPISUITE Vapour pressure at 25 [oC] 0.0003466372 Pa EPISUITE Water solubility at 25 [oC] 22 mg/L EPISUITE Octanol-water partition coefficient 4.44 - EPISUITE Koc 1857 L/kg EPISUITE BCF 4631 - EPISUITE Henry's law constant 0.005806 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 1.346 hr EPISUITE

Page 108: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 105

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 500 Tonnes/year Release to air 3.75 kg/year Release to wastewater 7500 kg/year Local PEC in surface water during emission episode (dissolved) 1.98 mg/l Local PEC in fresh-water sediment during emission episode 93.099998 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 180 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 67.199997 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 482 mg/(kg wet weight) Concentration in fish-eating marine top-predators 12.2 mg/(kg wet weight) Local total daily intake for humans 7.9699998 mg/(kg⋅d) Regional total daily intake for humans 8.2199997E-4 mg/(kg wet weight) Conclusion Quinalphos is used as a insecticide. Quinalphos is according to the ESIS database a LPV substance. Quinalphos is not readily biodegradable and has a high potential to bioaccumulate (log Kow=4.44). Based on EUSES estimations Quinalphos expected to be found in local surface water in concentrations up to 2 mg/L. Due to the persistency of the substance and the high potential bioaccumulation Quinalphos is of medium concern in relation to secondary poisoning and daily human intake. Quinalphos is considered as being of Medium Concern. Quinalphos is covered by Council Directive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed. Classification: XN;R21 T;R25 N;R50/53.

Page 109: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 106

Dibromochloropropane (DBCP) (CAS No.: 96-12-8) 1,2-Dibromo-3-Chloropropane; 1,3-Dibromo-3-chloropropane; os 1897; oxy dbcp; sd 1897; 1-chloro-2,3-dibromopropane; 3-chloro-1,2-dibromopropane; BBC 12; Dibromo-3-chloropropane, 1,2- (DBCP) ; dibro-mochloropropane; CBCP; DBCP; fumagon; Fumazone; fumazone 86; nemabrom; Nemafume; Nemagon; nemagon 20; nemagon 206; nemagon 20g; nemagon 90; nemagon soil fumigant; Nemanax; nemapaz; Nemaset; Nematocide; nematox; nemazon; Human related effects Exposed human workers. Azoospermia oligospermia and dose-dependent change in FSH, LH and testi-cle size Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C3 H5 Br2 CL1

Table 1: Physical/chemical properties of Dibromochloropropane (DBCP) Parameter Value Unit Reference Molecular weight 236.33 g/mol Melting point 6 ºC EPISUITE Boiling point 196 ºC EPISUITE Vapour pressure at 25 [oC] 77.32676 Pa EPISUITE Water solubility at 25 [oC] 1230 mg/L SYRACUSE

CHEMFATE Octanol-water partition coefficient 2.96 - EPISUITE Koc 130.8 L/kg EPISUITE BCF 1.8 - SYRACUSE

CHEMFATE Henry's law constant 14.89478 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) 36.124 Year EPISUITE t½(air) 28.636 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.76200002 mg/l Local PEC in fresh-water sediment during emission episode 6.5999999 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 3.02 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.68099999 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.61500001 mg/(kg wet weight) Concentration in fish-eating marine top-predators 1.6100001E-2 mg/(kg wet weight) Local total daily intake for humans 4.1299999E-2 mg/(kg⋅d) Regional total daily intake for humans 1.77E-7 mg/(kg wet weight)

Page 110: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 107

Conclusion Dibromochloropropane (DBCP) is used as a pesticide as well as an industrial intermediate. DBCP is according to the ESIS database produced in amounts < 10 tones/year and is thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. DBCP is not read-ily biodegradable and has medium potential to bioaccumulate in the environment (log kow=2.96). DBCP is in the environment mainly distributed to surface water in concentrations up to approx. 1 mg/L. Based on EUSES estimations for secondary poisoning and human intake DBCP is expected to be found in fish, predators and human food in minor amounts. DBCP is considered as being of Medium Concern. Cov-ered by Council Directive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed. Classification: CARC2;R45 MUT2;R46 REP1;R60 T;R25 XN;R48/20/22 R52/53.

Page 111: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 108

4-Nonylphenol (4-NP) (CAS No.: 104-40-5) 4-Nonylphenol; 4-Nonylphenol, mixture of isomers; Human related effects Rat in vivo study: Uterine weight, uterine/body weight significantly increased in 90 mg/kg and 120 mg/kg groups and a dose-response relationship was observed. Wildlife related effect Fish in vivo study: Induction of VTG. LOEC= 24.8 ug/l Chemical characteristics: Molecular formula: C15 H24 O1

Table 1: Physical/chemical properties of 4-Nonylphenol (4-NP) Parameter Value Unit Reference Molecular weight 220.36 g/mol Melting point 42 ºC EPISUITE Boiling point 324.47 ºC MST Vapour pressure at 25 [oC] 0.109057396 Pa EPISUITE Water solubility at 25 [oC] 7 mg/L EPISUITE Octanol-water partition coefficient 5.76 - EPISUITE Koc 60890 L/kg EPISUITE BCF 6.22 - EPISUITE Henry's law constant 3.44505 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 2.483 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 4.3400002 mg/l Local PEC in fresh-water sediment during emission episode 979 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 1920 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 743 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 933 mg/(kg wet weight) Concentration in fish-eating marine top-predators 424 mg/(kg wet weight) Local total daily intake for humans 245 mg/(kg⋅d) Regional total daily intake for humans 0.000157 mg/(kg wet weight) Conclusion Nonylphenol (NP) is widely used as a component of detergents, paints, pesticides, and many other for-mulated products. 4-Nonylphenol is produced is low amount and is according to the ESIS database nei-ther a HPV or LPV substance. 4-Nonylphenol is not readily biodegradable and has a high potential to bio-accumulate (log Kow=5.76). 4-Nonylphenol is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning 4-Nonylphenol is expected to be found both in fish and top predators in concentrations up to 1000 mg/kg wet weight. Local daily human intake is estimated to be up to 250 mg/kg body weight per day. Due to an

Page 112: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 109

expected close human contact to 4-Nonylphenol via detergents and paints, 4-Nonylphenol is considered as being of High Concern. In the EU there is a restriction on the use of nonylphenol and its ethoxylates (Annex I of Directive 76/769/EEC) limiting the inclusion of these substances in a variety of products to no more than 0.1%. Proposed classification: Rep.3;R62 Rep.3;R63 Xn;R22 C;R34 N;R50/53

Page 113: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 110

4-Cyclohexylphenol (CAS No.: 1131-60-8) p-Cyclohexylphenol; Human related effects Rat in vivo study: Uterotrophic assay. Increased uterine weight. LOAEL=200 mg/kg Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C12 H16 O1

Table 1: Physical/chemical properties of 4-Cyclohexylphenol Parameter Value Unit Reference Molecular weight 176.25999 g/mol Melting point 133 ºC EPISUITE Boiling point 294 ºC EPISUITE Vapour pressure at 25 [oC] 0.01016 Pa EPISUITE Water solubility at 25 [oC] 60 mg/L EPISUITE Octanol-water partition coefficient 4.22 - EPISUITE Koc 10120 L/kg EPISUITE BCF 15.92 - EPISUITE Henry's law constant 0.114 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 36.832 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 8.3000002 mg/l Local PEC in fresh-water sediment during emission episode 302 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 569 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 208 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 8.7700005 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.211 mg/(kg wet weight) Local total daily intake for humans 16.700001 mg/(kg⋅d) Regional total daily intake for humans 0.00000963 mg/(kg wet weight) Conclusion 4-Cyclohexylphenol is used in the formation of resin. Resin is widely used product. 4-Cyclohexylphenol is according to the ESIS database produced in low amount and is neither a HPV or LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. 4-Cyclohexylphenol is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=4.22). 4-Cyclohexylphenol is in the environment mainly distributed to surface water as well as sediments and

Page 114: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 111

agricultural soils. Based on EUSES estimations for secondary poisoning 4-Cyclohexylphenol is expected to be found in fish and top predators in minor amount. A medium human exposure is expected. 4-Cyclohexylphenol is considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found, however the substance is related to nonylphenol.

Page 115: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 112

2,4-Dihydroxybenzophenon = Resbenzophenone (CAS No.: 131-56-6) 2,4-Dihydroxybenzophenone; Benzoresorcinol; Methanone, (2,4-dihydroxyphenyl)phenyl-; Human related effects Rat in vivo study: Benzophenone (Bp)-1 increased uterine wt. in immature rats. Furthermore, benzophe-none-1 (Bp-1) was in a previous in vitro experiment (MCF-7 cells) shown to have clear estrogenic activity (EC-50: 2.08 uM) Wildlife related effect Fish in vivo study: Aquatiic exposure of fathead minnow with BP1 induced vitellogenin significantly at 4919 mg/l Chemical characteristics: Molecular formula: C13 H10 O3

Table 1: Physical/chemical properties of 2,4-Dihydroxybenzophenon = Resbenzophenone Parameter Value Unit Reference Molecular weight 214.22 g/mol Melting point 144 ºC EPISUITE Boiling point 374.59 ºC MST Vapour pressure at 25 [oC] 1.88e-005 Pa EPISUITE Water solubility at 25 [oC] 412.4 mg/L EPISUITE Octanol-water partition coefficient 2.96 - MST Koc 2885 L/kg EPISUITE BCF 94.5 - EPISUITE Henry's law constant 2.68e-006 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 0.641 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 1.08 kg/year Release to wastewater 2970 kg/year Local PEC in surface water during emission episode (dissolved) 5.2399998 mg/l Local PEC in fresh-water sediment during emission episode 45.400002 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 62.099998 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 18.4 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 12.7 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.266 mg/(kg wet weight) Local total daily intake for humans 2.3199999 mg/(kg⋅d) Regional total daily intake for humans 0.0000105 mg/(kg wet weight)

Page 116: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 113

Conclusion 2,4-Dihydroxybenzophenon is used as a UV sunscreen in cosmetics. 2,4-Dihydroxybenzophenon is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 50 tones per year has been used. 2,4-Dihydroxybenzophenon is not readily biodegradable and has a poten-tial to bioaccumulate in the environment (log kow=2.96). 2,4-Dihydroxybenzophenon is in the environ-ment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning 2,4-Dihydroxybenzophenon is not expected to be found in fish and top predators. A high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. 2,4-Dihydroxybenzophenon is therefore considered as being of High Concern. None specifically regulatory or legal status for this substance was found..

Page 117: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 114

4,4'-Dihydroxybenzophenon (CAS No.: 611-99-4) 4,4'-Dihydroxybenzophenone; DHBP; Human related effects rat in vivo assay: Induced uterotrophy and exerted both estrogen agonistic effect and reduced the estro-genic effect of ethynylestradiol Wildlife related effect Fish in vivo assay: VTG response. In vitro: Full dose-response curves in in vitro assay (recombinant yeast carrying the estrogen receptor of rainbow trout (rtERa)). In vivo: VTG response Chemical characteristics: Molecular formula: C13 H10 O3

Table 1: Physical/chemical properties of 4,4'-Dihydroxybenzophenon Parameter Value Unit Reference Molecular weight 214.22 g/mol Melting point 210 ºC EPISUITE Boiling point 374.59 ºC MST Vapour pressure at 25 [oC] 3.28e-006 Pa EPISUITE Water solubility at 25 [oC] 1905 mg/L EPISUITE Octanol-water partition coefficient 2.19 - MST Koc 2826 L/kg EPISUITE BCF 33.52 - EPISUITE Henry's law constant 2.13e-009 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 2.103 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9.0000004E-2 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.98199999 mg/l Local PEC in fresh-water sediment during emission episode 3.8499999 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 3.05 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.73199999 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.176 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.00358 mg/(kg wet weight) Local total daily intake for humans 0.34400001 mg/(kg⋅d) Regional total daily intake for humans 4.3599999E-7 mg/(kg wet weight)

Page 118: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 115

Conclusion 4,4'-Dihydroxybenzophenon is used as a UV sunscreen in cosmetics. 4,4'-Dihydroxybenzophenon is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. 4,4'-Dihydroxybenzophenon is not readily biodegradable and has a medium potential to bioaccumulate in the environment (log kow=2.19). 4,4'-Dihydroxybenzophenon is in the environment mainly distributed to sur-face water. Based on EUSES estimations for secondary poisoning 4,4-Dihydroxybenzophenon is ex-pected to be found in fish and top predators in minor amounts. A high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. 4,4-Dihydroxybenzophenon is therefore considered as being of Medium Concern. None specifically regula-tory or legal status for this substance was found.

Page 119: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 116

Methyl tertiary butyl ether (MTBE) (CAS No.: 1634-04-4) 2-methoxy-2-methylpropane; methyl t-butyl ether; Methyl Tertiary Butyl Ether; Methyl Tertiary Butyl Ether (MTBE) ; MTBE; Tert-butyl methyl ether; Human related effects Rat in vio study: Increase of testis weight. Interstitial fluid and serum testosterone levels as well as serum prolactin levels were decreased only in animals treated with 1500 mg MTBE/kg/day for 15 days. Wildlife related effect Amphibian in vivo study: Accelarated development and earlier metamorphosis. LOEC<2500 mg/L Chemical characteristics: Molecular formula: C5 H12 O1

Table 1: Physical/chemical properties of methyl tertiary butyl ether (MTBE) Parameter Value Unit Reference Molecular weight 88.150002 g/mol Melting point -108.6 ºC IUCLID Boiling point 55.3 ºC IUCLID Vapour pressure at 25 [oC] 26800 Pa IUCLID Water solubility at 25 [oC] 26000 mg/L IUCLID Octanol-water partition coefficient 1.06 - IUCLID Koc 5.258 L/kg EPISUITE BCF 28.4 - IUCLID Henry's law constant 59.47778 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - IUCLID

t½(hydrolysis) Year t½(air) 2.6 hr IUCLID Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50000 Tonnes/year Release to air 1251000 kg/year Release to wastewater 75000 kg/year Local PEC in surface water during emission episode (dissolved) 4.73 mg/l Local PEC in fresh-water sediment during emission episode 7.54 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.199 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 8.6900003E-2 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 3.0899999 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.163 mg/(kg wet weight) Local total daily intake for humans 0.39500001 mg/(kg⋅d) Regional total daily intake for humans 4.0999999E-5 mg/(kg wet weight) Conclusion Methyl tertiary butyl ether is used as a petrol additive and is according to the ESIS database a HPV substance. For the EUSES calculations a production volume of 50000 tones per year has been used. Methyl tertiary butyl ether is not readily biodegradable and has a low potential to bioaccumulate in the environment (log kow=1.06). Methyl tertiary butyl ether is in the environment mainly distributed to surface

Page 120: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 117

waters. Based on EUSES estimations for secondary poisoning 2,4- Methyl tertiary butyl ether is expected to be found in fish and top predators in minor amount. A relatively low daily human intake is expected. Due to the fact that Methyl tertiary butyl ether is a high volume substance and not readily biodegradable relatively high concentrations in surface waters can be expected and Methyl tertiary butyl ether is thus considered as being of Medium Concern. RAR from 2002 is available on ESIS. Classification: F;R11 XI;R38

Page 121: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 118

Cyclotetrasiloxane (CAS No.: 556-67-2) Octamethylcyclotetrasiloxane; Human related effects Rat in vivo assay. Uterotrophic assay with two species: Relative uterine wts. and uterine epithelial cell height were statistically significantly increased in both strains of rats at doses above 100 mg/kg/day. LO-AEL=250 mg/kg/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C8 H24 O4 Si4

Table 1: Physical/chemical properties of Cyclotetrasiloxane Parameter Value Unit Reference Molecular weight 296.62 g/mol Melting point 17.5 ºC EPISUITE Boiling point 175.8 ºC EPISUITE Vapour pressure at 25 [oC] 139.9881 Pa EPISUITE Water solubility at 25 [oC] 0.005 mg/L EPISUITE Octanol-water partition coefficient 4.45 - SYRACUSE

CHEMFATE Koc 17960 L/kg EPISUITE BCF 1.392 - EPISUITE Henry's law constant 11855.03 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 107.246 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50000 Tonnes/year Release to air 300000 kg/year Release to wastewater 90000 kg/year Local PEC in surface water during emission episode (dissolved) 0.65899998 mg/l Local PEC in fresh-water sediment during emission episode 31.4 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 4.3299999E-2 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 8.7299999E-3 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 328 mg/(kg wet weight) Concentration in fish-eating marine top-predators 149 mg/(kg wet weight) Local total daily intake for humans 1.15 mg/(kg⋅d) Regional total daily intake for humans 3.8400001E-4 mg/(kg wet weight)

Page 122: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 119

Conclusion Cyclotetrasiloxane has numerous industrial and consumer applications and is according to the ESIS database a HPV substance. For the EUSES calculations a production volume of 50000 tones per year has been used. Cyclotetrasiloxane is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=5.45). Cyclotetrasiloxane is in the environment mainly distributed to surface water. Based on EUSES estimations for secondary poisoning Cyclotetrasiloxane is expected to be found in fish and top predators in minor amounts. Cyclotetrasiloxane has a potential for human exposure as it is used in numerous industrial and consumer. Applications. Cyclotetrasiloxane is considered as being of High Concern. None specifically regulatory or legal status for this substance was found. Classification: REP3;R62 R53

Page 123: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 120

2-ethyl-hexyl-4-methoxycinnamate (CAS No.: 5466-77-3) 2-Ethylhexyl 4-methoxycinnamate; 2-Ethylhexyl cinnamate; 3-(4-Methoxyphenyl)-2-propenoic acid 2-ethylhexyl ester; Escalol 557; Neo Heliopan AV.; Octyl 4-methoxycinnamate; Octyl methoxycinnamate; Parsol MCX; Parsol MOX; Human related effects Rat in vivo assay. Uterine wt. was dose-dependently increased by OMC (ED50 935 mg/kg/day) Wildlife related effect Fish in vivo assay. Increase in plasma VTG + and increased mRNA expression levels of estrogen recep-tor (ER) alpha, among sex hormone receptors in the liver. Chemical characteristics: Molecular formula: C18 H26 O3

Table 1: Physical/chemical properties of 2-ethyl-hexyl-4-methoxycinnamate Parameter Value Unit Reference Molecular weight 290.41 g/mol Melting point 99.87 ºC EPISUITE Boiling point 360.54 ºC MST Vapour pressure at 25 [oC] 0.00184 Pa EPISUITE Water solubility at 25 [oC] 0.1548 mg/L EPISUITE Octanol-water partition coefficient 5.8 - MST Koc 12280 L/kg EPISUITE BCF 12400 - EPISUITE Henry's law constant 0.18 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) 35.562 Year EPISUITE t½(air) 2.483 hr EPISUITE

Page 124: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 121

Table 2: Use, exposure and emissions Parameter Value unit Tonnage of substance in Europe 5000 Tonnes/year Release to air 5.0100002 kg/year Release to wastewater 15000 kg/year Local PEC in surface water during emission episode (dissolved) 1.0599999 mg/l Local PEC in fresh-water sediment during emission episode 251 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 490 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 190 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 73900 mg/(kg wet weight) Concentration in fish-eating marine top-predators 34400 mg/(kg wet weight) Local total daily intake for humans 89.199997 mg/(kg⋅d) Regional total daily intake for humans 0.0131 mg/(kg wet weight) Conclusion 2-ethyl-hexyl-4-methoxycinnamate is used as a UV sunscreen in cosmetics. 2-ethyl-hexyl-4-methoxycinnamate is according to the ESIS database a HPV substance. For the EUSES calculations a production volume of 5000 tones per year has been used. 2-ethyl-hexyl-4-methoxycinnamate is readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=5.8). 2-ethyl-hexyl-4-methoxycinnamate is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning 2-ethyl-hexyl-4-methoxycinnamate is expected to be found in fish and top predators in amounts up to approx. 70000 mg/kg ww. Furthermore a high regional human exposure is expected. Besides a high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. 2-ethyl-hexyl-4-methoxycinnamate is therefore considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 125: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 122

3-(4-Methylbenzylidene)camphor (CAS No.: 36861-47-9) 3-(4-Methylbenzyliden)camphor; Eusolex 6300; Human related effects Rat in vivo study. Delayed male puberty, and dose-dependently affected reproductive organ wts. of adult male and female F1 offspring, with partly different effect patterns. Thyroid wt. was increased by higher 4-MBC doses. LOAEL=7 mg/kg/day Wildlife related effect Amphibian in vivo study.The rate of metamorphosis was not affected, and no obvious differences in body and tail length compared to controls were observed. Chemical characteristics: Molecular formula: C18 H22 O1

Table 1: Physical/chemical properties of 3-(4-Methylbenzylidene)camphor Parameter Value Unit Reference Molecular weight 254.38 g/mol Melting point 121 ºC EPISUITE Boiling point 349.42 ºC MST Vapour pressure at 25 [oC] 0.002027 Pa EPISUITE Water solubility at 25 [oC] 0.1966 mg/L EPISUITE Octanol-water partition coefficient 5.22 - MST Koc 12210 L/kg EPISUITE BCF 3.162 - EPISUITE Henry's law constant 0.218 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 1.443 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 0.3996 kg/year Release to wastewater 799.20001 kg/year Local PEC in surface water during emission episode (dissolved) 0.85900003 mg/l Local PEC in fresh-water sediment during emission episode 102 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 202 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 76.599998 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 1730 mg/(kg wet weight) Concentration in fish-eating marine top-predators 594 mg/(kg wet weight) Local total daily intake for humans 15.7 mg/(kg⋅d) Regional total daily intake for humans 0.000237 mg/(kg wet weight)

Page 126: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 123

Conclusion 3-(4-Methylbenzylidene)camphor is used as a UV sunscreen in cosmetics. 3-(4-Methylbenzylidene)camphor is according to the ESIS database a LPV substance. For the EUSES calcu-lations a production volume of 50 tones per year has been used. 3-(4-Methylbenzylidene)camphor is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=5.22). 3-(4-Methylbenzylidene)camphor is in the environment mainly distributed to surface water as well as sedi-ments and agricultural soils. Based on EUSES estimations for secondary poisoning 3-(4-Methylbenzylidene)camphor is expected to be found in fish and top predators in amounts up to approx. 2000 mg/kg ww. A high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. 3-(4-Methylbenzylidene)camphor is therefore considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 127: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 124

p-Hydroxybenzoic acid (CAS No.: 99-96-7) 4-Hydroxybenzenecarboxylic acid; 4-Hydroxybenzoic acid; Human related effects Rat in vivo assay: Dose-dependent response (0.5, 5, 50, and 500 g/kg) on vaginal cornification and utero-trophic activity in both immature and adult ovariectomized mice. Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C7 H6 O3

Table 1: Physical/chemical properties of p-Hydroxybenzoic acid Parameter Value Unit Reference Molecular weight 138.12 g/mol Melting point 214.5 ºC EPISUITE Boiling point 298.03 ºC MST Vapour pressure at 25 [oC] 2.6397756e-005 Pa EPISUITE Water solubility at 25 [oC] 5000 mg/L EPISUITE Octanol-water partition coefficient 1.58 - SYRACUSE

CHEMFATE Koc 23.47 L/kg EPISUITE BCF - EPISUITE Henry's law constant 1.14e-006 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 9.873 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 1000 Tonnes/year Release to air 9.9899998 kg/year Release to wastewater 3000 kg/year Local PEC in surface water during emission episode (dissolved) 6.2899999E-2 mg/l Local PEC in fresh-water sediment during emission episode 0.14399999 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.0275 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.0106 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.114 mg/(kg wet weight) Concentration in fish-eating marine top-predators 1.8100001E-2 mg/(kg wet weight) Local total daily intake for humans 8.6300001E-3 mg/(kg⋅d) Regional total daily intake for humans 4.17E-7 mg/(kg wet weight) Conclusion p-Hydroxybenzoic acid is the common metabolite of all parabens and thus used as a preservative in food, pharmaceutical and cosmetic formulations. p-Hydroxybenzoate is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 1000 tonnes per year has been used. P-hydroxybenzoic acid is readily biodegradable and has a low potential for bioaccumulation (log Kow=1.58). Based EUSES calculations p-Hydroxybenzoic acid is distributed to the environment at low concentrations. P-hydroxybenzoic acid is expected to be found in fish, predators and human food in in-

Page 128: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 125

significant amounts. However, as P-hydroxybenzoic acid is used as a preservative in food and cosmetics a high direct human exposure is expected. P-hydroxybenzoic acid is thus considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found. It is the opinium of the Scientific Commitee on Consumer Products (SCCP) that, viewing the current knowledge, there is no evi-dence of demonstrable risk for the development of breast cancer caused by the use of underarm cosmet-ics including parabens.

Page 129: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 126

Methyl p-hydroxybenzoate (CAS No.: 99-76-3) 4-Hydroxybenzoic acid methyl ester; 4-Hydroxy methyl benzoate; Aseptoform; Methyl paraben; Methyl 4-hydroxybenzoate; Methyl Parasept; Methyl Chemosept; Nipagin; Nipagin M; Tegosept M; Human related effects In vivo mice assay: The highest MePben dose (165 mg/kg) was able to produce uterotrophic effects (38 to 76%) compared to E-2 efects (100%). LOAEL=165 mg/kg Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C8 H8 O3

Table 1: Physical/chemical properties of Methyl p-Hydroxybenzoate Parameter Value Unit Reference Molecular weight 152.14999 g/mol Melting point 131 ºC EPISUITE Boiling point 275 ºC EPISUITE Vapour pressure at 25 [oC] 0.114 Pa EPISUITE Water solubility at 25 [oC] 2500 mg/L EPISUITE Octanol-water partition coefficient 1.96 - EPISUITE Koc 125.6 L/kg EPISUITE BCF 3.162 - EPISUITE Henry's law constant 0.000366 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) 34.506 Year EPISUITE t½(air) 11.6 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 500 Tonnes/year Release to air 5 kg/year Release to wastewater 10000 kg/year Local PEC in surface water during emission episode (dissolved) 1.25 mg/l Local PEC in fresh-water sediment during emission episode 3.96 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.87199998 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.33899999 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.79500002 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.127 mg/(kg wet weight) Local total daily intake for humans 0.0276 mg/(kg⋅d) Regional total daily intake for humans 0.00000145 mg/(kg wet weight) Conclusion Methyl p-Hydroxybenzoate is used as a preservative in food, pharmaceutical and cosmetic formula-tions. Methyl p-Hydroxybenzoate is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 500 tones per year has been used. Methyl p-hydroxybenzoate is readily biodegradable and has a low potential for bioaccumulation (log Kow=1.96). Based EUSES calcu-

Page 130: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 127

lations Methyl p-hydroxybenzoate is in the environment mainly distributed to surface water in concentra-tions up to approx. 1 mg/L. Methyl p-hydroxybenzoate is expected to be found in fish, predators and hu-man food in insignificant amounts. However, as Methyl p-hydroxybenzoate is used as a preservative in food and cosmetics a high direct human exposure is expected. Methyl p-hydroxybenzoate is thus consid-ered as being of Medium Concern. None specifically regulatory or legal status for this substance was found. It is the opinium of the Scientific Commitee on Consumer Products (SCCP) that, viewing the cur-rent knowledge, there is no evidence of demonstrable risk for the development of breast cancer caused by the use of underarm cosmetics including parabens.

Page 131: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 128

Ethyl 4-hydroxybenzoate (CAS No.: 120-47-8) 4-Hydroxybenzoic acid ethyl ester; Ethyl paraben; Ethyl 4-hydroxybenzoate; Ethyl Parasept; Nipagin A; Solbrol A; Human related effects Rat and mice in vivo study: Increased uterine weight in immature and ovariectomized animals. ED50 18-74 µmol/ kg body weight Wildlife related effect Fish in vivo study. VTG induction in rainbow trouts. LOAEL=100 mgkg Chemical characteristics: Molecular formula: C9 H10 O3

Table 1: Physical/chemical properties of ethyl 4-hydroxybenzoate Parameter Value Unit Reference Molecular weight 254.38 g/mol Melting point 117 ºC EPISUITE Boiling point 297.5 ºC EPISUITE Vapour pressure at 25 [oC] 0.01239 Pa EPISUITE Water solubility at 25 [oC] 885 mg/L EPISUITE Octanol-water partition coefficient 2.47 - EPISUITE Koc 231.6 L/kg EPISUITE BCF 9.141 - EPISUITE Henry's law constant 0.000486 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) Year t½(air) 10.207 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 0.50099999 kg/year Release to wastewater 999 kg/year Local PEC in surface water during emission episode (dissolved) 0.0207 mg/l Local PEC in fresh-water sediment during emission episode 0.107 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 2.6799999E-2 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.0105 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.214 mg/(kg wet weight) Concentration in fish-eating marine top-predators 3.4400001E-2 mg/(kg wet weight) Local total daily intake for humans 0.00177 mg/(kg⋅d) Regional total daily intake for humans 2.3299999E-7 mg/(kg wet weight) Conclusion Ethyl 4-hydroxybenzoate is used as preservatives in food, pharmaceutical and cosmetic formulations. Ethyl 4-hydroxybenzoate is produced in amounts up to 50 tones per year and thus a LPV substance.

Page 132: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 129

Ethyl 4-hydroxybenzoate is readily biodegradable and has a medium potential for bioaccumulation. Based EUSES calculations Ethyl 4-hydroxybenzoate is expected to be released to the environment in insignifi-cant amounts and is not expected to give any problems in relation to secondary poisoning. However, as ethyl 4-hydroxybenzoate as a preservative in food and cosmetics a high human exposure is expected. Ethyl 4-hydroxybenzoate is thus considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found.

Page 133: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 130

n-propyl p-hydroxybenzoate (CAS No.: 94-13-3) Parabens; 4-Hydroxybenzoic acid propyl ester; Propyl chemsept; protaben p; pulvis conservans; Solbrol P; tegosept p; 4-hydroxybenzoic propyl ester; p-hydroxy propyl benzoate; aseptoform p; betacide p; bo-nomold op; Chemacide PK; Chemocide PK; Chemoside PK; nipagin p; Nipasol; nipasol m; nipasol p; ni-pazol; n-Propyl paraben; n-propyl p-hydroxybenzoate; paseptol; preserval p; propagin; Propyl paraben; Propyl 4-hydroxybenzoate; Propyl Parasept; propyl aseptoform; propyl butex; Propyl Chemosept; Human related effects In vivo rat assay: The epididymal sperm reserves and concentrations decreased dose dependently and the difference was significant at doses of 0.1% and above. LOAEL=0.1% Wildlife related effect Fish in vivo assay: Clear dose response increase in VTG response. ED50 = 22 mg kg-1 2-d. NOEC = 225 mg/L Chemical characteristics: Molecular formula: C10 H12 O3

Table 1: Physical/chemical properties of n-propyl p-hydroxybenzoate Parameter Value Unit Reference Molecular weight 180.21001 g/mol Melting point 97 ºC EPISUITE Boiling point 285.14 ºC MST Vapour pressure at 25 [oC] 0.04093 Pa EPISUITE Water solubility at 25 [oC] 500 mg/L EPISUITE Octanol-water partition coefficient 3.04 - EPISUITE Koc 427.2 L/kg EPISUITE BCF 111.9 - EPISUITE Henry's law constant 0.000645 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) 43.052 Year EPISUITE t½(air) 9.124 hr EPISUITE

Page 134: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 131

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 9.5200005 mg/l Local PEC in fresh-water sediment during emission episode 90 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 124 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 36.799999 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.99900001 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.021 mg/(kg wet weight) Local total daily intake for humans 2.0799999 mg/(kg⋅d) Regional total daily intake for humans 0.00000106 mg/(kg wet weight) Conclusion N-propyl p-hydroxybenzoate is used as a preservative in food, pharmaceutical and cosmetic formula-tions. N-propyl p-hydroxybenzoate is produced in amounts up to 10 tones per year and thus a LPV sub-stance. N-propyl p-hydroxybenzoate is readily biodegradable and has potential for bioaccumulation (log Kow=3.04). Based EUSES calculations N-propyl p-hydroxybenzoate is in the environment mainly distrib-uted to surface waters in concentrations up to approx. 10 mg/L. N-propyl p-hydroxybenzoate is expected to be found in fish, predators and human food in insignificant amounts. However, as n-propyl p-hydroxybenzoate is used as a preservative in food and cosmetics a high human exposure is expected. N-propyl p-hydroxybenzoate is thus considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found. It is the opinium of the Scientific Commitee on Consumer Products (SCCP) that, viewing the current knowledge, there is no evidence of demonstrable risk for the development of breast cancer caused by the use of underarm cosmetics including parabens

Page 135: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 132

n-Butyl p-Hydroxybenzoate (CAS No.: 94-26-8) 4-(butoxycarbonyl)phenol; 4-Hydroxybenzoic acid butyl ester; p-hydroxybenzoic acid n-butyl ester; p-Hydroxy butyl benzoate; aseptoform butyl; Butoben; Butyl paraben; Butyl 4-hydroxybenzoate; Butyl Para-sept; butyl butex; Butyl Chemosept; butyl tegosept; n-Butyl paraben; n-Butyl p-Hydroxybenzoate; nipabu-tyl; preserval b; solbrol b; SPF; Tegosept B; tegosept butyl; Human related effects In vivo mice study. A dose-dependent decrease of both round and elongated spermatid ounts in stages VII-VIII seminiferous tubules was observed, and the elongated spermatid counts were significantly lower in all of the treated groups. The serum testosterone concentration decreased in a dose-dependent fash-ion and was significant at 1.00%. LOAEL=1504 mg/kg body weight. Day Wildlife related effect Rainbow trout in vivo study. Vitellogenin response. LOED: oral exposure to 9 mg butylparaben kg-1 2d-1 Chemical characteristics: Molecular formula: C11 H14 O3

Table 1: Physical/chemical properties of n-Butyl p-Hydroxybenzoate Parameter Value Unit Reference Molecular weight 194.23 g/mol Melting point 68.5 ºC EPISUITE Boiling point 300.26 ºC MST Vapour pressure at 25 [oC] 0.0334 Pa EPISUITE Water solubility at 25 [oC] 207 mg/L EPISUITE Octanol-water partition coefficient 3.57 - EPISUITE Koc 787.8 L/kg EPISUITE BCF 37.95 - EPISUITE Henry's law constant 0.000856 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) 43.052 Year EPISUITE t½(air) 8.291 hr EPISUITE

Page 136: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 133

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 1.1900001 mg/l Local PEC in fresh-water sediment during emission episode 20.4 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 5.6700001 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 2.26 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.35299999 mg/(kg wet weight) Concentration in fish-eating marine top-predators 5.9099998E-2 mg/(kg wet weight) Local total daily intake for humans 0.105 mg/(kg⋅d) Regional total daily intake for humans 2.4600001E-7 mg/(kg wet weight) Conclusion n-Butyl p-Hydroxybenzoate is used as a preservative in food, pharmaceutical and cosmetic formula-tions. N-Butyl p-hydroxybenzoate is according to the ESIS database produced in amounts < 10 tones/year and is thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. n-Butyl p-hydroxybenzoate is readily biodegradable and has a relatively high potential for bioaccumulation (log Kow=3.57). Based EUSES calculations N-Butyl p-hydroxybenzoate is in the environment mainly distributed to surface waters in concentrations up to approx. 1 mg/L. N-Butyl p-hydroxybenzoate is expected to be found in fish, predators and human food in insignificant amounts. However, as n-Butyl p-hydroxybenzoate is used as a preservative in food and cosmetics a high direct human exposure is expected. N-Butyl p-hydroxybenzoate is thus considered as being of Medium Con-cern. None specifically regulatory or legal status for this substance was found. It is the opinium of the Scientific Commitee on Consumer Products (SCCP) that, viewing the current knowledge, there is no evi-dence of demonstrable risk for the development of breast cancer caused by the use of underarm cosmet-ics including parabens

Page 137: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 134

3-Benzylidene camphor (3-BC) (CAS No.: 15087-24-8) Human related effects Rat in vivo study: Increase in uterus weight. LOED = 2 mg/kg body weight.day Wildlife related effect Fish in vivo study: Vitellogenin induction. ED10, ED50 and ED90 of 3-benzylidene camphor after 6 days (2 injections) were 6.4, 16 and 26 mg/kg/injection, resp Chemical characteristics: Molecular formula: C17 H20 O1

Table 1: Physical/chemical properties of 3-Benzylidene camphor (3-BC) Parameter Value Unit Reference Molecular weight 240.35001 g/mol Melting point 109.87 ºC EPISUITE Boiling point 337.59 ºC MST Vapour pressure at 25 [oC] 0.005066 Pa EPISUITE Water solubility at 25 [oC] 0.6893 mg/L EPISUITE Octanol-water partition coefficient 4.67 - MST Koc 7540 L/kg EPISUITE BCF 385 - EPISUITE Henry's law constant 0.198 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 2.015 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 0.5 kg/year Release to wastewater 1000 kg/year Local PEC in surface water during emission episode (dissolved) 7.1999998 mg/l Local PEC in fresh-water sediment during emission episode 445 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 861 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 316 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 183 mg/(kg wet weight) Concentration in fish-eating marine top-predators 10.2 mg/(kg wet weight) Local total daily intake for humans 38 mg/(kg⋅d) Regional total daily intake for humans 6.9499998E-5 mg/(kg wet weight) Conclusion 3-Benzylidene camphor is used as a UV sunscreen in cosmetics. 3-Benzylidene camphor is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 50 tones per year has been used. 3-Benzylidene camphor is not readily biodegradable and has a high potential to bio-

Page 138: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 135

accumulate in the environment (log kow=4.67). 3-Benzylidene camphor is in the environment mainly dis-tributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning 3-Benzylidene camphor is expected to be found in fish and top predators in minor amount. A high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. 2,4-3-Benzylidene camphor is therefore considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 139: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 136

Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone (CAS No.: 131-55-5) 2,2',4,4'-Tetrahydroxybenzophenone; Benzophenone-2 (2,2',4,4'-tetrahydroxybenzophenone; Methanone, bis(2,4-dihydroxyphenyl)-; Human related effects Rat in vivo study: Increased rat uterine weights. ED10=544.6 mg/kg body weight/day Wildlife related effect Fish in vivo study: Dose response related VTG induction. LOEC = 8783 mg/L Chemical characteristics: Molecular formula: C13 H10 O5

Table 1: Physical/chemical properties of Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone Parameter Value Unit Reference Molecular weight 246.22 g/mol Melting point 186.56 ºC EPISUITE Boiling point 444.26 ºC MST Vapour pressure at 25 [oC] 6.586e-008 Pa EPISUITE Water solubility at 25 [oC] 398.5 mg/L EPISUITE Octanol-water partition coefficient 2.78 - MST Koc 7726 L/kg EPISUITE BCF 5.521 - EPISUITE Henry's law constant 3.66e-011 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 0.64 hr EPISUITE

Page 140: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 137

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50 Tonnes/year Release to air 0.5 kg/year Release to wastewater 1000 kg/year Local PEC in surface water during emission episode (dissolved) 9.6400003 mg/l Local PEC in fresh-water sediment during emission episode 68.800003 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 85.599998 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 24.1 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 3.04 mg/(kg wet weight) Concentration in fish-eating marine top-predators 6.3199997E-2 mg/(kg wet weight) Local total daily intake for humans 4.0700002 mg/(kg⋅d) Regional total daily intake for humans 0.00000413 mg/(kg wet weight) Conclusion Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is used as a UV sunscreen in cosmet-ics. Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 50 tones per year has been used. Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is not readily biodegradable and has a me-dium potential to bioaccumulate. Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is not expected to be found in fish and top predators. A high human exposure is expected mainly due to the fact that the substance is used as a UV screen in cosmetics. Benzophe-none-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone is therefore considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 141: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 138

Boric acid (CAS No.: 10043-35-3) Orthoboric acid; Orthoboric acid (H3BO3); Boracic acid; Borofax; Boron trihydroxide; hydrogen orthobo-rate; Kill-off; Kjel-sorb; three elephant; Trihydroxyborane; Human related effects Rat in vivo study: After a 4-wk administration by gavage, testis and epididymis wts. were decreased in the 300 and 500 mg/kg groups Wildlife related effect Amphibian in vivo study: Boric acid exerted reproductive toxicity in Xenopus laevis + transgenerational toxicity to the developing progeny. Chemical characteristics: Molecular formula: H3 O3 B1

Table 1: Physical/chemical properties of Boric acid Parameter Value Unit Reference Molecular weight 61.830002 g/mol Melting point 171 ºC IUCLID Boiling point 300 ºC IUCLID Vapour pressure at 25 [oC] 9.799e-015 Pa EPISUITE Water solubility at 25 [oC] 50000 mg/L EPISUITE Octanol-water partition coefficient -0.757 - IUCLID Koc 35.04 L/kg EPISUITE BCF 543.5 - EPISUITE Henry's law constant 0 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - EPISUITE

t½(hydrolysis) Year t½(air) 25.467 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 50000 Tonnes/year Release to air 375 kg/year Release to wastewater 112500 kg/year Local PEC in surface water during emission episode (dissolved) 2.3699999 mg/l Local PEC in fresh-water sediment during emission episode 2.0799999 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.0517 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 1.7999999E-2 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 1.38 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.21799999 mg/(kg wet weight) Local total daily intake for humans 6.7000002E-2 mg/(kg⋅d) Regional total daily intake for humans 0.0000163 mg/(kg wet weight) Conclusion Boric acid is used in consumer products as e.g. cosmetics and is according to the ESIS database a HPV substance. For the EUSES calculations a production volume of 50000 tones per year has been used. Bo-ric acid is not bioaccumulative and is readily biodegradable in the environment. EUSES calculations for secondary poisoning shows that the substance is not accumulated in significant amounts in fish and top predators. A relatively high human exposure is however expected due to the defined use of the sub-

Page 142: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 139

stance. Based on these evaluations Boric acid is considered as being of Medium Concern. Presently no EU classification is applied to Boric acid. A risk assessment on Boric acid is at the moment being per-formed by Austria. Proposed classification: R62; R63.

Page 143: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 140

2,2-Bis(4-hydroxyphenyl)-n-butan = Bisphenol B (CAS No.: 77-40-7) Human related effects In vivo immature rat uterotrophic assay: Positive response in the uterotrophic assay. Dose reponse rela-tionship (0, 2, 20 and 200 mg/kg) Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C16 H18 O2

Table 1: Physical/chemical properties of 2,2-Bis(4-hydroxyphenyl)-n-butan = Bisphenol B Parameter Value Unit Reference Molecular weight 242.32001 g/mol Melting point 102.5 ºC EPISUITE Boiling point 379.74 ºC MST Vapour pressure at 25 [oC] 3.293e-005 Pa EPISUITE Water solubility at 25 [oC] 29.23 mg/L EPISUITE Octanol-water partition coefficient 4.69 - MST Koc 149000 L/kg EPISUITE BCF 14.72 - EPISUITE Henry's law constant 1.23e-006 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 1.571 hr EPISUITE

Page 144: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 141

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9.0000004E-2 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.73799998 mg/l Local PEC in fresh-water sediment during emission episode 46.700001 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 91.699997 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 35 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 35.200001 mg/(kg wet weight) Concentration in fish-eating marine top-predators 1.9 mg/(kg wet weight) Local total daily intake for humans 4.1799998 mg/(kg⋅d) Regional total daily intake for humans 0.0000294 mg/(kg wet weight) Conclusion Bisphenol B is component of Phenolic Resin which is thermosetting resin used as Adhesive and Rein-forcement. Bisphenol B is used in many industrial applications. Bisphenol B is according to the ESIS da-tabase produced in low amount and is neither a HPV or LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. Bisphenol B is not readily biodegradable and has a high potential to bioaccumulate in the environment (log kow=4.69). Bisphenol B is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES estima-tions for secondary poisoning Bisphenol B is expected to be found in fish and top predators in minor amount. A medium human exposure is expected. Bisphenol B is considered as being of Medium Con-cern. None specifically regulatory or legal status for this substance was found.

Page 145: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 142

3,3'-Bis(4-hydroxyphenyl)phthalid = Phenolphthaleine (CAS No.: 77-09-8) 2-[Bis (4-hydroxyphenyl)methyl]benzoic acid; 3,3-bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone; 3,3-bis(p-hydroxyphenyl)phthalide; Alophen; Espotabs; Ex-Lax; Feen-a-mint; feen-a-mint gum; Figsen; Laxet-tes; Phenolax; Phenolphthalein; Human related effects Rat and mice in vivo study. Exposure of mice to phenolphthalein in feed for 2 years resulted in increased incidences of atypical hyperplasia of the thymus in males and females, degeneration of the germinal epi-thelium of the testis in males, and ovarian hyperplasia in females. LOAEL=300 mg/kg Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C20 H14 O4

Table 1: Physical/chemical properties of 3,3'-Bis(4-hydroxyphenyl)phthalid = Phenolphthaleine Parameter Value Unit Reference Molecular weight 318.32999 g/mol Melting point 262.5 ºC EPISUITE Boiling point 512.44 ºC MST Vapour pressure at 25 [oC] 8.373e-011 Pa EPISUITE Water solubility at 25 [oC] 400 mg/L EPISUITE Octanol-water partition coefficient 3.06 - MST Koc 307000 L/kg EPISUITE BCF 304.3 - EPISUITE Henry's law constant 9.1e-011 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 1.525 hr EPISUITE

Page 146: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 143

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 9.5100002 mg/l Local PEC in fresh-water sediment during emission episode 91.900002 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 132 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 40.099998 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 1.04 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.0218 mg/(kg wet weight) Local total daily intake for humans 4.27 mg/(kg⋅d) Regional total daily intake for humans 1.2199999E-6 mg/(kg wet weight) Conclusion Phenolphthalein is used as a laboratory reagent and acid-base indicator and in over-the-counter laxative preparations. Phenolphthalein is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. Phenolphthalein is not readily biodegradable and has potential to bioaccumulate (log Kow=3.06). Based on EUSES estimations Phenolphthalein is expected to be found in local surface water in relatively high concentrations (approx. 10 mg/L) as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning and human intake Chlordimeform is expected to be found in fish, predators and human food in insignificant amounts. Based on the expected high concentrations in surface waters PCA is considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found.

Page 147: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 144

4,4'-Dihydroxybiphenyl = 4,4'-Biphenol (CAS No.: 92-88-6) 4,4[-Dihydroxybiphenyl; 4,4'-Dihydroxybiphenyl; 4,4'-Biphenol; 4,4'-Biphenyldiol; PPDP; Human related effects Rat in vivo study. Rat uterotrophic assay. Uterine weight increase. LOAEL=60 mg/kg body weight/day. Wildlife related effect In vitro study. Recombinant yeast assay for trout ER and trout hepatocyte cultures. Competitive binding to ER Chemical characteristics: Molecular formula: C12 H10 O2

Table 1: Physical/chemical properties of 4,4'-Dihydroxybiphenyl = 4,4'-Biphenol Parameter Value Unit Reference Molecular weight 186.21001 g/mol Melting point 126.99 ºC EPISUITE Boiling point 354.41 ºC MST Vapour pressure at 25 [oC] 1.533e-006 Pa EPISUITE Water solubility at 25 [oC] 798.2 mg/L EPISUITE Octanol-water partition coefficient 2.8 - MST Koc 16400 L/kg EPISUITE BCF 43.73 - EPISUITE Henry's law constant 4.54e-007 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 2.68 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9.0000004E-2 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.96399999 mg/l Local PEC in fresh-water sediment during emission episode 7.02 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 8.8299999 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 2.51 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.56900001 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.0118 mg/(kg wet weight) Local total daily intake for humans 0.40900001 mg/(kg⋅d) Regional total daily intake for humans 8.4800001E-7 mg/(kg wet weight) Conclusion 4,4'-Biphenol used as sunscreens, preservatives, disinfectants, antioxidants, flavorings, or for perfumery. 4,4'-Biphenol is according to the ESIS database produced in amounts < 10 tones/year and is thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. 4,4'-Biphenol is not readily biodegradable and has a medium potential to bioaccumulate in the environ-

Page 148: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 145

ment (log kow=2.8). 4,4'-Biphenol is in the environment mainly distributed to surface water in concentra-tions up to approx. 1 mg/L. Based on EUSES estimations for secondary poisoning and human intake 4,4'-Biphenol is expected to be found in fish, predators and human food in insignificant amounts, however, a high human exposure is expected due to the defined use of the substance. 4,4'-Biphenol is considered as being of High Concern. None specifically regulatory or legal status for this substance was found.

Page 149: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 146

4-Hydroxybiphenyl = 4-Phenylphenol (CAS No.: 92-69-3) [1,1'-Biphenyl]-4-ol; 4-Biphenylol; 4-hydroxybiphenyl; 4-Phenylphenol; Paraxenol; Biphenyl-4-ol; Human related effects Rat in vivo assay: Uterotrophic assay and Calbindin-D9k (CaBP-9K) mRNA expression were examd. in ovariectomized Sprague-Dawley female rats. 4-phenylphenol produced dose-dependent (10, 50, 200, and 400 mg/kg/day( increases in the uterine wts. of ovariectomized rats). LOAEL=200 mg/kg/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C12 H10 O1

Table 1: Physical/chemical properties of 4-Hydroxybiphenyl = 4-Phenylphenol Parameter Value Unit Reference Molecular weight 170.21001 g/mol Melting point 166 ºC EPISUITE Boiling point 305 ºC EPISUITE Vapour pressure at 25 [oC] 0.002306 Pa EPISUITE Water solubility at 25 [oC] 56.2 mg/L EPISUITE Octanol-water partition coefficient 3.2 - EPISUITE Koc 10120 L/kg EPISUITE BCF 25 - EPISUITE Henry's law constant 0.00436 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - CHRIP NITE

t½(hydrolysis) Year t½(air) 4.695 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 1000 Tonnes/year Release to air 30 kg/year Release to wastewater 24000 kg/year Local PEC in surface water during emission episode (dissolved) 3.77 mg/l Local PEC in fresh-water sediment during emission episode 42.5 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 63.900002 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 19.9 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 162 mg/(kg wet weight) Concentration in fish-eating marine top-predators 3.4400001 mg/(kg wet weight) Local total daily intake for humans 2.1600001 mg/(kg⋅d) Regional total daily intake for humans 7.5099997E-5 mg/(kg wet weight) Conclusion 4-Phenylphenol in an industrial intermediate. 4-Phenylphenol is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 1000 tones per year has been used. 4-Phenylphenol is not readily biodegradable and has potential to bioaccumulate in the environment (log

Page 150: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 147

kow=3.2). 4-Phenylphenol is in the environment mainly distributed to surface water in concentrations up to approx. 4 mg/L. Based on EUSES estimations for secondary poisoning and human intake 4-Phenylphenol is expected to be found in fish, predators and human food in minor amounts. 4-Phenylphenol is considered as being of Medium Concern. None specifically regulatory or legal status for this substance was found.

Page 151: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 148

p-Coumaric acid (PCA) (CAS No.: 7400-08-0) 3-(4-Hydroxyphenyl)propenoic acid; p-hydroxy-cinnamic acid; 4'-hydroxycinnamic acid; Human related effects Rat in vivo assay: 189 and 201% thyroid wts increase compared to control value. hyroid lesions in p-coumaric acid group were assocd. with significant increases in cellular proliferation as indicated by [3H]thymidine incorporation. In addn., the goitrogenic effect of p-coumaric acid was further confirmed by significant decreases (50%) in serum triiodothyronine (T3) and thyroxine (T4), and a parallel increase (90%) in serum TSH compared to control group. ED=0.25 mmol/kg/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C9 H8 O3

Table 1: Physical/chemical properties of p-Coumaric acid (PCA) Parameter Value Unit Reference Molecular weight 164.16 g/mol Melting point 211.5 ºC EPISUITE Boiling point 329.8 ºC MST Vapour pressure at 25 [oC] 0.0001613 Pa EPISUITE Water solubility at 25 [oC] 18300 mg/L EPISUITE Octanol-water partition coefficient 1.79 - EPISUITE Koc 78.21 L/kg EPISUITE BCF 45.18 - EPISUITE Henry's law constant 1.36e-007 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) Year t½(air) 2.481 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 1.26 mg/l Local PEC in fresh-water sediment during emission episode 3.4200001 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.71100003 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.27500001 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.0114 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.00182 mg/(kg wet weight) Local total daily intake for humans 0.131 mg/(kg⋅d) Regional total daily intake for humans 2.9100001E-8 mg/(kg wet weight) Conclusion p-Coumaric acid (PCA) is a natural phenolic acid. PCA is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production vol-

Page 152: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 149

ume of 10 tones per year has been used. PCA is readily biodegradable and has a low potential to bioac-cumulate (log Kow=1.79). Based on EUSES estimations PCA is expected to be found in local surface water in concentrations up to approx. 1 mg/L. Based on EUSES estimations for secondary poisoning and human intake PCA is expected to be found in fish, predators and human food in insignificant amounts. PCA is considered as being of Low Concern. None specifically regulatory or legal status for this sub-stance was found.

Page 153: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 150

Phenol, (1,1,3,3-tetramethylbutyl)- = Octylphenol (CAS No.: 27193-28-8) (1,1,3,3-tetramethylbutyl)phenol; octyl phenol; OP; (Tetramethylbutyl)phenol; Human related effects Rat in vivo study. Reduced sperm counts resulting from lowered plasma testosterone in male rats just after puberty. ED=3 mg/kg body weight.day Wildlife related effect Fish in vivo study. VTG induction + intersex gonads. LOEC=11.4 ug/L Chemical characteristics: Molecular formula: C14 H22 O1

Table 1: Physical/chemical properties of Phenol, (1,1,3,3-tetramethylbutyl)- = Octylphenol Parameter Value Unit Reference Molecular weight 206.33 g/mol Melting point 82.77 ºC EPISUITE Boiling point 310.93 ºC MST Vapour pressure at 25 [oC] 0.01301 Pa EPISUITE Water solubility at 25 [oC] 3.114 mg/L EPISUITE Octanol-water partition coefficient 5.5 - MST Koc 33010 L/kg EPISUITE BCF 5.623 - EPISUITE Henry's law constant 0.456 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 2.553 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 5.1900001 mg/l Local PEC in fresh-water sediment during emission episode 860 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 1690 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 659 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 672 mg/(kg wet weight) Concentration in fish-eating marine top-predators 256 mg/(kg wet weight) Local total daily intake for humans 167 mg/(kg⋅d) Regional total daily intake for humans 0.000107 mg/(kg wet weight) Conclusion Octylphenol is used as a precursor to produce surfactants (ethoxylates) and in plastic products. Octyl-phenol is according to the ESIS database not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. Octylphenol is not readily biodegradable and has a high po-tential to bioaccumulate in the environment (log kow=5.5). Octylphenol is in the environment mainly dis-tributed to surface water as well as sediments and agricultural soils. Based on EUSES estimations for secondary poisoning Octylphenol is expected to be of medium concern. A high local daily human intake is

Page 154: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 151

expected (up to approx. 170 mg/kg/day). Octylphenol is considered as being of High Concern. The PBT properties have been assessed by the EU and it was concluded that Octylphenol does not fulfil the PBT criteria. The database for p-tert.-octylphenol is very comprehensive, including a high quality multi-generation study. The EU CMR group recently decided that Octylphenol should not be classified for re-protoxic effects.

Page 155: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 152

Chlordimeform (CAS No.: 6164-98-3) Acaron; Bermat; Dimethyl-N'-(2-methyl-4-chlorophenyl)formamidine; CDM; Chlordimeform; Chloro-phenamidine; Formamidine, N'-(4-chloro-o-tolyl)-N,N-dimethyl-; Fundal; Fundex; Galecon; Galecron; N'-(4-chloro-2-methylphenyl)-N,N-dimethylmethanimidamide; Ovatoxion; RS-141; Spanone; Human related effects In vivo rat study. Delay in breeding and a significant redn. in litter size. ED=50 mg/kg. Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C10 H13 CL1 N2

Table 1: Physical/chemical properties of Chlordimeform Parameter Value Unit Reference Molecular weight 196.67999 g/mol Melting point 35 ºC EPISUITE Boiling point 156.5 ºC EPISUITE Vapour pressure at 25 [oC] 0.123056206 Pa EPISUITE Water solubility at 25 [oC] 270 mg/L EPISUITE Octanol-water partition coefficient 2.89 - EPISUITE Koc 3090 L/kg EPISUITE BCF 1524 - EPISUITE Henry's law constant 0.034857 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 1.416 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9.0000004E-2 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.958 mg/l Local PEC in fresh-water sediment during emission episode 7.6900001 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 9.71 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 2.74 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.67400002 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.0141 mg/(kg wet weight) Local total daily intake for humans 0.134 mg/(kg⋅d) Regional total daily intake for humans 7.5299999E-7 mg/(kg wet weight) Conclusion Chlordimeform is used as a insecticide. Chlordimeform is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production vol-ume of 10 tones per year has been used. Chlordimeform is not readily biodegradable and has a medium potential to bioaccumulate (log Kow=2.89). Based on EUSES estimations Chlordimeform is expected to

Page 156: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 153

be found in local surface waters in concentrations up to approx. 1 mg/L. Based on EUSES estimations for secondary poisoning and human intake Chlordimeform is expected to be found in fish, predators and hu-man food in minor amounts. Chlordimeform is considered as being of Low Concern. Covered by Council Directive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesti-cides to be reviewed.

Page 157: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 154

Cyclophosphamide (CAS No.: 50-18-0) Cyclophosphoramide; Cytophosphane; 2-(bis(2-Chloroethyl)-amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; Cycloblastin; Cyclostin; Sendoxan; bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; bis(2-Chloroethyl)phosphoramide cyclic propanolamide ester; N,N-bis(beta-Chloroethyl)-N',O-propylenephosphoric acid ester diamide; N-bis(beta-Chloroethyl)-N'O,trimethylenephosphoric acid ester diamide; N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide; N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide; N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide; Semdoxan; Senduxan; sk 20501; tatrahydro-2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide; (-)-Cyclophosphamide; Asta B 518; Cla-fen; Claphene; Cyclophosphamidum; cb 4564; Endoxan R; Endoxan-Asta; Endoxana; Endoxanal; En-doxane; Enduxan; Genoxal; Mitoxan; Cyclophosphamides; Procytox; Cyclophosphamide; N,N-Bis(2-Chloroethyl)tetrahydro-2H-1,3,2-Oxazaphosphorin-2-Amine, 2-Oxide; Cytoxan; Cyclophosphane; B 518; Neosar; 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine; 2-(di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane 2-oxide; ASTA; N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidic acid intramol. ester; tetrahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; Human related effects Rat in vivo assay: Decreased ovarian and uterin weight and reduction serum estradiol and progesterone. LOAEL=50 mg/kg body weight Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C7 H15 CL2 N2 O2 P1

Table 1: Physical/chemical properties of Cyclophosphamide Parameter Value Unit Reference Molecular weight 261.09 g/mol Melting point 51.5 ºC EPISUITE Boiling point 359.82 ºC MST Vapour pressure at 25 [oC] 0.005866 Pa EPISUITE Water solubility at 25 [oC] 40000 mg/L EPISUITE Octanol-water partition coefficient 0.63 - EPISUITE Koc 317.7 L/kg EPISUITE BCF 5856 - EPISUITE Henry's law constant 1.38e-006 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - EPISUITE

t½(hydrolysis) Year t½(air) 1.826 hr EPISUITE

Page 158: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 155

Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 9.0000004E-2 kg/year Release to wastewater 180 kg/year Local PEC in surface water during emission episode (dissolved) 0.99699998 mg/l Local PEC in fresh-water sediment during emission episode 1.26 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.12800001 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 3.0200001E-2 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.0174 mg/(kg wet weight) Concentration in fish-eating marine top-predators 3.4900001E-4 mg/(kg wet weight) Local total daily intake for humans 4.3499999E-2 mg/(kg⋅d) Regional total daily intake for humans 2.12E-7 mg/(kg wet weight) Conclusion Cyclophosphamide is used as a insecticide as well as in chemotherapy. Cyclophosphamide is accord-ing to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production volume of 10 tones per year has been used. Cyclophosphamide is not readily biodegradable and has a low potential to bioaccumulate (log Kow=0.63). Based on EUSES esti-mations Cyclophosphamide is expected to be found in local surface water in concentrations up to approx. 1 mg/L. Based on EUSES estimations for secondary poisoning and human intake Cyclophosphamide is expected to be found in fish, predators and human food in minor amounts. Chlordimeform is considered as being of Low Concern. The substance is covered by Council Directive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed.

Page 159: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 156

Mono-n-butylphthalate (CAS No.: 131-70-4) Butyl Hydrogen Phthalate; Monobutyl phthalate; Human related effects Rat in vivo study: Decreased male anogenital distance and increased incidence of fetuses with un-descended testes. LOAEL=250 mg/kg body weight/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C12 H14 O4

Table 1: Physical/chemical properties of Mono-n-butylphthalate Parameter Value Unit Reference Molecular weight 222.24001 g/mol Melting point 117.82 ºC EPISUITE Boiling point 353.12 ºC MST Vapour pressure at 25 [oC] 0.001787 Pa EPISUITE Water solubility at 25 [oC] 125.7 mg/L EPISUITE Octanol-water partition coefficient 2.84 - MST Koc 43.49 L/kg EPISUITE BCF 523.4 - EPISUITE Henry's law constant 0.000166 Pa·m3/mole EPISUITE Biodegradation Readily biode-

gradable - MST

t½(hydrolysis) 6.855 Year EPISUITE t½(air) 24.405 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 1.23 mg/l Local PEC in fresh-water sediment during emission episode 9.3800001 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 2.48 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 0.98199999 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 8.7499999E-2 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.0142 mg/(kg wet weight) Local total daily intake for humans 6.3100003E-2 mg/(kg⋅d) Regional total daily intake for humans 7.5199999E-8 mg/(kg wet weight)

Page 160: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 157

Conclusion Consumer and industrial applications for phthalates are numerous and range from making nail polish flexible and screwdriver handles less brittle to helping make the time-release coatings on numerous pharmaceutical products. Mono-n-butylphthalate is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calculations a production vol-ume of 10 tones per year has been used. Mono-n-butylphthalate is readily biodegradable and has a me-dium potential to bioaccumulate (log Kow=2.84). Based on EUSES calculations Mono-n-butylphthalate is not expected to be found in significant amounts in the environment (surface waters and sediments) and is not expected to give any problems in relation to secondary poisoning and human intake. Mono-n-butylphthalate is considered as being of Low Concern. None specifically regulatory or legal status for this substance was found. The related substance Dibutylphthalat is on the list of dangerous substances (An-nex I to Directive 67/548/EEC)

Page 161: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 158

Omethoate (CAS No.: 1113-02-6) O,O-dimethyl S-(2-methylamino)-2-oxoethyl phosphorothioate; BAY 45432; Dimethoate oxon; dimethoate oxygen analog; dimethoxon; Dimethyl S-((methylcarbamoyl)methyl) phosphorothioate; Folimat; Ometho-ate; Phosphorothioic acid, O,O-dimethyl ester, S-ester with 2-mercapto-N-methylacetamide; Human related effects Mice in vivo study: Increase in body wt. and decreased testicle wt. The activities of AKP, ACP, LDH in mouse testicles significantly increased compared with the control. Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C5 H12 N1 O4 P1 S1

Table 1: Physical/chemical properties of Omethoate Parameter Value Unit Reference Molecular weight 213.19 g/mol Melting point 87.02 ºC EPISUITE Boiling point 364.27 ºC MST Vapour pressure at 25 [oC] 0.0033063856 Pa EPISUITE Water solubility at 25 [oC] 1000000 mg/L EPISUITE Octanol-water partition coefficient -0.75 - EPISUITE Koc 77.67 L/kg EPISUITE BCF 707.5 - EPISUITE Henry's law constant 4.62e-009 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) Year t½(air) 4.938 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 500 Tonnes/year Release to air 3.75 kg/year Release to wastewater 7500 kg/year Local PEC in surface water during emission episode (dissolved) 2.5 mg/l Local PEC in fresh-water sediment during emission episode 2.1900001 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 0.0297 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 7.0400001E-3 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 0.72600001 mg/(kg wet weight) Concentration in fish-eating marine top-predators 0.0146 mg/(kg wet weight) Local total daily intake for humans 3.5999998E-2 mg/(kg⋅d) Regional total daily intake for humans 0.0000102 mg/(kg wet weight) Conclusion Omethoate is used as a pesticide. Omethoate is according to the ESIS database a LPV substance. For the EUSES calculations a production volume of 500 tones per year has been used. Omethoate is not readily biodegradable, but has a low potential to bioaccumulate (log Kow=-0.75). Based on EUSES esti-

Page 162: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 159

mations Omethoate expected to be found in local surface water in concentrations up to 4 mg/L. As Omethoate is not potential bioaccumulative the substance is not expected to give any problems in relation to secondary poisoning. Omethoate is considered as being of Low Concern. Covered by Council Direc-tive 91/414/EEC. No RAR has been provided and the substance is not included in the list for pesticides to be reviewed. Classification: XN;R21 T;R25 N;R50.

Page 163: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 160

Mono 2 ethyl hexylphthalate (MEHP) (CAS No.: 4376-20-9) 1,2-benzenedicarboxylic acid, mono-(2-ethylhexyl)ester; MEHP; mono(2-ethylhexyl) phthalate; Mono-ethylhexyl phthalate; PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER; Human related effects Rat in vivo study. Significantly decreased body weights and motile sperms. LOAEL=250 mg/kg body weight/day Wildlife related effect No or insufficient data gathered Chemical characteristics: Molecular formula: C16 H22 O4

Table 1: Physical/chemical properties of Mono 2 ethyl hexylphthalate (MEHP) Parameter Value Unit Reference Molecular weight 278.35001 g/mol Melting point 142.61 ºC EPISUITE Boiling point 392.54 ºC MST Vapour pressure at 25 [oC] 0.0001087 Pa EPISUITE Water solubility at 25 [oC] 1.492 mg/L EPISUITE Octanol-water partition coefficient 4.73 - MST Koc 463 L/kg EPISUITE BCF 3.162 - EPISUITE Henry's law constant 0.000514 Pa·m3/mole EPISUITE Biodegradation Not readily bio-

degradable - MST

t½(hydrolysis) 10.671 Year EPISUITE t½(air) 11.066 hr EPISUITE Table 2: Use, exposure and emissions Parameter Value Unit Tonnage of substance in Europe 10 Tonnes/year Release to air 0.1 kg/year Release to wastewater 200 kg/year Local PEC in surface water during emission episode (dissolved) 7.2800002 mg/l Local PEC in fresh-water sediment during emission episode 483 mg/(kg wet weight) Local PEC in agric. soil (total) averaged over 180 days 948 mg/(kg wet weight) Local PEC in grassland (total) averaged over 180 days 361 mg/(kg wet weight) Concentration in fish for secondary poisoning (fresh water) 41.799999 mg/(kg wet weight) Concentration in fish-eating marine top-predators 2.29 mg/(kg wet weight) Local total daily intake for humans 44.299999 mg/(kg⋅d) Regional total daily intake for humans 0.0000294 mg/(kg wet weight)

Page 164: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 161

Conclusion Mono 2 ethyl hexylphthalate (MEHP) is the major DEHP metabolite. MEHP is according to the ESIS database produced in amounts < 10 tones/year and thus not a LPV substance. For the EUSES calcula-tions a production volume of 10 tones per year has been used. MEHP is not readily biodegradable and has a high potential to bioaccumulate (log Kow=4.73). MEHP is in the environment mainly distributed to surface water as well as sediments and agricultural soils. Based on EUSES calculations MEHP is ex-pected to give minor problems in relation to secondary poisoning and human intake. Due to the persis-tency and high bioaccumulation potential Mono-n-butylphthalate is considered as being of Medium Con-cern. None specifically regulatory or legal status for this substance was found.

Page 165: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 162

A P P E N D I X A

Minutes from kick off meeting (17 November 2006)

Page 166: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 163

Study on ED priority list with a focus on LPV chemicals – First meeting

Brussels 17 November 2005, Beaulieu 9 Salle D MINUTES

Attendants: Katharina Spens (KS) The Commission, D4, Gitte Petersen (GIP) and Lise Samsøe-Petersen (LSP) both DHI. 1. Practical information (K. Spens)

− Re: Organisational framework. ! The position of the person who described this project is vacant and will be

filled by February. Until the KS will manage this project.

− Re: Financial issues ! The project must be finalised in time for the invoice to be paid before De-

cember 31 2006. The implications of this were discussed and the attached time schedule was prepared.

− Re: Database related issues ! KS explained that the database for storage of raw data from the data col-

lection, which was developed during the RPS BKH 2002 project, was available in an Access format.

! This database will be used for reporting the data from the present project as well.

! The Access database is not suitable as an internet databases. For this, ORACLE or FULCRUM formats have been recommeded. It was agreed that DHI will make a proposal for the work needed for converting the Ac-cess database into an internet compatible database.

! .

2. Presentation of the work plan (DHI) and discussion, including identification of stakeholders − Identification of stakeholders- method. It was agreed that

! KS will identify the stakeholders, which were contacted during the RPS BKH 2002 project.

! KS will contact colleagues working with general chemicals (REACH), plant protection products, biocides and food.

! DHI will contact DK EPA expert on REACH, Members of the OECD VMG-eco and Mammalian, member of recent EU EDC projects, and sci-entific colleagues

Page 167: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 164

− Identification of stakeholders - timing. It was agreed that ! The list of stakeholders for written consultation must be ready before

Christmas.

! The stakeholders for the consultation group will be identified when the an-swers on the questionnaires have been received.

! The stakeholders for the consultation group need not to be established be-fore summer 2006

! Number of stakeholders should not be fixed

− Questionnaire for stakeholders - timing. It was agreed that ! A draft questionnaire must be forwarded to KS on December 10. ! The final questionnaire must be ready before Christmas. ! The questionnaire will be distributed to the stakeholders immediately after

New Year with a deadline for answers of 1 February 2006.

− Questionnaire for stakeholders - reporting. It was agreed that ! The procedure and questionnaire as well as a summary of the answers will

be described in the report. ! The original answers of the questionnaires will be stores in electronic for-

mat and attached to the final report as a CD-ROM.

− List of substances to be assessed - method. It was agreed that ! DHI needs the list of the 172 substances, which were not evaluated in the

RPS BKH 2002 project. If it is not available on the CD with the Access database, KS will try to find it.

! Otherwise, it must be constructed based on files containing the lists of the 553, the 435 and the 204 substances, described in the strategy. If relevant, DHI will request readable files with these lists.

− List of substances to be assessed - timing. It was agreed that ! The list must be forwarded to D4February 28, 2006. ! The discussion of the list will take place on a meeting between DHI and

D4 on March 15, 2006.

− Reporting and meetings - timing. It was agreed that ! Meeting (D4 + DHI): Discussion on list of substances to

be evaluated: March 15, 2006 ! Interim report: May 31, 2006 ! Meeting (D4 + DHI): Discussion of interim report: June29, 2006 ! Draft final report: September 15,

2006 ! Stakeholder meeting: October

12, 2006 ! Meeting on draft final deliverable (D4 + DHI): October 13, 2006 ! Informal “close-to-final” report: November 10,

2006

Page 168: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 165

! Comment from D4 on informal report November 17, 2006 ! Final report a.o. deliverables: November 20,

2006 ! Approval of final report a.o. deliverables: November 22,

2006

3. Conclusions and agreement of next steps. This is described above. 4. Any other business

− KS pointed out that there is a call for FP6, which is including the establishment of a database on EDCs. KS will contact the relevant colleagues in DG Research and inform them about this and previous projects.

2005.11.18 / Lise Samsøe-Petersen

Page 169: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 166

TIME SCHEDULE Study on enhancing the Endocrine Disrupter priority list with a focus on low production

volume chemicals Contractor: DHI Water & Environment, Agern Allé, DK-2970 Hørsholm, Denmark DG ENV contact: Katharina Spens, unit D.4, tel. 02-2990521, [email protected]

" 28 October 2005: Contract signed = starting date

" 17 November: kick-off meeting between contractor and D4 for discussing the tasks.

" 28 February 2006: Discussion on the list of substances to be evaluated between con-tractor and Commission.

" 31 May 2006: Interim report sent to Commission

" 29 June 2006: Discussion of interim report between contractor and Commission

" 15 September 2006: Submission of draft final report

" 12 October 2006: draft final report to be discussed in a stakeholder meeting in Brussels (Beaulieu), it is planned that contractor presents report, D4 should be present and report on the strategy)

" 13 October 2006: Discussion of draft final deliverables (report and database) between contractor and Commission (D4)

" 10 November 2006: Informal “close-to-final” report

" 17 November 2006: Comments on informal report from D4 to DHI

" 20 November 2006: Final report including database to be submitted to Commission

" Final payment has to be made before 31 December (22 December in practice). The re-port therefore has to be approved by 22 November at the latest.

Page 170: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 167

A P P E N D I X B

Minutes – List of substances (15 March 2006)

Page 171: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 168

Study on ED priority list with a focus on LPV chemicals – Second meeting

Brussels 15 March 2006, Beaulieu 9 Salle D MINUTES

Attendants: Katharina Spens (KS) The Commission, D4, Sylvain Bintein (SB) The Commission, C3 and Gitte Petersen (GIP) DHI. 1. Stakeholder response

GIP presented the aim of the project to SB and the outcome of the request to written stakeholders was briefly presented. The questionnaire was sent to 160 potential stakeholders both by normal mail and by e-mail in December 2005. Two letters were received in return and 5 e-mails were received in return with a message on deliv-ery failure. Thus in total the request was send to approximately 155 people. Although the deadline for response was February 1st, quite many did not respond before late Febru-ary/beginning of March. A total of 34 stakeholders responded to the questionnaire. This means that the answer percentage was approx. 22%, which is regarded as acceptable. Most of the response received was a kind reply that the questionnaire was received but that no further data could be provided (65%). How-ever, among the replies, in which new information and data were provided, a total of 27 new substances has been suggested for addition to the list and thus to be evaluated in the present project

As the amount of information which followed the suggested new substances were quite diverse (from just a CAS No. to thorough information about the substances including attached references about EDC ef-fects) it was decided to include all suggested chemicals in the present study and perform the evaluation on these as on the rest of the priority substances. The suggested substances to be added to the list are the fol-lowing: CAS No. Substance name 556-67-2 Cyclotetrasiloxane 125116-23-6 Metconazole 81-14-1 1-tert-Butyl-3,5-dimethyl-2,6-dinitro-4-acetylbenzene 81-14-1 4,6-Dinitro-1,1,3,3,5-pentamethylindane 1222-05-5 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta(g)-2-benzopyrane 13171-00-1 4-Acetyl-1,1-dimethyl-6-tert.-butylindane 33704-61-9 6,7-dihydro-1,1,2,3,3-pentamethyl-4(5H)indanone 5466-77-3 2-ethyl-hexyl-4-methoxycinnamate 118-56-9 3,3,5-trimethyl-cyclohexyl salicilate 21245-02-3 2-ethyl-hexyl-4-dimethyl-aminobenzoate 36861-47-9 3-(4-Methylbenzylidene)camphor 131-57-7 2-hydroxy-4-methoxy-benzophenone No CAS Benzophenone derivatives 99-96-7 p-Hydroxybenzoic acid 99-76-3 Methyl p-Hydroxybenzoate 120-47-8 ethyl 4-hydroxybenzoate 94-13-3 n-propyl p-hydroxybenzoate 94-26-8 n-Butyl p-Hydroxybenzoate 15087-24-8 3-Benzylidene camphor (3-BC)

Page 172: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 169

CAS No. Substance name 131-55-5 Benzophenone-2 (Bp-2), 2,2',4,4'-tetrahydroxybenzophenone 10043-35-3 Boric acid 1303-96-4 Borax 1582-09-8 Trifluralin 13593-03-8 Chinalphos 100-02-7 4-nitrophenol 2581-34-2 3-methyl-4-nitrophenol No CAS 4-nitro-3-phenylphenol

It was agreed that GIP will prepare a list of approx. 20 potential stakeholders who will be invited to par-ticipate as a stakeholder group. The participating stakeholders should as far as possible represent NGO, governmental institutions and researchers furthermore it was emphasised that as many countries as possi-ble should be represented. Concerning the stakeholders meetings KS will find out the financial issues related to travel money and accommodation. 2. Definition of Low Production Volume Chemicals

The definition of Low Production Volume Chemicals has not been made clear neither in the invitation to tender nor in the proposal. A clear definition was thus necessary and it was decided to use the definitions given in ESIS: European chemical substances information system which is the following: HPVC (High Production Volume Chemical). A HPVC, is a chemical which is defined as being pro-duced or imported in quantity of at least 1000 tonnes per year in EU by at least one Industry. LPVC (Low Production Volume Chemical). A LPVC, is a chemical which has been produced or im-ported in EU with a tonnage >10 t/y but never more than 1000 t/y. By definition a LPV Chemical is a chemical which is not a HPV Chemical. 3. Priority list of substances to be evaluated

SB was invited by KS to attend the meeting for having his response on the stakeholder responses on new chemicals to be added to the list. Before the meeting SB reviewed the priority list and found that several substances were not included in the ECB-ESIS database and thus not in use any longer. He also found that few of the substances were HPVC and that the majority of the substances were neither HPVC nor LPVC substances. These are existing substances but produced or imported in amounts ≤10 tons per year. Based on this information it was decided that the priority list of substances should include HPVC and LPVC plus existing substances registered in the ECB-ESIS database although they were produced or im-ported in amounts ≤10 tons per year. It was agreed that GIP should make a close evaluation of the priority substances list including the 27 new substances added by the written stakeholders and classify the sub-stances into the following categories:

1 = Current LPVC and HPVC according to ECB-ESIS. 2 = Substance found on ECB-ESIS list, but neither LPV or HPV (production volume < 10 ton/year) 3 = Substances not found on ECB-ESIS list and therefore excluded from the evaluation 4 = Substances with no CAS number and therefore excluded from the evaluation

For substances in category 3 and 4 it was decided that GIP should contact CEFIC to ask if they have any knowledge if the substances are still produced and if yes in which amounts. GIP will prepare a draft request to CEFIC and send it to KS. Based on this KS will prepare an official supporting letter from ENV.D4. After the meeting GIP did categorise the priority list and based on this evaluation it was found that:

− Category 1 contains 10 HPVC and 26 LPVC.

Page 173: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 170

− Category 2 contains 74 substances registered in ECB-ESIS database

− Category 3 contains 73 substances not registered ECB-ESIS database and thus ex-cluded from the present study. Contact to CEFIC will be made for more information about these substances.

− Category 4 contains 17 substances without CAS No. and thus excluded from the pre-sent study. Contact to CEFIC will be made for more information about these sub-stances.

The revised categorised list of substances is attached as Annex 1 (in this document Appendix D) 4. Time schedule

As the official start of the project is 2005.10.28 it is for administrative reasons necessary to send a draft final report by October 28. 2006. It was agreed that this report should include the draft final report planned to be send September 15 plus minutes from the stakeholder meeting October 12 and the meeting on draft final deliverables October 13. 5. DHI web page

It was agreed that DHI web page prepared for the present project needs to be updated. The background and state of the art shall be clearer. It was also agreed that the revised priority list including the latest categorisation shall be made available. GIP will take action. 2006.03.17 / Gitte Petersen

Page 174: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 171

A P P E N D I X C

Minutes – List of substances (29 June 2006)

Page 175: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 172

Study on ED priority list with a focus on LPV chemicals – Interim meeting

Brussels 29 June 2006, Beaulieu 9 Salle BU 9 0/191, 12.00-17.00 MINUTES

Attendants: DHI: Gitte Petersen; DG ENV: Katharina Spens, Sylvain Bintain, Reinhild Puergy 1. DHI - Presentation of the work status – Preliminary Interim report and presentation of

the database It was specified that, in the final report, the main objective of the present project shall be made clear i.e., the development of a database including collected data on endocrine disrupting proper-ties of substances placed on the priority list/candidate list. The definition of ‘priority list’ was discussed under this agenda item: According to the Com-munity Strategy for Endocrine Disrupters (1999), a short-term key action is the establishment of a priority list of substances for further evaluation of their role in endocrine disruption. The first study carried out in 2000 on the behalf of the Commission (BKH 2000) identified a candidate list of 553 substances. This candidate list of substances has thus since the BKH project in 2000 been named as ‘The Priority List’. The meaning of this wording is that substances placed on ‘The Pri-ority List’ have higher priority at data collection on endocrine disrupting properties than other substance lists, e.g. PBT substances, CMR substances etc.

Due to limitations in time, the number of substances to be evaluated, amount of data available and cost limitations, the evaluation of data collected on each individual substance is only based on a screening exercise. The wording ‘priority list of substances’ is therefore to be regarded as a starting point for further in depth evaluation of the endocrine disrupting properties of the sub-stances placed on the priority list. Gitte briefly presented the work status and it was decided that for the draft final report the fol-lowing issues should be included and explained more thoroughly: Task 3.2 Evaluation of data on their endocrine disrupting properties

• The methodology used for the evaluation of data shall be more thoroughly explained and shall be fully transparent. E.g., the categories defined in the previous work (BKH 2002) shall be included:

Page 176: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 173

CAT1, 2, 3a or 3b CAT 1. CAT 2. CAT 3a. CAT 3b.

Category 1, 2, 3a or 3b At least one study providing evidence of endocrine disruption in an intact organism. Not a formal weight of evidence approach. Potential for endocrine disruption. In vitro data indicating potential for endocrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated. May include struc-tural analyses and metabolic considerations No scientific basis for inclusion in list (ED studies available but no indications on ED effects) Substances with no or insufficient data gathered.

• It shall be clear that the Categorisation of the substances is based on evaluation of data at

a screening level. E.g., a thorough literature research has been adopted, but mainly only the abstracts have been evaluated. In cases in which the information obtained from the abstracts were not sufficient for categorisation of the individual substance, a primarily reference check was performed (the original article was purchased). In the database, ab-stracts from the articles are copied and an evaluated extract of the effects obtained is re-flected in the ‘effect field’. It shall be clearly stated that the choices for the categorisation were made by the consultant, and apart from the definition on the categories given above, it may thus be regarded as subjective.

• According to the tender from the Commission and the proposal made by DHI, a clear statement on the data evaluation to be performed was given. Namely “Starting points are the methodology developed in the RPS-BKH report (2002) and the database including the candidate substances which were identified in the BKH report of 2000, with data from background documents. The methodological approaches and evaluation of the se-lected substances with respect to endocrine disrupter potency towards humans and wild-life will be elaborated by the project team.” As stated in the interim report, the evaluation of endocrine disrupting potential will be based on the following screening criteria:

1. Relevance of test parameter (with aspects such as relations between endocrine disrupting effects and mechanistic causes)

2. Test reliability (validated protocols; experimental design; suitability, health and life stage of test species; statistics. Ranked indication of Data Quality (DQ 1-4). DQ: good data quality, fulfilling all (important) criteria; DQ2: Sufficient Data Quality, study fulfilling most of the (important) criteria; DQ3: Insufficient Data Quality, study cannot be used for identification; and DQ4: Not evaluated

3. Dose-response relationship or indications of effects thresholds 4. Endocrine disruption potency (including a categorization of the chemicals into 3

groups: 1. Evidence for endocrine disrupting (ED) effect; 2. Potential ED effect; 3. No evidence for ED effect)

5. Comparison with systemic toxicity (Standard toxicity data –NOECs/LOECs, E(L)C50s, NOALs/LOAELs from RTECS, ECOTOX (AQUIRE), DOSE and Ver-shuren databases)

• As the present work is based on a screening of available data for the substances on the priority list (a total of 109 substances) and as the quality of the available data is not stan-dardised but quite diverse, a description of a more standardised procedure than the one

Page 177: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 174

given above can be difficult. It was agreed that, in future, in depth evaluations of the col-lected data the criteria and the methodology for evaluation of the substances as having endocrine disrupting properties shall be well defined and fully transparent. In the present work a preliminary description and set up of a standard operating procedure (SOP) for the update of the database and the inclusion and exclusion of substances on the working list shall as far as possible be included.

2. Financial status

• Interim report payment It was agreed that Reinhild will send the forwarded interim report for approval and, in 4 weeks time, it should be possible for DHI to forward an invoice for the interim payment (EUR 40,000.00) to the Commission.

• Amount of time until this date and final invoice Gitte presented the amount of time used until date and it was briefly discussed that as far the re-vised time schedule (see item 3) is not exceeded, there should be no problems in having the final invoice paid before 31.12.06. 1. Revised time schedule Gitte presented the revised time schedule forwarded for the meeting and the following dates were agreed:

• 01.10.2006: Draft final report shall be sent to Reinhild • 08.10.2006: Draft final report available on the web at the DHI-web page

(http://projects.dhi.dk/Endocrine_Disrupter/testsite/) for stakeholder response • 08.11.2006: Response back from stakeholders • 17.11.2006: DHI/DG ENV meeting: Discussion of final deliverables • 20.11.2006: Final report

It was agreed that at the 4th meeting (17.11.2006) Reinhild will invite colleagues specifically in-terested in endocrine disrupting chemicals to participate. According to the contract, a final report shall be available to the Commission by 28.10.2006. Reinhild will check up if the above time schedule will give any problems in this respect. 2. Stakeholder meeting

Due to accommodation and travel expenses in relation to a stakeholder meeting it was decided not to have a physical meeting but instead have web-based stakeholder responses. Thus stake-holders and experts from a list, based on the one used for the written consultation, will be invited to go through the draft final report and collected data on selected CAT 1 chemicals in the data-base. The list will be provided by Reinhild after discussion with Gitte. It will be available on 31. August latest. If there are more than 35 stakeholders are commenting, the potential revision work will be divided between DHI and DG ENV.

As stated above, the draft final report will be made available for selected stakeholders by 08.10.2006 and deadline for response will be 08.11.2006. Sylvain suggested that the substances evaluated in the present project are checked to ensure that they are not already regulated by other current community legislation (e.g. Dir 76/769/EEC or REG 793/93/EEC or DIR 91/414/EC).

Page 178: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 175

3. DHI EDS Website comments Reinhild will correct the link (http://projects.dhi.dk/Endocrine_Disrupter/testsite/) and make sure that it will be made more visible on the EEC web page than presently. The preliminary quotation for transformation of the Access database to either SQL or an Oracle database made by DHI was briefly discussed. According to Bjørn Hansen (who was contacted after the meeting), this work might be performed by ECB (Reinhild please correct me here) and until this has been clarified, DHI will not provide a final quotation. It was briefly discussed that due to the fact that the present evaluation of the available data and substances in the database is based on a screening level, there might be a second project aiming at update and maintenance of an iterative EDC priority list. However, as long as the Community Strategy for Endocrine Dis-rupting substances are not perfectly clear it was decided not to discuss this item further. 4. How to proceed further with substances lacking info on Category 3 and 4 substances.

Outcome of Bjorn Hansen’s contact to CEFIC There was still no response from CEFIC. Bjørn Hansen was contacted after the meeting and once more he will try to get a reply. The final cut for response from CEFIC is 15.07.2006. It was de-cided that if no reply was obtained, the categories 3 and 4 substances (substances presently not included in the ESIS database and substances without CAS number) will not be included in the present evaluation. 5. Discuss perspectives how to proceed with the elaborated knowledge about EDS Gitte presented the proposal “The EU dynamic priority list/candidate list of substances with potential endocrine disrupting effects – proposal for ensuring a dynamic process” for-warded to the Commission by the Danish Environmental Protection Agency, October 2003. The proposal was briefly discussed and it was decided that Reinhild will distribute the paper to rele-vant people at DG ENV and thereby try to make the EU strategy on EDCs more exposed in order to ensure a prioritisation of the EDC area. The proposal is attached as a pdf.file to the e-mail forwarded to Reinhild with the present minutes from the 3rd meeting.

Page 179: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 176

A P P E N D I X D

Minutes. Discussion on final deliverables. 8 December 2006

Page 180: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 177

Study on ED priority list with a focus on LPV chemicals – Discussion of draft final deliverables, i.e.

report, database list

Brussels 8 December 2006, Beaulieu 9 Salle BU 9 0/191, 09.30-16.00

MINUTES

Attendants:; DG ENV: Sylvain Bintain and Reinhild Puergy DHI: Kim Gustavson and Gitte Petersen 1. Stakeholder response Stakeholders and experts from the list, based on the one used for the written consultation, were invited to go through the draft final report and collected data on selected CAT 1 chemicals in the database. An invi-tation to go through the report was forwarded to the stakeholders by November 3 2006 and as stated in the invitation the draft final report was made available on the web site: (http://projects.dhi.dk/Endocrine_Disrupter/testsite/) by November 15. Of the 141 stakeholders contacted 9 did respond by e-mail and approx 5 did respond by phone. The stakeholders that responded by phone did not have any comments to the report. Most of the comments received by e-mail were mainly minor. Major comments and criticism were received by the industry (CEFIC and European Crop Protection Association). Reinhild will have a meeting with CEFIC (Germot Klotz) before Christmas and comment the issues raised by CEFIC and European Crop Protection Asso-ciation. At the meeting all comments received were handled and discussed one by one and it was agreed that most of the comments received are appreciated very much and that they as far as possible will be taken into consideration in the final report. Beside taking the comments received into account in the final report the following specific corrections were agreed to be performed:

• A table with an overview of the systemic toxicity shall be included • In the summary a clear overview of the substances evaluated in the present study and previous

studies (BKH 2000 and RPS-BKH 2002) shall be given • In the summary a clear ‘break down’ of the 553 candidate substances shall be given • In the summary it shall be clearly described that the present evaluation is the last out of 3 evalua-

tions of substances placed on the EU candidate list and that the primary goal is the establishment of an EU priority-list on which further in depth evaluation of the endocrine properties shall be performed: 553 candidate substances => Evaluation at a screening level (BKH 2000 + RPS-BKH 2003 + DHI 2006)=> Priority list (CAT 1 substances) => Future in depth evaluation.

• The methodology was criticised by CEFIC. It shall therefore be clearly stated that due to the con-tinuation of the project (last out of 3 evaluations on the EU candidate list) the methodology used is comparable to the methodology used in the RPS-BKH 2002 project.

• In the summary and throughout the report it shall be clearly indicated that the present evaluation of the endocrine properties has been based on a screening level, that the evaluation shall be seen in line with previous studies and that the evaluations shall NOT be seen as risk assessments

Page 181: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 178

• In the presentation of the evaluated substances e.g., figures and tables the substances shall be or-dered by ascending CAS numbers.

• The use category of CAT 1 substances listed in table 5.3 shall be included in the table • The tonnage level used in the EUSES calculations shall be checked in relation to the tonnage

level (HPV/LPV) given in the ESIS database. • General editing (Headlines and wordings, annex with 2. stakeholder request)

2. Other issues Sylvain joined the meeting in the afternoon and the legal status of the evaluated CAT 1 substances were discussed. Among others Sylvain pointed out that Trifluralin was a POP candidate and that 4-nonylphenol has been restricted in the EU for some time. It was agreed that the legal status for all substances evaluated as CAT 1 substances in the present evalua-tion are checked carefully and that the legal status of the CAT 1 substances shall be described in the data-sheets of all 34 CAT 1 substances. 3. Discuss perspectives how to proceed with the elaborated knowledge about EDS Reinhild informed that ECB-Ispra are interested in taking the lead for the update of the Assess database to an ORACLE database. The hosting and future in depth evaluation of the priority substances will most probably be outsourced. 2006.12.11 Gitte Petersen

Page 182: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Final report/2007.06.04 179

A P P E N D I X E

List of stakeholders contacted

Page 183: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European
Page 184: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

181ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Fi

rst

nam

e L

ast

nam

e C

ompa

ny

or

inst

itu

tio

n

Dep

artm

ent

Ad

dres

s C

ity

Co

un

try

Pho

ne

Fax

E

mai

l Ju

kka

Aht

iain

en, R

e-se

arch

Sci

entis

t, P

h.D

.

Fin

ish

Env

ironm

ent I

nstit

ute

Res

earc

h D

epar

tmen

t P

.O. B

ox 1

40,

Hak

unin

maa

tie 6

F

IN-0

0251

H

elsi

nki

Fin

land

+

358-

9-40

30-

0886

+

358-

9-40

30-

0890

ju

kka.

ahtia

inen

@y

mpa

risto

.fi

Pro

f. D

r. T

. A

lban

is

Uni

vers

ity o

f Ioa

nnin

a D

epar

tmen

t of C

hem

istr

y P

.O. B

ox 1

186

4511

0 Io

-an

nina

G

reec

e +

30-6

51-

9834

8 +

30-6

51-

4483

6 ta

lban

is@

cc.u

oi.g

r

Ingv

ar

And

erss

on

Eur

opea

n E

nviro

nmen

tal

Age

ncy

Em

ergi

ng Is

sues

and

Sci

-en

tific

Lia

ison

K

onge

ns N

ytor

v 6

DK

-105

0

Cop

enha

gen

K

Den

mar

k +

45-3

336-

7142

+

45-3

336-

7128

Pau

l A

shfo

rd

Cal

eb M

anag

emen

t Ser

vice

s Li

mite

d

Gro

vela

nds

Hou

se, W

ood-

land

s, B

radl

ey

Sto

ke

Bris

tol,

BS

32

4JT

U

nite

d K

ingd

om

+44

-145

4-61

0220

+

44-1

454-

6102

40

PA

UL_

CA

LEB

GR

OU

P@

com

puse

rve.

com

Pro

f. dr

. G

eorg

B

eche

r N

orw

egia

n In

stitu

te o

f Pub

lic

Hea

lth (

NIP

H),

Div

isio

n of

E

nviro

nmen

tal M

edic

ine

Dep

artm

ent o

f ana

lytic

al

Che

mis

try

P.O

. Box

440

4 N

ydal

en, G

eit-

myr

svei

en 7

5

N-0

403

Osl

o N

orw

ay

+47

-22-

0422

42

+47

-22-

0426

86

geor

g.be

cher

@fh

i.no

Rac

hel

Ben

stea

d, S

enio

r E

coto

xico

logi

st

Env

ironm

ent A

genc

y S

cien

ce G

roup

W

aerb

erry

Driv

e P

O7

7XX

W

ater

loov

ille,

H

amps

hire

Uni

ted

Kin

gdom

+

44-2

39-2

23-

3868

+

44-2

39-2

23-

3869

ra

-ch

el.b

enst

ead@

env

ironm

ent-

agen

cy.g

ov.u

k P

rof.

dr. Å

ke

Ber

gman

S

tock

holm

Uni

vers

ity

Dep

artm

ent o

f Env

iron-

men

tal C

hem

istr

y S

vant

e ar

rhen

ius

väg

10-1

2 S

-106

91

S

tock

holm

S

wed

en

+46

-8-1

6399

7+

46-8

-163

979

ake.

berg

man

@m

k.s

u.se

D

r. C

hris

tian

Boe

gi

BA

SF

Akt

ieng

esel

lsch

aft

Pro

duct

Saf

ety-

Reg

ulat

ions

, Tox

icol

ogy

and

Eco

logy

Lu

dwig

shaf

en

Ger

man

y +

49-6

21-6

0-59

054

+49

-621

-60-

5804

3 ch

ris-

tian.

boeg

i@ba

sf-

ag.d

e D

r. J

an P

. B

oon

The

Net

herla

nds

Inst

itute

for

Sea

Res

earc

h N

IOZ

) D

ept.

Mar

ine

Bio

geo-

chem

istr

y &

Tox

icol

ogy

P.O

. Box

59,

La

ndsd

iep

4 N

L-17

90 A

B

Den

Bur

g,

Tex

el

The

Net

herla

nds

+31

-222

-369

-46

6 +

31-2

22-3

19-

674

boon

@ni

oz.n

l

Jean

-Pie

rre

Bou

rgui

gnon

U

nive

rsite

de

Lieg

e; C

entr

e de

N

euro

biol

ogie

Cel

lula

ire e

t M

olec

ulai

re

Inst

itute

of P

atho

logy

(+

4)

Bat

. B23

; C.H

.U. S

art

Tilm

an

Ave

nue

de l'

Hop

i-ta

l, 13

B

-400

0 Li

ege

Bel

gium

+

32-

4-36

6724

7 +

32-

4-36

6724

6 jp

gour

guig

-no

n@ul

g.ac

.be

Con

or

Cle

nagh

an

E

urop

ean

Com

mis

sion

, DG

E

nviro

nmen

t – U

nit D

.2 (

Wa-

ter,

mar

ine

and

soil)

Wat

er F

ram

ewor

k D

irec-

tive

Tea

m

B

ruxe

lles

Bel

gium

+

32-2

-296

-62-

95

+32

-2-2

9 68

700

Co-

nor.

clen

agha

n@ec

.eu

ropa

.eu

Sus

anne

B

rem

er

JRC

of t

he E

urop

ean

Com

-m

issi

on

Inst

itute

for

Hea

lth a

nd

Con

sum

er P

rote

ctio

n,

EC

VA

M T

P58

0

Via

E. F

erm

i 1

I-21

020

Ispr

a (V

A)

Italy

+

39-0

332-

78-

5914

+

39-0

332-

78-

53-3

6 S

u-sa

nne.

brem

er@

jrc.i

t P

rof.

dr.

Jam

es

Brid

ges

Uni

vers

ity o

f Sur

rey

Sch

ool o

f Bio

med

ical

and

Li

fe S

cien

ces

GU

2 7X

H, S

tag

Hill

G

uild

ford

, S

urre

y E

ngla

nd, U

K

+44

-148

3-87

3802

+

44-1

483-

8738

03

J.B

ridge

s@su

rrey

.ac.

uk

Pro

f. D

r. A

. (B

ram

) B

rouw

er

Vrij

e U

nive

rsite

it (I

VM

/VU

) In

stitu

te fo

r E

nviro

nmen

tal

Stu

dies

, Fac

ulty

of E

arth

an

d Li

fe S

cien

ce

De

Boe

lela

an

1087

N

L-10

81 H

V

Am

ster

dam

T

he N

ethe

rland

s+

31-2

0-59

8-95

35/9

555

+31

-20-

5989

553

Bra

m.B

rouw

er@

ivm

.vu.

nl

Pam

ela

Byr

ne

Pes

ticid

e C

ontr

ol S

ervi

ce

Dep

t. of

agr

icul

ture

&

Foo

d, A

bbot

stow

n La

bora

-to

ry C

ompl

ex

Cas

tlekn

ock

Dub

lin 1

5 Ir

elan

d +

353-

1-60

7-22

61

+35

3-1-

820-

4260

pa

m-

ela.

byrn

e@ag

ricul

ture

.gov

.ie

Pro

f. D

r.

Dan

iela

C

andi

a

Car

neva

li U

nive

rsity

of M

ilan

Dep

artm

ent o

f Bio

logy

, D

ivis

ion

of Z

oolo

gy a

nd

Cyt

olog

y

Via

Cel

oria

, 26

I-20

133

Mila

n Ita

ly

dan-

iela

.can

dia@

unim

i.it

Page 185: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

182ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Cas

als

A

rqui

mba

u D

éleg

atio

n P

erm

anen

te

Bur

eau

de T

rava

il et

des

A

ffaire

s S

ocia

les

6, r

ue G

reuz

e F

-751

16 P

aris

Fra

nce

+33

-1-

5370

0523

+

33-1

-53

7005

30

clab

o-ra

l.esp

.par

is@

wan

ado

o.fr

D

r. J

acob

de

Boe

r N

ethe

rland

s In

stitu

te fo

r F

ish-

erie

s R

esea

rch

(RIV

O)

P

.O. B

ox 6

8, H

ar-

ingk

ade

1 N

L-19

70 A

B

Ijmui

den

The

Net

herla

nds

+31

-255

-56

4736

+

31-2

55-

5646

44

j.deb

oer@

riva.

wag

-ur

.nl

Pro

f. dr

. W

im

de C

oen

Uni

vers

ity o

f Ant

wer

p D

epar

tmen

t of B

iolo

gy,

Res

earc

h G

roup

for

Eco

-ph

ysio

logy

, Bio

chem

istr

y an

d T

oxic

olog

y

Gro

enen

borg

er-

laan

171

B

-202

0 A

nt-

wer

p B

elgi

um

+32

-3-

2180

370

+32

-3-

2180

497

de-

coen

@ru

ca.u

a.ac

.be

Cha

rlotte

de

Roo

B

EU

C, B

urea

u E

urop

én d

es

Uni

ons

de C

onso

mm

ateu

rs

A

v. E

. Van

N

ieuw

enhu

yse

4 bt

e 1

B-1

160

Bru

x-el

les

Bel

gium

+

32-2

-743

-15

90

+32

-2-7

43-

7455

cr

o@be

uc.o

rg

Jaqu

es

de S

ellie

rs

Gre

enF

acts

Fou

ndat

ion

44

, rue

de

Pal

ais

B-1

030

Bru

x-el

les

Bel

gium

+

32-2

-211

-34

88

+32

-3-2

18-

8973

in

fo@

gree

nfac

ts.o

rg

Pro

f. dr

. W

olfg

ang

Dek

ant

Uni

vers

ity o

f Wür

zbur

g (U

WU

ER

Z)

Dep

artm

ent o

f Tox

icol

ogy

Ver

sbac

her

Str

. 9

D-9

7078

W

ürzb

urg

Ger

man

y +

49-9

31-2

01-

4844

9 +

49-9

31-2

01-

4886

5 de

kant

@to

xi.u

ni-

vuer

zbur

g.de

B

ohda

n A

. D

myt

rasz

, Tec

h-ni

cal C

oord

ina-

tion,

pet

role

um

Pro

duct

s

CO

NC

AW

E

B

oule

vard

de

Sou

vera

in 1

65

B-1

160

Bru

s-se

ls

Bel

gium

+

32-2

-566

-91

65

+32

-2-5

55-

9181

bo

.dm

ytra

sz@

conc

awe.

be

Mic

hael

D

orge

rloh

Bay

er C

ropS

cien

ce A

G

Inst

itute

for

Eco

toxi

colo

gy,

Labo

rato

ry fo

r A

quat

ic

Org

anis

ms

Alfr

ed-N

ovel

-Str

. 50

, Bui

ldin

g 66

20

D-4

0789

M

onhe

im

Ger

man

y +

49-2

173-

38-

3856

+

49-2

173-

38-

4981

m

i-ch

ael.d

orge

rloh@

bay

ercr

op-

scie

nce.

com

R

ik I.

L.

Egg

en

Sw

iss

Fed

eral

Inst

itute

for

Env

ironm

enta

l Sci

ence

and

T

ehcn

olog

y (E

AW

AG

)

Dep

artm

ent o

f Env

iron-

men

tal M

icro

biol

ogy

and

Mol

edul

ar E

coto

xico

logy

Ueb

erla

ndst

rass

e 13

3 C

H-8

600

D

uebe

ndor

f S

witz

erla

nd

+41

-1-

8235

320

+41

-1-

8235

547

egge

n@ea

wag

.ch

Pro

f. D

r.

Jerz

y F

alan

dysz

U

nive

rsity

of G

dans

k D

epar

tmen

t of E

nviro

n-m

enta

l Che

mis

try

and

Eco

toxi

colo

gy

ul. S

obie

skie

go

18/1

9, p

awilo

n 20

0, p

ok. 3

1/34

PL-

80-9

52

Gdańs

k P

olan

d +

48-5

8-34

5-04

45

+48

-300

-008

4jfa

-la

ndy@

chem

ik.c

hem

.uni

v.gd

a.pl

Je

anin

e F

erre

ira m

arqu

es M

inis

tère

des

Affa

ires

Soc

ia-

les,

de

la S

anté

Pub

lique

et d

e l’E

nviro

nnem

ent

C

ité a

dmin

istr

ativ

e de

l’E

tat,

Qua

rtie

r V

ésal

e lo

cal V

23

04, B

oule

vard

P

ache

co, 1

9 B

T 5

B-1

010

Bru

x-el

les

Bel

gium

+

32-2

-210

-48

47

+32

-2-2

10-

4704

je

anin

e.fe

rrei

ra@

heal

th.fg

ov.b

e

Gig

liola

F

onta

nesi

E

urop

ean

Com

mis

sion

D

G S

AN

CO

, C.7

Bru

xelle

s B

elgi

um

+32

-2-2

9-63

530

G

igli-

ola.

font

anes

i@ec

.eur

opa.

eu

Ale

xius

F

reyb

erge

r B

ayer

AG

, PH

PD

P

Inst

itute

of T

oxic

olog

y,

Pha

rma

Res

earc

h C

entr

e

D-4

2096

W

uppe

rtal

G

erm

any

+49

-202

-368

-83

2 +

49-2

02-3

64-

137

Ale

x-iu

s.F

reyb

erge

r@ba

yer-

ag.d

e P

rof.

Dr.

S

ilvan

a G

alas

si

Uni

vers

ità d

egli

Stu

die

di

Mila

no

Dip

artim

ento

de

Bio

logi

a V

ia C

elor

ia 2

6 I-

2013

3 M

ilan

Italy

+

39-0

2-50

3-14

838

+39

-02-

503-

1486

2 si

l-va

na.g

alas

si@

unim

ib.

it A

nton

G

errit

sen

Insi

tute

for

Inla

nd W

ater

Man

-ag

emen

t and

Was

te W

ater

T

reat

men

t (R

IZA

)

Dep

artm

ent o

f Ind

ustr

ial

Pol

lutio

n C

ontr

ol

Zui

derw

agen

plei

n 2;

PO

Box

17

NL-

8200

AA

Le

lyst

ad

The

Net

herla

nds

+31

-320

-29

8498

+

31-3

20-

2982

18

a.ge

rrits

en@

riza.

rws.

min

venw

.nl

And

reas

G

ies

Um

wel

tbun

desa

mt

IV2

Pf 3

3 00

22

D

-141

91

Ber

lin

Ger

man

y +

49-3

0-89

03-

2860

+

49-3

0-89

03-

3350

an

-dr

eas.

gies

@ub

a.de

Page 186: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

183ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Dr.

Syl

via

Gim

eno,

Sen

ior

Sci

entis

t P

& G

Bru

ssel

s In

nova

tion

Cen

ter

Cen

tral

Pro

duct

Saf

ety

- E

nviro

nmen

t T

emse

laan

, 100

B

-375

-601

0

Str

ombe

ek-

Bev

er

Bel

gium

+

32-2

-456

-60

10

+32

-2-4

56-

3248

gi

men

o.s@

pg.c

om

Ann

e G

ourm

elon

O

EC

D E

nviro

nmen

t H

ealth

and

Saf

ety

Div

isio

n2,

rue

And

ré-

Pas

cal

F-7

5775

Par

is

Céd

ex 1

6 F

ranc

e +

33-1

-45

2498

49

A

nne.

gour

mel

on@

oec

d.or

g Jo

hn W

. G

reen

, Sen

ior

Con

sulta

nt, B

io-

stat

istic

s

DuP

ont Q

ualit

y M

anag

emen

t &

Tec

hnol

ogy,

P.O

. Box

50

Stin

e-H

aske

l Res

earc

h C

ente

r B

lgd

H-1

Rm

42

3B, 1

090

Elk

ton

Roa

d

New

ard,

DE

19

714-

0050

U

.S.A

. +

1-30

2-36

6-53

10

+1-

302-

366-

5207

Jo

hn.W

.Gre

en@

usa.

dupo

nt.c

om

Eve

lyn

Güs

ken,

Man

-ag

er

Tec

hnic

al R

egul

ator

y A

ffairs

E

CP

A

6

Ave

nue

Van

N

ieuw

enhu

yse

B-1

160

Bru

s-se

ls

Bel

gium

+

32-2

-663

-15

57

+32

-2-6

63-

1560

ev

e-ly

ne.g

uske

n@ec

pa.

be

Pro

f. Ja

n-Å

ke

Gus

tafs

son

Kar

olin

ske

Inst

itute

/Nov

um,

Hud

ding

e U

nive

rsity

Hos

pita

l D

epar

tmen

t of B

iosc

i-en

ces/

Dep

t. of

Med

ical

N

utrit

ion

S

-141

86

H

uddi

nge

Sw

eden

+

46-8

-585

-83

7-46

/+46

-8-

774-

9207

/+46

-8-

585-

837-

01/+

46-8

-779

-87

-95

ja

n-ak

e.gu

staf

sson

@cn

t.ki.s

e

Pro

f. dr

. Ja

na

Haj

šlov

á In

stitu

te o

f Che

mic

al T

echn

ol-

ogy

Dep

artm

ent o

f foo

d C

hem

-is

try

and

Ana

lysi

s T

echn

icka

3

1662

8 P

ragu

e C

zech

Rep

ublic

+

420-

2-24

3140

96

+42

0-2-

2435

3185

ja

na.h

ajsl

ova@

vsch

t.cz

Inge

-Vib

eke

Han

sen

Dan

ish

EP

A

S

tran

dgad

e 29

D

K-1

401

C

open

hage

n K

Den

mar

k +

45-3

2660

316

iv

m@

mst

.dk

(ivh?

?)

Pau

l H

arris

on, A

ctin

g di

rect

or a

nd

Hea

d of

env

i-ro

nmen

tal t

oxi-

colo

gy g

roup

MR

C In

stitu

te fo

r E

nviro

nmen

t an

d he

alth

94 R

egen

t Roa

d Le

ices

ter

LE1

7DD

U

nite

d K

ingd

om

+44

-116

-223

-16

10

+44

-116

-223

-16

01

Ptc

hl.le

.ac.

uk

Ste

fan

Har

tung

U

nive

rsitä

tskl

inik

um H

ambu

rg-

Epp

endo

rf

Abt

eilu

ng fü

r A

ndro

logi

e;

AG

Mol

ekul

are

And

rolo

gie

Mar

tinis

traβ

e 52

D

-202

46

Ham

burg

G

erm

any

+49

-40-

4280

3-15

87 o

r -

1583

ha

rtun

g@ih

f.de

Ulla

H

ass;

Jen

s-Jø

rgen

Lar

sen

Dan

ish

Vet

erin

ary

and

Foo

d A

dmin

istr

atio

n; In

stitu

te o

f F

ood

Saf

ety

and

Nut

ritio

n

Dep

t. of

Tox

icol

ogy

rkhø

j Byg

ade

19

DK

-286

0 S

øbo

rg

Den

mar

k +

45-

7234

7538

; +

45-7

2347

544

+45

-339

5669

8ul

h@fd

ir.dk

; jjl

@fd

ir.dk

Bar

bara

H

einr

ich-

Hirs

ch

Fed

eral

Inst

itute

for

heal

th a

nd

Pro

tect

ion

of C

onsu

mer

s an

d V

eter

inar

y M

edic

ine

FG

825

T

hiel

alle

e 88

-92

D-1

4195

B

erlin

G

erm

any

+49

-188

-84

12-3

384

+49

-188

-84

12-3

003

b.he

inric

h-hi

rsch

@bf

r.bu

nd.d

e

Juer

gen

H

elbi

g E

urop

ean

Com

mis

sion

, D

G E

nviro

nmen

t – U

nit

B.3

Bio

tech

nolo

gy, P

esti-

cide

s an

d H

ealth

B

ruxe

lles

Bel

gium

03

2 2

29

8852

1

juer

-ge

n.he

lbig

@ec

.eur

opa

.eu

Pro

f. S

te-

phen

G.

Hill

ier

Uni

vers

ity o

f Edi

nbur

gh

Cen

tre

for

Rep

rodu

ctiv

e B

iolo

gy

51 L

ittle

Fra

nce

Cre

scen

t E

dinb

urgh

E

H16

4S

A

Sco

tland

, UK

+

44-1

31-2

42-

2695

/7

+44

-131

-242

-26

86

Ste

ve.H

illie

r@ed

.ac

.uk

Ber

told

H

ock

Tec

hnis

che

Uni

vers

ität

Mün

chen

Le

hrst

uhl f

ür Z

ellb

iolo

gie

Alte

aka

dem

ie 1

2 D

-853

54

Fre

isin

g G

erm

any

+49

-816

1-71

3396

+

49-8

161-

7144

03

hock

@w

zw.tu

m.d

e

Pro

f. Ilp

o T

. H

uhta

niem

i Im

peria

l Col

lege

facu

lty o

f M

edic

ine;

Ham

mer

smith

Hos

-pi

tal

Inst

itute

of R

epro

duct

ive

and

Dev

elop

men

tal B

iol-

ogy

Du

Can

e R

oad

Lond

on W

12

ON

N

Uni

ted

Kin

gdom

+

44-2

0-75

94-

2104

+

44-2

0-75

94-

2184

ilp

o.hu

htan

iem

i@ic

.ac

.uk

Tho

mas

H

utch

inso

n A

stra

Zen

eca

S

öder

tälje

S

-151

85

S

öder

tälje

S

wed

en

+46

-8-5

52-

5029

1 +

46-8

-552

-58

505

tom

.hut

chin

son@

astr

azen

eca.

som

Page 187: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

184ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Pro

f. F

aise

n Ig

uchi

N

atio

nal I

nstit

utes

of N

atur

al

Sci

ence

, Cen

tre

for

Inte

grat

ive

Bio

scie

nce

Oka

zaki

Inst

itute

for

Inte

-gr

ativ

e B

iosc

ienc

e, D

e-pa

rtm

ent o

f Bio

envi

ron-

men

tal R

esea

rch

5-1

Hig

ashi

yam

a,

Myo

daiji

44

4-87

87

Aka

zaki

Aic

hi

Japa

n +

81-5

-645

9-52

35

+81

-5-6

459-

5236

ta

isen

@ni

bb.a

c.jp

Pet

er

Illig

In

tern

atio

nal S

ocie

ty o

f Doc

-to

rs fo

r th

e E

nviro

nmen

t

Rue

de

la M

use,

9C

H-1

205

G

enev

a S

witz

erla

nd

+41

-21-

802-

6553

+

41-2

1-80

2-65

54

pilli

g@is

de.o

rg

Dr.

Toh

ru

Inou

e, D

irect

or

Nat

iona

l Ins

titut

e of

Hea

lth

Sci

ence

C

ente

r fo

r B

iolo

gica

l S

afet

y R

esea

rch

1-18

-1 K

amiy

oga,

S

etag

aya-

ku

158-

8501

T

okyo

Ja

pan

+81

-3-3

700-

1564

+

81-3

-370

0-16

22

bioc

en-

terd

g@ni

hs.g

o.jp

M

s. F

umi

Irie

, Chi

ef, E

nvi-

ronm

enta

l Hea

lth

Dep

artm

ent

Min

istr

y of

the

Env

ironm

ent

Env

ironm

enta

l Hea

lth a

nd

Saf

ety

Div

isio

n 1-

2-2

Kas

umi-

gase

ki, C

hiyo

da-

ku

100-

8975

T

okyo

Ja

pan

+81

-3-5

521-

8261

+

81-3

-358

0-35

96

fum

i_iri

e@en

v.go

.jp

Ric

hard

Iv

ell (

Ass

ocia

ted

Par

tner

); P

rofe

s-so

r an

d H

ead

of

Sch

ool

Sch

ool o

f Mol

ecul

ar a

nd B

io-

med

ical

Sci

ence

s; T

he U

ni-

vers

ity o

f Ade

laid

e

Med

ical

Sch

ool S

outh

, 4th

F

loor

F

rom

e R

oad

Ade

laid

e, S

A

5005

A

ustr

alia

+

61-8

-83

0331

14

ric

h-ar

d.iv

ell@

adel

aide

.ed

u.au

Mar

k Ja

ber

Wild

life

Ltd.

8598

Com

mer

ce

Driv

e E

asto

n, M

ary-

land

216

01

U.S

.A.

+1-

410-

822-

8600

+

1-41

0-82

2-06

32

mja

-be

r@w

ildlif

eint

erna

tio

nal.c

om

Ela

rd

Jaco

b B

AS

F A

G Z

470

Abt

. Tox

ikol

ogie

C

arl-B

osch

-S

tras

se 3

5 D

-670

56

Ludw

igsh

afen

G

erm

any

+49

-621

-604

-16

11

+49

-621

-605

-17

34

Ela

rd.ja

cob@

basf

-ag

.de

Sta

ffan

Jako

bsso

n, S

en-

ior

Res

earc

her

Sw

edis

h A

nim

al W

elfa

re A

u-th

ority

(S

AW

A)

P

.O. B

ox 8

0 S

E-5

33 2

1

Ska

ra

Sw

eden

+

46-5

11-2

7-43

4 +

46-5

11-2

7-49

0 st

af-

fan.

jako

bsso

n@dj

ursk

ydds

myn

-di

ghet

en.s

e P

rof.

Olli

nne

Uni

vers

ity o

f Hel

sink

i B

iom

edic

um H

elsi

nki

P.O

. Box

63;

H

aart

man

inka

tu 8

F

IN-0

0014

H

elsi

nki

Fin

land

+

358-

9-19

1-25

040

+35

8-9-

191-

2504

7 ol

li.ja

nne@

hels

inki

.fi

Dr.

R.

Jean

not

BR

GM

S

cien

tific

and

Tec

hnic

al

Cen

tre

3, a

venu

e C

laud

e G

uille

min

, BP

60

09

F-4

5060

Or-

léan

s C

ED

EX

2

Fra

nce

+33

-2-3

864-

3434

+

33-2

-386

4-35

18

r.je

anno

t@br

gm.fr

Ber

nard

JE

GO

U

Uni

vers

ité d

e R

enne

s IF

R 9

8 R

epro

duct

ion;

D

ével

oppe

men

t et E

co-

phys

iolo

gie

Cam

pus

de B

eau-

lieu,

Bât

. 13

F-3

5042

R

enne

s F

ranc

e +

33-2

-23

2369

11

+33

-2-

2323

5055

be

r-na

rd.je

gou@

renn

es.in

serm

.fr

Pro

f. dr

. B

jørn

Mun

ro

Jens

sen

Nor

weg

ian

Uni

vers

ity o

f Sci

-en

ce a

nd T

echn

olog

y (N

TN

U),

D

epar

tmen

t of Z

oolo

gy

Dep

artm

ent o

f Bio

logy

, E

coph

ysio

logy

and

Eco

-to

xico

logy

gro

up

Hog

skol

erin

gen

5 N

O-7

491

T

rond

heim

N

orw

ay

+47

-735

9626

7+

47-7

2591

309

bjor

n.m

unro

.jens

sen@

chem

bio.

ntnu

.no

Dr.

Sus

an

Jobl

ing

Bur

nel U

nive

rsity

In

stitu

te fo

r th

e E

nviro

n-m

ent

U

xbrid

ge,

Mid

dels

ex

UB

8 3P

H

Uni

ted

Kin

gdom

+

44-1

895-

2665

15

+44

-189

5-26

9761

su

-sa

n.jo

blin

g@br

unel

.ac

.uk

Dr.

Rod

ney

John

son

US

EP

A

OR

D-N

HE

ER

L, M

id C

on-

tinen

t Eco

logy

Div

isio

n 62

01 C

ongd

on

Bui

ldin

g D

ulut

h, M

N

5580

4 U

.S.A

. +

1-21

8-52

9-51

17

+1-

218-

529-

5003

jo

hn-

son.

rodn

ey@

stat

e.g

ov

Ian

John

son

WR

c-N

SF

Hen

ley

Roa

d,

Med

men

ham

, M

arlo

w, B

uck-

ingh

amsh

ire,

SL7

2 H

D

Uni

ted

Kin

gdom

“jo

hn-

son_

i”@w

rcpl

c.co

.uk

Ebb

a B

aran

y E

urop

ean

Com

mis

sion

; Re-

sear

ch D

irect

orat

e-G

ener

al

Dire

ctor

ate

E: B

iote

chno

l-og

y, a

gric

ultu

re a

nd F

ood;

U

nit E

2: F

ood

Qua

lity;

O

ffice

SD

ME

8/2

9

Squ

are

de

Mee

use

8 B

-105

0 B

rus-

sels

B

elgi

um

+32

2 2

9 88

068

+32

-2-2

96

4322

eb

ba.b

aran

y@ec

.eur

opa.

eu

Page 188: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

185ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Pro

f. D

r.m

ed.

Die

ter

Klin

gmül

ler

Inst

. für

Klin

. Bio

chem

ie;

And

reas

Grig

ull

S

igm

und-

Fre

ud-

Str

. 25

D-5

3127

B

onn

Ger

man

y +

49-2

28-2

87-

6564

+

49-2

28-2

87-

6028

d.

klin

gmue

ller@

uni-

bonn

.de

Pro

f. W

erne

r K

loas

Le

ibni

z In

stitu

te o

f Fre

shw

ater

E

colo

gy a

nd In

land

Fis

herie

s

Müg

gels

eeda

mm

31

0 D

-128

57

Ber

lin

Ger

man

y +

49-3

0-64

-18

1-63

0 +

49-3

0-64

-18

1-75

0 w

erne

r.kl

oas@

igb-

berli

n.de

G

erno

t K

lotz

B

ayer

AG

Lev

erku

sen

Cor

pora

te C

ente

r, G

over

-m

enta

l & p

rodu

ct A

ffairs

(B

GA

-GP

A)

D

-513

68

Leve

rkus

en

Ger

man

y +

49-2

14-3

0-61

656

+49

-214

-30-

5276

2 ge

r-no

t.klo

tz.g

k@ba

yer-

ag.d

e P

rof.

Jose

f K

öhrle

H

umbo

lt U

nive

rsity

Ber

lin

repr

esen

ted

by C

harit

e U

ni-

vers

ity H

ospi

tal

Inst

itute

for

Exp

erim

enta

l E

ndoc

rinol

ogy;

Mol

ecul

ar

End

ocrin

olog

y

Sch

uman

nstr

asse

20

-21

D-1

0098

B

erlin

G

erm

any

+49

-30-

450-

5240

21

+49

-30-

450-

5249

22

jose

f.koe

hrle

@ch

ari

te.d

e

Ann

eli

Koj

o, S

enio

r O

ffice

r N

atio

nal P

rodu

ct C

ontr

ol

Age

ncy

for W

elfa

re a

nd H

ealth

Che

mic

als

Dep

artm

ent

P.O

. Box

210

F

IN-0

0531

H

elsi

nki

Fin

land

+

358-

9-39

67-

2763

/+35

8-50

-51

44-2

21

+35

8-9-

3967

-27

97

anne

li.ko

jo@

sttv

.fi

And

reas

K

orte

nkam

p T

he S

choo

l of P

harm

acy

Cen

tre

for

Tox

icol

ogy

Uni

vers

ity o

f Lon

-do

n; B

runs

wic

k S

quar

e

Lond

on W

C1N

1A

X

Uni

ted

Kin

gdom

+

44-2

0-77

5359

08

+44

-20-

7753

5908

A

n-dr

eas.

kort

enka

mp

@ul

sop.

ac.u

k K

. Ole

K

usk

DT

U

Inst

itut f

or M

iljø

og

Res

-so

urce

r B

ygni

ngst

orve

t 11

5 D

K-2

800

Ly

ngby

D

enm

ark

+45

-452

5-15

69

ko

k@er

.dtu

.dk

Mat

thie

u LA

SS

US

M

inis

tère

de

l’Eco

logi

e et

de

Dév

elop

pem

ent D

urab

le

DP

PR

/ SD

PD

/ BS

PC

20

, ave

nue

de

Ség

ur

F-7

5302

Par

is

Ced

ex 0

7 S

P

Fra

nce

+33

-1-

4219

1542

+

33-1

-42

1914

68

mat

-th

ieu.

lass

us@

ecol

ogi

e.go

uv.fr

D

r. H

ellm

uth

Lilie

ntha

l R

uhr

Uni

vers

ität B

ochu

m

Ber

ufsg

enos

sens

chaf

tlich

es F

orsc

hung

s In

sittu

t für

aa

rbei

tsm

ediz

in

Bür

kle

de la

C

amp-

Pla

tz 1

D

-447

89

Boc

hum

G

erm

any

+49

-234

-361

-79

78

+49

-234

-302

-45

05

lilie

n@bg

fa.r

uhr-

uni-b

ochu

m.d

e

Gw

ynne

Ly

ons,

Tox

ics

Sci

ence

and

P

olic

y A

dvis

er

WW

F-U

K

17

The

Ave

nues

N

orw

ich

NR

2 3P

H

Eng

land

, UK

+

44-1

603-

507-

363

+44

-160

3-50

7-36

3 Ly

onsw

wf@

aol.c

om

Dr.

Sar

i M

äkel

ä U

nive

rsity

of T

urku

; Ins

titut

e of

B

iom

edic

ine

Dep

artm

ent o

f Ana

tom

y K

iinam

ylly

nkat

u 10

FIN

-205

20

Tur

ku

Fin

land

+

358-

2-33

3-68

37

+35

8-2-

333-

7352

sa

rmak

@ut

u.fi

Pro

f. Lu

dwik

K

. M

alen

dow

icz

K. M

arci

nkow

ski U

nive

rsity

of

Med

ical

Sci

ence

s D

epar

tmen

t of H

isto

logy

an

d E

mbr

yolo

gy; L

abor

a-to

ry o

f Exp

erim

enta

l En-

docr

inol

ogy

6 S

wie

cick

i St.

PL-

60-7

81

Poz

nan

Pol

and

+48

-61-

854-

6444

+

48-6

1-86

4-64

40

lkm

@am

.poz

nan.

pl

Alb

erto

M

anto

vani

Ita

lian

Nat

iona

l Hea

lth In

stitu

teD

ept.

of C

ompa

rativ

e T

oxic

olog

y V

iale

Rei

gna

Ele

na 2

99

I-00

161

Rom

a Ita

ly

+39

-06-

4990

-25

65

+39

-06-

4938

-71

39

albe

rto@

iss.

it

Erm

inio

M

araf

ante

IH

CP

-JR

C

V

ia E

. Fer

mi 1

I-

2102

0 Is

pra

(VA

) Ita

ly

Er-

min

io.M

araf

ante

@jr

c.it

Dr.

Sek

i M

asan

ori,

Re-

sear

cher

C

hem

ical

s E

valu

atio

n an

d R

esea

rch

Inst

itute

(C

ER

I)

Kur

ume

Labo

rato

ry, E

co-

toxi

city

Sec

tion

Kur

ume,

3-2

-7

Miy

anoj

in

839-

0801

F

ukuo

ka

Japa

n +

81-9

-423

4-15

00

+81

-9-4

239-

6139

se

ki-

mas

anor

i@ce

ri.jp

K

eith

D.

Mas

on

Per

man

ent D

eleg

atio

n S

cien

ce A

dvis

or fo

r E

nvi-

ronm

enta

l Affa

irs

12, a

venu

e R

apha

ël

F-7

5116

Par

is F

ranc

e +

33-1

-45

2474

25

+33

-1-

4524

7468

m

a-so

nkd@

stat

e.go

v P

rof.

Pet

er

Mat

thie

ssen

C

entr

e fo

r E

colo

gy a

nd H

y-dr

olog

y, L

anca

ster

Env

iron-

men

t Cen

tre

Env

ironm

enta

l Che

mis

try

and

Pol

lutio

n S

ectio

n Li

brar

y A

venu

e B

ailri

gg, L

an-

cast

er L

A1

4AP

Uni

ted

Kin

gdom

+

44-1

524-

5958

67

+44

-152

4-61

536

pmat

t@ce

h.ac

.uk

Ian

May

er

Uni

vers

ity o

f Ber

gen

Dep

artm

ent o

f Fis

herie

s an

d M

arin

e B

iolo

gy

PO

Box

780

0 N

-502

0 B

er-

gen

Nor

way

+

47-5

5-58

4444

2 +

47-5

5-58

4450

ia

n.m

ayer

@ifm

.uib

.no

Page 189: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

186ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

John

-Dav

id

Met

thew

s, D

irec-

tor

Eur

opea

n A

ffairs

Rho

dia

R

ond

Poi

nt,

Sch

uman

6

B-1

040

Bru

x-el

les

Bel

gium

+

32-2

-234

-77

30/+

32-4

74-

481-

448

(mo-

bile

)

+32

-2-2

34-

7930

Jo

hn-

Dav

id.M

AT

TH

EW

S@

EU

.RH

OD

IA.C

OM

E

llen

Mih

aich

E

nviro

nmen

tal a

nd R

egul

ator

y R

esou

rces

6807

Lip

scom

D

rive

Dur

ham

, NC

27

712

U.S

.A.

+1-

919-

479-

6047

+

1-91

9-47

9-69

47

emih

a-ic

h@nc

.rr.

com

P

rof.

Jam

ie

A.

Mog

uile

vsky

U

nive

rsid

ad d

e B

ueno

s A

ires;

F

acul

tad

de M

edic

ina

Dep

arta

men

to d

e F

isio

lo-

gia

D.P

. 112

1 B

ueno

s A

ires

Arg

entin

a

+54

-11-

4981

-99

12

mo-

fuile

v@m

ail.r

etin

a.a

r M

s. R

io

Nak

agaw

a C

hem

ical

s E

valu

atio

n an

d R

esea

rch

Inst

itute

(C

ER

I)

Che

mic

als

Ass

essm

ent

Cen

tre,

Res

earc

h an

d P

lann

ing

Dep

artm

ent

Bun

kyou

-ku,

1-4

-25

, Kau

raku

11

2-00

04

Tok

yo

Japa

n +

81-3

-580

4-61

35

+81

-3-5

804-

6139

rio

-na

kaga

wa@

ceri.

jp

José

Mar

ía

Nav

as A

ntón

, S

cien

tific

Re-

sear

cher

Inst

itut N

atio

nal d

es

Rec

herc

hes

Agr

aire

s D

epar

tem

ent f

or th

e E

nvi-

ronm

ent

Ctr

a. d

e la

Cor

uña

Km

7.5

28

040

Mad

rid

Spa

in

+34

-91-

347-

4155

+

34-9

1-35

7-22

93

jmna

vas@

inia

.es

Pol

yxen

i N

icol

opou

lou-

Sta

mat

i M

edic

al S

choo

l, N

atio

nal a

nd

Kap

odis

tria

n U

nive

rsity

of

Ath

ens

Dep

t. of

Pat

holo

gy

Mic

ras

Asi

as 7

5 G

R-1

1527

A

then

s G

reec

e +

30-2

10-

7462

163

+30

-210

-68

4048

8 as

-pi

s@at

h.fo

rthn

et.g

r

Pia

Juu

l N

iels

en

Dan

ish

Env

ironm

enta

l Pro

tec-

tion

Age

ncy

Bio

cide

s an

d C

hem

ical

s A

sses

smen

t (H

ealth

and

E

nvt G

roup

)

Str

andg

ade

29

DK

-140

1

Cop

enha

gen

K

Den

mar

k +

45-3

2660

418

+45

-326

6036

9pj

n@m

st.d

k

Leif

Nor

rgre

en

Sw

edis

h U

nive

rsity

of A

gric

ul-

tura

l Sci

ence

s; F

acul

ty o

f Vet

-er

inar

y m

edic

ine

and

Ani

mal

S

cien

ce

Dep

artm

ent o

f Bio

med

i-ci

ne a

nd V

eter

inar

y P

ublic

H

ealth

; Div

isio

n of

Pat

hol-

ogy,

Pha

rmac

olog

y an

d T

oxic

olog

y

Box

708

2; T

rav-

väge

n 12

D

S-7

5007

U

ppsa

la

Sw

eden

+

46-1

8-67

1206

+

46-1

8-67

3532

le

if.no

rrgr

en@

pat.s

lu.

se

Pro

f. D

r.

Jörg

O

ehlm

ann

Joha

nn W

olfg

ang

Goe

the

Uni

vers

ity F

rank

furt

am

Mai

n;

Bio

logi

cal a

nd c

ompu

ter

Sci

-en

ces

Div

isio

n

Dep

artm

ent o

f Eco

logy

an

d E

volu

tion

- E

coto

xi-

colo

gy

Sie

smay

erst

rass

e 70

D

-600

54

Fra

nkfu

rt

Ger

man

y +

49-6

9-79

8-24

871

oe

hl-

man

n@zo

olog

y.un

i-fr

ankf

urt.d

e

Agn

eta

Ohl

sson

, Ass

oc.

prof

. N

atio

nal C

hem

ical

s In

spec

tor-

ate

(Kem

I)

B

ox 2

S

-172

13

S

undb

yber

g S

wed

en

+46

-8-5

19-

4124

1 +

46-8

-735

-76

98

ag-

neta

.ohl

sson

@ke

mi

.se

Mr.

Hiro

kazy

O

kuda

, Chi

ef o

f R

epro

duct

ive

and

Dev

elop

-m

ent T

est

Japa

n B

ioss

ay R

esea

rch

Cen

-te

r D

ivis

ion

of E

xper

imen

tal

Tox

icol

ogy

2445

Hira

saw

a 25

7-00

15

Had

ano

Kan

agaw

a

Japa

n +

81-4

63-8

2-39

11

+81

-463

-82-

3860

ho

kuda

@jis

ha.o

r.jp

Nic

olas

O

lea

Uni

vers

idad

de

Gra

nada

; Fa-

culta

d de

Med

icin

a D

ept.

Rad

iolo

gia

y M

edi-

cina

Fis

ica

G

rana

da

1807

1 S

pain

+

34-9

-58-

242-

864

+34

-9-5

8-24

9-95

3 no

lea@

ugr.

es

Pro

f. S

tina

Ore

dsso

n Lu

nd U

nive

rsity

D

epar

tmen

t of C

ell a

nd

Org

anis

m B

iolo

gy, A

nim

al

Phy

siol

ogy

Bui

ldin

g

Hel

gona

väge

n 3B

S

E-2

23 6

2 Lu

nd

Sw

eden

+

46-4

6-22

2-94

97

+46

-46-

222-

4539

S

tina.

Ore

dsso

n@co

b.lu

.se

Will

ie

Ow

ens,

Prin

cipa

l S

cien

tist

Pro

cter

& G

ambl

e C

entr

al P

rodu

ct S

afet

y 11

810

Eas

t Mia

mi

Riv

er R

oad

Cin

cinn

ati,

OH

45

252

U.S

.A.

+1-

513-

627-

1385

+

1-51

3-62

7-12

08

owen

s.jw

@pg

.com

Joan

ne

Par

rott

Env

ironm

ent C

anad

a N

atio

nal W

ater

Res

earc

h In

stitu

te

867

Lake

shor

e R

oad

Bur

lingt

on,

Ont

ario

L7R

4A

6

Can

ada

+1-

905-

336-

4451

+

1-90

5-33

6-64

30

jo-

anne

.par

rott@

ec.g

c.c

a D

r. J

ohn

Par

sons

U

nive

rsity

of A

mst

erda

m

Dep

t. E

nviro

nmen

tal a

nd

Tox

icol

ogic

al C

hem

istr

y N

ieuw

e A

chte

r-gr

acht

166

6 N

L-10

18 W

V

Am

ster

dam

T

he N

ethe

rland

s+

31-2

0-52

5-65

80

+31

-20-

525-

6522

jp

ar-

sons

@ch

em.u

va.n

l

Page 190: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

187ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Rag

nor

Ped

erse

n, S

cien

-tif

ic P

roje

ct M

an-

ager

Uni

vers

ity o

f Lon

don,

Sch

ool

of P

harm

acy

Clu

ster

of R

esea

rch

into

E

ndoc

rine

Dis

rupt

ion

in

Eur

ope,

Cen

tre

for

Tox

i-co

logy

29/3

9 B

runs

wic

k S

quar

e, B

loom

s-bu

ry

Lond

on W

C1N

1A

X

Uni

ted

Kin

gdom

+

44-2

0-77

53-

5811

+

44-2

0-77

53-

5811

R

ag-

nor.

pede

rsen

@ul

sop.

ac.u

k

Pro

f. dr

. Lo

renz

P

oelli

nger

K

arol

insk

e In

stitu

tet

Dep

artm

ent o

f Cel

l and

M

olec

ular

Bio

logy

V

on E

uler

s V

äg 3

S

E-1

71 7

7

Sto

ckho

lm

Sw

eden

+

46-8

-728

-73

30

+46

-8-3

4881

9lo

-re

nz.p

oelli

nger

@cm

b.ki

.se

Fra

nces

P

ollit

t D

epar

tmen

t of H

ealth

P

ublic

Hea

lth G

roup

S

kipt

on H

ouse

, R

m 6

85D

, 80

Lond

on R

oad,

E

leph

ant a

nd

Cas

tle

Lond

on S

E1

6LW

U

nite

d K

ingd

om

+44

-20-

972-

5317

+

44-2

0-97

2-51

67

fran

-ce

s.po

llitt@

doh.

gsi.

gov.

uk

Jean

-Mar

c P

OR

CH

ER

IN

ER

IS

Uni

té d

’Eva

luat

ion

de

Ris

ques

Eco

toxi

-co

logi

ques

Par

c T

echn

olog

ique

A

LAT

A, B

.P. 2

F-6

0550

Ver

-ne

uil-e

n-H

alat

te

Fra

nce

+33

-3-

4455

6584

+

33-3

-44

5567

67

jean

-m

arc.

porc

her@

iner

is.

fr

Dr.

Cin

ta

Por

te

Inst

itut d

’Inve

stig

acio

ns Q

uí-

miq

ues

de B

arce

lona

D

epar

tmen

t of E

nviro

n-m

enta

l Che

mis

try,

Env

i-ro

nmen

tal T

oxic

olog

y G

roup

c/ J

ordi

Giro

na,

18-2

6 E

-080

34 B

ar-

celo

na

Spa

in

+34

-93-

400-

6175

+

34-9

3-20

4-59

04

cpvq

am@

iiqab

.csi

c.es

Tho

mas

P

ottin

ger

Cen

tre

for

Eco

logy

and

Hy-

drol

ogy

Lanc

aste

r E

nviro

nmen

t C

entr

e Li

brar

y A

veny

e B

ailri

gg; L

an-

cast

er; L

A1

4AP

Uni

ted

Kin

gdom

+

44-1

524-

5958

00

tg

p@ce

h.ac

.uk

Juan

M.

Rie

go S

inte

s,

Tes

ting

Met

hods

C

oord

inat

or

Join

t Res

earc

h C

entr

e of

the

Eur

opea

n C

omm

issi

on, E

uro-

pean

Che

mic

als

Bur

eau

Inst

itute

for

Hea

lth a

nd

Con

sum

er P

rote

ctio

n T

.P. 5

82

I-21

020

Ispr

a (V

A)

Italy

+

39-0

3-32

7859

87

+39

-03-

3278

9963

ju

an.r

iego

-si

ntes

@jrc

.it

Mik

e R

ober

ts

DE

FR

A C

hem

ical

s &

GM

P

olic

y D

ivis

ion

3/E

6 A

shdo

wn

Hou

se, 1

23 V

icto

-ria

Str

eet

Lond

on S

W1E

6D

E

Uni

ted

Kin

gdom

+

44-2

0-70

82-

8099

+

44-2

0-70

82-

8086

M

ike.

Rob

ers@

defr

a.g

si.g

ov.u

k

Kla

us P

. R

othe

nbac

her

BS

EF

S

cien

ce P

rogr

am

118,

Av.

de

Cor

tenb

ergh

B

-100

0 B

rux-

elle

s B

elgi

um

+32

-2-7

43-

6619

+

32-2

-735

-60

63

klau

s_ro

then

bach

er@

be.b

m.c

om

And

rea

Sal

zbru

nn

Uni

vers

ität H

ambu

rg;

Uni

vers

itäts

-Klin

ikum

E

ppen

dorf

Dep

artm

ent o

f And

rolo

gy

Mar

tinis

traβ

e 52

D

-202

46

Ham

burg

G

erm

any

+49

-40-

4280

3490

8 +

49-4

0-42

8034

875

salz

brun

n@uk

e.un

i-ha

mbu

rg.d

e

Jorg

e S

avio

E

urop

ean

Com

mis

sion

D

G E

NV

/B2

B

ruxe

lles

Bel

gium

+

32-2

-29

5789

1d

Jo

rge.

savi

o@

ec.e

urop

a.eu

P

D D

r. M

ar-

gret

S

chlu

mpf

/Pro

f. W

alte

r Li

chte

n-st

eige

r

GR

EE

N T

ox

Gro

up fo

r R

epro

duct

ive,

E

ndoc

rine

and

Env

iron-

men

tal T

oxic

olog

y

Win

tert

hure

r-st

rass

e 19

0 C

H-8

057

Z

üric

h S

witz

erla

nd

+41

-43-

233-

9517

+

41-4

3-26

8-95

73

Mar

-gr

et.S

chlu

mpf

@ac

ces

s.un

izh.

ch/W

alte

r.L

icht

enst

eige

r@ac

ess.

uniz

h.ch

P

rof.

dr.

Die

ter

Sch

renk

U

nive

rsity

of K

aise

rsla

uter

n F

ood

Che

mis

try

& E

nvi-

ronm

enta

l Tox

icol

ogy

Erw

in-S

chrö

ding

er

Str

. 52

D-6

7663

K

aise

rsla

uter

n G

erm

any

+49

-631

-20

5304

3 +

49-6

31-

2054

398

schr

enk@

rhrk

.uni

-kl

.de

Ale

xand

er

Sco

tt C

entr

e fo

r E

nviro

nmen

t, F

ish-

erie

s an

d A

quac

ultu

re S

cien

ce

(CE

FA

S)

Wey

mou

th L

abor

ator

y T

he N

othe

, Bar

-ra

ck R

oad

Wey

mou

th

DT

4 8U

B

Eng

land

, UK

+

44-1

305-

2066

37

+44

-130

5-20

6601

a.

p.sc

ott@

cefa

s.co

.uk

Hel

mut

S

egne

r U

nive

rsity

of B

ern

Inst

itute

of A

nim

al P

ahto

l-og

y, C

entr

e fo

r F

ish

and

Wild

life

Hea

lth

Läng

gass

-Str

aβe

122

CH

-301

2

Ber

n S

witz

erla

nd

+41

-31-

6312

441

+41

-31-

6312

611

helm

ut.s

egne

r@itp

a.u

nibe

.ch

Has

so

Sei

bert

U

nive

rsity

Kie

l In

stitu

te fo

r E

xper

imen

tal

Tox

icol

ogy

Wei

mar

er S

tr.8

D

-241

06 K

iel

Ger

man

y +

49-4

31-

5974

931

se

iber

g@to

xi.u

ni-

kiel

.de

Page 191: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

188ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Tro

y S

eidl

e, D

irect

or

of S

cien

ce P

olic

y P

ET

A (

Peo

ple

for

the

Eth

ical

T

reat

men

t of A

nim

als)

11 B

rent

woo

d A

venu

e K

itehe

nev,

ON

H

2H 2

C4

Can

ada

+1-

519-

570-

3208

+

1-51

9-57

0-46

40

Tro

yS@

peta

.org

Man

uel

Ten

a S

empe

re

Uni

vers

idad

de

Cor

doba

D

epar

tmen

t of C

ell B

iol-

ogy,

Phy

siol

ogy

and

Im-

mun

olog

y;

Fac

ulty

of M

edi-

cine

, Men

ende

z P

idal

S/N

E-1

4071

Cor

-do

ba

Spa

in

+34

-957

-21

8280

+

34-9

57-

2182

88

fi1te

sem

@uc

o.es

Ric

hard

S

harp

e M

RC

Hum

an R

epro

duct

ive

Sci

ence

Uni

t T

he C

hanc

ello

r’s B

uild

ing

49 L

ittle

Fra

nce

Cre

sent

; Old

D

alke

ith R

oad

Edi

nbur

gh,

EH

16 4

SB

S

cotla

nd, U

K

+44

-131

-242

-63

87

+44

-131

-242

-62

31

r.sh

arpe

@hr

su.m

rc.

ac.u

k

Jae-

Ho

Shi

n, S

enio

r R

esea

rche

r N

atio

nal I

nstit

ute

of T

oxic

o-lo

gica

l Res

earc

h, K

orea

DA

E

ndoc

rine

Tox

icol

ogy

Div

isio

n 5,

Nok

bund

ong,

E

unpy

ongk

u S

eoul

K

orea

+

82-2

-380

-18

78

+82

-2-3

80-

1879

sh

injh

@kf

da.g

o.kr

Pro

f. dr

. Ja

nnec

he

Utn

e

Ska

are

Nat

iona

l Vet

erin

ary

Inst

itute

(N

VI)

N

orw

egia

n S

choo

l of V

et-

erin

ary

Sci

ence

P

O B

ox 8

156,

U

lleva

lsve

ien

68

N-0

033

Osl

o N

orw

ay

+47

-23-

2162

00

+47

-23-

2162

01

jan-

nech

e.sk

aare

@ve

tins

t.no

Nie

ls E

. S

kakk

ebæ

k R

igsh

ospi

tale

t; S

ect.

GR

506

4U

nive

rsity

Dep

artm

ent o

f G

row

th a

nd R

epro

duct

ion

Ble

gdam

svej

9

DK

-210

0 C

o-pe

nhag

en Ø

D

enm

ark

+45

-354

5-50

86

+45

-354

5-60

54

nes@

rh.d

k

Dio

ni

Sot

iropo

ulos

E

urop

ean

Env

ironm

enta

l Bu-

reau

(E

EB

)

Av.

du

Feu

illag

e 42

B

-118

0 B

rus-

sels

B

elgi

um

+32

-2-3

75-

5330

dion

i@sk

ynet

.be

Han

s C

hris

-tia

n

Sto

lzen

berg

F

eder

al E

nviro

nmen

tal

Age

ncy

(um

wel

tbun

desa

mt)

E

coto

xico

logi

cal A

sses

s-m

ent o

f Syb

stan

ces

P.O

. Box

140

6 D

-068

13

Des

sau

Ger

man

y +

49-3

40-

2103

-311

3 +

49-3

40-

2104

-311

3 ha

ns-

chris

-tia

n.st

olze

nber

g@u

ba.d

e Jo

hn

Sum

pter

B

rune

l Uni

vers

ity

Dep

artm

ent o

f Bio

logi

cal

Sci

ence

s K

ings

ton

Lane

U

xbrid

ge,

Mid

dles

ex,

UB

8 3P

H

Eng

land

, UK

+

44-1

895-

2740

00

+44

-189

5-20

3099

JP

S@

brun

el.a

.c.u

k

Dr.

Mic

hihi

to

Tak

ahas

hi

Pat

holo

gy P

eer

Rev

iew

Cen

-te

r

3-45

-11-

104

Ue-

hara

, Shi

nuya

-du

151-

0064

T

okyo

Ja

pan

+81

-3-5

433-

1460

+

81-3

-543

3-14

60

taka

hash

i@pe

er-

revi

ew.o

rg

Dr.

Nor

ihis

a T

atar

azak

o,

Sen

ior

re-

sear

cher

Nat

iona

l Ins

titut

e fo

r E

nviro

n-m

enta

l Stu

dies

E

nviro

nmen

tal C

hem

istr

y D

ivis

ion,

Eco

logi

cal

Che

mis

try

Sec

tion

16-2

Ono

gaw

a,

Tsu

kuba

30

5-85

06

Ibar

aki

Japa

n +

81-2

-985

0-28

87

+81

-2-9

850-

2851

ta

ta-

raza

ko.n

orih

isa@

nies

.go.

jp

And

rea

Tilc

he, H

ead

of

the

Uni

t “W

ater

cy

cle

and

solid

-re

late

d as

pect

s”

Eur

opea

n C

omm

issi

on

DG

Res

earc

h R

ue d

e Lu

xem

-bo

urg

46, 1

/026

B

-104

9 B

rux-

elle

s B

elgi

um

+32

-2-2

99-

6342

+

32-2

-295

-20

97

andr

ea.ti

lche

@

ec.e

urop

a.eu

Gar

y T

imm

U

.S. E

nviro

nmen

tal P

rote

ctio

n A

genc

y O

ffice

of P

reve

ntio

n, P

es-

ticid

es &

Tox

ic S

ub-

stan

ces

1200

Pen

nsyl

-va

nia

Ave

nue

N.W

.

Was

hing

ton

DC

204

60

U.S

.A.

+1-

202-

564-

8474

+

1-20

2-56

4-84

83

timm

.gar

y@ep

amai

l.e

pa.g

ov

Jorm

a T

oppa

ri U

nive

rsity

of T

urku

D

epar

tmen

ts o

f Ped

iatr

ics

and

Phy

siol

ogy

Kiin

amyl

lynk

atu

10F

IN-2

0520

T

urku

F

inla

nd

+35

8-2-

333-

7297

+

358-

2-25

0-26

10

jorm

a.to

ppar

i@ut

u.f

i P

rof.

Jesú

s T

resg

uerr

es

Uni

vers

idad

Com

plut

ense

-C

iuda

d U

nive

rsita

ria; F

acul

tad

de M

edic

ina

Dep

arta

men

to d

e F

isio

logí

a H

uman

a;

End

ocrin

olog

ía

Exp

erim

enta

l

E

-280

40 M

a-dr

id

Spa

in

+34

-491

-394

-14

84

+34

-491

-394

-16

28

guer

-re

s@m

ed.u

cm.e

s

Pro

f. C

har-

les

R.

Tyl

er

Uni

vers

ity o

f Exe

ter,

Hat

herly

La

bora

torie

s E

nviro

nmen

tal a

nd M

o-le

cula

r F

ish

Bio

logy

, S

choo

l of B

iolo

gica

l and

C

hem

ical

Sci

ence

s

Prin

ce o

f Wal

es

Roa

d E

xete

r, E

X4

4PS

U

nite

d K

ingd

om

+44

-139

2-26

4450

+

44-1

392-

2637

00

c.r.

tyle

r@ex

eter

.ac.

uk

Pro

f. dr

. M

ats

Tys

klin

d U

meå

Uni

vers

ity (

Um

U)

Dep

artm

ent o

f Che

mis

try,

E

nviro

nmen

tal C

hem

istr

y K

BC

Bui

ldin

g S

E-9

01 8

7

Um

Sw

eden

+

46-9

0-78

6-66

68

+46

-90-

1281

33

Mat

s.T

yskl

ind@

che

m.u

mu.

se

Pro

f. dr

. M

artin

va

n de

n B

erg

U

nive

rsity

of U

trec

ht

Inst

itute

for

Ris

k A

sses

s-m

ent S

cien

ces

(IR

AS

) P

.O. B

ox 8

0.17

6,

Yal

elaa

n 2

NL-

3508

TD

U

trec

ht

The

Net

herla

nds

+31

-6-2

5-52

3-91

9 +

31-3

0-25

3507

7 m

.van

denb

erg@

iras.

uu.n

l

Page 192: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

189ERA/53559/Revised report/2007.06.04

DHI Water & Environment

Firs

t na

me

Las

t n

ame

Com

pan

y o

r in

stit

uti

on

D

epar

tmen

t A

ddr

ess

Cit

y C

ou

ntr

y P

hon

e F

ax

Em

ail

Ike

Van

der

Put

te

RP

Sgr

oep

E

lect

roni

caw

eg 2

, P

ostb

us 5

094-

2600

NL-

2628

XG

D

elft

The

Net

herla

nds

Ike.

van.

der.

Put

te@

RP

Sgr

oep.

nl

Ter

ttu

Var

tiain

en

Nat

iona

l Pub

lic H

ealth

Inst

itute

M

anne

rhei

min

tie

166

FIN

-003

00

Hel

sink

i F

inla

nd

+35

8-17

-20

1395

+

358-

17-

2012

65

tert

tu.v

artia

inen

@kt

l.fi

N

ico

P.E

. V

erm

eule

n V

rije

Uni

vers

iteit

Am

ster

dam

; LA

CD

R-S

ectio

n of

Mol

ecul

ar

Tox

icol

ogy

Dep

t. O

f Che

mis

try

&

Pha

rmac

oche

mis

try

De

Boe

lela

an

1083

N

L-10

81 H

V

Am

ster

dam

T

he N

ethe

rland

s+

31-2

0-44

4759

0 +

31-2

0-44

4761

0 np

e.ve

rmeu

len@

few

.vu.

nl

Dr.

A. D

ick

Vet

haak

N

atio

nal I

nstit

ute

for

Coa

stal

an

d M

arin

e M

anag

emen

t (R

IKZ

)

Eco

toxi

colo

gy S

ectio

n P

.O. B

ox 8

039,

G

rena

dier

sweg

31

NL-

4338

EA

M

idde

lbur

g T

he N

ethe

rland

s+

31-1

13-

3770

06

+31

-113

-37

2855

A

.D.V

etha

ak@

rikz.

rw

s.m

inve

nw.n

l

Pro

f. Je

ff G

. V

os

Nat

iona

l Ins

titut

e fo

r P

ublic

H

ealth

and

the

Env

ironm

ent

(RIV

M)

P

.O. B

ox 1

, A

nton

ie v

an

Leeu

wen

hoek

laan

9

NL-

3720

BA

B

iltho

ven

The

Net

herla

nds

+31

-30-

2742

075

+31

-30-

2744

437

j.vos

@riv

m.n

l

Mik

e W

ade,

Res

earc

h S

cien

tist

Hea

lth C

anad

a S

afe

Env

ironm

ents

Pro

-gr

am

Rm

. 200

Env

iron.

H

ealth

Cen

tre

FL

0803

D T

unne

y’s

Pas

ture

Otta

wa,

On-

tario

K1A

0L2

C

anad

a +

1-61

3-94

6-51

27

+1-

613-

941-

4768

m

ike_

wad

e@hc

-sc

.gc.

ca

Pro

f. dr

. G

erha

rd

Win

neke

M

ediz

inis

ches

Inst

itut f

ür

Um

wel

thyg

iene

(M

IU),

a.d

. H

einr

ich-

Hei

ne-U

nive

rsitä

t D

üsse

ldor

f

Neu

ro-

und

Ver

halte

n-st

oxik

olog

ie

P.O

. Box

103

751,

A

uf’m

Hen

neka

mp

50

D-4

0225

D

üsse

ldor

f G

erm

any

+49

-211

-33

8929

1 +

49-2

21-

3389

331

gerh

ard.

win

neke

@u

ni-d

uess

eldo

rf.d

e

Pro

f. D

r.

Wol

fgan

g W

uttk

e/P

rof.

H.

Jarr

y U

nive

rsity

of G

öttin

gen;

Fac

-ul

ty o

f Med

icin

e di

visi

on o

f Clin

ical

and

E

xper

imen

tal E

ndoc

rinol

-og

y

Rob

erg-

Koc

h-S

traβ

40

D-3

7075

Göt

-tin

gen

Ger

man

y +

49-5

51-

3967

14

+49

-551

-39

6518

U

fken

do@

med

.uni

-go

ettin

-ge

n.de

/hub

jarr

y@m

ed.u

ni-

goet

tin-

gen.

de/d

mba

lmer

@m

ed.u

ni-

goet

tinge

n.de

D

r. K

anji

Yam

asak

i, D

ep-

uty

Man

ager

C

hem

ical

s E

valu

atio

n an

d R

esea

rch

Inst

itute

C

hem

ical

s A

sses

smen

t C

ente

r 3-

822

Ishi

i-mac

hi

877-

0061

Hita

O

ita

Japa

n +

81-9

73-

2472

11

+81

-973

-23

9800

ya

mas

aki-

kanj

i@ce

ri.jp

Page 193: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 190

A P P E N D I X F

Questionnaire for identification of new candidate LPVC

Page 194: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 191

<code>

Dear Study on enhancing the Endocrine Disrupter priority list with focus on low production volume chemicals

The European Commission DG Environment has contracted DHI Water and Environment to perform a study on enhancing the Endocrine Disrupter priority list with focus on Low Production Volume Chemicals (LPVC). The project includes two main tasks: • Identify new candidate substances that are LPVC and may have endocrine disrupting properties • Collect data on LPVC identified in this and previous studies in order to assess the potential of

endocrine disruption of each candidate substance For this, DHI needs the co-operation from academia, industry and governments. We have identified you, as a potential stakeholder because you belong to one or several of the following groups:

• National focal points in EU Member States • NGOs • Industrial branch organisations, e.g. CEFIC, EUROCHLOR, ECETOC and individual indus-

tries • Experts involved in international work regarding endocrine disrupters, e.g. OECD Validation

Management Groups for Ecotoxicity Tests (VMG-eco) and Mammalian toxicity test (VMG-mammal) of the Task Force on Endocrine Disrupters Testing and Assessment (EDTA)

• Participants in EU research projects on endocrine disrupters e.g., CREDO, EDEN, FIRE • Stakeholders consulted for previous studies to set up the ED priority list

As belonging to one of the above groups, we expect you to have access to specific knowledge on en-docrine disrupting chemicals and the effects related to these. Therefore, we would like to invite you to join this project as a stakeholder. Background In December 1999, the European Commission adopted the Communication Community Strategy for Endocrine Disrupters (COM(1999)706). One of the actions identified in the Strategy is the estab-lishment of a priority list of substances for further evaluation of their role in endocrine disruption.

Agern Allé 5 DK-2970 Hørsholm, Denmark Tel: +45 4516 9200 Fax: +45 4516 9292 Dept fax: +45 45169292 E-mail: [email protected] Web: www.dhigroup.com Ref: gip Init: gip Date: 2005.12.09

Page 195: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 192

In two previous studies (BKH-report 2000 and RPS-BKH report 20021) a preliminary candidate list of 553 substances was evaluated. The assessment exercise concentrated mainly on substances, which were either High Production Volume Chemicals and/or highly persistent in the environment. In their evaluation, the Scientific Committee on Toxicity, Eco-toxicity and Environment (CSTEE) concluded that the RPS-BKH report provided a significantly improved assessment methodology in comparison with the previous BKH report. The Committee was, however, of the opinion that LPVC of high endocrine potency or with high emission rates were not sufficiently covered in the evalua-tion2. Aims of this project and our request for information The overall objective of the present project is to enhance the Endocrine Disrupter priority list with special focus on LPVC. The study will be based on the candidate substance list, which was identified in the BKH-project and those of the candidate substances, which were not evaluated in the RPS-BKH-project. An overview of the chemicals in question is presented in Table 1 and from this it ap-pears that 173 substances will be evaluated in the present project. The candidate list including all 553 substances and their present status of evaluation is available on the web site: http://projects.dhi.dk/Endocrine_Disrupter. Table 1. Overview of candidate list substances Selection criteria No. sub-

stances No sub-stance

Original candidate list of substances with ED effects 565 565 Excluded at the ED expert meeting of 1999 11 Candidate list of substances with ED effects, 2000 553 553 HPV already restricted to bans (109) + in depth evaluation (9)

118

Remaining substances 435 435 HPV and/or persistent and/or high exposure (in depth evaluation RPS-BKH-2002)

204

Group names (not to be evaluated) 13 Mixtures or polymers (not to be evaluated) 41 Substances two times in list (not to be evaluated) 4 Remaining substances to be evaluated in the present project

173 173

In the IUCLID database, 7829 chemicals are registered as LPVC but no information regarding their potential endocrine disrupting effects is registered. One of the aims of this project is to identify addi-tional substances with endocrine disrupting properties among these 7829 chemicals. For this identifi-cation, we ask for your cooperation. Therefore, we kindly ask you as a stakeholder to assist us in:

6. Identifying new candidate substances, which are not included in the present list 7. Collecting data regarding endocrine disrupting effects on any of the chemicals to be evalu-

ated in the present project In order to facilitate your contribution to the project we have prepared a table (Appendix 1) for in-formation delivering. We kindly ask you to fill in your data and knowledge on chemicals, which you

1 http://europa.eu.int/comm/environment/endocrine/strategy/substances_en.htm#r 2 http://europa.eu.int/comm/health/ph_risk/committees/sct/documents/out208_en.pdf

Page 196: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 193

identify as new candidate substances, and/or regarding the 173 substances, which have already been identified for evaluation in the project. We need the following information on each chemical:

• Production volume • Persistence in the environment • Evidence of endocrine disruption from literature data (including reference) • Exposure considerations

We kindly ask you to provide answers (preferably by e-mail) to one of the below e-mail addresses. The deadline for the answers is 1 February, 2006. We thank you in advance for your cooperation and are looking forward hearing from you.

Yours sincerely DHI Water & Environment Gitte Petersen (Project manager) Lise Samsøe-Petersen Senior Biologist, Ph.D. Senior Biologist, Ph.D Phone: +45 4516 9312 (direct) Phone: +45 4516 9307 (direct) E-mail: [email protected] E-mail: [email protected]

Page 197: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 194

Appendix 1 Questionnaire scheme for Study on enhancing the Endocrine Disrupter priority list with focus on low production volume chemicals Name and contact details (for possible contact regarding clarification of answers) Substance name: CAS no. SMILE notation: Other information: Production volume Persistence in the

environment Evidence of endo-crine disruption from literature data (in-cluding reference)

Exposure consid-erations

Page 198: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 195

A P P E N D I X G

Request to CEFIC

Page 199: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 196

CEFIC Av.E. Van Nieuwenhuyse 4 B-1160 Bruxelles Belgium Att.: Simon Webb (I am not sure if he is the right person to contact) Dear Simon Webb?? Re.: Study on enhancing the Endocrine Disrupter priority list with focus on low production volume chemicals

The European Commission DG Environment has contracted DHI Water and Environment to perform a study on enhancing the Endocrine Disrupter priority list with focus on Low Production Volume Chemicals (LPVC). Background In December 1999, the European Commission adopted the Communication Community Strategy for Endocrine Disrupters (COM(1999)706). One of the actions identified in the Strategy is the estab-lishment of a priority list of substances for further evaluation of their role in endocrine disruption. In two previous studies (BKH-report 2000 and RPS-BKH report 20023) a preliminary candidate list of 553 substances was evaluated. The assessment exercise concentrated mainly on substances, which were either High Production Volume Chemicals and/or highly persistent in the environment. In their evaluation, the Scientific Committee on Toxicity, Eco-toxicity and Environment (CSTEE) concluded that the RPS-BKH report provided a significantly improved assessment methodology in comparison with the previous BKH report. The Committee was, however, of the opinion that LPVC of high endocrine potency or with high emission rates were not sufficiently covered in the evalua-tion4. Aims of this project and our request for information

3 http://europa.eu.int/comm/environment/endocrine/strategy/substances_en.htm#r 4 http://europa.eu.int/comm/health/ph_risk/committees/sct/documents/out208_en.pdf

Agern Allé 5 DK-2970 Hørsholm, Denmark Tel: +45 4516 9200 Fax: +45 4516 9292 Dept fax: +45 45169292 E-mail: [email protected] Web: www.dhigroup.com Ref: gip Init: gip Date: 2006.03.28

Page 200: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 197

The overall objective of the present project is to enhance the Endocrine Disrupter priority list with special focus on LPVC. The study will be based on the candidate substance list, which was identified in the BKH-project and those of the candidate substances, which were not evaluated in the RPS-BKH-project. The candidate list of substances to be evaluated in the present project consists of ap-prox. 200 substances. After a close evaluation of the priority list of substances it was found that 73 substances were not registered in the ECB-ESIS database (http://ecb.jrc.it/esis/) and thus regarded as chemicals not in use any longer and furthermore, that 17 substances were without CAS No. Please find these substances attached as Annex 1 and Annex 2. We kindly ask if CEFIC could assist us in identifying if the substances listed in Appendix 1 and 2 are still produced and if yes in which amounts. We kindly ask you to provide answers (preferably by e-mail) to the e-mail address below. We thank you for your kind cooperation and are looking forward hearing from you.

Yours sincerely DHI Water & Environment Gitte Petersen (Project manager) Senior Biologist, Ph.D Phone: +45 4516 9312 (direct) E-mail: [email protected]

Page 201: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 198

A P P E N D I X H

Request for comments to the draft final deliverables

Page 202: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 199

<code> Dear Re.: Study on enhancing the Endocrine Disrupter priority list with focus on low produc-tion volume chemicals As previously informed, the European Commission - DG Environment has contracted DHI Water & En-vironment to perform a study on enhancing the Endocrine Disrupter priority list with focus on Low Pro-duction Volume Chemicals (LPVC), which will be finalised at the end of this year Background In December 1999, the European Commission adopted the Communication Community Strategy for En-docrine Disrupters (COM(1999)706). One of the actions identified in the Strategy is the establishment of a priority list of substances for further evaluation of their role in endocrine disruption. In two previous studies (BKH-report 2000 and RPS-BKH report 20025), a preliminary candidate list of 553 substances was evaluated. The assessment exercise concentrated mainly on substances, which were either High Production Volume Chemicals and/or highly persistent in the environment. In their evaluation, the Scientific Committee on Toxicity, Eco-toxicity and Environment (CSTEE) con-cluded that the RPS-BKH report provided a significantly improved assessment methodology in compari-son with the previous BKH report. The Committee was, however, of the opinion that LPVC of high endo-crine potency or with high emission rates were not sufficiently covered in the evaluation6. Aims of this project and our request for information The overall objective of the present project is to enhance the Endocrine Disrupter priority list with special focus on LPVC. The study is based on the candidate substance list, which was identified in the BKH pro-ject and those of the candidate substances, which were not evaluated in the RPS-BKH project. The evalu-ated data are entered in the Access database developed in the RPS-BKH 2002 project. We are now close to finalising the study and would therefore kindly invite you to go through the draft final report and the collected data on selected CAT 1 chemicals in the database. Your comments would be highly appreciated.

5 http://europa.eu.int/comm/environment/endocrine/strategy/substances_en.htm#r 6 http://europa.eu.int/comm/health/ph_risk/committees/sct/documents/out208_en.pdf

Agern Allé 5 DK-2970 Hørsholm Denmark Tel: +45 4516 9200 Fax: +45 4516 9292 E-mail: [email protected] Web: www.dhigroup.com Ref: Init: GIP/TKH Date: 2006.11.03

Page 203: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 200

The draft final report and database will be made available for your evaluation on the web site: http://projects.dhi.dk/Endocrine_Disrupter/testsite/ on 15 November 2006. We kindly ask you to provide your response (preferably by e-mail) to the below e-mail address. The deadline for the answers is 1 December 2006. We thank you in advance for your cooperation and are looking forward to hearing from you. Yours sincerely DHI Water & Environment Gitte Petersen (Project manager) Senior Biologist, Ph.D. Phone: +45 4516 9312 (direct) E-mail: [email protected]

Page 204: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 201

A P P E N D I X I

Revised list of priority substances for evaluation in the present study

Page 205: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 202

According to ECB-ESIS database, current LPV and HPV substances. LPV: 10-<1000 ton/year; HPV >1000 ton/year Will be evaluated in the present study

No. CAS Name LPV/HPV Existing labeling (ESIS) 302 92-69-3 4-Hydroxybiphenyl = 4-

Phenylphenol LPV

244 3115-49-9 4-nonylphenoxy acetic acid LPV 271 131-18-0 Di-n-pentylphthalate (DPP) =

Dipentylphthalate LPV R60/61: May impair fertil-

ity / May cause harm to unborn child

291 131-54-4 2,2'-Dihydroxy-4,4'-dimethoxybenzophenon

LPV

293 131-56-6 2,4-Dihydroxybenzophenon = Res-benzophenone

LPV

295 620-92-8 Bis(4-hydroxyphenyl)methane LPV 320 90-15-3 1-Naphthol HPV 429 84-69-5 Diisobutylphthalate HPV 551 1634-04-4 methyl tertiary butyl ether (MTBE) HPV 158 79-44-7 Dimethyl carbamyl chloride LPV 182 2597-03-7 Elsan = Dimephenthoate LPV 184 2540-82-1 Formothion LPV 187 1113-02-6 Omethoate LPV 205 314-40-9 Bromacil LPV 190 13593-03-8 Quinalphos = Chinalphos LPV 169 96-45-7 Ethylene Thiourea (ETU) LPV R61: May cause harm to

unborn child New-4 556-67-2 Cyclotetrasiloxane HPV New-8 81-14-1 1-tert-Butyl-3,5-dimethyl-2,6-dinitro-

4-acetylbenzene LPV

New-8 1222-05-5 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta(g)-2-benzopyrane

HPV

New-8 13171-00-1 4-Acetyl-1,1-dimethyl-6-tert.-butylindane

LPV

New-8 5466-77-3 2-ethyl-hexyl-4-methoxycinnamate HPV New-8 118-56-9 3,3,5-trimethyl-cyclohexyl salicilate LPV New-8 21245-02-3 2-ethyl-hexyl-4-dimethyl-

aminobenzoate LPV

New-8/10

36861-47-9 3-(4-Methylbenzylidene)camphor LPV

New-8 131-57-7 2-hydroxy-4-methoxy-benzophenone

LPV

New-8 99-96-7 p-Hydroxybenzoic acid LPV New-8 99-76-3 Methyl p-Hydroxybenzoate LPV New-8 120-47-8 ethyl 4-hydroxybenzoate LPV New-8 94-13-3 n-propyl p-hydroxybenzoate LPV New-10 15087-24-8 3-Benzylidene camphor (3-BC) LPV New-10 131-55-5 Benzophenone-2 (Bp-2), 2,2',4,4'-

tetrahydroxybenzophenone LPV

New-12 10043-35-3 Boric acid HPV New-17 1582-09-8 Trifluralin HPV New-28 100-02-7 4-nitrophenol HPV New-28 106-44-5 4-nitro-3-phenylphenol HPV

Page 206: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 203

Substance found on ECB-ESIS list, but neither LPV or HPV (Production volume < 10 ton/year Will be evaluated in the present study No. CAS Name Existing labeling (ESIS) 549 485-72-3 Formononetin 548 491-80-5 Biochanin A 300 1806-29-7 2,2'-Dihydroxybiphenyl = 2,2'-Biphenol 301 92-88-6 4,4'-Dihydroxybiphenyl = 4,4'-Biphenol 309 2051-60-7 PCB 1 (2-Chlorobiphenyl) 311 2050-68-2 PCB 15 (4,4'-Dichlorobiphenyl) 313 2051-61-8 PCB 2 (3-Chlorobiphenyl) 315 2051-62-9 PCB 3 (4-Chlorobiphenyl) 233 104-51-8 n-Butylbenzene 235 25167-81-1 Dichlorophenol 238 87-26-3 2-sec-Pentylphenol = 2-(1-Methylbutyl)phenol 239 1131-60-8 4-Cyclohexylphenol 240 1009-11-6 4-Hydroxy-n-butyrophenone 241 70-70-2 4-Hydroxypropiophenone 242 104-40-5 4-Nonylphenol (4-NP) 243 20427-84-3 4-Nonylphenoldiethoxylate (NP2EO) 245 99-71-8 4-sec-Butylphenol = 4-(1-Methylpropyl)phenol 247 7786-61-0 4-vinylguaiacol (4-VG) 248 2628-17-3 4-vinylphenol (4-VP) 249 27986-36-3 Ethanol, 2-(nonylphenoxy)- 250 1322-97-0 Ethanol, 2-(octylphenoxy)- = Octylphenolethoxy-

late

255 27193-28-8 Phenol, (1,1,3,3-tetramethylbutyl)- = Octylphenol 256 27985-70-2 Phenol, (1-methylheptyl)- 257 3884-95-5 Phenol, 2-(1,1,3,3-tetramethylbutyl)- 258 17404-44-3 Phenol, 2-(1-ethylhexyl)- 259 18626-98-7 Phenol, 2-(1-methylheptyl)- 260 37631-10-0 Phenol, 2-(1-propylpentyl)- 261 949-13-3 Phenol, 2-octyl- 262 3307-00-4 Phenol, 4-(1-ethylhexyl)- 263 1818-08-2 Phenol, 4-(1-methylheptyl)- 264 3307-01-5 Phenol, 4-(1-propylpentyl)- 268 25013-16-5 tert.-Butylhydroxyanisole (BHA) 270 84-75-3 Di-n-hexyl phthalate (DnHP) = Dihexylphthalate

(DHP)

272 131-16-8 Di-n-propylphthalate (DprP) = Dipropylphthalate 273 4376-20-9 Mono 2 ethyl hexylphthalate (MEHP) 274 131-70-4 Mono-n-butylphthalate 275 33204-76-1 2,6-cis-Diphenylhexamethylcyclotetrasiloxane -

2,6-cis-[(PhMeSiO)2(Me2SiO)2][

277 56-33-7 Diphenyltetramethyldisiloxane PhMe2-SiOSiMe2Ph

278 10448-09-6 Phenylheptamethylcyclotetrasiloxane [(PhMe-SiO)(Me2SiO)3]

279 28994-41-4 Phenyl-2-hydroxyphenylmethane = 2-Benzylphenol = o-Benzylphenol

284 3373-03-3 1,1-Bis(4-hydroxyphenyl)-n-heptane 285 24362-98-9 1,1-Bis(4-hydroxyphenyl)-n-hexane 288 6807-17-6 2,2-Bis(4-hydroxyphenyl)-4-methyl-n-pentane R60: May impair fertility 289 77-40-7 2,2-Bis(4-hydroxyphenyl)-n-butan = Bisphenol B 290 14007-30-8 2,2-Bis(4-hydroxyphenyl)-n-hexane

Page 207: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 204

No. CAS Name Existing labeling (ESIS) 292 52479-85-3 2,3,4,3',4',5'-Hexahydroxybenzophenon 294 611-99-4 4,4'-Dihydroxybenzophenon 297 81-92-5 2-[Bis(4-hydroxyphenyl)methyl]benzylalkohol =

Phenolphthalol

298 77-09-8 3,3'-Bis(4-hydroxyphenyl)phthalid = Phenol-phthaleine

321 1125-78-6 5,6,7,8-Tetrahydro-2-naphthol = 6-Hydroxytetralin 322 15231-91-1 6-Bromo-2-naphthol 323 530-91-6 Tetrahydronaphthol-2 335 303-38-8 2,3-dihydroxybenzoicacid (2,3-DHBA) 337 490-79-9 2,5-dihydroxybenzoicacid (2,5-DHBA) 342 537-98-4 Ferulic acid (FA) 343 533-73-3 Hydroxyhydroquinone 346 7400-08-0 p-Coumaric acid (PCA) 348 463-56-9 Thiocyanate 409 26401-75-2 Phenol, 2-sec-octyl- 411 27214-47-7 Phenol, 4-sec-octyl- 552 545-55-1 TEPA 328 53-96-3 n-2-fluorenylacetamide 178 50-18-0 Cyclophosphamide 179 682-80-4 Demefion 220 6164-98-3 Chlordimeform 223 25550-58-7 Dinitrophenol 375 70393-85-0 Glufosinate-ammonium 222 96-12-8 Dibromochloropropane (DBCP) R60: May impair fertility 377 121-29-9 Pyrethrin 365 83-05-6 p,p'-DDA 667 114369-43-6 Fenobucanazole 170 14868-03-2 Bis-OH-MDDE New-8 33704-61-9 6,7-dihydro-1,1,2,3,3-pentamethyl-4(5H)indanone New-8 94-26-8 n-Butyl p-Hydroxybenzoate New-28 2581-34-2 3-methyl-4-nitrophenol

Page 208: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 205

Substances not found on ECB - ESIS list and therefore excluded from the evaluation

No. CAS Name 229 135505-63-4 4-Hydroxyphenyl-di-a-naphthylmethane 230 630-95-5 Diphenyl-a-naphthylcarbinol 339 57-12-5 Cyanide 513 20291-73-0 1,9-Dimethylphenanthrene 515 58024-06-9 2,8-Dihydroxy-4b,5,6,10b,11,12-hexahydrochrysene 522 5684-12-8 Dehydrodoisynolacid = Bisdehydrodoisynolacid 303 53905-30-9 2-Hydroxy-2',5'-dichlorobiphenyl 304 53905-29-6 3-Hydroxy-2',5'-dichlorobiphenyl 305 53905-28-5 4-Hydroxy-2',5'-dichlorobiphenyl 306 23719-22-4 4-Hydroxy-2-chlorobiphenyl 308 28034-99-3 4-Hydroxy-4'-chlorobiphenyl 310 2050-67-1 PCB 11 (3,3'-Dichlorobiphenyl) 316 13029-08-8 PCB 4 (2,2'-Dichlorobiphenyl) 317 34883-43-7 PCB 8 (2,4'-Dichlorobiphenyl) 318 11104-28-2 PCB Aroclor 1221 319 11141-16-5 PCB Aroclor 1232 479 34883-39-1 2,5-Dichlorobiphenyl 481 34883-41-5 3,5-Dichlorobiphenyl 484 56858-70-9 4,4'-Dihydroxy-2'-chlorobiphenyl 489 79881-33-7 4-Hydroxy-2',6'-dichlorobiphenyl 246 94-06-4 4-sec-Pentylphenol = 4-(1-Methylbutyl)phenol = p-sec-amylphenol 276 30026-85-8 Diphenylhexamethylcyclotetrasiloxane [(PhMeSiO)2(Me2SiO)2] 281 2081-08-5 1,1-Bis(4-hydroxyphenyl)ethane 282 2081-32-5 1,1-Bis(4-hydroxyphenyl)-iso-pentane 283 4731-84-4 1,1-Bis(4-hydroxyphenyl)-n-butane 286 1576-13-2 1,1-Bis(4-hydroxyphenyl)-n-propane 299 4081-02-1 Bis(4-Hydroxyphenyl)phenylmethane 340 482-49-5 Doisynolic acid 392 1805-61-4 4-iso-Pentylphenol = 4-(3-Methylbutyl)phenol 408 1331-54-0 Phenol, (2-ethylhexyl)-

433 31751-59-4 2,4-trans-Diphenyltetramethylcyclotrisiloxane - 2,4-trans-[(PhMeSiO)2(Me2SiO)]

434 33204-77-2 2,6-trans-Diphenylhexamethylcyclotetrasiloxane - 2,6-trans-[(PhMeSiO)2(Me2SiO)2]

435 51134-25-9 Diphenyltetramethylcyclotrisiloxane [(PhMeSiO)2(Me2SiO)] 436 35964-76-2 o-Tolylheptamethylcyclotetrasiloxane [(o-TolylMeSiO)(Me2SiO3)] 437 17156-72-8 Phenylhexamethylcyclotetrasiloxane [(PhHSiO)(Me2SiO)3] 438 17964-44-2 PhMe[SiCH2CH2SiMePhO] 439 92569-29-4 1,1-Bis(4-hydroxyphenyl)-2-ethyl-n-butane 441 1844-00-4 1,1-Bis(4-hydroxyphenyl)-iso-butane 442 7615-24-9 2,2,5,5-Tetra(4-hydroxyphenyl)-n-hexane 444 3555-19-9 2,2-Bis(4-hydroxyphenyl)-3-methyl-n-butane 445 41709-94-8 2,2-Bis(4-hydroxyphenyl)-n-heptane 446 6052-90-0 2,2-Bis(4-hydroxyphenyl)-n-octane 447 4204-58-4 2,2-Bis(4-hydroxyphenyl)-n-pentane 448 31127-54-5 2,3,4,4'-Tetrahydroxybenzophenon 449 10196-77-7 3,3-Bis(4-hydroxyphenyl)-n-hexane 450 3600-64-4 3,3-Bis(4-hydroxyphenyl)-n-pentane 451 7425-79-8 4,4-Bis(4-hydroxyphenyl)-n-heptane 453 21388-77-2 4-Hydroxyphenyl-4'-methoxyphenylmethane 454 57547-76-9 5,5-Bis(4-hydroxyphenyl)-n-nonane 455 59176-75-9 6,6-Bis(4-hydroxyphenyl)-n-undekane

Page 209: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 206

No. CAS Name 456 10193-50-7 Bis(3-hydroxyphenyl)methane 466 115489-12-8 1,1-Bis(4-hydroxyphenyl)-1-(4-methoxyphenyl)ethane 467 1571-75-1 1,1-Bis(4-hydroxyphenyl)-1-phenylethane 470 791-92-4 4-Hydroxy-triphenylmethane 471 115481-73-7 Bis(4-hydroxyphenyl)[(2-phenoxysulfonyl)phenyl]methane 473 4865-83-2 1,3-Bis(4-hydroxyphenyl)pentane 474 2549-50-0 1,3-Bis(4-hydroxyphenyl)propane 475 85-95-0 2,4-Bis(4-hydroxyphenyl)-3-ethylhexane 477 140131-31-3 3,5-Bis(4-hydroxyphenyl)heptane 510 553-39-9 2-Hydroxy-6-naphthylpropionacid 546 NoCAS052 Allenolic acid 514 573-22-8 1-Oxo-1,2,3,4-tetrahydrophenanthrene 144 76578-14-8 Quizalofop-ethyl 341 64529-56-2 Ethiozin 167 3567-62-2 1-(3,4-Dichlorophenyl)-3-methylurea 349 463-77-4 Carbamate 369 17356-61-5 1-(3,4-Dichlorophenyl)-3-methoxyurea 146 34113-46-7 o,p'-DDA 352 65148-76-7 3-MeO-o,p'-DDA 357 65148-77-8 5-MeO-o,p'-DDA 172 2132-70-9 MDDE 372 75938-34-0 Mono-OH-MDDE 373 28463-03-8 Mono-OH-Methoxychlor

New-7 125116-23-6 Metconazole New-12 1303-96-4 Borax

Page 210: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 207

Substances with no CAS number + (? substances) and therefore excluded from the evaluation

No. CAS Name 516 NoCAS089 2,8-dihydroxy-5,6,11,12,13,14-hexahydrochrysene 491 NoCAS126 4-hydroxy-3,5-dichlorobiphenyl 394 NoCAS016 4-Nonylphenoxycarboxylic acid (NP1EC) 395 NoCAS013 4-tert-Pentylphenol = p-tert-Amylphenol 399 NoCAS015 Nonylphenolcarboxylic acid 400 NoCAS017 Nonylphenolethoxylate carboxylic acid 404 NoCAS106 nonylphenolethyleneoxyphosphate 405 NoCAS014 Octylphenol-5-ethoxylate 440 NoCAS025 1,1-Bis(4-hydroxyphenyl)-2-n-propylpentane 452 NoCAS026 4,4-Bis(4-hydroxyphenyl)-n-octane 476 NoCAS030 2,4-Bis(4-hydroxyphenyl)-3-ethylpentane 374 NoCAS108 1-methyl-2-methylcarbamoylvinyldimethyl phosphate 383 NoCAS009 Indole(3.2-b)carbazole (ICZ) 376 NoCAS122 Metalodemeton 382 NoCAS130 Febuconazole

New-8 NoCAS Benzophenone derivatives

Page 211: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 208

A P P E N D I X J

References to studies and reports on endocrine disruption incorporated in the database

Page 212: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 209

ID REF.REFERENCE Ada95a Adams, W.J., G.R. Biddinger, K.A. Robillard, and J.W. Gorsuch,1995. A Summary of the Acute

Toxicity of 14 Phthalate Esters toRepresentative Aquatic Organisms. Envi-ron.Toxicol.Chem.14(9):1569-1574. 15040

Ahn(05) Ahn, Ji Yun; Kim, Sung Ran; Ha, Tae Youl; Kim, Sung Su; Han, Chan Kyu (2005). Uterotrophic and Hershberger assay for butyl p-hydroxybenzoic acid. Journal of Toxicology and Public Health, (2005) Vol. 21, No. 2, pp. 175-178.

Alb(75) Albanus, Lennart; Bjorklund, Nils E.; Gustafsson, Borje; Jonsson, Monica (1975). Forty days oral toxicity of 2,6-cis-diphenylhexamethylcyclotetrasiloxane (KABI 1774) in beagle dogs with special reference to effects on the male reproductive system. Acta Ph

Ali77 Ali, A., and M.S. Mulla, 1977. The IGR Diflubenzuron andOrganophosphorus Insecticides Against Nuisance Midges in Man-Made Residential-Recreational Lakes. J.Econ.Entomol. 70(5):571-577.5170

Als(05) Alslev, Bo; Korsgaard, Bodil; Bjerregaard, Poul (2005). Estrogenicity of butylparaben in rainbow trout Oncorhynchus mykiss exposed via food and water. Aquatic Toxicology, (2005) Vol. 72, No. 4, pp. 295-304.

Ano(01) Anonym (2001) Disruption of spermatogenesis and Sertoli cell structure and function by the indenopyridine CDB-4022 in rats Biology of Reproduction, (2001) Vol. 65, No. 6, pp. 1771-1779.

Ano(03) Anonymous (2003). NTP-CERHR Monograph on the potential human reproductive and devel-opmental effects of Di-n-Hexyl Phthalate (DnHP). National Toxicology Program. Center for the Evaluation of Risks to Human Reproduction, (2003) NIH 03-4489 114 p.

Ano(97) Anonymous (1997). Reproductive toxicology. Di-n-propylphthalate. Environmental health perspectives, (1997 Feb) Vol. 105 Suppl 1, pp. 257-8.

Aru97 Arukwe, Augustine, Frank R. Knudsen and Anders Goks÷yr. Fish Zona Radiata (Eggshell) Pro-tein: A Sensitive Biomarker for Environmental Estrogens. Environmental Health Perspectives Vol.105, No.4, 1997.

Asa(02) Asano, Masahiro; Sakaguchi, Yuji; Ike, Michihiko; Tsunoi, Shinji; Tanaka, Minoru; Fujita, Masa-nori (2002). Evaluation of endocrine disrupting activities of metabolites of nonylphenol polyeth-oxylates by yeast two-hybrid assay. Kankyo Gijutsu, (2002) Vol. 3

Asa02 Asano, Masahiro; Sakaguchi, Yuji; Ike, Michihiko; Tsunoi, Shinji; Tanaka, Minoru; Fujita, Masanori Evaluation of endocrine disrupting activities of metabolites of nonylphenol polyethoxylates by yeast two-hybrid assay Kankyo Gijutsu, (2002) Vol. 31,

ash04 John Ashby, Helen Tinwell, Jenny Odum, and Paul Lefevre (2004). Natural Variability and the Influence of Concurrent Control Values on the Detection and Interpretation of Low-Dose or Weak Endocrine Toxicities. Environmental Health Perspectives • VOLUME 112

Bac(75) Baccetti B.; Bigliardi E.; Vegni M. (1975). Ultrastructural observations on the effect of TEPA chemosterilant on male rat germinal tissue in vitro. Cell Differentiation, (1975) Vol. 4, No. 5, pp. 327-338.

bag90 Bagchi, P.; Chatterjee, S.; Ray, A.; Deb, C. (1990). Effect of quinalphos, organophosphorus insecticide, on testicular steroidogenesis in fish, Clarias batrachus. Bulletin of Environmental Contamination and Toxicology, (1990) Vol. 44, No. 6, pp. 871-5.

bai81 Baimuradov, T. B.; Khaitov, V. R.; Shamsiev, B. M. (1981) Effect of organophosphorus pesti-cides on the reproductive function of animals. Trudy UzNIVI, (1981) Vol. 31, pp. 6-9.

bal80 Bal H S (1980). Teratogenicity of pesticides, fungicides and their effect on mammalian repro-ductive systems. Zentralbl. Veterinaermed. Reihe C, (1980) 9 (1) 89-90.

Bal97 Baldwin W.S., et al. Env. Tox. Chem. Vol. 16: 1905-1911, 1997

Page 213: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 210

ID REF.REFERENCE Bec81 Beck, S.L. (1981) Assessment of adult skeletons to detect prenatal exposure to 2,4,5-T or triflu-

ralin in mice. Teratology, 23, 33-55. Bel95 Belpoggi F., M. Soffritti and C. Maltoni (1995), Methyl-tertiary-butyl ether (MBTE) - a gasoline

additive - causus testicular and lympho-haematopoietic cancers in rats, Toxicol. Ind. Health, 11(2): 119-149.

Ben83 Bengtsson, B.E., and M. Tarkpea, 1983. The Acute Aquatic Toxicity of Some Substances Car-ried by Ships. Mar.Pollut.Bull.14(6):213-214. 10905

Bha(05) Bhattacharya, Nandini; Dufour, Jannette M.; Vo, My-Nuong; Okita, Janice; Okita, Richard; Kim, Kwan Hee (2005). Differential effects of phthalates on the testis and the liver. Biology of Repro-duction, (2005) Vol. 72, No. 3, pp. 745-754.

Bha71 Bhatia, H.L., 1971. Toxicity of Some Pesticides to Puntius ticto(Hamilton). Sci.Cult. 37(3):160-161. 962

bha93 Bhattacharya, Shelley (1993). Target and nontarget effects of anticholinesterase pesticides in fish. Science of the Total Environment, (1993) No. Suppl., Pt. 2, pp. 859-66.

Bib(86) BIBRA working group (1986). Butylated hydroxyanisole (BHA). Toxicity profile. The British In-dustrial Biological Research Association, (1986) 8 p.

bil87 Biles, R.W. et al (1987) Methyl tertiary butyl ether inhalation in rats: a single generation repro-duction study. Toxicol. Ind. Health, 3 (4): 519-534.

bit02 Bitsch, N.; Dudas, C.; Korner, W.; Failing, K.; Biselli, S.; Rimkus, G.; Brunn, H. (2002). Estro-genic activity of musk fragrances detected by the E-screen assay using human MCF-7 cells. Archives of Environmental Contamination and Toxicology, (2002) Vol. 4

Bit70 Bitman J, Cecil HC. Estrogenic activity of DDT analogs and polychlorinated biphenyls. J Agr Food Chem 18:1108- 1112, 1970.

Bit78 Bitman J, Cecil HC, Harris SJ, Feil VJ. Estrogenic activity of o,p'-DDT metabolitus and related compounds. J. Agric. Food Chem 1978; 26: 1, 149-151.

bje03 Bjerregaard, Poul; Andersen, Dorthe N.; Pedersen, Knud L.; Pedersen, Soren N.; Korsgaard, Bodil (2003). Estrogenic effect of propylparaben (propylhydroxybenzoate) in rainbow trout Oncorhynchus mykiss after exposure via food and water. Comparative Biochem

Bla00 Blair RM; Fang H; Branham WS; Hass BS; Dial SL; Moland CL; Tong W; Shi L; Perkins R; Sheehan DM (2000). The estrogen receptor relative binding affinities of 188 natural and xeno-chemicals: structural diversity of ligands. Toxicol Sci; VOL 54, ISS 1, 2000,

Bla69b Blackmore R.H., 1969b. Chlorphenamidine (Schering 36268): 24-month repeated feeding study in rats (Project No. 728-118). Falls Church, Virginia, Hazleton Laboratories Inc. (Unpublished report submitted to the 1971 joint F.A.O./ W.H.O. Meeting on Pesticide

Bla69c Blackmore R.H., 1969c. Chlorphenamidine (Schering 36268): three generation reproduction study (Project No. 728-118). Falls Church, Virginia, Hazleton Laboratories Inc. (Unpublis hed report submitted to the 1971 Joint F.A.O./ W.H.O. Meeting on Pesticide Re

Bla69d Blackmore R.H., 1969d. Chlorphenamidine (Schering 36268): Segment II: Teratology Study - Rabbits (Project No. 728-157). Falls Church, Virginia, Hazleton Laboratories Inc. (Unpu blished report submitted to the 1971 Joint F.A.O./ W.H.O. Meeting on Pesticide

Bob83 Bobra, A.M., W.Y. Shiu, and D. MacKay, 1983. A PredictiveCorrelation for the Acute Toxicity of Hydrocarbons andChlorinated Hydrocarbons to the Water Flea (Daphnia magna).Chemosphere 12(9-10):1121-1129. 11936

Bou79 Boumaiza, M., M.H. Ktari, and P. Vitiello, 1979. Toxicity ofSeveral Pesticides Used in Tunisia, for Aphanius fasciatus Nardo, 1827 (Pisces, Cyprinodontidae). Arch.Inst.Pasteur Tu-nis56(3):307-342 (FRE). 5365

bro04 Broschard T H; Schubert C; Marburger A; Czasch S; Klieber H; von Landenberg F; Kramer P J (2004). Absence Of Estrogenic Activity Of The UV Filter 4-methyl-Benzylidene Camphor In A One-Generation Reproduction Study In Rats. Toxicology and Ap-plied Pharmaco

Bru93a Bruner, K.A., and S.W. Fisher, 1993. The Effects of Temperature,pH, and Sediment on the Fate and Toxicity of 1-Naphthol to theMidge Larvae Chironomus riparius. J.Environ.Sci.HealthA28(6):1341-1360. 7929

Page 214: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 211

ID REF.REFERENCE bur02 Burns-Naas, Leigh Ann; Meeks, Robert G.; Kolesar, Gary B.; Mast, Richard W.; Elwell, Michael

R.; Hardisty, Jerry F.; Thevenaz, Philippe (2002). Inhalation toxicology of octamethylcyclotetra-siloxane (D4) following a 3-month nose-only exposure in Fischer 34

Bur92bir97

Burleigh-Flayer, H.D., J.S. Chun and W.J. Kintigh (1992), Methyl tertiary butyl ether: vapor in-halation oncogenicity study in CD-1 mice (Laboratory project ID 91N0013A), Export, Pennsyl-vania, Bushy Run Research Center, 1068 pp (Report to the Methyl Tertia

Bus86 Bush B, Bennett A, Snow J. Polychlorinated biphenyl congeners, p,p'-DDE, and sperm function in humans. Arch Environ Contamin Toxicol 1986; 15: 333-41.

byf02 Byford, J. R.; Shaw, L. E.; Drew, M. G. B.; Pope, G. S.; Sauer, M. J.; Darbre, P. D. (2002). Estrogenic activity of parabens in MCF7 human breast cancer cells. Jour-nal of Steroid Biochemistry and Molecular Biology, (2002) Vol. 80, No. 1, pp. 49-60.

Cal87 Call, D.J., L.T. Brooke, R.J. Kent, M.L. Knuth, S.H. Poirier,J.M. Huot, and A.R. Lima, 1987. Bromacil and Diuron Herbicides:Toxicity, Uptake, and Elimination in Freshwater Fish.Arch.Environ.Contam.Toxicol. 16(5):607-613. 12612

Cam40 Campbell NR. Molecular structure in relation to oestregenic activity: derivatives of 4:4'- dihy-droxidiphenylmethane. Proc. Roy. Soc. B 1940; 129, 528-538.

Can80 Canton, J.H., R.C.C. Wegman, A. Van Oers, A.H.M. Tammer, E.A.M.Mathijssen-Spiekman, and H.H. Van den Broek, 1980. EnvironmentalToxicological Research with Dimethoate and Omethoate.Rep.No.121/80, Natl.Inst.Public Health Environ.Hyg.:6 p.(DUT).5180

Car75 Carlson, R.M., H.L. Kopperman, R. Caple, and R.E. Carlson, 1975.Structure-Activity Relation-ships Applied. In: Int.JointComm.Symp.Structure-Activity Correlations in Studies of Toxicityand Bioconcentration with Aquatic Organisms, March 11-13, 1975,Canad

Car77 Carlson, R.M., and R. Caple, 1977. Chemical/BiologicalImplications of Using Chlorine and Ozone for Disinfection.Epa-600/3-77-066, U.S.Epa, Duluth, Mn:88 P.(U.S.Ntis Pb-270694).15251

carl00 Carlsson, G.; Orn, S. [Reprint author]; Andersson, P. L.; Soderstrom, H.; Norrgren, L. (2000). The impact of musk ketone on reproduction in zebrafish (Danio rerio). Marine Environmental Research, (July-December, 2000) Vol. 50, No. 1-5, pp. 237-241.

Cat77 Cater, B.R., M.H. Cook, S.D. Gangolli and P. Grasso (1977), Studies on dibutyl phthala te-induced testicular atrophy in the rat: Effect on zinc metabolism, Toxicol. Appl. Pharmacol., 41(3): 609-618.

Cha92b Chatterjee S,, Ray A., Bagchi P., Deb C. (I 992) Estrogenic effects of aldrin and quinalphos in rats. Bull. Environ. Contam. Toxicol. 48: 124-130.

Chi(03) Chikae, Miyuki; Ikeda, Ryuzoh; Hasan, Quamrul; Morita, Yasutaka; Tamiya, Eiichi (2003). Effect of alkylphenols on adult male medaka: plasma vitellogenin goes up to the level of estrous female. Environmental Toxicology and Pharmacology, (2003) Vol. 15, No

cho99 Chou, Ya-Juin; Dietrich, Daniel R. [Reprint author](1999). Interactions of nitromusk parent compounds and their amino-metabolites with the estrogen receptors of rainbow trout (On-corhynchus mykiss) and the South African clawed frog (Xenopus laevis). Toxico

Chu92bir97

Chun, J.S., H.D. Burleigh-Flayer and W.J. Kintigh (1992), Methyl tertiary butyl ether (MTBE): vapor inhalation oncogenicity study in Fischer 344 rats (Laboratory project ID 91N0013B), Ex-port, Pennsylvania, Bushy Run Research Center, 1463 pp (Report for th

Con85 Conaway, C.C., R.E. Schroeder and N.K. Snyder (1985), Teratology evaluation of methyl terti-ary butyl ether in rats and mice, J. Toxicol. Environm. Health, 16: 797-809.

Coo(94) Cooper, Ralph L.; Barrett, Michelle A.; Goldman, Jerome M.; Rehnberg, Georgia R.; McElroy, W. K.; Stoker, Tammy E. (1994). Pregnancy alterations following xenobi-otic-induced delays in ovulation in the female rat. Fundamental and Applied Toxicology, (1994

Cop97a Cope, W.G., M.R. Bartsch, and L.L. Marking, 1997. Efficacy ofCandidate Chemicals for Pre-venting Attachment of Zebra Mussels(Dreissena polymorpha). Environ.Toxicol.Chem. 16(9):1930-1934.18157

Cou84 Couch, J.A. (1984). Histopathology and enlargement of the pituitary of a teleost exposed to the herbicide trifluralin. J. Fish Diseases, 7, 157-163.

Cre83 Creasy, Dianne M.; Foster, John R.; Foster, Paul M. D. (1983). The morphological development of di-n-pentyl phthalate-induced testicular atrophy in the rat. Journal of Pathology, (1983) Vol. 139, No. 3, pp. 309-21.

Page 215: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 212

ID REF.REFERENCE Cur(82) Curto, Karen A.; Thomas, John A. (1982). Comparative effects of diethylhexyl phthalate or

monoethylhexyl phthalate on male mouse and rat reproductive organs. Toxicology and Applied Pharmacology, (1982) Vol. 62, No. 1, pp. 121-5.

Dal(01) Dalgaard, Majken [Reprint author]; Nellemann, Christine; Lam, Henrik Rye; Sorensen, Ilona Kryspin; Ladefoged, Ole (2001). The acute effects of mono(2-ethylhexyl)phthalate (MEHP) on testes of prepubertal Wistar rats. Toxicology Letters (Shannon), (May 31st

Dan97 Danzo BJ. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect., VOL 105, ISS 3, 1997,294-301

Das(04) Daston, George P. (2004). Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats. Birth Defects Research, Part B: Developmental and Reproductive Toxicology, (2004) Vol. 71, No. 4, pp. 296-302.

deb00 Debnath, Dipankar; Mandal, Tapas Kumar (2000). Study of quinalphos (an environmental es-trogenic insecticide)formulation (Ekalux 25 E.C.)-induced damage of the testicular tissues and antioxidant defense systems in Sprague-Dawley albino rats. Journal of App

Dey89 Dey, S. and S. Bhattacharya (1989), Ovarian damage to Channa punctatus after chronic expo-sure to low concentrations of elsan, mercury and ammonia, Ecotoxicol. Env. Safety, 17: 247-57.

Dil82 Dill, D.C., M.A. Mayes, C.G. Mendoza, G.U. Boggs, and J.A.Emmitte, 1982. Comparison of the Toxicities of Biphenyl,Monochlorobiphenyl, and 2,2',4,4'-Tetrachlorobiphenyl to Fish and Daph-nids. In: J.G.Pearson, R.B.Foster, and W.E.Bishop (Eds.),Aquatic Tox

div96 Divi RL., Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chemical research in toxicology, (1996 Jan-Feb) Vol. 9, No. 1, pp. 16-23.

Dod38 Dodds EC, Goldberg L, Lawson W, Robinson R. Estrogenic activity of certain synthetic com-pounds. Nature 1938; 141: 3562, 247-248.

dur05 Durrer, Stefan; Maerkel, Kirsten; Schlumpf, Margret; Lichtensteiger, Walter [Reprint Author] (2005). Estrogen target gene regulation and coactivator expression in rat uterus after develop-mental exposure to the ultraviolet filter 4-methylbenzylidene campho

Eco74 Ecobichon DJ, MacKenzie DO. The uterotropic activity of commercial and isomerically pure chlorobiphenyls in the rat. Res. Commun. Chem. Pathol. Pharmacol 1974; 9: 85-95.

Egn80 Egnatz DG, Ott MG, Townsend JC, e.a. DBCP and testicular effects in chemical workers: an epidemiological survey in Midland, Michigan. J Occup Med 1980; 22: 727-32.

Ema(01) Ema, M.; Miyawaki, E. (2001). Adverse effects on development of the reproductive system in male offspring of rats given monobutyl phthalate, a metabolite of dibutyl phthalate, during late pregnancy. Reproductive Toxicology, (2001) Vol. 15, No. 2, pp. 189-

EmaM(01) Ema M; Miyawaki E (2001). Decreased anogenital distance (AGD) and undescended testes in fetuses of rats given monobutyl phthalate (MBP) during pregnancy. Toxicologist, (2001 Mar) 60 (1) 216-7.

Fah(01) Fahmy, Maha A.; Abdalla, E. F. (2001). Cytogenetic effects induced by the natural pyrethrins and the synthetic lambda cyhalothrin in mice in vivo. Cytologia, (2001) Vol. 66, No. 2, pp. 139-149.

Fal85 Falk-Petersen, I.B., E. Kjorsvik, S. Lonning, A.M. Naley, andL.K. Sydnes, 1985. Toxic Effects of Hydroxylated AromaticHydrocarbons on Marine Embryos. Sarsia 70:11-16. 11059

Fer(02) Ferguson, Sherry A. [Reprint author]; Flynn, Katherine M.; Delclos, K. Barry; Newbold, Retha R.; Gough, Bobby J. (2002). Effects of lifelong dietary exposure to genistein or nonylphenol on amphetamine-stimulated striatal dopamine release in male and femal

Flo95 FLOURIOT G., PAKDEL F., DUCOURET B., VALOTAIRE Y. Influence of xenobiotics on rain-bow trout liver estrogen receptor and vitellogenin gene expression.. JOURNAL OF MOLE CU-LAR ENDOCRINOLOGY., 15 (2). 1995. 143-151.

for01 Fort, Douglas J.; Stover, Enos L.; Bantle, John A.; Dumont, James N.; Finch, Robert A. (2001). Evaluation of a reproductive toxicity assay using Xenopus laevis: boric acid, cadmium and ethylene glycol monomethyl ether. Journal of Applied Toxicology, (200

for90 Ford, R. A.; Api, A. M.; Newberne, P. M. (1990). 90-Day dermal toxicity study and neurotoxicity evaluation of nitromusks in the albino rat. Food and Chemical Toxicology, (1990) Vol. 28, No. 1, pp. 55-61.

Page 216: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 213

ID REF.REFERENCE fos81 Foster, P.M.D. et al (1981) Studies on the testicular effects and zinc excretion produced by

various isomers of monobutyl-o- phthalate in the rat., Chem-Biol. Interact., 34: 233-238. freu77 Freudenthal, Ralph I.; Kerchner, Gail; Persing, Ronald; Baron, Ronald L. (1977). Dietary suba-

cute toxicity of ethylene thiourea in the laboratory rat. Journal of Environmental Pathology and Toxicology, (1977) Vol. 1, No. 1, pp. 147-61.

fuk00 Fukuda, Ryo; Hirode, Mitsuhiro; Mori, Ikuo; Chatani, Fumio; Morishima, Hideki; Mayahara, Hiroshi (2000). Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. Part 24. Testicular toxicity of boric acid afte

Fuk93 Fukuoka, M., T. Kobayashi, Y. Zhou, and T. Hayakawa (1993), Mechanism of testicular atrophy induced by di-n-butyl phthalate in rats, Part 4, Changes in the activity of succinate dehydro genase and the levels of transferrin and ferritin in the Sertoli and

Gan(82) Gangolli, S. D. (1982). Testicular effects of phthalate esters. Environmental Health Perspec-tives, (1982) Vol. 45, pp. 77-84.

Gar90 Garten, C.T.J., 1990. Multispecies Methods of Testing forToxicity: Use of the Rhizobium-Legume Symbiosis in NitrogenFixation and Correlations Between Responses by Algae andTer-restrial Plants. In: W.Wang, J.W.Gorsuch, and W.R.Lower(Eds.), Plants for To

Geh91 Gehring P.J., Nolan R.J., Watanabe P.G., Schumann A.M. (1991) Solvents, fumigant and re-lated compounds. In: Hayes W.J., Laws E..R. (Hrsg.) Handbook of pesticide toxicology. Aca-demic Press, Inc. San Diego, New York, Boston, London, Sydney, Tokyo, Toronto,

Gei85 Geiger, D.L., C.E. Northcott, D.J. Call, and L.T. Brooke, 1985.Acute Toxicities of Organic Chemicals to Fathead Minnows(Pimephales promelas), Vol. 2. Center for Lake SuperiorEnvi-ronmental Studies, University of Wisconsin, Superior, WI:326. 12447

Gei88 Geiger, D.L., D.J. Call, and L.T. Brooke, 1988. Acute Toxicitiesof Organic Chemicals to Fat-head Minnows (Pimephales promelas),Vol. 4. Center for Lake Superior Environmental Stud-ies,University of Wisconsin, Superior, W I:355. 12859

Gel(74) Gellert, R. J.; Heinrichs, W. L.; Swerdloff, R. (1974). Effects of neonatally-administered DDT homologs on reproductive function in male and female rats. Neuroendocrinology, (1974) Vol. 16, No. 2, pp. 84-94.

Gel(75) Gellert, Ronald J.; Heinrichs, W. LeRoy (1975). Effects of DDT homologs administered to fe-male rats during the perinatal period. British Journal of Anaesthesia, (1975) Vol. 26, No. 3-4, pp. 283-90.

geo04 George, P. J. Edward [Reprint Author]; Ambrose, Dunston P.(2004). Toxic effects of insecti-cides in the histomorphology of alimentary canal, testis and ovary in a reduviid Rhynocoris ku-marii Ambrose and Livingstone (Hemiptera : Reduviidae). Journal of Adv

Gha86 Ghate, H.V., 1986. Teratogenic Effects of Ethylenethiourea inFrog Embryo. Geobios 13:82-85. 18545

Gie97 GIERTHY JF., ARCARO KF., FLOYD M. Assessment of PCB estrogenicity in a human breast cancer cell line. CHEMOSPHERE., 34 (5-7). 1997. 1495-1505.

Gol(05) Golden, Robert; Gandy, Jay; Vollmer, Guenter (2005). A Review of the Endocrine Activity of Parabens and Implications for Potential Risks to Human Health. Critical Reviews in Toxicology, (2005) Vol. 35, No. 5, pp. 435-458.

Gol(91) GOLDMAN J M [Reprint author]; COOPER R L; EDWARDS T L; REHNBERG G L; MCELROY W K; HEIN J F (1991). SUPPRESSION OF THE LUTEINIZING HORMONE SURGE BY CHLORDIMEFORM IN OVARIECTOMIZED STEROID-PRIMED FEMALE RATS. Pharmacol-ogy and Toxicology, (1991) Vol. 68, No.

Gol90 Goldman JM, Cooper RL, Laws SC, Rehnberg GL, Edwards TL, McElroy WK, Hein JF. Chlor-dimeform-induced alterations in endocrine regulation within the male rat reproductive system. Toxicol Appl Pharmacol 104:25-35, 1990.

Gol91 Goldman JM, Cooper RL, Edwards TL, Rehnberg GL, McElroy WK, Hein JF. Suppression of the luteinizing hormone surge by chlordimeform in ovariectomized, steroid-primed female rats. Pharmacol Toxicol 68:131-136, 1991.

Gol93 Goldman J.M., Stoker T.E., Perreault S.D., Cooper R.L. and Crider M.A., 1993. Influence of the formamidine ticide chlordimeform on ovulation in the female hamster - Dossociable shifts in the luteinizing hormone surge and oocyte release. Toxicol Appl. Phar

Page 217: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 214

ID REF.REFERENCE Gol94b Goldman, M.A., R.L. Cooper, M.A. Barrett, G.L. Rehnberg, W.K. McElroy and T.E. Stoker

(1994b), Pregnancy alterations following xenobiotic-induced delays in ovulation in the female rat, Fundam. Appl. Toxicol., 22: 474-480.

gom05 Gomez, E.; Pillon, A.; Fenet, H.; Rosain, D.; Duchesne, M. J.; Nicolas, J. C.; Balaguer, P.; Casellas, C. (2005). Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. Journal of Toxicology and Environmental

Gra82 Gray LE Jr. Neonatal chlordecone exposure alters behavioral sex differentiation in female ham-sters. Neurotoxicology 3:67-80, 1982.

gra84/gra86

Gray, T.J.B. & Beamand, J.A. (1984) Effetc of some phtalate esters and other testicular toxins on primary cultures of testicullar cells. Food Chem. Toxicol., 22: 123-131. Gray, T.J.B. & Gan-golli, S.D. (1986) Aspects of the testicular toxicity of phthalate

Gra92 Gray, L.E. Jr., Chemical-induced alteations of sexual differentation: a review of effects in hu-mans and rodents, in: Chemical-induced alterations in sexual and functional development: The Wildlife/Human Connection (eds. T. Colbern & C. Clement), p.203- 23

Guh88 Guhathakurta, S., and S. Bhattacharya, 1988. Target and Nontarget Actions of Phenthoate and Carbofuran: Brain Acetylcholinesterase, Kidney Iodide Peroxidase, and Blood Thyroxine Pro-files in. Biomed.Environ.Sci. 1:59-63. Aquire code:C

Gul(91) Gulati, D. K.; Mounce, R. C.; Russell, S.; Chapin, R. E.; Heindel, J. (1991). Final report on the reproductive toxicity of phenolphthalein (CAS No. 77-09-8) in CD-1-Swiss mice (revised). Re-port, (1991) No. NTP-T0196; Order No. PB91-178707, pp. 262 pp., Go

Guz97 Guzzella, L., A. Gronda, and L. Colombo, 1997. Acute Toxicity ofOrganophosphorus Insecticides to Marine Invertebrates.Bull.Environ.Contam.Toxicol. 59:313-320. 18363

Han(82) Hansen, Ernst V.; Meyer, Otto; Olsen, Preben (1982). Study on toxicity of butylated hy-droxyanisole (BHA) in pregnant gilts and their fetuses. Toxicology, (1982) Vol. 23, No. 1, pp. 79-83.

Han98 Hansen P.D., et al. Trends in analytical chemistry Vol. 17,7: 448-451, 1998 Har95 Harries JE, Jobling S, Matthiessen P, Sheahan DA, Sumpter JP. Effects of trace organics in

fish--phase 2. Report to the Department of the Environment, Foundation for Water Research, The Listons, Liston Road, Marlow Bucks SL7 1 FD, Great Britain. Report No

Har97 Harris CA; Henttu P; Parker MG; Sumpter JP (1997). The estrogenic activity of phthalate esters in vitro.Environ Health Perspect; VOL 105, ISS 8, P802-11

Hay72 Hayden JF, Barlow SA. Structure-activity relationships of organosiloxanes and the female re-productive system. Toxicol. Appl. Pharmacol 1972; 21: 68-79.

Hein89 Heindel, Jerrold J.; Gulati, Dushyant K.; Mounce, Robin C.; Russell, Susan R.; Lamb, James C., (1989) Reproductive toxicity of three phthalic acid esters in a continuous breeding protocol Fundamental and Applied Toxicology, (1989) Vol. 12, No. 3,

hein94 Heindel, Jerrold J.; Price, Catherine J.; Schwetz, Bernard A. (1994). The developmental toxicity of boric acid in mice, rats, and rabbits. Environmental Health Perspectives Supplements, (1994) Vol. 102, No. Suppl. 7, pp. 107-12.

Her(04) Herath C B; Jin W Z; Watanabe G; Arai K; Suzuki A K; Taya K (Reprint) (2004). Adverse ef-fects of environmental toxicants, octylphenol and bisphenol A, on male reproductive functions in pubertal rats. ENDOCRINE, (NOV 2004) Vol. 25, No. 2, pp. 163-172.

Hil(03) Hill, Robert L., Jr.; Janz, David M. (2003). Developmental estrogenic exposure in zebrafish (Danio rerio): I. Effects on sex ratio and breeding success. Aquatic Toxicology, (2003) Vol. 63, No. 4, pp. 417-429.

Hir(70) Hiraga, Kogo; Hayashida, Shinobu; Ichikawa, Hisatsugu; Yoneyama, Masako; Fujii, Takashi; Ikeda, Torao; Yano, Norio (1970). Toxicological potentiation studies on food ad-ditives. I. Acute and subacute oral toxicities of butylated hydroxy anisole, butylated

Page 218: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 215

ID REF.REFERENCE Hir76 Hirose, K., and M. Kitsukawa, 1976. Acute Toxicity ofAgricultural Chemicals to Seawater Tele-

osts, with Special Respect to TLM and the Vertebral Abnormality. Bull.TokaiReg.Fish.Res.Lab./Tokai-Ku Suisan Kenkyusho Kenkyo Hokoku84:11-20 (JPN) (ENG ABS). 61

Hir79 Hirose, K., M. Yamazaki, and A. Ishikawa, 1979. Effects of WaterTemperature on Median Le-thal Concentrations (LC50) of a FewPesticides to Seawater Teleosts. Bull.TokaiReg.Fish.Res.Lab./Tokai-Ku Suisan Kenkyusho Kenkyu Hokoku98:45-53 (JPN) (ENG ABS). 57

Hof84 Hoffman, D.J. & Albers P.H.; (1984) Evaluation of potential embryotoxicity and teratogenicity of 42 herbicides insecticides and petroleum contaminant to mallard eggs. Arch. environm. Con-tamin. Toxicol. 13, 15-27

hol02 Holbech, Henrik; Norum, Ulrik; Korsgaard, Bodil; Bjerregaard, Poul (2002). The chemical UV-filter 3-benzylidene camphor causes an estrogenic effect in an in vivo fish assay. Pharmacology Toxicology (Oxford, United Kingdom), (2002) Vol. 91, No. 4, pp. 204-

Hon98 Hongslo, J.K. et al. (1998). Estrogen-like charateristics of various phenolic compounds in MCF-7 cells. Abstract Presented at ICT VIII Paris 98, Juli, 5-9.

hos00 Hossaini, A.; Larsen, J.-J.; Larsen, J. C. (2000). Lack of estrogenic effects of food preservatives (parabens) in uterotrophic assays. Food and Chemical Toxicology, (2000) Vol. 38, No. 4, pp. 319-323.

How(01) Howarth, J. A.; Price, S. C.; Dobrota, M.; Kentish, P. A.; Hinton, R. H. (2001). Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexyl phthalate administered alone or in combina-tion. Toxicology Letters, (2001) Vol. 121, No. 1, pp. 35-43.

How(80) Howe G R; Steward R (1980). Fertility regulation in male rats and hamsters with alkylating agents. Contraception, (1980 Aug) Vol. 22, No. 2, pp. 175-81.

hub95 Hubbard S A; Sullivan F M (1995). Toxicological effects of inorganic boron compounds in ani-mals: a review of the literature. Journal of Trace Elements in Experimental Medicine, (1995) 8 (2) 133.

hun(04) Hunag Yi-na; Cheng Wei-bo; Xu Pei-yu; Yu Wen-san; Li Qiong-ying; Wang Wen-dong; Wang Zheng-shu; Pang Ding-quo; Liu Yu-qing (2004). Exploring the sensitive indicators of uterotro-phic assay in immature SD rats exposed to para-nonylphenol.Journal of Sichuan

Hur98 Hurley PM (1998). Mode of carcinogenic action of pesticides inducing thyroid follicular cell tu-mors in rodents.Environ Health Perspect; VOL 106, ISS 8, P437-45

Ike83 Ikemoto, I., S. Kotera, K. Katsurai, Y. Inaba, T. Machida and A. Tanaka (1983), Experi mental testicular damage induced by dibutyl phthalata and monobutyl phthalate, Jpn. J. Fertil. Steril., 28(7): 159-165.

ike85 Ikemoto, I. (1985) Experimental studies on testiculat damage induced by phthalic acid esters. Tokyo Jikeihai Med. J., 100: 1115-1127.

ike95 Ikemi N; Kawata M; Yasuda M (1995). Variations in palatal rugae in rat fetuses from dams treated with retinoic acid or ethylenethiourea. International Toxicologist 1995 Jul;7(1):AB# 74-P-16.

inu03 Inui, Madoka; Adachi, Tetsuya; Takenaka, Shigeo; Inui, Hiroshi; Nakazawa, Masami; Ueda, Mitsuhiro; Watanabe, Hajime; Mori, Chisato; Iguchi, Taisen; Miyatake, Kazutaka [Reprint Au-thor] (2003). Effect of UV screens and preservatives on vitellogenin and chor

IRIS94 IRIS (1994) EPA's Integrated Risk Information System, US Environmental Protection Agency, Silverplatter 3.11 CD-Rom sytrem (through October 1994). Silverplatter International, N.V. USA.

iso05 Isoda, Hiroko; Talorete, Terence P. N.; Han, Junkyu; Oka, Shuichi; Abe, Yukuo; Inamori, Yuhei (2005). Effects of organophosphorous pesticides used in China on vari-ous mammalian cells. Environmental Sciences (Tokyo, Japan), (2005) Vol. 12, No. 1, pp. 9-19

jan04 Janjua, Nadeem Rezaq; Mogensen, Brian; Andersson, Anna-Maria; Petersen, Jorgen Holm; Henriksen, Mette; Skakkebaek, Niels E.; Wulf, Hans Christian (2004). Systemic absorption of the sunscreens benzophenone-3, octylmethoxycinnamate, and 3-(4-methyl-benzyli

Page 219: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 216

ID REF.REFERENCE Jar87 Jarrell J, YoungLai EV, Barr RD, McMahon A, Belbeck L, O'Connell G. Ovarian toxicity of cy-

clophosphamide alone and in combination with ovarian irradiation in the rat. Cancer Res 47:2340-2343, 1987.

Jef02 Jefferson WN., Padilla-Banks E., Clark G., Newbold RR. Assessing estrogenic activity of phy-tochemicals using transcriptional activation and immature mouse uterotrophic responses. Jour-nal of chromatography. B, Analytical technologies in the biomedical and

Jeo(03) Jeong S; Kim B; Kim S; Cho J; Kim O (2003). Steroid and thyroid hormonal receptor gene tran-scription assay and one-generation reproduction study of butylated hydroxyanisole. Toxicolo-gist 2003 Mar;72(S-1):284.

Jeo(05) Jeong, Sang-Hee; Kim, Byung-Yong; Kang, Hwan-Goo; Ku, Hyun-Ok; Cho, Joon-Hyoung (2005). Effects of butylated hydroxyanisole on the development and functions of reproductive system in rats. Toxicology, (2005) Vol. 208, No. 1, pp. 49-62.

ji90 Ji, Yunjing; Pei, Shu; Ji, Yongping; Liu, Jianzhong (1990). Toxicology and health standard of omethoate in workplace. Weisheng Dulixue Zazhi, (1990) Vol. 4, No. 4, pp. 213-15, 251.

Job93 Jobling S, Sumpter JP. Detergent components in sewage effluent are weakly oestrogenic to fish: an in vitro study using rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquatic Toxicol 27:361-372, 1993.

Job95 Jobling, S., Reynolds, T., White, R., Parder, M.G. & Sumpter, J.P. (1995). A variety of environ-mentally persistent chemicals, including some phtalate plasticizers, are weakly estrogenic. En-viron. Health Perspec., 103, 582-587.

Job96 Jobling S, Sheahan D, Osborne JA, Mathiessen P, Sumpter JP. Inhibition of testicular growth in rainbow trout (Oncorhynchus mykiss) exposed to estrogenic alkylphenolic chemicals. Environ Toxicol Chem 15:194-202, 1996.

Joc54 Jochle, Wolfgang (1954). Effect of p-hydroxypropiophenone on amphibia. (Influence of drugs on the pituitary. Klinische Wochenschrift, (1954) Vol. 32, pp. 979-81.

Joh80 Johnson, W.W., and M.T. Finley, 1980. Handbook of Acute Toxicityof Chemicals to Fish and Aquatic Invertebrates. Resour.Publ.137,Fish Wildl.Serv., U.S.D.I., Washington, D.C :98 p.. 666

Jon(93) Jones, H. B.; Garside, D. A.; Liu, R.; Roberts, J. C. (1993) The influence of phthalate esters on Leydig cell structure and function in vitro and in vivo Experimental and Molecular Pathology, (1993) Vol. 58, No. 3, pp. 179-93.

Jos(70) Joshi, Sewa R.; Page, Elaine C.; Arnold, Elsie; Bishop, Yvonne; Epstein, Samuel S. (1970). Fertilization and early embryonic development subsequent to mating with TEPA [triethylene phosphoramide]-treated male mice. Genetics, (1970) Vol. 65, No. 3, pp. 483

Jos90 Joshi, H.C., and M.K. Mukhopadhyay, 1990. Toxicity of Quinalphosand Endosulfan to Different Life-Stages of Tiger Prawn (Penaeusmonodon). Environ.Conserv. 17(3):266-267. 7939

Kah97 Kahl, M.D., E.A. Makynen, P.A. Kosian, and G.T. Ankley, 1997.Toxicity of 4-Nonylphenol in a Life-Cycle Test with the MidgeChironomus tentans. Ecotoxicol.Environ.Saf. 38(2):155-160. 18610

Kai(05) Kai Hiroki; Shono Takeshi; Tajiri Tatsuro; Suita Sachiyo (2005). Long-term effects of intrauter-ine exposure to mono-n-butyl phthalate on the reproductive function of postnatal rats. Journal of pediatric surgery, (2005 Feb) Vol. 40, No. 2, pp. 429-33.

Kan(02) Kang, Kyung-Sun; Che, Jeong-Hwan; Ryu, Doug-Young; Kim, Tae-Won; Li, Guang-Xun; Lee, Yong-Soon [Reprint author] (2002). Decreased sperm number and motile activity on the F1 off-spring maternally exposed to butyl p-hydroxybenzoic acid (butyl paraben). Journ

kan(03) Kang, Ik Joon [Reprint Author]; Yokota, Hirofumi; Oshima, Yuji; Tsuruda, Yukinari; Hano, Takeshi; Maeda, Masanobu; Imada, Nobuyoshi; Tadokoro, Hiroshi; Honjo, Tsuneo (2003). Effects of 4-nonylphenol on reproduction of Japanese medaka, Oryzias latipes. E

Kan(04) Kang, Mi Kyung; Ahn, Mee Ryung; Chung, Hye Joo; Choi, Sun Ok; Choi, Hong Serk; Yang, Ji Sun; Lee, Yong Bok; Yoo, Tae Moo; Sohn, Soo Jung (2004).Tissue distribution and toxicokinetics of 4-Tert-octylphenol in rats. Journal of Toxicology and Public Health,

Page 220: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 217

ID REF.REFERENCE Kan(05) Kang, Hwan Goo; Jeong, Sang Hee [Reprint Author]; Cho, Joon Hyoung; Kim,

Dong Gyu; Park, Jong Myung; Cho, Myung Haing (2005). Evaluation of estrogenic and andro-genic activity of butylated hydroxyanisole in immature female and castrated rats. Toxicology,

Kar(03) Karels, Arthur Alan; Manning, Steve; Brouwer, Thea Hoexum; Brouwer, Marius (2003). Repro-ductive effects of estrogenic and antiestrogenic chemicals on sheepshead minnows (Cyprino-don variegatus). Environmental Toxicology and Chemistry, (2003) Vol. 22, No. 4

Kha73 Khan, M.A.Q., R.H. Stanton, D.J. Sutherland, J.D. Rosen, and N.Maitra, 1973. Toxicity-Metabolism Relationship of thePhotoisomers of Certain Chlorinated Cyclodiene Insecti-cideChemicals. Arch.Environ.Contam.Toxicol. 1(2):159-169. 5514

Khe(03) Khelifi-touhami, Fatima; Taha, Ragia A.; Badary, Osama A.; Lezzar, Alkassem; Hamada, Farid M. A. (2003). Goitrogenic activity of p-coumaric acid in rats. Journal of Biochemical and Mo-lecular Toxicology, (2003) Vol. 17, No. 6, pp. 324-328.

Kim(02) Kim, Hyung Sik; Shin, Jae-Ho; Moon, Hyun Ju; Kang, Il Hyun; Kim, Tae Sung; Kim, In Young; Seok, Ji-Hyun; Pyo, Myoung-Yun; Han, Soon Young [Reprint author] (2002). Comparative estrogenic effects of p-nonylphenol by 3-day uterotrophic assay and female pube

Kin(03) Kinnberg, Karin; Korsgaard, Bodil; Bjerregaard, Poul (2003). Effects of octylphenol and 17?-estradiol on the gonads of guppies (Poecilia reticulata) exposed as adults via the water or as embryos via the mother. Comparative Biochemistry and Physiology, Par

Kit(03) Kitagawa, Yoko; Takatori, Satoshi; Oda, Hajime; Nishikawa, Junichi; Nishihara, Tsutomu; Nakazawa, Hiroyuki; Hori, Shinjiro (2003). Detection of thyroid hormone receptor-binding activities of chemicals using a yeast two-hybrid assay. Journal of Health Sci

kla05 Klann, Anja; Levy, Gregor; Lutz, Ilka; Mueller, Christian; Kloas, Werner; Hildebrandt, Jan-Peter (2005). Estrogen-like effects of ultraviolet screen 3-(4-methylbenzylidene)-camphor (Eusolex 6300) on cell proliferation and gene induction in mammalian and a

klam05 Klammer, Holger; Schlecht, Christiane; Wuttke, Wolfgang; Jarry, Hubertus (2005). Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo. A 5-day subacute pharmacodynamic study with ovariectomized rats. Toxicology, (2005)

Klo(97) Klotz, Diane M.; Ladlie, Beth L.; Vonier, Peter M.; McLachlan, John A.; Arnold, Steven F. (1997). o,p’-DDT and its metabolites inhibit progesterone-dependent re-sponse in yeast and human cells. Molecular and Cellular Endocrinology, (1997) Vol. 129, No. 1,

klo70 Klotzsche J R. (1970). Teratological and embryotoxic studies with formothion and thiometon. Pharm. Acta Helv., (1970) 45 (7) 434-40. Ref: 9.

kod05 Koda Tomoko; Umezu Toyoshi; Kamata Ryo; Morohoshi Kaori; Ohta Toshiko; Morita Masato-shi (2005). Uterotrophic effects of benzophenone derivatives and a p-hydroxybenzoate used in ultraviolet screens Environmental research, (2005 May) Vol. 98, No. 1, pp. 40

Kop74 Kopperman, H.L., R.M. Carlson, and R. Caple, 1974. AqueousChlorination and Ozonation Studies. I. Structure-ToxicityCorrelations of Phenolic Compounds to Daphnia magna.Chem.-Biol.Interact. 9(4):245-251. 2120

Kora88 Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Molec. Pharmacol 1988; 33: 120-126.

Koy96 Koyama, J., 1996. Vertebral Deformity Susceptibilities of MarineFishes Exposed to Herbicide. Bull.Environ.Contam.Toxicol.56(4):655-662. 17085

kun04 Kunz, Petra Y.; Galicia, Hector F.; Fent, Karl [Reprint Author] (2004). Assessment of hormonal activity of UV filters in tadpoles of frog Xenopus laevis at environmental concentrations. Marine Environmental Research, (August 2004) Vol. 58, No. 2-5, pp. 43

kun06 Kunz, Petra Y.; Galicia, Hector F.; Fent, Karl (2006). Comparison of In Vitro and In Vivo Estro-genic Activity of UV Filters in Fish. Toxicological Sciences, (2006) Vol. 90, No. 2, pp. 349-361.

Page 221: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 218

ID REF.REFERENCE Kwa02 Kwack, Seung Jun; Kwon, Oran; Kim, Hyung Sik; Kim, Soon Sun; Kim, So Hee;

Sohn, Kyung Hee; Da Lee, Rhee; Park, Chul Hoon; Jeung, Eui Bae; et al. (2002) Comparative evaluation of alkylphenolic compounds on estrogenic activity in vitro and in vivo J

Lan(96) Lanno R P (Reprint); Dixon D G (1996). The comparative chronic toxicity of thiocyanate and cyanide to rainbow trout. AQUATIC TOXICOLOGY, (DEC 1996) Vol. 36, No. 3-4, pp. 177-187.

Lat02 Latonelle K, Fostier A, Le Menn F, Bennetau-Pelissero C (2002). Binding affinities of hepatic nuclear estrogen receptors for phytoestrogens in rainbow trout (Onchorhynchus mykiss) and Siberian sturgeon (Acipenser baeri). General and comparative endocrinol

Lat02a Latonnelle K, Le Menn F, Kaushik S J, Bennetau-Pelissero C (2002a). Effects of dietary phy-toestrogens in vivo and in vitro in rainbow trout and Siberian sturgeon: interests and limits of the in vitro studies of interspecies differences. General and compa

Lee85a Van Leeuwen, C.J., F. Moberts, and G. Niebeek, 1985. AquaticToxicological Aspects of Dithio-carbamates and Related Compounds.II. Effects on Survival, Reproduction and Growth of Daphniamagna. Aquat.Toxicol.7(3):165-175; Aquat.Toxicol.11(3/4):421-422(198

Lee85b Van Leeuwen, C.J., J.L. Maas-Diepeveen, G. Niebeek, W.H.A.Vergouw, P.S. Griffioen, and M.W. Luijken, 1985. AquaticToxicological Aspects of Dithiocarbamates and Related Com-pounds.I. Short-Term Toxicity Tests. Aquat.Toxicol. 7(3):145-164. 11455

Lee96 Lee PC, Lee W. In vivo estrogenic action of nonylphenol in immature female rats. Bull. Envi-ronm. Contam. Toxicol 1996; 57: 341-348.

leh99 Lehman-McKeeman, L. D.; Caudill, D.; Vassallo, J. D.; Pearce, R. E.; Madan, A.; Parkinson, A. (1999). Effects of musk xylene and musk ketone on rat hepatic cytochrome P450 enzymes. Toxicology Letters, (1999) Vol. 111, No. 1-2, pp. 105-115.

Lem(03) Lemini, Cristina [Reprint Author]; Jaimez, Ruth; Estela Avila, Maria; Franco, Yanira; Larrea, Fernando; Elena Lemus, Ana(2003). In vivo and in vitro estrogen bioactivities of alkyl parabens. Toxicology and Industrial Health, (2003) Vol. 19, No. 2-6, pp. 6

lem03 Lemini, Cristina [Reprint Author]; Jaimez, Ruth; Estela Avila, Maria; Franco, Yanira; Larrea, Fernando; Elena Lemus, Ana (2003). In vivo and in vitro estrogen bio-activities of alkyl parabens. Toxicology and Industrial Health, (2003) Vol. 19, No. 2-6, pp.

lem04 Lemini, C. [Reprint Author]; Hernandez, A.; Jaimez, R.; Franco, Y.; Avila, M. E.; Castell, A. (2004). Morphometric analysis of mice uteri treated with the preservatives methyl, ethyl, propyl, and butylparaben. Toxicology and Industrial Health, (SEP 2004)

lem97 Lemini, C.; Silva, G.; Timossi, C.; Luque, D.; Valverde, A.; Gonzalez-Martinez, M.; Hernandez, A.; Rubio-Poo, C.; Lara, B. Chavez; Valenzuela, F. (1997). Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environmental Research, (1997) Vol. 75, No

LeV(72) Le Vier, R. R.; Jankowiak, M. E. (1972). Effects of oral 2,6-cis-diphenylhexamethylcyclotetrasiloxane on the reproductive system of the male rat. Toxicology and Applied Pharmacology, (1972) Vol. 21, No. 1, pp. 80-8.

Lev83 Levine, R.J., P.B. Blunden, D. DalCorso, T.B. Starr and C.E. Ross. 1983. Superiority of repro-ductive histories to sperm counts in detecting infertility at a dibromochlo ropropane manufactu ring plant. Journal Occupational Medicine 25:591-597.

Lin(04) Lin, Bin-Le; Hagino, Satoshi; Kagoshima, Michio; Ashida, Shouji; Hara, Takumi; Iwamatsu, Ta-kashi; Tokai, Akihiro; Yoshida, Kikuo; Yonezawa, Yoshitaka; et al. (2004). Three-generation full-life-cycle study on 4-nonylphenol using S-rR strain medaka (Oryzias

Lin79 Linden, E., B.E. Bengtsson, O. Svanberg, and G. Sundstrom, 1979.The Acute Toxicity of 78 Chemicals and Pesticide FormulationsAgainst Two Brackish Water Organisms, the Bleak (Al-burnusalburnus) and the Harpacticoid. Chemosphere 8(11/12):843-851(Author C

Lin89+86\Arn52

Lindsay, R.H. & Gaitan, E. (1989) Polyhydroxyphenols and phenols derivati ves. In: Gaitan, E. (ed.), Environmental Goitrogenesis, CRC Press, Boca Raton, FL, pp. 74-93.Nem58: Nemeth, S. (1958) Short-tearm decrease of serum protein-bound iodine concen trati

Page 222: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 219

ID REF.REFERENCE Lin89+86\Nem58\gol55

Lindsay, R.H. & Gaitan, E. (1989) Polyhydroxyphenols and phenols derivati ves. In: Gaitan, E. (ed.), Environmental Goitrogenesis, CRC Press, Boca Raton, FL, pp. 74-93.Nem58: Nemeth, S. (1958) Short-tearm decrease of serum protein-bound iodine concen trati

Lin92 Linder R.E., Strader L.F., Slott V.L. and Suarez J.D., 1992. Endpoints of spermatotoxicity in the rat after short duration exposures to fourteen reproductive toxicants. Reprod. Toxicol, 6: 491-505.

LiP(94) Li, Ping; Wang, Huai-Zhou [Reprint author]; Wang, Xu-Qing; Wu, Yong-Ning (1994). The block-ing effect of phenolic acid on N-nitrosomorpholine formation in vitro. Biomedical and Environ-mental Sciences, (1994) Vol. 7, No. 1, pp. 68-78.

Lod(01) Lodovici M.; Guglielmi F.; Meoni M.; Dolara P. (2001). Effect of natural phenolic acids on DNA oxidation in vitro. Food and Chemical Toxicology, (2001) Vol. 39, No. 12, pp. 1205-1210.

Lov(01) Lovekamp, T. N.; Davis, B. J. (2001). Mono-(2-ethylhexyl) Phthalate Suppresses Aromatase Transcript Levels and Estradiol Production in Cultured Rat Granulosa Cells. Toxicology and Applied Pharmacology, (2001) Vol. 172, No. 3, pp. 217-224.

Mac76 Macek, K.J., M.A. Lindberg, S. Sauter, K.S. Buxton, and P.A.Costa, 1976. Toxicity of Four Pes-ticides to Water Fleas andFathead Minnows. EPA-600/3-76-099, Envi-ron.Res.Lab.,U.S.Environ.Prot.Agency, Duluth, M N:68. 632

Mad(01) Madigou, T.; Le Goff, P.; Salbert, G.; Cravedi, J. P.; Segner, H.; Pakdel, F. [Reprint author]; Valotaire, Y. (2001. Effects of nonylphenol on estrogen receptor conforma-tion, transcriptional activity and sexual reversion in rainbow trout (Oncorhynchus my

Mad(03) Madsen, Louise L. [Reprint Author]; Korsgaard, Bodil; Bjerregaard, Poul (2003). Estrogenic ef-fects in flounder Platichthys flesus orally exposed to 4-tert-octylphenol. Aquatic Toxicology (Amsterdam), (10 September 2003) Vol. 64, No. 4, pp. 393-405.

mae05 Maerkel, Kirsten; Lichtensteiger, Walter; Durrer, Stefan; Conscience, Marianne; Schlumpf, Margret (2005). Sex- and region-specific alterations of progesterone receptor mRNA levels and estrogen sensitivity in rat brain following developmental exposure to t

mai94 Maitra, Saumen K.; Sarkar, Rita (1994). Testicular responsiveness of a Wild passerine bird, Lonchura malabarica, to the oral administration of quinalphos, an organophosphorous pesti-cide. Journal of the Yamashina Institute for Ornithology, (1994) Vol. 26,

Man00 Mancozeb Addendum. Filenaam: mancozeb_addendum01_tox(endpoints)-MH dated 14-04-00.Mar89a Marks, TA., Kimmel, GL., Staples, RE. Influence of symmetrical polychlorinated biphenyl iso-

mers on embryo and fetal development in mice. II. Comparison of 4,4’-dichlorobiphenyl, 3,3’,4,4’-tetrachlorobiphenyl, 3,3’,5,5’-tetrachlorobiphenyl, and 3,3’,4,4’-

Mar97 Marinovich, M., M. Guizzetti, F. Ghilardi, B. Viviani, E. Corsini and C.L. Galli. Thyroid Peroxi-dase as Toxicity Target for Dithiocarbamates. Arch. Toxicol. 71, 508-512, 1997.

Mat05 Matsumoto H.; Adachi S.; Suzuki Y. (2005). Estrogenic activity of ultraviolet absorbers and the related compounds. Yakugaku Zasshi, (2005) Vol. 125, No. 8, pp. 643-652.

May(03) Mayer, Loretta P.; Dyer, Cheryl A.; Propper, Catherine R. (2003). Exposure to 4-tert-octylphenol accelerates sexual differentiation and disrupts expression of steroidogenic factor 1 in developing bullfrogs. Environmental Health Perspectives, (2003) Vol. 1

May77 Mayer, F.L., P.M. Mehrle, and H.O. Sanders, 1977. ResidueDynamics and Biological Effects of Polychlorinated Biphenyls inAquatic Organisms. Arch.Environ.Contam.Toxicol. 5(4):501-511. 681

May86 Mayer, F.L.J., and M.R. Ellersieck, 1986. Manual of AcuteToxicity: Interpretation and Data Base for 410 Chemicals and 66Species of Freshwater Animals. Re-sour.Publ.No.160,U.S.Dep.Interior, Fish Wildl.Serv., Washington, DC :505. 6797

McC(04) McClusky, Leon M.; de Jager, Christiaan; Bornman, Marianna S. (2004). Life-time exposure of male rats to phyto-oestrogens and p-nonylphenol: implications for spermatogenesis stages VII-VIII. Proceedings - Microscopy Society of Southern Africa, (2004) Vol.

mck01 McKim, James M., Jr.; Wilga, Paul C.; Breslin, William J.; Plotzke, Kathy P.; Gallavan, Robert H.; Meeks, Robert G. (2001). Potential estrogenic and antiestrogenic ac-tivity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane

Page 223: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 220

ID REF.REFERENCE McL81 McLeese, D.W., V. Zitko, D.B. Sergeant, L. Burridge, and C.D.Metcalfe, 1981. Lethality and

Accumulation of Alkyphenols inAquatic Fauna. Chemosphere 10(7):723-730. 15164 Mei94 Meinelt, T., and G. Staaks, 1994. The Embryo-Larval Test withZebrafish (Brachydanio rerio):

Validity, Limits and Perspectives. In: R.Muller and R.Lloyd (Eds.), Sublethal and Chronic Ef-fectsof Pollutants on Freshwater Fish, Chapter 15, Fishing News Books

Mil(98) Milligan, Stuart R.; Khan, Omar; Nash, Marnie (1998). Competitive binding of xenobiotic estro-gens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma. General and Comparative Endocrinology,

Mil01 Miller, D; Wheals, BB.; Beresford, N; Sumpter, J P. (2001). Estrogenic activity of phenolic addi-tives determined by an in vitro yeast bioassay. Environmental Health Perspectives, (2001) Vol. 109, No. 2, pp. 133-138.

Mil98a Milligan SR; Balasubramanian AV; Kalita JC (1998). Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay.Environmental health perspectives; 106; 1; 23-601

Mil99a Miles-Richardson, S.R., S.L. Pierens, K.M. Nichols, V.J. Kramer,E.M. Snyder, S.A. Snyder, J.A. Render, S.D. Fitzgerald,, 1999.Effects of Waterborne Exposure to 4-Nonylphenol and Nonyl-phenolEthoxylate on Secondary Sex Characteristics and Gonads of Fathe

Mill98 Milligan, Stuart R.; Khan, Omar; Nash, Marnie (1998) Competitive binding of xenobiotic estrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma General and Comparative Endocrino

Mol51 Molina, C.; Lauzel, J. P. (19519 Action of p-hydroxypropiophenone on the manifestations of thehypophyseal-sexual cycle in female rats and rabbits. Comptes Rendus des Seances de la So-ciete de Biologie et de Ses Filiales (1951) Vol. 145, pp. 1151-4.

Mor05 Morohoshi, K.; Yamamoto, H.; Kamata, R.; Shiraishi, F.; Koda, T.; Morita, (2005). Estrogenic activity of 37 components of commercial sunscreen lotions evaluated by in vitro assays. Toxi-cology In Vitro, (JUN 2005) Vol. 19, No. 4, pp. 457-469.

mor98 Morgan T.M.; Parr R.A.; Reed B.L.; Finnin B.C. (1998). Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol. Journal of Pharmaceutical Sciences, (1998) Vol. 87, No. 10, pp. 1219-1225.

Mos96a Moser, G.J., B.A. Wong, D.C. Wolf, O.R. Moss and T.L. Goldsworthy (1996a), Comparati ve short-term effects of methyl tertiary butyl ether and unleaded gasoline vapor in female B6C3P1 mice, Fundam. Appl. Toxicol., 31: 173-183.

Mos98 Moser G.J., et al., Tox. Sciences 41, 1, 77-87, 1998 mose98 Moser, Glenda J.; Wolf, Douglas C.; Sar, Madhabananda; Gaido, Kevin W.;

Janszen, Derek; Goldsworthy, Thomas L. (1998). Methyl tertiary butyl ether-induced endocrine alterations in mice are not mediated through the estrogen receptor. Toxicological Science

Mue78 Mueller GC, Kim UH. Displacement of estradiol from estrogen receptors by simple alkylphe nols. Endocrinology 102:1429-1435, 1978.

Mur(86) Murakami, Kenji; Nishiyama, Keitaro; Higuchi, Tomihiko (1986). Toxicity of dibutyl phthalate and its metabolites in rats. Nippon Eiseigaku Zasshi, (1986) Vol. 41, No. 4, pp. 775-81.

Nag97 Nagel S. et al., Environ. Health Perspect., Vol 105, 70-76, 1997 nagh97 Naghii M.R.; Samman S. (1997). The effect of boron on plasma testosterone and plasma lipids

in rats. Nutrition Research, (1997) Vol. 17, No. 3, pp. 523-531. nak02 Nakagawa, Yoshio [Reprint author]; Suzuki, Toshinari (2002). Metabolism of 2-hydroxy-4-

methoxybenzophenone in isolated rat hepatocytes and xenoestrogenic effects of its metabo-lites on MCF-7 human breast cancer cells. Chemico-Biological Interactions, (Febr

Nee91 Neeper-Bradley, T.L. (1991), Two-generation reproduction study of inhaled methyl tertiary butyl ether in CD (Sprague-Dawley) rats, Export, Pennsylvania, Bushy Run Research Center, 499 pp (Report No. 53-594 to the Methyl Tertiary Butyl Ether Toxicology Com

Nee91bev97

Neeper-Bradley, T.L. (1991), Two-generation reproduction study of inhaled methyl tertiary butyl ether in CD (Sprague-Dawley) rats, Export, Pennsylvania, Bushy Run Research Center, 499 pp (Report No. 53-594 to the Methyl Tertiary Butyl Ether Toxicology Com

Page 224: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 221

ID REF.REFERENCE Nis00 Tsutomu Nishihara, 2000. Estrogenic Activities of 517 Chemicals by Yeast Two-Hybrid Assay.

Journal of Health Science, 46(4) 282-298 Nis72 Nishiuchi, Y., and K. Yoshida, 1972. Toxicities of Pesticides toSome Fresh Water Snails.

Bull.Agric.Chem.Insp.Stn.12:86-92 (JPN)(ENG ABS) (ENG TRANSL) (Author Communication Used). 9158

Nis79 Nishiuchi, Y., 1979. Toxicity of Pesticides to Animals inFreshwater. LXII. The Aquiculture /Suisan Zoshoku 27(2):119-124(JPN). 6956

Nis90 Nishiuchi, Y., 1990. Toxicity of Pesticides to Some AquaticAnimals-XI. Toxicity of Some Pesti-cides to Tadpoles.C.A.Sel.-Environ.Pollut.18:3-72754Y (ABS);Aquat.Ecol.Chem./Seitai Kaguku 9(4):23-26 (JPN) (1989). 8589

Noz(04) Nozaka, Toshiki; Abe, Tatsuo; Matsuura, Takeshi; Sakamoto, Tamami; Nakano, Nahoko; Maeda, Masanobu; Kobayashi, Kunio (2004). Development of vitellogenin assay for endocrine disruptors using medaka (Oryzias latipes). Environmental Sciences (Tokyo, Japan),

NTP(96) NTP working group (1996). Toxicology and carcinogenesis studies of phenolphthalein in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program Technical Report Series, (1996) 465 348 p.

nus05 Nusier, Mohamad; Bataineh, H. N. (2005). Effect of boric acid on fertility, aggressiveness and sex behaviour in male rats. Asian Journal of Chemistry, (2005) Vol. 17, No. 4, pp. 2579-2588.

Oik92 Oikari, A., J. Kukkonen, and V. Virtanen, 1992. Acute Toxicity of Chemicals to Daphnia magna in Humic Waters. Sci.Total Environ.117/118:367-377. 5679

Ois(02) Oishi, Shinshi (2002). Effects of butyl paraben on the male reproductive system in mice. Ar-chives of Toxicology, (July, 2002) Vol. 76, No. 7, pp. 423-429.

ois02 Oishi, S. (2002). Effects of propyl paraben on the male reproductive system. Food and Chemi-cal Toxicology, (2002) Vol. 40, No. 12, pp. 1807-1813.

ois04 Oishi, Shinshi (2004). Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food and Chemical Toxicology, (2004) Vol. 42, No. 11, pp. 1845-1849.

Ois80a Oishi, S. and K. Hiraga (1980a), Testicular atrophy induced by phthalic acid esters, Effect on testosterone and zinc concentrations, Toxicol. Appl. Pharmacol., 53: 35-41.

Ois80b Oishi, S. and K. Hiraga (1980b), Effect of phthalic acid esters on mouse testes, Toxicol. Lett., 5: 413-416.

ois80c Oishi, S. & Hiraga, K. (1980c) Testicular atrophy induced by phthalic acid monoesters: Effects of zinc and testostereone con centrations. Toxicology, 15: 197-202.

ois80d Oishi, S. & Hiraga, K. (1980d) Effects of phthalic acid monoe sters on mouse testes. Toxiciol. Lett, 6: 239-242.

oish02 Oishi S. (2002). Effects of parabens on the male reproductive system in rats (2). Environmental Sciences: an International Journal of Environmental Physiology and Toxicology, (2002) 9 (2-3) 181.

Ols03 Olsen, Christel M. [Reprint Author]; Meussen-Elholm, Elise T. M.; Samuelsen, Mari; Holme, Jorn A.; Hongslo, Jan K. (2003) Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4’-dih

Ols78 Olson K.L. Boush G.M. and Matsumura F., 1978. Behavioural effects of perinatal exposure of chlordimeform in rats. Bull. Environ. Contam. Toxicol, 20: 760-768.

Ols90 Olsen GW, Lanham JM, Bodner KM, e.a. Determinants of spermatopgenesis recovery among workers exposed to 1,2-dibromo-3-chloropropane. J Occup Med 1990; 32: 979-984.

opi05 Opitz, Robert; Braunbeck, Thomas; Boegi, Christian; Pickford, Daniel B.; Nentwig, Gerrit; Oehlmann, Joerg; Tooi, Osamu; Lutz, Ilka; Kloas, Werner (2005). Description and initial evaluation of a Xenopus metamorphosis assay for detection of thyroid system-

Ort(05) Ortiz-Zarragoitia, Maren; Cajaraville, Miren P. (2005). Effects of selected xenoestrogens on liver peroxisomes, vitellogenin levels and spermatogenic cell proliferation in male zebrafish. Comparative Biochemistry and Physiology, Part C: Toxicology Pharmac

Ost83 Osterloh J; Letz G; Pond S; Becker C (1983). An Assessment Of The Potential Testicular Tox-icity Of 10 Pesticides Using The Mouse-Sperm Morphology Assay. Mutation Research; Vol. 116, No. 3-4, pages 407-415, 31 references, 19831983

Page 225: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 222

ID REF.REFERENCE Pad88 Padmaja, K., P. Nagalakshmi, and M.B. Rao, 1988. A ComparativeEvaluation of the Toxicity of

Metacid (Methyl Parathion),Quinalphos and Nuvan (DDVP) to the Freshwater Snail, Bellamy-adissimilis (Muller). Indian J.Comp.Anim.Physiol. 6(1):34-38. 3039

Pag85 Pagano, G.; Cipollaro, M.; Corsale, G.; Esposito, A.; Ragucci, E.; Giordano, G. G.; Trieff, N. M. (1985). Comparative toxicities of chlorinated biphenyls on sea urchin egg fertilization and embryogenesis. Marine Environmental Research, (1985) Vol. 17, N

Pak(79) Pakrashi A.; Pakrasi P.L.; Kabir S.N. (1979). Effect of p-coumaric acid on immature estrogen treated and cyclic female mice. Experientia, (1979) Vol. 35, No. 6, pp. 843-844.

Pak(80) Pakrasi, Pranab Lal; Pakrashi, Anita (1980). Role of p-coumaric acid in experimentally induced delayed implantation in mice. IRCS Medical Science: Library Compendium, (1980) Vol. 8, No. 8, pp. 573.

pan03 Pant, N.; Srivastava, S. P. (2003). Testicular and spermatotoxic effects of quinalphos in rats. Journal of Applied Toxicology, (2003) Vol. 23, No. 4, pp. 271-274.

Par02 Paris F.; Balaguer P.; Terouanne B.; Servant N.; Lacoste C.; Cravedi J.P.; Nicolas J.C.; Sultan C. (2002). Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit a and b estrogen activities and antiandrogen activity in reporter cell lines

Pau87 Paulov, S. (1987), Action of the anti-detonation preparation tert-butyl methyl ether on the model species Rana temporaria L., Biologia, 42: 185-189 (in Slovak with English abstract).

Pau93 Pauli, W., S. Berger, L. Jaskulka, and S. Schmitz, 1993. A Casefor the Inclusion of a Protozoan Test in Aquatic ToxicityAssessment Using Tetrahymena. Sci.Total Environ.(Suppl.):779-786. 4344

Pau94 Pauli, W., S. Berger, S. Schmitz, and L. Jaskulka, 1994.Chemosensory Responses of Ciliates: A Sensitive End Point inXenobiotic Hazard Assessment. Environ.Toxicol.Water Qual.9(4):341-346. 17554

Ped(00) Pedersen, Knud L.; Pedersen, Soren N.; Christiansen, Lisette B.; Korsgaard, Bodil; Bjerre-gaard, Poul (2000). The preservatives ethyl-, propyl- and butylparaben are oestrogenic in an in vivo fish assay. Pharmacology Toxicology (Copenhagen), (2000) Vol. 86,

Ped(03) Pedersen, Kristine H.; Pedersen, Soren N.; Pedersen, Knud L.; Korsgaard, Bodil; Bjerregaard, Poul [Reprint Author] (2003). Estrogenic effect of dietary 4-tert-octylphenol in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology (Amsterdam), (26 February

ped00 Pedersen K.L.; Pedersen S.N.; Christiansen L.B.; Korsgaard B.; Bjerregaard (2000). The pre-servatives ethyl-, propyl- and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol-ogy and Toxicology, (2000) Vol. 86, No. 3, pp. 110-113.

Pel91 Pellissero, C. Bennetau, B. Babin, P., Le Menn, F. Dunogues, J. (1991). The estrogenic activity of certain phytoestrogens in the Siberian Sturgeon, Acipenser baeri. J. Steroid Biochem. Molec. Biol., 38 (3), 293-299.

pet91a Peterson G., Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochemical and biophysical research communications, (1991 Aug 30) Vol. 179, No. 1, pp. 661-7

Pet97 Petit F., Le Goff P., Cravedi JP., Valotaire Y., Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures J Mol Endocrinol., VOL 19, ISS 3, 1997,

Pre86 Presing, M., and J.E. Ponyi, 1986. Studies on the Acute andChronic Effect of a 2,4-D-Containing Herbicide (Dikonirt) onEudiaptomus gracilis (G.O. Sars) (Crustacea, Cope-poda).Arch.Hydrobiol. 106(2):275-286. 12427

pri91 Price, C. J.; Marr, M. C.; Myers, C. B.; Heindel, J. J.; Schwetz, B. A. (1991). Final report on the developmental toxicity of boric acid (CAS No. 10043-35-3) in New Zealand white rabbits by ga-vage on gestational days 6 through 19 (final study report and a

Pro97 Propst, T.L., D.J. Fort, and E.L. Stover, 1997. Evaluation of the Developmental Toxicity of Benzo(a)pyrene and2-Acetylaminofluorene Using Xenopus: Modes of Biotransformation.Drug Chem.Toxicol. 20(1/2):45-61. 14027

Page 226: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 223

ID REF.REFERENCE pug05 Pugazhendhi, D.; Pope, G. S.; Darbre, P. D. (2005). Oestrogenic activity of p-hydroxybenzoic

acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. Journal of Applied Toxicology, (2005) Vol. 25, No. 4, pp. 301-309.

Ram93 Ramakrishnan, R., and A.A. Sivakumar, 1993. Effect of Quinolphoson the Fish Oreochromis mossambicus. J.Ecobiol. 5(1):45-50. 13386

Rao81 Rao, K.R., F.R. Fox, P.J. Conklin, and A.C. Cantelmo, 1981.Comparative Toxicology and Pharmacology of Chlorophenols: Studies on the Grass Shrimp, Palaemonetes pugio. In: F.J.Vernberg,A.Calabrese, F.P.Thurberg, and W.B.Vernberg (Eds.), BiologicalMonitor

Rao84 Rao, D.M., A.S. Murty, and P.A. Swarup, 1984. Relative Toxicityof Technical Grade and For-mulated Carbaryl and 1-Naphthol to, and Carbaryl-Induced Biochemical Changes in, the Fish Cirrhinusmrigala. Environ.Pollut.Ser.A Ecol.Biol. 34(1):47-54. 10502

Rav(87) RAVDIN P M [Reprint author]; VAN BEURDEN M; JORDAN V C (1987). ESTROGENIC EF-FECTS OF PHENOLPHTHALEIN ON HUMAN BREAST CANCER CELLS IN-VITRO. Breast Cancer Research and Treatment, (1987) Vol. 9, No. 2, pp. 151-154.

Raw98 Rawlings NC; Cook SJ; Waldbillig D (1998). Effects of the pesticides carbofuran, chlorpyrifos, dimethoate, lindane, triallate, trifluralin, 2,4-D, and pentachlorophenol on the metabolic endo-crine and reproductive endocrine system in ewes. J Toxicol Envir

Rei44 Reid, E.E. Wilson, 1994. The relation of estrogenic activity to structure in some 4,4'-dihydroxydiphenylmethanes. J.A.C.S., 66, 967-969.

Rei79 Reish D; Rossi SS; Mearns AJ; Oshida PS; Wilkes FG (1979). Marine and estuarine pollution. J Water Pollut Control Fed; 51(6): 1477-1517 1979 (385 References)

Ren96 Ren L., Lewis SK., Lech JJ., 1996. Effects of estrogen and nonylphenol on the post-transcriptional regulation of vitellogenin gene expression. Chem. Biol. Interact., 100, 67-76

Rho95 Rhodes, J.E., W.J. Adams, G.R. Biddinger, K.A. Robillard, andJ.W. Gorsuch, 1995. Chronic Toxicity of 14 Phthalate Esters toDaphnia magna and Rainbow Trout (Oncorhynchus my-kiss).Environ.Toxicol.Chem. 14(11):1967-1976. 16380

Ric(72) Richert, Edward P.; Prahlad, Kadaba V. (1972). Effects of DDT and its metabolites on thyroid of the Japanese quail, Coturnix coturnix japonica. Poultry Science, (1972) Vol. 51, No. 1, pp. 196-200.

Rob(04) Robinson, Craig D.; Brown, Elaine; Craft, John A.; Davies, Ian M.; Moffat, Colin F. (2004). Effects of prolonged exposure to 4-tert-octylphenol on toxicity and indices of oestrogenic exposure in the sand goby (Pomatoschistus minutus, Pallas). Marine Env

Rou96 Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15:241-258, 1996.

Roy04 Roy, Partha; Salminen, Heli; Koskimies, Pasi; Simola, Janne; Smeds, Annika; Saukko, Pekka; Huhtaniemi, Ilpo T. (2004). Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. Journal of Steroid Biochemistr

RTE06 RTEC Database 2006 Sac79b Sachse K., Suter P., Luetkemeier H., Zak F. and Hess R., 1979b. Chlordimeform-HC1: 60- day

feeding study in the rat - Final report (Project No. Siss 6138). Basel, Switzerland, Ciba- Geigy Ltd. (Unpublished report).

Sai(79) Saito T.; Nohno T.; Yoshida H.; Yokoya H. (1979). Trans-4-hydroxy-3-methoxycinnamic acid (ferulic acid) inhibits the effect of androgens on the rat prostate. Experientia, (1979) Vol. 35, No. 5, pp. 696-699.

sai05 Saillenfait, Anne-Marie [Reprint Author]; Sabate, Jean-Philippe; Gallissot, Frederic (2005). De-velopmental toxic effects of di-iso-butyl phthalate administered by gavage to rats. Toxicology, (OCT 1 2005) Vol. 213, No. 3, Sp. Iss. SI, pp. 231-232.

sar00 Sarkar, R.; Mohanakumar, K. P.; Chowdhury, M. (2000). Effects of an organophosphate pesti-cide, quinalphos, on the hypothalamo-pituitary-gonadal axis in adult male rats. Journal of Re-production and Fertility, (2000) Vol. 118, No. 1, pp. 29-38.

Sat(05) Satoh, Kanako; Nonaka, Ryouichi; Ikeda, Miki; Satoh, Tsuyoshi; Kamimura, Hisashi; Nagai, Fumiko (2005). Study on androgenic and anti-androgenic effects of phthalate esters with the reporter gene assay using AR-EcoScreen, stable transfected CHO-K1 cells.

Page 227: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 224

ID REF.REFERENCE sat05 Satoh, Kanako; Nonaka, Ryouichi; Ohyama, Ken-ichi; Nagai, Fumiko (2005). Androgenic and

antiandrogenic effects of alkylphenols and parabens assessed using the reporter gene assay with stably transfected CHO-K1 cells (AR-EcoScreen system). Journal of Heal

Sato(05) Satoh, Kanako; Nonaka, Ryouichi; Ohyama, Ken-ichi; Nagai, Fumiko (2005). Androgenic and antiandrogenic effects of alkylphenols and parabens assessed using the reporter gene assay with stably transfected CHO-K1 cells (AR-EcoScreen system). Journal of Heal

sch04 Schlumpf, Margret; Schmid, Peter; Durrer, Stefan; Conscience, Marianne; Maerkel, Kirsten; Henseler, Manuel; Gruetter, Melanie; Herzog, Ingrid; Reolon, Sasha; et al. (2004). Endocrine activity and developmental toxicity of cosmetic UV filters - an update.

sch04a Schlumpf, Margret; Jarry, Hubert; Wuttke, Wolfgang; Ma, Risheng; Lichtensteiger, Walter (2004). Estrogenic activity and estrogen receptor ??binding of the UV filter 3-benzylidene camphor. Comparison with 4-methylbenzylidene camphor. Toxicology, (2004) Vo

sch05 Schreurs, Richard H. M. M.; Sonneveld, Edwin; van der Saag, Paul T.; van der Burg, Bart; Seinen, Willem [Reprint Author] (2005). Examination of the in vitro (anti) estrogenic, (anti) an-drogenic and (anti)dioxin-like activities of tetralin, indane and isoc

Sch70 Schoettger, R.A., 1970. Fish-Pesticide Research Laboratory.U.S.Dep.Interior, Bur.Sport Fish.Wildl.Res., Publ. 106:2-40. 6615

Sch89 Schultz, T.W., M. Cajina-Quezada, M. Chang, D.T. Lin, and R.Jain, 1989. Structure-Toxicity Relationships of Para-PositionAlkyl- and Halogen-Substituted Monoaromatic Compounds. In:G.W.Suter II and M.A.Lewis (Eds.), Aquatic Toxicology andEnvironmental F

Sch94 Schafer, H., H. Hettler, U. Fritsche, G. Pitzen, G. Roderer, andA. Wenzel, 1994. Biotests Using Unicellular Algae and Ciliatesfor Predicting Long-Term Effects of Toxi-cants.Ecotoxicol.Environ.Saf. 27(1):64-81. 4008

Sch98 Schrader, K.K., M.Q. De Regt, P.R. Tidwell, C.S. Tucker, and S.O. Duke, 1998. Selective Growth Inhibition of the Musty-OdorProducing Cyanobacterium Oscillatoria cf. chalybea by NaturalCompounds. Bull.Environ.Contam.Toxicol. 60:651-658. 18707

schl01 Schlumpf, Margret; Cotton, Beata; Conscience, Marianne; Haller, Vreni; Steinmann, Beate; Lichtensteiger, Walter (2001). In vitro and in vivo estrogenicity of UV screens Environmental Health Perspectives, (2001) Vol. 109, No. 3, pp. 239-244.

schl04 Schlecht, Christiane; Klammer, Holger; Jarry, Hubertus; Wuttke, Wolfgang (2004). Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern of the estrogen re-ceptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ER

schm04 Schmutzler, Cornelia; Hamann, Inka; Hofmann, Peter J.; Kovacs, Gabor; Stemmler, Luise; Mentrup, Birgit; Schomburg, Lutz; Ambrugger, Petra; Grueters, Annette; et al. (2004). Endocrine active compounds affect thyrotropin and thyroid hormone levels in seru

schn05 Schneider, Steffen; Deckardt, Klaus; Hellwig, Juergen; Kuettler, Karin; Mellert, Werner; Schulte, Stefan [Reprint Author]; van Ravenzwaay, Bennard (2005). Octyl methoxycinnamate: Two generation reproduction toxicity in Wistar rats by dietary administratio

Scho97 Scholz, N., Menzel, B. and Tholmann, D. (1997). Are phtalate esters bioaccumulating and per-sisting chemicals ? In Proceedings of 18th Annual Meeting of the Society of Environmental Toxicology and Chemistry, San Francisco.

schr05 Schreurs, Richard H. M. M.; Sonneveld, Edwin; Jansen, Jenny H. J.; Seinen, Willem; van der Burg, Bart (2005). Interaction of Polycyclic Musks and UV Filters with the Es-trogen Receptor (ER), Androgen Receptor (AR), and Progesterone Receptor (PR) in Report

Schu98 Schultz TW., Kraut DH., Sayler GS., Layton AC. Estrogenicity of selected biphenyls evaluated using a recombinant yeast assay Environ Toxicol Chem., VOL 17, ISS 9, 1998, 1727-1729

see90 Seegmiller R E; Carter M W; Ford W H; White R D (1990). Induction of maternal toxicity in the rat by dermal application of retinoic acid and its effect on fetal outcome. Reproductive Toxicol-ogy, (1990) 4 (4) 277-81.

Page 228: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 225

ID REF.REFERENCE sei04 Seidlova-Wuttke, D.; Jarry, H.; Wuttke, W. (2004). Pure estrogenic effect of benzophenone-2

(BP2) but not of bisphenol A (BPA) and dibutylphthalate (DBP) in uterus, vagina and bone. Toxicology, (2004) Vol. 205, No. 1-2, pp. 103-112.

sei06 Seidlova-Wuttke, D.; Jarry, H.; Christoffel, J.; Rimoldi, G.; Wuttke, W. (2006). Comparison of effects of estradiol (E2) with those of octylmethoxycinnamate (OMC) and 4-methylbenzylidene camphor (4MBC) - 2 filters of UV light - on several uterine, vaginal

Sek(03) Seki, Masanori [Reprint Author]; Yokota, Hirofumi; Maeda, Masanobu; Tadokoro, Hiroshi; Ko-bayashi, Kunio. (2003). Effects of 4-nonylphenol and 4-tert-octylphenol on sex differentiation and vitellogenin induction in medaka (Oryzias latipes). Environmental T

sen92 Seneviratne, D.; Jayatunga, Y. N. A.; Ratnasooriya, W. D. (1992). Anthio 33 (an organophos-phorous pesticide) immobilizes human spermatozoa in vitro. Medical Science Research, (1992) Vol. 20, No. 1, pp. 31-3.

Sev97 Sever LE; Arbuckle TE; Sweeney A (1997). Reproductive and developmental effects of occupa-tional pesticide exposure: the epidemiologic evidence. Occup Med. Vol 12(2), 305-25

She96 Shelby et al., 1996. Assessing environmetal chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environm. Health Perspect. 104, 1296-1300

sher75 Sherman, Henry; Kaplan, A. Michael (1975). Toxicity studies with 5-bromo-3-sec-butyl-6-methyluracil. Toxicology and Applied Pharmacology, (1975) Vol. 34, No. 2, pp. 189-96.

Shi73 Shim, J.C., and L.S. Self, 1973. Toxicity of AgriculturalChemicals to Larvivorous Fish in Korean Rice Fields. Trop.Med.15(3):123-130. 8977

Sho(03) Shono, Takeshi [Reprint Author]; Suita, Sachiyo (2003). Dose-dependent effect of phthalate ester on testicular descent in pre-and post natal rats. Urological Research, (October 2003) Vol. 31, No. 5, pp. 293-296. print.

Sho85 Shopp G.M. Jr., McCay J.A., Holsapple M.P., 1985. Suppression of the antibody response by a formamidine pesticide: dependence on the route of exposure. J. Toxicol Environ Health, 15: 293-304.

Sin81b Singh, O., and R.A. Agarwal, 1981. Toxicity of Certain Pesticides to Two Economic Species of Snails in Northern India.J.Econ.Entomol. 74:568-571. 917

Sin83 Singh, D.K., and R.A. Agarwal, 1983. In Vivo and In Vitro Studies on Synergism with Anticholi-nesterase Pesticides in the SnailLymnaea acuminata. Arch.Environ.Contam.Toxicol. 12(4):483-487.10898

Son(03) Sonne-Hansen, Katrine; Nielsen, Majken; Byskov, Anne Grete [Reprint Author] (2003). Oocyte number in newborn mice after prenatal octylphenol exposure. Repro-ductive Toxicology, (January-February 2003) Vol. 17, No. 1, pp. 59-66.

son02 Soni, M. G.; Taylor, S. L.; Greenberg, N. A.; Burdock, G. A. (2002). Evaluation of the health aspects of methyl paraben: a review of the published literature. Food and Chemical Toxicology, (2002) Vol. 40, No. 10, pp. 1335-1373.

Sot91 Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic re-leased from "modified" polystyrene. Environ Health Perspect 92:167-173, 1991.

Sot92 Soto AM, Lin TM, Justicia H, Silvia RM, Sonnenschein C. An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-Screen). In: Chemically Induced Alterations in Sexual and Func-tional Development: The Wildli fe/Human Connection. Colborn T, Cle

Sot95 Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea, N. and Serrano, F.O. (1995). The E-screen assay as a tool to identify estrogens: an update on estrogenic environ mental pollutants. Environ. Health Perspect., 103, Suppl. 7, 113-122.

Sra(75) Sram, R. J.; Kocisova, Jaroslava (1975). Effect of antibiotics on the mutagenic activity induced by chemicals. I. Chromosome aberrations during spermatogenesis in mice. Folia Biologica (Prague, Czech Republic), (1975) Vol. 21, No. 1, pp. 60-4.

Sto(91) Stoker, Tammy E.; Goldman, Jerome M.; Cooper, Ralph L.; McElroy, W. Keith (1991). Influ-ence of chlordimeform on alpha-adrenergic receptor-associated mechanisms of hormonal regu-lation in the rat: pituitary and adrenocortical secretion. Toxicology, (1991) V

Sto69 Stock, J.N. and O.B. Cope (1969), Some effects of TEPA, an insect chemosterilant, on the guppy, Poecilia reticulata, Trans. Am. Fish. Soc., 2: 280-87.

Page 229: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 226

ID REF.REFERENCE Sto91 Stoker T.E., Goldman J.M., Cooper R.L. and McElroy W.K., 1991. Influence of chlordimeform

form on alpha-adrenergic receptor-associated mechanisms of hormonal regulation in the rat: pituitary and adrenocortial secretion. Toxicology, 69: 257-268.

Str77 Streufert, J.M., 1977. Some Effects of Two Phthalic Acid Esterson the Life Cycle of the Midge (Chironomus phumosus). M.S.Thesis, University of Missouri, Columbia, Missouri. 19952

Str80 Streufert, J.M. et al. (1980) Toxicity and biological effects of phthalate esters on midges (Chi-ronomus plumosus). Trans. Mis souri Acad. Sci., 14: 33-40.

stu00 Stump D G; Holson J F; Kirkpatrick D T; Reynolds V L; Siddiqui W H; Meeks R G (2000). Evaluation of octamethylcyclotetrasiloxane (D4) in a 2-generation reproductive toxicity study in rats. Toxicologist, (2000 Mar) 54 (1) 370.

Suo(03) Suominen, Janne S.; Linderborg, Jussi; Nikula, Hannu; Hakovirta, Harri; Parvinen, Martti; Toppari, Jorma [Reprint Author] (2003). The effects of mono-2-ethylhexyl phathalate, adriamy-cin and N-ethyl-N-nitrosourea on stage-specific apoptosis and DNA synthes

Suz(05) Suzuki, Tomoharu; Kitamura, Shigeyuki; Khota, Ryuki; Sugihara, Kazumi; Fujimoto, Nariaki; Ohta, Shigeru (2005). Estrogenic and antiandrogenic activities of 17 benzophenone derivatives used as UV stabilizers and sunscreens. Toxicology and Applied Pharmac

suz05 Suzuki, Tomoharu; Kitamura, Shigeyuki; Khota, Ryuki; Sugihara, Kazumi; Fujimoto, Nariaki; Ohta, Shigeru (2005). Estrogenic and antiandrogenic activities of 17 benzophenone derivatives used as UV stabilizers and sunscreens. Toxicology and Applied Pharmacol

Svo88a Svobodova, Z., and B. Vykusova, 1988. Comparing the Sensitivityof Rainbow Trout and Ras-bora heteromorpha to Various ToxicSubstances. Bul.Vyzk.Ustav Ryb.Hydrobiol.Vodnany 24(2):14-19(CZE) (ENG ABS). 315

Swa(05) Swan, Shanna H. [Reprint Author]; Main, Katharina M.; Liu, Fan; Stewart, Sara L.; Kruse, Robin L.; Calafat, Antonia M.; Mao, Catherine S.; Redmon, J. Bruce; Ternand, Christine L.; Sullivan, Shannon; Teague, J. Lynn (2005). Decrease in anogenital distance

Tak(80) TAKAHASHI O [Reprint author]; HIRAGA K (1980). 4- TERT BUTYL-2 6-DIISOPROPYL PHE-NOL ANOTHER PHENOL INDUCING HEMORRHAGE IN RATS. JPN Toxicology Letters (Shannon), (1980) Vol. 5, No. 2, pp. 147-150.

tan04 Taneda, Shinji; Mori, Yoki; Kamata, Kazuyuki; Hayashi, Hideyuki; Furuta, Chie; Li, Chunmei; Seki, Koh-ichi; Sakushima, Akiyo; Yoshino, Shin; et al. (2004). Estrogenic and anti-androgenic activity of nitrophenols in diesel exhaust particles (DEP).Biologic

Tar(78) Tarasek, C. D.; Zimmerman, K. J.; Aire, T. A.; Crabo, B. G. (1978). The effects of low oral doses of 2,6-cis-diphenylhexamethylcyclotetrasiloxane on male rats and rabbits. International Journal of Andrology, (1978) Vol. 1, No. 4, pp. 378-92.

Ter(05) Terasaki, Masanori; Kazama, Takeshi; Hashimoto, Shinya; Makino, Masakazu (2005). An evaluation of estrogenic activity for 4-(methylthio)phenols on the basis of yeast two hybrid as-say. Kankyo Kagaku, (2005) Vol. 15, No. 4, pp. 855-861.

ter75 Teramoto S; Kaneda M; Shirasu Y (1975). Teratogenicity of ethylenethiourea in rats. I. Rela-tionship of dosage and time of administration to types of malformation. Teratology, (1975) 12 (2) 215-216.

tin02 Tinwell, Helen; Lefevre, Paul A.; Moffat, Graeme J.; Burns, A.; Odum, Jenny; Spurway, T. D.; Orphanides, George; Ashby, John (2003). Confirmation of uterotrophic activity of 3-(4-methylbenzylidine)camphor in the immature rat. Environmental Health Perspec

Tok(93) Tokumo, Kenji; Umemura, Takashi; Sirma, Huseyin; Gebhardt, Rolf; Poirier, Miriam C.; Wil-liams, Gary M. (1993). Inhibition by gonadectomy of effects of 2-acetylaminofluorene in livers of male, but not female rats. Carcinogenesis, (1993) Vol. 14, No. 9, pp.

Tos91 Tosato, M.L., L. Vigano, B. Skagerberg, and S. Clement, 1991. ANew Strategy for Ranking Chemical Hazards. Framework andApplication. Environ.Sci.Technol. 25:695-702. 16968

Tsu86 Tsuji, S., Y. Tonogai, Y. Ito, and S. Kanoh, 1986. The Influenceof Rearing Temperatures on the Toxicity of Various EnvironmentalPollutants for Killifish (Oryzias latipes). J.Hyg.Chem./EiseiKagaku 32(1):46-53 (JPN) (ENG ABS). 12497

Tyl89 Tyl, R.W. (1989), Developmental toxicity study of inhaled methyl tertiary butyl ether in New Zealand White Rabbets, Export, Pennsylvania, Bushy Run Research Center, 260 pp (Report No. 51-628 to the Methyl Tertiary Butyl Ether Toxicology Committee, Washing

Page 230: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 227

ID REF.REFERENCE Tyl89a Tyl, R.W. and T.L. Neeper-Bradley (1989), Developmental toxicity study of inhaled methyl terti-

ary butyl ether in CD-1 mice, Export, Pennsylvania, Bushy Run Research Center, 342 pp (Re-port No. 52-526 to the Methyl Tertiary Butyl Ether Toxicology Committee,

USN78 US National Cancer Institute (1978), Bioassay of trifluralin for possible carcinogenicity (Techni-cal Rport series No 34; DHEW Publ. No. (NIH) 78-834), Bethesda, MD

Van86 Van Leeuwen, C.J., A. Espeldoorn, and F. Mol, 1986. AquaticToxicological Aspects of Dithio-carbamates and Related Compounds.III. Embryolarval Studies with Rainbow Trout (Salmo gairdneri).Aquat.Toxicol. 9(2/3):129-145. 12096

Ver81 Verma, S.R., S. Rani, and R.C. Dalela, 1981. Synergism,Antagonism, and Additivity of Phenol, Pentachlorophenol, andDinitrophenol to a Fish (Notopterus notopterus).Arch.Environ.Contam.Toxicol. 10(3):365-370. 15670

Ver98 Verma SP, Goldin BR (1998). Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutrition and cancer; 30 (3): 232-9.

Vie72 Vier RR le, Jankowiak ME. The hormonal and antifertility activity of 2,6-cis-diphenyl- hexame-thylcyclotetrasiloxane in the female rat. Biology of Reprod 1972; 7: 260-266.

Vig93 Vigano, L., 1993. Reproductive Strategy of Daphnia magna andToxicity of Organic Com-pounds. Water Res. 27(5):903-909. 6984

Vil95 Villalobos et al., 1995. The E-screen assay: a comparison of different MCF-7 cell stocks. Envi-ronm, Hlth. Perspect., 103, 844-850

Vir89 Virtanen, V., J. Kukkonen, and A. Oikari, 1989. Acute Toxicity of Organic Chemicals to Daphnia magna in Humic Waters. In: A.Oikari (Ed.), Nordic Symposium on Organic Environmental Chemicals,University of Joensuu, Finland 29:84-86. 16674

Wan(92) Wang, Huisu; Cui, Changan; Huang, Zhiying (1992). Effect of chlordimeform hydrochloride on germinal cells in male mice. Jinan Daxue Xuebao, Ziran Kexue Yu Yixueban, (1992) Vol. 13, No. 2, pp. 38-41.

War94 Ward, J.B., W.W. Au, E.B. Whorton and M.S. Legator (1994), Genetic toxicology of methyl ter-tiary butyl ether, Galveston, Texas, University of Texas, pp 57-134 (Final Report to the Agency for Toxic Substances and Disease Registry).

Whi94 White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylpheno-lic compounds are estrogenic. Endocrinology 135:175-182, 1994.

Wil(05) Willoughby, Kristine N.; Sarkar, Abby J.; Boyadjieva, Nadka I.; Sarkar, Dipak K. (2005). Neonatally administered tert-octylphenol affects onset of puberty and repro-ductive development in female rats. Endocrine, (2005) Vol. 26, No. 2, pp. 161-168.

Wil72 Wildish, D.J., and R.L. Phillips, 1972. Acute Lethality ofFenitrothion to Freshwater Aquatic In-sects. ManuscriptRep.Ser.No.1210, Fish.Res.Board Can., Biological Station,St.Andrews, New Brunswic k:10. 17231

Wil78 Wiltrout R.W., Ercegovich C.D. and Ceglowski W.S., 1978. Humoral immunity in mice following oral administration of selected pesticides. Bull. Environ. Contam. Toxicol, 20: 423- 431.

Wil78a Wilson, W.B., C.S. Giam, T.E. Goodwin, A. Aldrich, V. Carpenter,and Y.C. Hrung, 1978. The Toxicity of Phthalates to the MarineDinoflagellate Gymnodinium breve. Bull.Environ.Contam.Toxicol.20:149-154. 555

will00 Williams, Tracy M.; Cattley, Russel C.; Borghoff, Susan J. (2000) Alterations in endocrine re-sponses in male Sprague-Dawley rats following oral administration of methyl tert-butyl ether. Toxicological Sciences, (2000) Vol. 54, No. 1, pp. 168-176.

will00a Williams, Tracy M.; Borghoff, Susan J. (2000). Induction of testosterone biotransformation en-zymes following oral administration of methyl tert-butyl ether to male Sprague-Dawley rats. Toxicological Sciences, (2000) Vol. 57, No. 1, pp. 147-155.

Win57 Winkler, C.; Phlippen, R. (1957). Influence of p-hydroxypropiophenone and thyrotropin on the radioiodine metabolism of the guinea pig thyroid. Arzneimittel-Forschung, (1957) Vol. 7, pp. 201-2.

Woe(64) Woeber, Kenneth A.; Barakat, Russell M.; Ingbar, Sidney H. (1964). Effects of salicylate and its noncalorigenic congeners on the thyroidal release of 131I in patients with thyrotoxicosis. Jour-nal of Clinical Endocrinology and Metabolism, (1964) Vol. 24, N

Page 231: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 228

ID REF.REFERENCE Yam(02) Yamasaki, Kanji; Takeyoshi, Masahiro; Yakabe, Yoshikuni; Sawaki, Masakuni;

Imatanaka, Nobuya; Takatsuki, Mineo (2002). Comparison of reporter gene assay and imma-ture rat uterotrophic assay of twenty-three chemicals. Toxicology, (2002) Vol. 170, No. 1-2,

Yam(03) Yamasaki, Kanji [Reprint Author]; Takeyoshi, Masahiro; Yakabe, Yoshikuni; Sawaki, Masakuni; Takatsuki, Mineo (2003). Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals. Toxicology Letter

yam(04a) Yamasaki, Kanji; Sawaki, Masakuni; Noda, Shoji; Muroi, Takako; Takakura, Saori; Mitoma, Hideo; Sakamoto, Satoko; Nakai, Makoto; Yakabe, Yoshikuni (2004) Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals To

yam(04b) Yamasaki, Kanji; Noda, Shuji; Imatanaka, Nobuya; Yakabe, Yoshikuni (2004) Comparative study of the uterotrophic potency of 14 chemicals in a uterotrophic assay and their receptor-binding affinity Toxicology Letters, (2004) Vol. 146, No. 2, pp. 111-

Yam02 Yamasaki, Kanji [Reprint author]; Sawaki, Masakuni; Noda, Shuji; Takatsuki, Mineo (2002). Uterotrophic and Hershberger assays for n-butylbenzene in rats. Ar-chives of Toxicology, (January, 2002) Vol. 75, No. 11-12, pp. 703-706.

yam03 Yamasaki, Kanji [Reprint Author]; Takeyoshi, Masahiro; Yakabe, Yoshikuni; Sawaki, Masakuni; Takatsuki, Mineo. (2003). Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals. Toxicology Lett

Yam03a Yamasaki, Kanji; Takeyoshi, Masahiro; Sawaki, Masakuni; Imatanaka, Nobuya; Shinoda, Kazutoshi; Takatsuki, Mineo (2003). Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. Toxicology, (2003) Vol. 183, No. 1-3, pp. 93-11

yam04 Yamasaki, Kanji [Reprint Author]; Noda, Shuji; Imatanaka, Nobuya; Yakabe, Yoshikuni (2004). Comparative study of the uterotrophic potency of 14 chemicals in a uterotropbic assay and their receptor-binding affinity Toxicology Letters (Shannon), (January 15

Yama(03) Yamasaki, Kanji; Takeyoshi, Masahiro; Sawaki, Masakuni; Imatanaka, Nobuya; Shinoda, Ka-zutoshi; Takatsuki, Mineo (2003). Immature rat uterotrophic assay of 18 chemicals and Her-shberger assay of 30 chemicals. Toxicology, (2003) Vol. 183, No. 1-3, pp. 93-115

yos99 Yoshizaki, Hiroshi [Reprint author]; Izumi, Yuko; Hirayama, Chizuka; Fujimoto, Akihiro; Kandori, Hitoshi; Sugitani, Toshiyasu; Ooshima, Yojiro (1999). Availability of sperm examination for male reproductive toxicities in rats treated with boric acid. Jou

Zha(05) Zhang Yun-Hui; Liu Zhi-Wei; Chen Bing-Heng [Reprint Author] (2005). Toxicity of phthalates on Sertoli cells of rat testis. Zhongguo Yaolixue Yu Dulixue Zazhi, (AUG 2005) Vol. 19, No. 4, pp. 300-304.

zha05 Zhang, Bo; Xu, Guang-cui; Liu, Feng; Zhao, Tong (2005). Effect of omethoate on the activity of characteristic enzymes in the mouse testicles and the antagonism by tea polyphenol. Huanjing Yu Jiankang Zazhi, (2005) Vol. 22, No. 5, pp. 340-342.

Zhe(97) Zheng R L; Zhang H (1997). Effects of ferulic acid on fertile and asthenozoospermic infertile human sperm motility, viability, lipid peroxidation, and cyclic nucleotides. Free radical biology medicine, (1997) Vol. 22, No. 4, pp. 581-6.

Page 232: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 229

A P P E N D I X K

Manual for the VEIW version of the EDC Database

Page 233: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 230

Manual for the VIEW version of the EDS Database

Updated 2006 by DHI Water & Environment

Page 234: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 231

CONTENTS

ABBREVIATIONS ...................................................................................................................232

1 INTRODUCTION.......................................................................................................233 1.1 Installing the EDS database ......................................................................................233

2 WORKING WITH THE EDS DATABASE ..................................................................233 2.1 Start Menu.................................................................................................................233 2.2 Selection of chemicals and type of data ....................................................................234 2.3 Short overview window..............................................................................................234 2.4 Pre-print Short overview............................................................................................234 2.5 Details window ..........................................................................................................234 2.6 Print preview of the details ........................................................................................235 2.7 Categorisation Window .............................................................................................235 2.8 EUSES calculations ..................................................................................................235 2.9 Datasheets................................................................................................................235

ANNEX 1: EXPLANATION OF THE FIELDS IN THE EDS DATABASE..................................236

Page 235: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 232

ABBREVIATIONS

EM 1999 and EM 2002 EDS Expert meeting 1999 and 2002

BKH 2000 BKH 2000 report

RPS BKH 2002 BKH 2003 report

DHI 2000 Underlying report

DQ Data Quality 1 – 2 – 3 – 4:

DQ1 • Good data quality, fulfilling all (important) criteria

DQ2 • Sufficient data quality, study fulfilling most of the (important) criteria

DQ3 • Insufficient data quality, study cannot be used for identification

DQ4 • Not evaluated

CAT1, 2, 3a or 3b Category 1, 2, 3 or 4

CAT1 At least one study providing evidence of endocrine disruption in an intact organism. Not a formal weight of evidence approach.

CAT2 Potential for endocrine disruption. In vitro data indicating potential for en-docrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated. May include structural analyses and metabolic considerations.

CAT3a No scientific basis for inclusion in list (ED studies available but no indications on ED effects)

CAT3b Substances with no or insufficient data gathered

Page 236: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 233

1 INTRODUCTION

The EDS database is the result of three studies on the identification of Endocrine Dis-rupters for further research, conducted by RPS BKH Consulting Engineers in 1999-2000 and 2002 and by DHI in 2006. All three studies have been contracted by the Euro-pean Commission DG Environment E1. The EDS database holds information for more than 500 chemicals on Human health and Wildlife relevant data concerning both Endocrine disrupting effects and Systemic toxic-ity. Furthermore, the results of categorisations prepared by experts at two separate EU Expert meetings on endocrine disrupters held on 27-28 September 1999 and 9-10 Sep-tember 2002 are included. The EDS database gives the opportunity to select (groups of) chemicals, view and print all available effects data, identified key-studies, categorisa-tions and qualifying remarks given by experts. More information on the data in the EDS database, the evaluation and categorisation procedure can be found in the RPS BKH re-port 2002 and the DHI report 2006. If you have any questions or comments to these instructions or the EDS database, please do not hesitate to contact us via ([email protected])

1.1 Installing the EDS database

Two separate EDS database versions are developed for Access 2000 and Access 2003. Depending on the operating system and Office package installed on your computer, the appropriate version of the EDS database plus the help.doc file must be copied to a sepa-rate directory (e.g. C:\EDSdatabase\…).

After having copied the Access file to your computer, make sure to remove the read-only option under properties (in file manager).

2 WORKING WITH THE EDS DATABASE

The database can be opened in Access using Office version 2000 or 2003. In this man-ual, not all options in the different Windows are explained. However, most of these op-tions are self-explanatory.

2.1 Start Menu

After opening the EDS database, the ‘Start Menu’ is activated. This menu consists of a number of options including a ‘View module’. Other options are ‘Categorisation’ which gives the results of the categorisation plus qualifying remarks; ‘References’ and ‘Litera-ture sources’. In principle, the view module consists of 5 windows: 1. Selection of chemicals and type of data (Human Health or Wildlife relevant)

Page 237: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 234

2. Short overview of the data 3. Pre-print Short overview 4. Details of the data 5. Pre-print of the details 6. Results of EUSES calculations (CAT1 and CAT2) 7. Datasheets for CAT1 substances

2.2 Selection of chemicals and type of data

The first window in the View Module can be used to select chemical(s) of interest. This window includes the ‘Identified chemicals’ form and the ‘Selected chemicals’ form. To start the search, chemicals can be selected using the chemical name field, the CAS number field or chemical group field. Using the ‘chemical names’ field, chemicals can be selected using parts of their names and adding wild cards (*). Chemicals are identified when the button next to the selection field is applied. Here-after in the ‘Identified chemicals’ form, all chemicals will appear that have been attrib-uted to the selection made. Using the options, one or more chemicals can be (de)selected. After selecting the option ‘Human Health’ or ‘Wildlife’ relevant data, the next window can be opened, choosing the window ‘short overview’ or immediate to ‘details’ or de-tails on key studies. It should be emphasised that the EDS database does NOT contain effects data on all chemicals. In some cases, categorisation is based on data available for ‘reference’ chemicals only.

2.3 Short overview window

This window gives a short overview of the studies available on the selected chemical(s). Fields included in this overview are explained in Annex 1. This window has a number of options to select specific types of data such as in-vivo or in-vitro ED-related data, systemic toxicity data and key studies (if available). Other available options to choose from are: ‘Pre-print Short overview’, Details of se-lected studies, the overview of the categorisation or change the selection of chemicals

2.4 Pre-print Short overview

This window gives the opportunity to print out a short overview of all data on the se-lected chemicals. To print or close the window, a temporary BAR appears.

2.5 Details window

This window is subdivided into 4 tab-sheets and gives extended information on the se-lected studies and the four parts of the expert evaluation.

Page 238: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 235

Tab-sheet one shows Part 1 of the expert evaluation: Identification of key studies with details of a study and the Tag-field Key study. In a separate Tab-sheet, also the refer-ence and source of information are included plus information on whether the primary reference will be available at the expert meeting. The fields included in this tab-sheet are explained in Annex 1. Part 2: Evaluation of the Data quality of the key studies includes free fields for the ex-perts to fill in their reasoning on the quality of the specific study. Parts 3 and 4: Categorisation of the chemicals plus qualifying remarks and Additional considerations include free fields with the experts reasoning on the categorisation of a chemical. The Details window has a number of options to select specific types of data such as ED-related studies, systemic toxicity studies, DQ1 and DQ2 studies etc. Furthermore, options are available to go to ‘Print preview’, ‘Short overview’ of the se-lected studies, go to ‘Categorisation’ or to change the selection of chemicals.

2.6 Print preview of the details

This Window gives an overview of all details of selected studies including data quality, categorisation and remarks.

2.7 Categorisation Window

The ‘Categorisation’ form shows all categorisations based on Human Health and Wild-life relevant data and overall categorisation, of chemicals incorporated in the EDS data-base including the event when the categorisation was applied. The form gives the possibility to select chemicals categorised at specific events such as Expert meeting 1999 or 2002 (EM 1999 or EM 2002), categorisation given in the BKH 2000 report or RPS BKH 2002 report, and DHI 2006 report. Additionally, specific Categories can be selected (CAT1, CAT2, CAT3 (BKH 2000 report) CAT3a and CAT3b (explanation see Annex 1). All these lists or the complete list can be printed. Hereafter, additional information on the selected chemicals can be viewed selecting ‘Qualifying remarks’, ‘Short overview’ or ‘Details’.

2.8 EUSES calculations

For the CAT1 and CAT2 substances assessed in the 2006 project, it is possible to see/print the results of the EUSES calculations including the physical-chemical proper-ties used for the calculations.

2.9 Datasheets

For the CAT1 substances assessed in the 2006 project, it is possible to see/print a data-sheet summarizing the properties of the substance, the EUSES calculations, and the conclusion on the assessment.

Page 239: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 236

ANNEX 1: EXPLANATION OF THE FIELDS IN THE EDS DATABASE

Field Explanation: Recno Record code in the database

for example: GPh001 (Gitte Peterson– author; H – human relevant ED data; 001 – first record); LBw021 (Lamert van Breemen– author; W – wildlife relevant ED data 021 – 21 record); GPsh059 (Gitte Peterson– author; SH – systemic toxicity); CGse311 (Christa Groshart– author; SE – systemic Ecotoxicity). The code is unique.

Chemno Chemical number: each chemical has a number, which can be found in the Totlist. So there is no need to type the chemical name

Test type Human health relevant data included are epidemiological, in-vitro and in-vivo experiments. In-vivo studies are sometimes subdivided into ACUTE, REP (Repro-duction) or RDT (Repeated Dose Toxicity). Wildlife relevant data are field, in-vitro and in-vivo experiments.

Test method OECD ... or other procedures used for the test Species/receptor Information such as: species, strain, age, weight, gender, cell type.

e.g. rat, Salmon or Human MCF-7 cells Exposure route Food, water, oral, intraperitoneal, subcutaneous ... Dose-conc. Numerical value of the amount of substance applied Unit Unit of the dose or concentration applied Relative Potency Endocrine effects related to a reference substance as for example estradiol:

In the remarks field, it should be made clear how this ratio is calculated Effect Effect parameter tested, e.g. feminized females, testicular or ovarian effects hor-

mone effects, thyroid effect (a listing of effect parameters is given in Annex 1) Criterion NOEL (No observed effect level), LOEL (lowest observed effect level), ED (effect

dose), LC50 (lethal concentration 50%), NOEC (No observed effect concentra-tion), TDlow (lowest toxic dose) The exposure concentration/dose preferably referred to the LOEL if available. If more criteria were reported, these were put in the remarks field

Code The data have been given a code (class) to combine the different groups of ef-fects. The following groups of effects are distinguished:

e: Suspected endocrine effects on (anti) estrogenic (anti) androgenic pi: Effect on pituitary organ re: Retinoid effects th: Effects on thyroid organ y: Reproductive/teratogenic effects z: Other systemic toxicity effects

The code was combined with a ‘-‘ or ‘+’ sign (e.g. +e). The ‘-‘ sign attached to the experiment-code stands for no effects at all concentrations tested, whereas the ‘+’ sign refers to the observation that effects were found in the experiment.

RefID Reference code of the experiment (a first three letters of first author, year, and if there are more publications of the same author in one year use a letter a, b, c, d etc.)

SourceID Source code of the experiment, like the Ref ID.

Page 240: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 237

Field Explanation: Remarks Detailed information on experimental design and test results. If on ED there is a

NOEC and LOEC or NOEL and LOEL is available, then put the NOEC/NOEL in the remarks field and LOEC/LOEL in the criteria field. Other information in the remarks field is: • Exposure period (e.g. 21 days, 2 generations ...)/ frequency • Number of test concentrations plus levels • Test system (static/renewal/flow through) • Details on types of effects • Concentrations measured/analyse • Life stage • Details on critical window

Data Quality DQ1: good data quality, fulfilling all (important) criteria; DQ2: sufficient data quality, study fulfilling most of the (important) criteria; DQ3: insufficient data quality, study cannot be used for identification; DQ4: not evaluated

Evaluation Data Quality

Relevance effect parameter: • Relation ED effects with mechanistic cause Test reliability: • Use of validated protocols (analysis, test procedure) • Experimental design: controls, concentration range • Test species: suitability, health, life stage... • Analysis of results: statistics • Dose – Response relationship ED potency: • Comparison with indicator hormone activity (e.g. estradiol), if available

CATEGORY CAT1 At least one study providing evidence of endocrine disruption in an intact organism. Not a formal weight of evidence approach.

CAT2 Potential for endocrine disruption. In vitro data indicating potential for en-

docrine disruption in intact organisms. Also includes effects in-vivo that may, or may not, be ED-mediated. May include structural analyses and metabolic considerations

CAT3a No scientific basis for inclusion in list, based on data in the ED database

(ED studies available but no indications on ED effects) CAT3b Substances with no or insufficient data gathered. CAT3 No scientific basis for inclusion in list or Substances with no or insufficient

data gathered (BKH 2000 report) Qualifying re-marks

Coherence of results ED related tests; • ‘other ED evidence is supporting’ • ‘other evidence is lacking’ • ‘other evidence is contradicting’ Qualifying remarks may also concern the identification certain "groups" of sub-stances with an overall ED categorisation on the basis of reference substances;

Additional con-siderations

• The amount of ED evidence • ED Potency • Comparison with systemic toxicity

Page 241: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 238

A P P E N D I X L

Updated ranked priority list

Page 242: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 239

CAS No. NAME Human health Wildlife Overall cate-

gorization NoCAS 040 4-Hydroxy-3,3',4',5'-

tetrachlorobiphenyl CAT1 CAT2 CAT1

53905-33-2 4-Hydroxy-2,2',5'-trichlorobiphenyl CAT1 CAT2 CAT1 4400-06-0 4-Hydroxy-3,4',5-trichlorobiphenyl CAT1 CAT2 CAT1 67651-37-0 3-Hydroxy-2',3',4',5'-

tetrachlorobiphenyl CAT1 CAT2 CAT1

100702-98-5 4,4'-Dihydroxy-2,3,5,6-tetrachlorobiphenyl

CAT1 CAT2 CAT1

13049-13-3 4,4'-Dihydroxy-3,3',5,5'-tetrachlorobiphenyl

CAT1 CAT2 CAT1

4329-12-8 m,p'-DDD CAT1 CAT3b CAT1 72-54-8 p,p'-DDD CAT1 CAT3b CAT1 8068-44-8 Clophen A50 CAT1 CAT2 CAT1 65148-75-6 5-MeO-o,p'-DDD CAT1 CAT3b CAT1 NoCAS 036 PCB Aroclor 1016 CAT1 CAT1 CAT1 54991-93-4 Clophen A30 CAT1 CAT2 CAT1 53-19-0 o,p'-DDD CAT1 CAT2 CAT1 NoCAS 037 PCB 126 (3,3',4,4',5-

Pentachlorobiphenyl) CAT1 CAT1 CAT1

118174-38-2 6-Methyl-1,3,8-trichlorodibenzofuran CAT1 CAT2 CAT1 56614-97-2 3,9-Dihydroxybenz(a)anthracene CAT1 CAT2 CAT1 65148-72-3 4-MeO-o,p'-DDT CAT1 CAT3b CAT1 65148-73-4 5-OH-o,p'-DDT CAT1 CAT3b CAT1 65148-74-5 5-MeO-o,p'-DDT CAT1 CAT3b CAT1 57-97-6 7,12-Dimethyl-1,2-benz(a)anthracene CAT1 CAT2 CAT1 56-49-5 3-Methylcholanthrene CAT1 CAT3b CAT1 NoCAS 038 Mixture of 2,3,4,5-tetrachlorobiphenyl

(PCB 61), 2,2',4,5,5'-octachlorobiphenyl (PCB 101) and 2,2',3,3',4,4',5,5'-octachlorobiphenyl (PCB 194)

CAT1 CAT1 CAT1

7099-43-6 5,6-Cyclopento-1,2-benzanthracene CAT1 CAT2 CAT1 NoCAS 039 PCB 104 (2,2',4,6,6'-

Pentachlorobiphenyl) CAT1 CAT1 CAT1

35693-99-3 PCB 52 (2,2';5,5'-Tetrachlorobiphenyl) CAT1 CAT1 CAT1 NoCAS 042 PCB 122 (2,3,3',4,5 -

Pentachlorobiphenyl) CAT1 CAT1 CAT1

2971-36-0 Bis-OH-Methoxychlor = 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (HTPE)

CAT1 CAT1 CAT1

38380-07-3 PCB 128 (2,2',3,3',4,4'-Hexachlorobiphenyl)

CAT1 CAT1 CAT1

NoCAS 041 PCB 105 (2,3,3',4,4' -Pentachlorobiphenyl)

CAT1 CAT1 CAT1

67651-34-7 4-Hydroxy-2',3',4',5'-tetrachlorobiphenyl

CAT1 CAT2 CAT1

50-32-8 Benzo[a]pyrene CAT1 CAT2 CAT1 9006-42-2 Metiram (Metiram-complex) CAT1 CAT3b CAT1 55702-46-0 PCB 21 (2,3,4-Trichlorobiphenyl) CAT1 CAT1 CAT1 32809-16-8 Procymidon CAT1 CAT3b CAT1 87-86-5 Pentachlorophenol (PCP) CAT1 CAT3b CAT1 608-73-1 Hexachlorocyclohexane = HCH mixed CAT3b CAT3b CAT1

Page 243: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 240

CAS No. NAME Human health Wildlife Overall cate-

gorization 319-85-7 Beta-HCH CAT2 CAT1 CAT1 9016-45-9 Nonylphenolethoxylate CAT2 CAT1 CAT1 72-43-5 Methoxychlor CAT1 CAT1 CAT1 85535-84-8 Short chain chlorinated paraffins CAT1 CAT3b CAT1 72-43-5 p,p'-Methoxychlor CAT1 CAT1 CAT1 8018-01-7 Mancozeb CAT1 CAT3b CAT1 60168-88-9 Fenarimol CAT1 CAT2 CAT1 10453-86-8 Resmethrin CAT1 CAT3b CAT1 52918-63-5 Deltamethrin CAT1 CAT2 CAT1 30668-06-5 1,3-Dichloro-2,2-bis(4-methoxy-3-

methylphenyl)propane CAT1 CAT1 CAT1

21087-64-9 Metribuzin CAT1 CAT3b CAT1 72-55-9 p,p'-DDE CAT1 CAT1 CAT1 12642-23-8 PCT Aroclor 5442 CAT1 CAT1 CAT1 65148-80-3 3-MeO-o,p'-DDE CAT1 CAT3b CAT1 11081-15-5 Phenol, isooctyl- CAT1 CAT1 CAT1 14962-28-8 4-Hydroxy-2',4',6'-trichlorobiphenyl CAT1 CAT2 CAT1 37680-65-2 PCB 18 (2,2',5-Trichlorobiphenyl) CAT1 CAT1 CAT1 2971-22-4 1,1,1-Trichloro-2,2-bis(4-

chlorophenyl)ethane CAT1 CAT1 CAT1

65148-82-5 5-MeO-o,p'-DDE CAT1 CAT3b CAT1 3424-82-6 o,p'-DDE CAT1 CAT2 CAT1 101-53-1 Phenyl-4-hydroxyphenylmethane = 4-

Benzylphenol = p-Benzylphenol CAT1 CAT3b CAT1

84-66-2 Diethyl phthalate (DEP) CAT1 CAT3b CAT1 84-61-7 Dicyclohexyl phthalate (DCHP) CAT1 CAT2 CAT1 65148-83-6 o,p'-DDA-glycinat = N-[(2-

chlorophenyl)(4-chlorophenyl)acettyl]glycin

CAT1 CAT3b CAT1

14835-94-0 o,p'-DDMU CAT1 CAT3b CAT1 85535-85-9 Intermediate chain chlorinated paraf-

fins CAT1 CAT3b CAT1

65148-81-4 4-MeO-o,p'-DDE CAT1 CAT3b CAT1 65277-42-1 Ketoconazol CAT1 CAT3b CAT1 5103-73-1 Cis-Nonachlor CAT2 CAT1 CAT1 608-93-5 Pentachlorobenzene CAT1 CAT3b CAT1 1918-02-1 Picloram CAT1 CAT3b CAT1 63-25-2 Carbaryl CAT1 CAT2 CAT1 43216-70-2 3-OH-o,p'-DDT CAT1 CAT3b CAT1 50585-41-6 2,3,7,8-TeBDD CAT1 CAT2 CAT1 886-50-0 Terbutryn CAT1 CAT3b CAT1 39765-80-5 Trans-Nonachlor CAT2 CAT1 CAT1 7012-37-5 PCB 28 (2,4,4'-trichlorobiphenyl) CAT1 CAT1 CAT1 31508-00-6 PCB 118 (2,3',4,4',5-

pentachlorobiphenyl) CAT1 CAT1 CAT1

1806-26-4 Phenol, 4-octyl- CAT1 CAT1 CAT1 12002-48-1 Trichlorobenzene CAT1 CAT3b CAT1 91465-08-6 Cyhalothrin (@Karate) CAT1 CAT3b CAT1 82657-04-3 Bifenthrin (@Talstar) CAT1 CAT3b CAT1 1689-83-4 Ioxynil CAT1 CAT3b CAT1 NoCAS 088 PCB180 2,2',3,4,4',5,5'-

heptachlorobiphenyl CAT1 CAT1 CAT1

Page 244: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 241

CAS No. NAME Human health Wildlife Overall cate-

gorization 789-02-6 o,p'-DDT CAT1 CAT1 CAT1 NoCAS 127 2,4-6-trichlorobiphenyl CAT1 CAT2 CAT1 94-82-6 2,4-dichlorophenoxybutyric acid = 2,4-

DB CAT1 CAT3b CAT1

NoCAS 128 3,4',5-trichlorobiphenyl CAT1 CAT2 CAT1 72-33-3 Mestranol CAT1 CAT2 CAT1 106-89-8 Epichlorohydrin (1-chloro-2,3-

epoxypropane) CAT1 CAT3b CAT1

NoCAS 087 PCB138 2,2',3,4,4',5'-hexachlorobiphenyl

CAT1 CAT1 CAT1

25036-25-3 2,2'-bis(2-(2,3-epoxypropoxy)phenyl)-propane

CAT3b CAT1 CAT1

106-93-4 Dibromoethane (EDB) CAT1 CAT3b CAT1 NoCAS 092 PCB 114 (2,3,4,4',5-

pentachlorobiphenyl) CAT1 CAT1 CAT1

NoCAS 096 1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (HPTE)

CAT1 CAT1 CAT1

NoCAS 097 4-OH-2,2',4',5,5'-pentachlorobiphenyl CAT1 CAT2 CAT1 122-14-5 Fenitrothion CAT1 CAT2 CAT1 1022-22-6 p,p'-DDMU CAT1 CAT3b CAT1 104-40-5 4-Nonylphenol (4-NP) CAT1 CAT1 CAT1 25013-16-5 tert.-Butylhydroxyanisole (BHA) CAT1 CAT1 CAT1 1131-60-8 4-Cyclohexylphenol CAT1 CAT3b CAT1 99-96-7 p-Hydroxybenzoic acid CAT1 CAT3b CAT1 131-55-5 Benzophenone-2 (Bp-2), 2,2',4,4'-

tetrahydroxybenzophenone CAT1 CAT1 CAT1

13593-03-8 Quinalphos = Chinalphos CAT1 CAT1 CAT1 15087-24-8 3-Benzylidene camphor (3-BC) CAT1 CAT1 CAT1 94-26-8 n-Butyl p-Hydroxybenzoate CAT1 CAT1 CAT1 94-13-3 n-propyl p-hydroxybenzoate CAT1 CAT1 CAT1 556-67-2 Cyclotetrasiloxane CAT1 CAT3b CAT1 99-76-3 Methyl p-Hydroxybenzoate CAT1 CAT3b CAT1 1582-09-8 Trifluralin CAT1 CAT2 CAT1 36861-47-9 3-(4-Methylbenzylidene)camphor CAT1 CAT3a CAT1 96-45-7 Ethylene Thiourea (ETU) CAT1 CAT1 CAT1 92-69-3 4-Hydroxybiphenyl = 4-Phenylphenol CAT1 CAT3b CAT1 5466-77-3 2-ethyl-hexyl-4-methoxycinnamate CAT1 CAT1 CAT1 131-18-0 Di-n-pentylphthalate (DPP) = Dipen-

tylphthalate CAT1 CAT3b CAT1

96-12-8 Dibromochloropropane (DBCP) CAT1 CAT3b CAT1 120-47-8 ethyl 4-hydroxybenzoate CAT1 CAT1 CAT1 10043-35-3 Boric acid CAT1 CAT2 CAT1 7400-08-0 p-Coumaric acid (PCA) CAT1 CAT3b CAT1 1634-04-4 methyl tertiary butyl ether (MTBE) CAT1 CAT2 CAT1 27193-28-8 Phenol, (1,1,3,3-tetramethylbutyl)- =

Octylphenol CAT1 CAT1 CAT1

6164-98-3 Chlordimeform CAT1 CAT3b CAT1 77-09-8 3,3'-Bis(4-hydroxyphenyl)phthalid =

Phenolphthaleine CAT1 CAT3b CAT1

131-70-4 Mono-n-butylphthalate CAT1 CAT3b CAT1 4376-20-9 Mono 2 ethyl hexylphthalate (MEHP) CAT1 CAT3b CAT1

Page 245: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 242

CAS No. NAME Human health Wildlife Overall cate-

gorization 92-88-6 4,4'-Dihydroxybiphenyl = 4,4'-

Biphenol CAT1 CAT2 CAT1

1113-02-6 Omethoate CAT1 CAT3b CAT1 33204-76-1 2,6-cis-

Diphenylhexamethylcyclotetrasiloxane - 2,6-cis-[(PhMeSiO)2(Me2SiO)2][

CAT1 CAT3b CAT1

77-40-7 2,2-Bis(4-hydroxyphenyl)-n-butan = Bisphenol B

CAT1 CAT3b CAT1

611-99-4 4,4'-Dihydroxybenzophenon CAT1 CAT1 CAT1 131-56-6 2,4-Dihydroxybenzophenon = Res-

benzophenone CAT1 CAT1 CAT1

50-18-0 Cyclophosphamide CAT1 CAT3b CAT1 26354-18-7 2-propenoic acid, 2-methyl-, methyl

ester = Stannane, tributylmeacrylate CAT2 CAT1 CAT1

50-29-3 DDT (technical) = clofenotane CAT1 CAT1 CAT1 2385-85-5 Mirex CAT1 CAT2 CAT1 8001-35-2 Toxaphene = Camphechlor CAT1 CAT2 CAT1 143-50-0 Kepone (Chlordecone) CAT1 CAT2 CAT1 12789-03-6 Chlordane CAT1 CAT2 CAT1 57-74-9 Chlordane (cis- and trans-) CAT1 CAT2 CAT1 26636-32-8 Tributyltinnaphthalate CAT2 CAT1 CAT1 50-29-3 p,p'-DDT = clofenotane CAT1 CAT1 CAT1 3563-45-9 1,1,1,2-Tetrachloro-2,2-bis(4-

chlorophenyl)ethane (tetrachloro DDT)

CAT2 CAT1 CAT1

58-89-9 Gamma-HCH (Lindane) CAT1 CAT2 CAT1 1983-10-4 Stannane, tributylfluoro- CAT2 CAT1 CAT1 95-76-1 3,4-Dichloroaniline CAT2 CAT1 CAT1 26239-64-5 Stannane, tribu-

tyl[[[1,2,3,4,4a,4b,5,6,1 CAT2 CAT1 CAT1

25154-52-3 Phenol, nonyl- CAT1 CAT1 CAT1 24124-25-2 Stannane, tributyl[(1-oxo-9,12-

octadecad CAT2 CAT1 CAT1

2155-70-6 Tributyl[(2-methyl-1-oxo-2-propenyl)oxy]stannane

CAT2 CAT1 CAT1

330-55-2 Linuron (Lorox) CAT1 CAT3 CAT1 36631-23-9 Stannane, tributyl = Tributyltin naphta-

late CAT2 CAT1 CAT1

2437-79-8 PCB 47 (2,2',4,4'-Tetrachlorobiphenyl) CAT1 CAT1 57117-31-4 2,3,4,7,8-Pentachlorodibenzofuran

(2,3,4,7,8-PeCDF) CAT1 CAT1

688-73-3 Tributyltin hydride CAT2 CAT1 CAT1 56-35-9 Tributyltin oxide = bis(tributyltin) oxide CAT2 CAT1 CAT1 NoCAS 050 Tributyltin compounds CAT2 CAT1 CAT1 NoCAS 051 Triphenyltin CAT3 CAT1 CAT1 99-99-0 4-Nitrotoluene CAT1 CAT3 CAT1 3090-35-5 Stannane, tributyl[(1-oxo-9-

octadecenyl) CAT2 CAT1 CAT1

NoCAS 099 Tributyltincarboxylate CAT2 CAT1 CAT1 1746-01-6 2,3,7,8-Tetrachlorodibenzo-p-dioxin

(2,3,7,8-TCDD) CAT1 CAT1

NoCAS 101 Tributyltinpolyethoxylate CAT2 CAT1 CAT1

Page 246: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 243

CAS No. NAME Human health Wildlife Overall cate-

gorization NoCAS 004 PBBs = Brominated Flame retardants

= PBB (mixed group of 209 Conge-ners)

CAT1 CAT1

4342-30-7 Phenol, 2-[[(tributylstannyl)oxy]carbony

CAT2 CAT1 CAT1

4342-36-3 Stannane, (benzoyloxy)tributyl- CAT2 CAT1 CAT1 4782-29-0 Stannane, [1,2-

phenylenebis(carbonyloxy) CAT2 CAT1 CAT1

85409-17-2 Stannane, tributyl-, mono(naphthenoyloxy

CAT2 CAT1 CAT1

2279-76-7 Tri-n-propyltin (TPrT) CAT3 CAT1 CAT1 1461-25-2 Tetrabutyltin (TTBT) CAT2 CAT1 CAT1 900-95-8 Fentin acetate = triphenyltin acetate CAT3 CAT1 CAT1 137-42-8 Metam Natrium CAT1 CAT3 CAT1 34256-82-1 Acetochlor CAT1 CAT3 CAT1 108-46-3 Resorcinol CAT1 CAT3 CAT1 NoCAS 100 Methoxyetylacrylate tinbutyltin, co-

polymer CAT2 CAT1 CAT1

84-74-2 Di-n-butylphthalate (DBP) CAT1 CAT3 CAT1 137-26-8 Thiram CAT1 CAT3 CAT1 12122-67-7 Zineb CAT1 CAT3 CAT1 1912-24-9 Atrazine CAT1 CAT2 CAT1 61-82-5 Amitrol = Aminotriazol CAT1 CAT3 CAT1 50471-44-8 Vinclozolin CAT1 CAT3 CAT1 15972-60-8 Alachlor CAT1 CAT2 CAT1 1836-75-5 Nitrofen CAT1 CAT3 CAT1 100-42-5 Styrene CAT1 CAT3 CAT1 118-74-1 Hexachlorobenzene (HCB) CAT1 CAT3 CAT1 40321-76-4 1,2,3,7,8-Pentachlorodibenzodioxin CAT1 CAT1 85-68-7 Butylbenzylphthalate (BBP) CAT1 CAT3 CAT1 12427-38-2 Maneb CAT1 CAT3 CAT1 117-81-7 Di-(2-ethylhexyl)phthalate (DEHP) CAT1 CAT3 CAT1 80-05-7 2,2-Bis(4-hydroxyphenyl)propan =

4,4'-isopropylidenediphenol = Bisphe-nol A

CAT1 CAT1 CAT1

53469-21-9 PCB Aroclor 1242 CAT1 CAT1 12672-29-6 PCB Aroclor 1248 CAT1 CAT1 32598-13-3 PCB 77 (3,3',4,4'-Tetrachlorobiphenyl) CAT1 CAT1 35065-27-1 PCB 153 (2,2',4,4',5,5'-

Hexachlorobiphenyl) CAT1 CAT1

1336-36-3 PCB CAT1 CAT1 11097-69-1 PCB Aroclor 1254 CAT1 CAT1 11096-82-5 PCB Aroclor 1260 (Clophen A60) CAT1 CAT1 32774-16-6 PCB 169 (3,3',4,4',5,5'-

Hexachlorobiphenyl) CAT1 CAT1

140-66-9 4-tert-Octylphenol=1,1,3,3-Tetramethyl-4-butylphenol

CAT1 CAT1 CAT1

Page 247: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 244

CAS No. NAME Human health Wildlife Overall cate-

gorization 125652-14-4 6-n-Propyl-1,3,8-

trichlorodibenzofuran CAT3b CAT2 CAT2

131167-13-0 2-Bromo-1,3,7,8-tetrachlorodibenzodioxin

CAT3b CAT2 CAT2

103124-72-7 8-Bromo-2,3,4-trichlorodibenzofuran CAT3b CAT2 CAT2 112344-57-7 8-Methyl-2,3,7-

trichlorodibenzodioxin CAT3b CAT2 CAT2

172485-97-1 6-Methyl-2,3,8-trichlorodibenzofuran CAT3b CAT2 CAT2 172485-98-2 8-Methyl-1,3,7-trichlorodibenzofuran CAT3b CAT2 CAT2 172485-96-0 8-Methyl-1,3,6-trichlorodibenzofuran CAT3b CAT2 CAT2 109333-33-7 2-Bromo-3,7,8-

trichlorodibenzodioxin CAT3b CAT2 CAT2

125652-16-6 6-Ethyl-1,3,8-trichlorodibenzofuran CAT3b CAT2 CAT2 97741-74-7 7-Bromo-2,3-dichlorodibenzodioxin CAT3b CAT2 CAT2 125652-13-3 6-i-Propyl-1,3,8-

trichlorodibenzofuran CAT3b CAT2 CAT2

125652-12-2 6-t-Butyl-1,3,8-trichlorodibenzofuran CAT3b CAT2 CAT2 139883-51-5 6-Methyl-2,3,4,8-

tetrachlorodibenzofuran CAT3b CAT2 CAT2

139883-50-4 8-Methyl-1,2,4,7-tetrachlorodibenzofuran

CAT3b CAT2 CAT2

172486-00-9 8-Methyl-2,3,4,7-tetrachlorodibenzofuran

CAT3b CAT2 CAT2

56-55-3 Benz(a)anthracene CAT2 CAT2 CAT2 172485-99-3 8-Methyl-2,3,7-trichlorodibenzofuran CAT3b CAT2 CAT2 51630-58-1 Fenvalerate CAT2 CAT2 CAT2 116-06-3 Aldicarb CAT2 CAT3b CAT2 16752-77-5 Methomyl CAT2 CAT3b CAT2 2597-11-7 1-Hydroxychlordene CAT2 CAT3b CAT2 93-76-5 2,4,5-T = 2,4,5-

Trichlorophenoxyaceticacid CAT2 CAT3b CAT2

470-90-6 Chlorfenvinphos CAT3a CAT2 CAT2 584-79-2 Bioallethrin = d- trans allethrin CAT2 CAT3b CAT2 109333-32-6 2,8-Dibromo-3,7-

dichlorodibenzodioxin CAT3b CAT2 CAT2

26002-80-2 Fenothrin = sumithrin CAT2 CAT3b CAT2 50585-40-5 2,3-Dibromo-7,8-

dichlorodibenzodioxin CAT3b CAT2 CAT2

69409-94-5 Fluvalinate CAT2 CAT3b CAT2 52645-53-1 Permethrin CAT2 CAT3b CAT2 88378-55-6 3,5-Dichlorophenylcarbaminacid-(1-

carboxy-1-methyl)-allyl CAT2 CAT3b CAT2

83792-61-4 N-(3,5-Dichlorophenyl)-2-hydroxy-2-methyl-3-butenacidamid

CAT2 CAT3b CAT2

72490-01-8 Fenoxycarb CAT3b CAT2 CAT2 14409-72-4 4-Nonylphenolnonaethoxylat (Tergi-

tol NP 9) CAT3b CAT2 CAT2

50585-46-1 1,3,7,8-Tetrachlorodibenzodioxin CAT3b CAT2 CAT2 52315-07-8 Cypermethrin CAT3a CAT2 CAT2 2593-15-9 Etridiazole CAT2 CAT3b CAT2 21725-46-2 Cyanazine CAT2 CAT3b CAT2 30560-19-1 Acephate CAT2 CAT2 CAT2

Page 248: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 245

CAS No. NAME Human health Wildlife Overall cate-

gorization 13171-21-6 Phosophamidon CAT2 CAT3b CAT2 7287-19-6 Prometryn CAT2 CAT3b CAT2 123-88-6 Triadimenol CAT2 CAT3b CAT2 52-68-6 Trichlorfon = Dipterex CAT2 CAT3b CAT2 1689-84-5 Bromoxynil CAT2 CAT3b CAT2 NoCAS 115 1,3,7,8-TeBCDD CAT3b CAT2 CAT2 NoCAS 112 1,2,4,7,8-PeCDD CAT3b CAT2 CAT2 109333-34-8 1,2,3,7,8-PeBDD CAT3b CAT2 CAT2 103456-39-9 TeBDD CAT3b CAT2 CAT2 319-86-8 Delta-HCH CAT2 CAT3b CAT2 1563-66-2 Carbofuran CAT2 CAT2 CAT2 7786-34-7 Mevinphos = Phosdrin CAT3a CAT2 CAT2 51-03-6 Piperonyl butoxide CAT3b CAT2 CAT2 25085-99-8 Bisphenol A-diglycidylether polymer

(mw<700) CAT3b CAT2 CAT2

131-57-7 2-hydroxy-4-methoxy-benzophenone

CAT2 CAT2 CAT2

2051-61-8 PCB 2 (3-Chlorobiphenyl) CAT2 CAT3b CAT2 2051-60-7 PCB 1 (2-Chlorobiphenyl) CAT2 CAT3b CAT2 1806-29-7 2,2'-Dihydroxybiphenyl = 2,2'-

Biphenol CAT2 CAT2 CAT2

81-92-5 2-[Bis(4-hydroxyphenyl)methyl]benzylalkohol = Phenolphthalol

CAT2 CAT3b CAT2

6807-17-6 2,2-Bis(4-hydroxyphenyl)-4-methyl-n-pentane

CAT2 CAT3b CAT2

2581-34-2 3-methyl-4-nitrophenol CAT2 CAT3b CAT2 14007-30-8 2,2-Bis(4-hydroxyphenyl)-n-hexane CAT2 CAT3b CAT2 100-02-7 4-nitrophenol CAT2 CAT3b CAT2 3115-49-9 4-nonylphenoxy acetic acid CAT2 CAT2 CAT2 99-71-8 4-sec-Butylphenol = 4-(1-

Methylpropyl)phenol CAT2 CAT2 CAT2

20427-84-3 4-Nonylphenoldiethoxylate (NP2EO)

CAT2 CAT2 CAT2

84-69-5 Diisobutylphthalate CAT2 CAT3b CAT2 2051-62-9 PCB 3 (4-Chlorobiphenyl) CAT2 CAT3b CAT2 131-54-4 2,2'-Dihydroxy-4,4'-

dimethoxybenzophenon CAT2 CAT3b CAT2

121-29-9 Pyrethrin CAT2 CAT3b CAT2 84-75-3 Di-n-hexyl phthalate (DnHP) = Di-

hexylphthalate (DHP) CAT2 CAT3b CAT2

83-05-6 p,p'-DDA CAT2 CAT2 CAT2 131-16-8 Di-n-propylphthalate (DprP) =

Dipropylphthalate CAT2 CAT3b CAT2

106-44-5 p-cresol CAT2 CAT3b CAT2 2597-03-7 Elsan = Dimephenthoate CAT3b CAT2 CAT2 106340-44-7 Tetrabromodibenzofuran (TeBDF) CAT2 CAT2 107555-93-1 1,2,3,7,8-Pentabromodibenzofuran CAT2 56-38-2 Parathion = Parathion(-ethyl) CAT2 CAT3 CAT2 121-75-5 Malathion CAT2 CAT2 CAT2 298-00-0 Methylparathion CAT3 CAT2 CAT2 39801-14-4 Photomirex CAT2 CAT3 CAT2

Page 249: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 246

CAS No. NAME Human health Wildlife Overall cate-

gorization 333-41-5 Diazinon CAT3 CAT2 CAT2 75-15-0 Carbon disulphide CAT2 CAT3 CAT2 330-54-1 Diuron CAT2 CAT3 CAT2 36734-19-7 Iprodione CAT2 CAT3 CAT2 115-32-2 Dicofol = Kelthane CAT3 CAT2 CAT2 60-51-5 Dimethoate CAT2 CAT3 CAT2 94-75-7 2,4-Dichlorophenoxy acetic acid

(2,4-D) CAT2 CAT2 CAT2

1570-64-5 4-chloro-2-methylphenol CAT2 CAT3 CAT2 33213-65-9 Endosulfan (beta) CAT2 CAT2 CAT2 959-98-8 Endosulfan (alpha) CAT2 CAT2 CAT2 115-29-7 Endosulfan CAT2 CAT2 CAT2 27304-13-8 Oxychlordane CAT2 CAT3 CAT2 72-20-8 Endrin CAT2 CAT2 CAT2 60-57-1 Dieldrin CAT2 CAT2 CAT2 309-00-2 Aldrin CAT2 CAT2 CAT2 28553-12-0 diisononyl phthalate = 1,2-

Benzenedicarboxylic acid, diisononyl ester (DINP)

CAT2 CAT3 CAT2

10605-21-7 Carbendazim CAT2 CAT3 CAT2 67747-09-5 Prochloraz CAT2 CAT3 CAT2 71998-72-6 1,3,6,8-Tetrachlorodibenzofuran CAT2 CAT2 33284-53-6 PCB 61 (2,3,4,5-

Tetrachlorobiphenyl) CAT2 CAT2

70362-47-9 PCB 48 (2,2',4,5-Tetrachlorobiphenyl)

CAT2 CAT2

38411-22-2 PCB 136 (2,2',3,3',6,6'-Hexachlorobiphenyl)

CAT2 CAT2

38380-08-4 PCB 156 (2,3,3',4,4',5-Hexachlorobiphenyl)

CAT2 CAT2

NoCAS 043 Octabrominated diphenyl ether (oc-taBDE)

CAT2 CAT2

NoCAS 044 Decabrominated diphenyl ether (decaBDE)

CAT2 CAT2

NoCAS 045 Pentabrominated diphenyl ether (pentaBDE)

CAT2 CAT2

26761-40-0 Diisodecyl phthalate CAT2 CAT3 CAT2 1675-54-3 2,2'-bis(4-(2,3-

epoxypropoxy)phenyl)propane = 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane

CAT2 CAT3 CAT2

74-83-9 Methylbromide (bromomethane) CAT2 CAT3 CAT2 NoCAS 046 2,2',4,4'-Tetrabrominated diphenyl

ether (2,2',4,4'-tetraBDE) CAT2 CAT2

43121-43-3 Triadimefon CAT2 CAT3 CAT2 58802-20-3 1,2,7,8-Tetrachlorodibenzofuran CAT2 CAT2 709-98-8 Propanil CAT2 CAT3 CAT2 98-54-4 4-tert-Butylphenol CAT2 CAT2 CAT2 51207-31-9 2,3,7,8-Tetrachlorodibenzofuran CAT2 CAT2 57117-41-6 1,2,3,7,8-Pentachlorodibenzofuran CAT2 CAT2 120-83-2 2,4 Dichlorophenol CAT2 CAT3 CAT2 76-44-8 Heptachlor CAT2 CAT3 CAT2 83704-53-4 1,2,3,7,9-Pentachlorodibenzofuran CAT2 CAT2

Page 250: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 247

CAS No. NAME Human health Wildlife Overall cate-

gorization 90-43-7 o-phenylphenol CAT2 CAT2 CAT2 127-18-4 Perchloroethylene CAT2 CAT3 CAT2 122-34-9 Simazine CAT2 CAT3 CAT2 137-30-4 Ziram CAT2 CAT2 CAT2 59-50-7 4-chloro-3-methylphenol CAT2 CAT3 CAT2 32598-12-2 PCB 75 (2,4,4',6-

Tetrachlorobiphenyl) CAT2 CAT2

67733-57-7 2,3,7,8-Tetrabromodibenzofuran CAT2 CAT2

CAS No. NAME Human health Wildlife Overall cate-

gorization 2921-88-2 Chlorpyrifos CAT3a CAT3b CAT3a 3734-48-3 Chlordene CAT3a CAT3b CAT3a 40487-42-1 Pendimethalin CAT3a CAT3b CAT3a 35367-38-5 Diflubenzuron CAT3a CAT3b CAT3a 919-86-8 Demeton-s-methyl CAT3a CAT3b CAT3a 62-73-7 Dichlorvos CAT3a CAT3b CAT3a 1024-57-3 Heptachlor-epoxide CAT3a CAT3b CAT3a 92-52-4 Diphenyl CAT3a CAT3b CAT3a 17804-35-2 Benomyl CAT3a CAT3b CAT3a 11141-17-6 Azadirachtin CAT3a CAT3b CAT3a 299-84-3 Ronnel = fenchlorfos CAT3a CAT3b CAT3a 22248-79-9 Tetrachlorvinphos = Gardona CAT3a CAT3b CAT3a 71751-41-2 Abamectin CAT3a CAT3b CAT3a 33089-61-1 Amitraz CAT3a CAT3b CAT3a 51276-47-2 Glufosinate CAT3a CAT3b CAT3a 2439-99-8 Glyphosate CAT3a CAT3b CAT3a 3554-44-0 Imazalil CAT3a CAT3b CAT3a 301-12-2 Oxydemeton-methyl CAT3a CAT3b CAT3a 19044-88-3 Oryzalin CAT3a CAT3b CAT3a 545-55-1 TEPA CAT3a CAT3b CAT3a 537-98-4 Ferulic acid (FA) CAT3a CAT3b CAT3a 104-51-8 n-Butylbenzene CAT3a CAT3b CAT3a 314-40-9 Bromacil CAT3a CAT3b CAT3a

CAS No. NAME Human health Wildlife Overall cate-

gorization 29082-74-4 Octachlorostyrene CAT3b CAT3b CAT3b 88-85-7 Dinoseb CAT3b CAT3b CAT3b 107534-96-3 Tebuconazole CAT3b CAT3b CAT3b 74115-24-5 Clofentezine = chlorfentezine CAT3b CAT3b CAT3b 119-61-9 Benzophenone CAT3b CAT3b CAT3b 76674-21-0 Flutriafol CAT3b CAT3b CAT3b NoCAS 121 Epiconazol CAT3b CAT3b CAT3b 55179-31-2 Bitertanol CAT3b CAT3b CAT3b 106-47-8 4-chloroaniline CAT3b CAT3b CAT3b 69806-50-4 Fluazifop-butyl CAT3b CAT3b CAT3b 9014-90-8 Poly(oxy-1,2-ethanediyl), alpha-

sulfo-omega-nonylphenoxy CAT3b CAT3b CAT3b

88671-89-0 Myclobutanil CAT3b CAT3b CAT3b

Page 251: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 248

CAS No. NAME Human health Wildlife Overall cate-

gorization 53792-11-3 4-(4-Hydroxyphenyl)-2,2,6,6-

tetramethylcyclohexanecarbonacid CAT3b CAT3b CAT3b

23950-58-5 Pronamide CAT3b CAT3b CAT3b 85535-86-0 Long chain chlorinated paraffins CAT3b CAT3b CAT3b 117-84-0 1,2-Benzenedicarboxylic acid, dioctyl

ester CAT3b CAT3b CAT3b

1335-87-1 Halowax 1014 CAT3b CAT3b CAT3b 117-84-0 Di-n-octylphthalate (DnOP) CAT3b CAT3b CAT3b 103-23-1 Bis(2-ethylhexyl)adipate CAT3b CAT3b CAT3b 135-19-3 2-Naphthol CAT3b CAT3b CAT3b NoCAS 027 2,2,6,6-Tetramethyl-4,4-bis(4-

hydroxyphenyl)-n-heptan CAT3b CAT3b CAT3b

82-68-8 Pentachloronitrobenzene (PCNB) CAT3b CAT3b CAT3b 80844-07-1 Ethofenprox CAT3b CAT3b CAT3b 2717-05-5 Heptaoctatrikosan-1-ol, 23-

(nonylphenoxy)3,6,9,12,15,18,21-nonylphenolmonoethoxylate

CAT3b CAT3b CAT3b

4685-14-7 Paraquat = 1,1'-dimethyl-4,4'-bipyridinium

CAT3b CAT3b CAT3b

60207-90-1 Propiconazole CAT3b CAT3b CAT3b 108-05-4 Vinyl acetate CAT3b CAT3b CAT3b 120068-37-3 Fipronil CAT3b CAT3b CAT3b 66230-04-4 Esfenvalerate CAT3b CAT3b CAT3b 119446-68-3 Difenoconazole CAT3b CAT3b CAT3b 142-59-6 Nabam CAT3b CAT3b CAT3b NoCAS 008 Epoxiconazole CAT3b CAT3b CAT3b 117718-60-2 Thiazopyr CAT3b CAT3b CAT3b 29091-21-2 Prodiamine CAT3b CAT3b CAT3b 66246-88-6 Penconazole CAT3b CAT3b CAT3b 68-12-2 Dimethylformamide (DMFA) CAT3b CAT3b CAT3b 2212-67-1 Molinate CAT3b CAT3b CAT3b 94361-07-6 Cyproconazole CAT3b CAT3b CAT3b 28994-41-4 Phenyl-2-hydroxyphenylmethane =

2-Benzylphenol = o-Benzylphenol CAT3b CAT3b

10448-09-6 Phenylheptamethylcyclotetrasiloxane [(PhMeSiO)(Me2SiO)3]

CAT3b CAT3b CAT3b

1322-97-0 Ethanol, 2-(octylphenoxy)- = Octyl-phenolethoxylate

CAT3b CAT3b CAT3b

56-33-7 Diphenyltetramethyldisiloxane PhMe2-SiOSiMe2Ph

CAT3b CAT3b

17404-44-3 Phenol, 2-(1-ethylhexyl)- CAT3b CAT3b CAT3b 1818-08-2 Phenol, 4-(1-methylheptyl)- CAT3b CAT3b CAT3b 18626-98-7 Phenol, 2-(1-methylheptyl)- CAT3b CAT3b CAT3b 26401-75-2 Phenol, 2-sec-octyl- CAT3b CAT3b CAT3b 1009-11-6 4-Hydroxy-n-butyrophenone CAT3b CAT3b 14868-03-2 Bis-OH-MDDE CAT3b CAT3b 87-26-3 2-sec-Pentylphenol = 2-(1-

Methylbutyl)phenol CAT3b CAT3b

7786-61-0 4-vinylguaiacol (4-VG) CAT3b CAT3b CAT3b 2628-17-3 4-vinylphenol (4-VP) CAT3b CAT3b CAT3b 25167-81-1 Dichlorophenol CAT3b CAT3b CAT3b 620-92-8 Bis(4-hydroxyphenyl)methane CAT3b CAT3b

Page 252: Study on enhancing the Endocrine Disrupter priority list ... · DHI Water & Environment ERA/53559/Revised report/2007.06.04 1 1 PREFACE By letter of 10 November 2005, the European

DHI Water & Environment

ERA/53559/Revised report/2007.06.04 249

CAS No. NAME Human health Wildlife Overall cate-

gorization 70-70-2 4-Hydroxypropiophenone CAT3b CAT3b 303-38-8 2,3-dihydroxybenzoicacid (2,3-

DHBA) CAT3b CAT3b

530-91-6 Tetrahydronaphthol-2 CAT3b CAT3b 2540-82-1 Formothion CAT3b CAT3b 70393-85-0 Glufosinate-ammonium CAT3b CAT3b 114369-43-6 Fenbuconazole CAT3b CAT3 25550-58-7 Dinitrophenol CAT3b CAT3b 79-44-7 Dimethyl carbamyl chloride CAT3b CAT3b 490-79-9 2,5-dihydroxybenzoicacid (2,5-

DHBA) CAT3b CAT3b

949-13-3 Phenol, 2-octyl- CAT3b CAT3b CAT3b 463-56-9 Thiocyanate CAT3b CAT3b 53-96-3 n-2-fluorenylacetamide CAT3b CAT3b 1222-05-5 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-

hexamethylcyclopenta(g)-2-benzopyrane

CAT3b CAT3b CAT3b

13171-00-1 4-Acetyl-1,1-dimethyl-6-tert.-butylindane

CAT3b CAT3b

33704-61-9 6,7-dihydro-1,1,2,3,3-pentamethyl-4(5H)indanone

CAT3b CAT3b CAT3b

118-56-9 3,3,5-trimethyl-cyclohexyl salicilate CAT3b CAT3b CAT3b 533-73-3 Hydroxyhydroquinone CAT3b CAT3b 27214-47-7 Phenol, 4-sec-octyl- CAT3b CAT3b 24362-98-9 1,1-Bis(4-hydroxyphenyl)-n-hexane CAT3b CAT3b 3373-03-3 1,1-Bis(4-hydroxyphenyl)-n-heptane CAT3b CAT3b 90-15-3 1-Naphthol CAT3b CAT3b 1125-78-6 5,6,7,8-Tetrahydro-2-naphthol = 6-

Hydroxytetralin CAT3b CAT3b

15231-91-1 6-Bromo-2-naphthol CAT3b CAT3b 682-80-4 Demefion CAT3b CAT3b CAT3b 21245-02-3 2-ethyl-hexyl-4-dimethyl-

aminobenzoate CAT3b CAT3b CAT3b

52479-85-3 2,3,4,3',4',5'-Hexahydroxybenzophenon

CAT3b CAT3b

27985-70-2 Phenol, (1-methylheptyl)- CAT3b CAT3b CAT3b 27986-36-3 Ethanol, 2-(nonylphenoxy)- CAT3b CAT3b CAT3b 3307-00-4 Phenol, 4-(1-ethylhexyl)- CAT3b CAT3b CAT3b 3307-01-5 Phenol, 4-(1-propylpentyl)- CAT3b CAT3b CAT3b 37631-10-0 Phenol, 2-(1-propylpentyl)- CAT3b CAT3b CAT3b 3884-95-5 Phenol, 2-(1,1,3,3-tetramethylbutyl)- CAT3b CAT3b CAT3b 2050-68-2 PCB 15 (4,4'-Dichlorobiphenyl) CAT3b CAT3b